Radioisotopes production and applications

International Nuclear Information System (INIS)

Dash, Ashutosh

2015-01-01

Application of radioisotopes for both medical and industrial applications constitutes one of the most important peaceful uses of atomic energy. The striking diffusion and the exciting perspective of radioisotope for a plethora of medical and industrial applications are mainly attributable to the penetrating and ionization properties of radiation emanating from radioisotopes. The revolutionary medical applications of radioisotopes for the diagnosis and treatment of a multitude of diseases are causing a rapid expansion of the nuclear medicine field. While the industrial uses of radioisotopes are not expanding as quickly, also require large amounts of radioisotopes. Production of radioisotopes is not only the first step, but also the most crucial for the success as well as sustainable growth of radioisotope applications. With the rapid growth and expanding areas of applications, the demands for isotopes have increased several folds. A number of radioisotopes of different physical half-life, energy of the particle or gamma emission, specific activity and chemistry are now regularly produced both at commercial centers as well as at selected nuclear science research institutes utilizing reactors and cyclotrons to meet the ever growing need

Radioisotope handling facilities and automation of radioisotope production

International Nuclear Information System (INIS)

2004-12-01

If a survey is made of the advances in radioisotope handling facilities, as well as the technical conditions and equipment used for radioisotope production, it can be observed that no fundamental changes in the design principles and technical conditions of conventional manufacture have happened over the last several years. Recent developments are mainly based on previous experience aimed at providing safer and more reliable operations, more sophisticated maintenance technology and radioactive waste disposal. In addition to the above observation, significant improvements have been made in the production conditions of radioisotopes intended for medical use, by establishing aseptic conditions with clean areas and isolators, as well as by introducing quality assurance as governing principle in the production of pharmaceutical grade radioactive products. Requirements of the good manufacturing practice (GMP) are increasingly complied with by improving the technical and organizational conditions, as well as data registration and documentation. Technical conditions required for the aseptic production of pharmaceuticals and those required for radioactive materials conflicting in some aspects are because of the contrasting contamination mechanisms and due consideration of the radiation safety. These can be resolved by combining protection methods developed for pharmaceuticals and radioactive materials, with the necessary compromise in some cases. Automation serves to decrease the radiation dose to the operator and environment as well as to ensure more reliable and precise radiochemical processing. Automation has mainly been introduced in the production of sealed sources and PET radiopharmaceuticals. PC controlled technologies ensure high reliability for the production and product quality, whilst providing automatic data acquisition and registration required by quality assurance. PC control is also useful in the operation of measuring instruments and in devices used for

Material science as basis for nuclear medicine: Holmium irradiation for radioisotopes production

Science.gov (United States)

Usman, Ahmed Rufai; Khandaker, Mayeen Uddin; Haba, Hiromitsu; Otuka, Naohiko

2018-05-01

Material Science, being an interdisciplinary field, plays important roles in nuclear science. These applications are seen in weaponry, armoured vehicles, accelerator structure and development, semiconductor detectors, nuclear medicine and many more. Present study presents the applications of some metals in nuclear medicine (radioisotope production). The charged-particle-induced nuclear reactions by using cyclotrons or accelerators have become a very vital feature of the modern nuclear medicine. Realising the importance of excitation functions for the efficient production of medical radionuclides, some very high purity holmium metals are generally prepared or purchased for bombardment in nuclear accelerators. In the present work, various methods to obtain pure holmium for radioisotope production have been discussed while also presenting details of our present studies. From the experimental work of the present studies, some very high purity holmium foils have been used in the work for a comprehensive study of residual radionuclides production cross-sections. The study was performed using a stacked-foil activation technique combined with γ-ray spectrometry. The stack was bombarded with 50.4 MeV alpha particle beam from AVF cyclotron of RI Beam Factory, Nishina Centre for Accelerator-Based Science, RIKEN, Japan. The work produced thulium radionuclides useful in nuclear medicine.

Manual of radioisotope production

International Nuclear Information System (INIS)

1966-01-01

The Manual of Radioisotope Production has been compiled primarily to help small reactor establishments which need a modest programme of radioisotope production for local requirements. It is not comprehensive, but gives guidance on essential preliminary considerations and problems that may be met in the early stages of production. References are included as an aid to the reader who wishes to seek further in the extensive literature on the subject. In preparing the Manual, which is in two parts, the Agency consulted several Member States which already have long experience in radioisotope production. An attempt has been made to condense this experience, firstly, by setting out the technical and economic considerations which govern the planning and execution of an isotope programme and, secondly, by providing experimental details of isotope production processes. Part I covers topics common to all radioisotope processing, namely, laboratory design, handling and dispensing of radioactive solutions, quality control, measurement and radiological safety. Part II contains information on the fifteen radioisotopes in most common use. These are bromine-82, cobalt-58, chromium-51, copper-64, fluorine-18, gold-198, iodine-131, iron-59, magnesium-28, potassium-42, sodium-24, phosphorus-32, sulphur-35, yttrium-90 and zinc-65. Their nuclear properties are described, references to typical applications are given and published methods of production are reviewed; also included are descriptions in detail of the production processes used at several national atomic energy organizations. No attempt has been made to distinguish the best values for nuclear data or to comment on the relative merits of production processes. Each process is presented essentially as it was described by the contributor on the understanding that critical comparisons are not necessary for processes which have been well tried in practical production for many years. The information is presented as a guide to enable

Evaluation of medical isotope production with the accelerator production of tritium (APT) facility

International Nuclear Information System (INIS)

Benjamin, R.W.; Frey, G.D.; McLean, D.C., Jr; Spicer, K.M.; Davis, S.E.; Baron, S.; Frysinger, J.R.; Blanpied, G.; Adcock, D.

1997-01-01

The accelerator production of tritium (APT) facility, with its high beam current and high beam energy, would be an ideal supplier of radioisotopes for medical research, imaging, and therapy. By-product radioisotopes will be produced in the APT window and target cooling systems and in the tungsten target through spallation, neutron, and proton interactions. High intensity proton fluxes are potentially available at three different energies for the production of proton- rich radioisotopes. Isotope production targets can be inserted into the blanket for production of neutron-rich isotopes. Currently, the major production sources of radioisotopes are either aging or abroad, or both. The use of radionuclides in nuclear medicine is growing and changing, both in terms of the number of nuclear medicine procedures being performed and in the rapidly expanding range of procedures and radioisotopes used. A large and varied demand is forecast, and the APT would be an ideal facility to satisfy that demand

Historical sketch of the discovery, production, and application of radioisotopes

International Nuclear Information System (INIS)

Williams, C.

1975-01-01

The Joliot-Curies made the first artificial radioisotope ( 30 P) by bombarding aluminum with alpha particles. The development of the cyclotron and other high-energy particle accelerators in the early 1930's led to the production of numerous radioisotopes in measurable quantities. By the beginning of the 1950's, with the abundant neutron fluxes available at the U. S. Atomic Commission reactors, radioisotopes of many species really became abundant. Naturally occurring radioactive lead had been used very sparingly as tracers as far back as 1918 in determining chemical solubility and in 1923 in plant uptake from lead solutions. Now many new uses were developed and tested as tracers in medical diagnosis, agricultural, and industrial chemical and metallurigical processes. Many therapeutic applications were tested. The industrial labs developed thickness and level gauges for control of various manufacturing processes. Cobalt gamma-ray irradiators were developed for medical therapy and have also been used for sterilization of surgical instruments and materials, for food preservation, and for initiation of certain chemical reactions. The most significant development in the 1960's was the rapidly increasing role of private industry in taking over the development, production, sales, as well as research, into new methods of production and applications of radioisotopes

A Review of the Production of ''Special'' Radioisotopes

International Nuclear Information System (INIS)

Stang, L.G. Jr.

1963-01-01

Six useful characteristics of radioisotopes and advantages which may be taken of them are cited briefly, with examples. The Information Sheet announcing this Seminar listed four advantages of short-lived over long-lived isotopes. Two other reasons why owners of small research reactors should concern themselves with short half- life isotopes are economy and particular suitability for production, the latter being due to the pronounced effect of half-life on the net rate of production. Besides short half-life, type and energy of emitted radiation should be of concern to producers of isotopes. Nine advantages of a nuclear reactor over a particle accelerator for radioisotope production are outlined. Following this general orientation, a survey of unusual or less frequently used production techniques is presented. These include: (n, p) reactions and secondary reactions such as (t, n) and (t, p) induced by thermal neutrons, various techniques for obtaining useful fluxes of fast neutrons with which to effect other reactions, recoil techniques including classic Szilard-Chalmers reactions, use of charged wires to collect short-lived daughters of gaseous parents, parent-daughter milking system, parasitic irradiations, possible use of ''knocked- on'' protons or deuterons (from the moderator) as a means of effecting reactions such as (p,n), (d,n), etc. and the possible use of circulating ''loops'' in reactors with which to utilize the radiation from ultra-short-lived radioisotopes such as Ag 110 , In 114 , 116 , Dy 155m , etc. Although not a production technique, the possibility of using certain stable isotopes (e. g. of silver) as tracers which can be readily detected via subsequent activation is mentioned. Production figures for Brookhaven's ''special'' radioisotopes are cited to show differences in long- and short-term fluctuations among these isotopes, which are also compared as a class to those in heavier demand supplied by Oak Ridge. Present production methods of all

A compact and high current FFAG for the production of radioisotopes for medical application

CERN Document Server

Bruton, David; Edgecock, Rob; Seviour, Rebecca; Johnstone, Carol

2017-01-01

A low energy Fixed Field Alternating Gradient(FFAG)accelerator has been designed for the production of radioisotopes. Tracking studies have been conducted using the OPAL code, including the effects of space charge. Radioisotopes have a wide range of uses in medicine, and recent disruption to the supply chain has seen a renewed effort to find alternative isotopes and production methods. The design features separate sector magnets with non-scaling, non-linear field gradients but without the counter bends commonly found in FFAG’s. The machine is isochronous at the level of 0.3% up to at least 28MeV and hence able to operate in Continuous Wave (CW) mode. Both protons and helium ions can be used with this design and it has been demonstrated that proton beams with currents of up to 20 mA can be accelerated. An interesting option for the production of radioisotopes is the use of a thin internal target. We have shown that this design has large acceptance, ideal for allowing the beam to be recirculated through t...

Spallation production of neutron deficient radioisotopes in North America

International Nuclear Information System (INIS)

Jamriska, D.J.; Peterson, E.J.; Carty, J.

1997-01-01

The US Department of Energy produces a number of neutron deficient radioisotopes by high energy proton induced spallation reactions in accelerators at Los Alamos National Laboratory in New Mexico and Brookhaven National Laboratory in New York. Research isotopes are also recovered from targets irradiated at TRIUMF in British Columbia, Canada. The radioisotopes recovered are distributed for use in nuclear medicine, environmental research, physics research, and industry worldwide. In addition to the main product line of Sr-82 from either Mo or Rb targets, Cu-67 from ZnO targets, and Ge-68 and RbBr targets, these irradiation facilities also produce some unique isotopes in quantities not available from any other source such as Al-26, Mg-28, Si-32, Ti-44, Fe-52, Gd-148, and Hg-194. The authors will describe the accelerator irradiation facilities at the Los Alamos and Brookhaven National Laboratories. The high level radiochemical processing facilities at Los Alamos and brief chemical processes will be described

Radioisotope detection with accelerators

International Nuclear Information System (INIS)

Mast, T.S.; Muller, R.A.; Tans, P.P.

1979-12-01

High energy mass spectrometry is a new and very sensitive technique of measuring rare radioisotopes. This paper describes the techniques used to select and identify the individual radioisotope atoms in a sample and the status of the radioisotope measurements and their applications

Accelerator Production of Isotopes for Medical Use

Science.gov (United States)

Lapi, Suzanne

2014-03-01

The increase in use of radioisotopes for medical imaging and therapy has led to the development of novel routes of isotope production. For example, the production and purification of longer-lived position emitting radiometals has been explored to allow for nuclear imaging agents based on peptides, antibodies and nanoparticles. These isotopes (64Cu, 89Zr, 86Y) are typically produced via irradiation of solid targets on smaller medical cyclotrons at dedicated facilities. Recently, isotope harvesting from heavy ion accelerator facilities has also been suggested. The Facility for Rare Isotope Beams (FRIB) will be a new national user facility for nuclear science to be completed in 2020. Radioisotopes could be produced by dedicated runs by primary users or may be collected synergistically from the water in cooling-loops for the primary beam dump that cycle the water at flow rates in excess of hundreds of gallons per minute. A liquid water target system for harvesting radioisotopes at the National Superconducting Cyclotron Laboratory (NSCL) was designed and constructed as the initial step in proof-of-principle experiments to harvest useful radioisotopes in this manner. This talk will provide an overview of isotope production using both dedicated machines and harvesting from larger accelerators typically used for nuclear physics. Funding from Department of Energy under DESC0007352 and DESC0006862.

Energy-Recovery Linacs for Commercial Radioisotope Production

International Nuclear Information System (INIS)

Johnson, Rolland Paul

2016-01-01

Most radioisotopes are produced by nuclear reactors or positive ion accelerators, which are expensive to construct and to operate. Photonuclear reactions using bremsstrahlung photon beams from less-expensive electron linacs can generate isotopes of critical interest, but much of the beam energy in a conventional electron linac is dumped at high energy, making unwanted radioactivation. The largest part of this radioactivation may be completely eliminated by applying energy recovery linac technology to the problem with an additional benefit that the energy cost to produce a given amount of isotope is reduced. Consequently, a Superconducting Radio Frequency (SRF) Energy Recovery Linac (ERL) is a path to a more diverse and reliable domestic supply of short-lived, high-value, high-demand isotopes at a cost lower than that of isotopes produced by reactors or positive-ion accelerators. A Jefferson Lab approach to this problem involves a thin photon production radiator, which allows the electron beam to recirculate through rf cavities so the beam energy can be recovered while the spent electrons are extracted and absorbed at a low enough energy to minimize unwanted radioactivation. The thicker isotope photoproduction target is not in the beam. MuPlus, with Jefferson Lab and Niowave, proposed to extend this ERL technology to the commercial world of radioisotope production. In Phase I we demonstrated that 1) the ERL advantage for producing radioisotopes is at high energies (~100 MeV), 2) the range of acceptable radiator thickness is narrow (too thin and there is no advantage relative to other methods and too thick means energy recovery is too difficult), 3) using optics techniques developed under an earlier STTR for collider low beta designs greatly improves the fraction of beam energy that can be recovered (patent pending), 4) many potentially useful radioisotopes can be made with this ERL technique that have never before been available in significant commercial quantities

Energy-Recovery Linacs for Commercial Radioisotope Production

Energy Technology Data Exchange (ETDEWEB)

Johnson, Rolland Paul [Muplus, Inc., Newport News, VA (United States)

2016-11-19

Most radioisotopes are produced by nuclear reactors or positive ion accelerators, which are expensive to construct and to operate. Photonuclear reactions using bremsstrahlung photon beams from less-expensive electron linacs can generate isotopes of critical interest, but much of the beam energy in a conventional electron linac is dumped at high energy, making unwanted radioactivation. The largest part of this radioactivation may be completely eliminated by applying energy recovery linac technology to the problem with an additional benefit that the energy cost to produce a given amount of isotope is reduced. Consequently, a Superconducting Radio Frequency (SRF) Energy Recovery Linac (ERL) is a path to a more diverse and reliable domestic supply of short-lived, high-value, high-demand isotopes at a cost lower than that of isotopes produced by reactors or positive-ion accelerators. A Jefferson Lab approach to this problem involves a thin photon production radiator, which allows the electron beam to recirculate through rf cavities so the beam energy can be recovered while the spent electrons are extracted and absorbed at a low enough energy to minimize unwanted radioactivation. The thicker isotope photoproduction target is not in the beam. MuPlus, with Jefferson Lab and Niowave, proposed to extend this ERL technology to the commercial world of radioisotope production. In Phase I we demonstrated that 1) the ERL advantage for producing radioisotopes is at high energies (~100 MeV), 2) the range of acceptable radiator thickness is narrow (too thin and there is no advantage relative to other methods and too thick means energy recovery is too difficult), 3) using optics techniques developed under an earlier STTR for collider low beta designs greatly improves the fraction of beam energy that can be recovered (patent pending), 4) many potentially useful radioisotopes can be made with this ERL technique that have never before been available in significant commercial quantities

Production of radioisotopes for medical use

International Nuclear Information System (INIS)

Ido, Tatsuo

1977-01-01

As problems in the process of production of short-lived radioisotopes for medical use and in clinical application of them, the following three items were mentioned: 1. separation and purification in a short time, 2. devices to decrease exposure dose in workers, and 3. preservation of radiochemical purity and chemical purity, and avoidance of mixture of impurities. In consideration of these problems, an outline of on-line production system of radioactive gases (from irradiation by accelerated particles to separation, purification, and administration of them), which was exploited in National Institute of Radiological Sciences, was described. Production of 13 NH 3 , the aqueous solution of 18 F, and 123 I was also given an outline. Simultaneous production method of many nuclides by means of laminated target and compounds labelled with positron emitter were also described. (Tsunoda, M.)

Radioisotope detection with tandem electrostatic accelerators

Energy Technology Data Exchange (ETDEWEB)

Gove, H E; Elmore, D; Ferraro, R [Rochester Univ., NY (USA). Nuclear Structure Research Lab.; Beukens, R P; Chang, K H; Kilius, L R; Lee, H W; Litherland, A E [Toronto Univ., Ontario (Canada). Dept. of Physics; Purser, K H [General Ionex Corp., Newburyport, MA (USA)

1980-01-01

An MP tandem Van de Graaff accelerator at the University of Rochester has been employed since May 1977 to detect /sup 14/C in terrestrial samples, /sup 36/Cl in terrestrial and extraterrestrial samples and /sup 10/Be and /sup 26/Al in samples produced by reactor and accelerator irradiation. The sample sizes ranged from about 10 to less than 1 mg and the ratio of the radioisotope to the stable isotopes approached one part in 10/sup 16/ for /sup 14/C and /sup 36/Cl and one part in 10/sup 14/ for /sup 10/Be and /sup 26/Al. /sup 14/C has been measured in a number of samples of geological and archaelogical interest. /sup 36/Cl has been measured in various groundwater samples as well as samples at Antarctic meteorites and ice. Dedicated systems for /sup 14/C dating and geological measurements based on the tandem electrostatic accelerator principle are presently under construction for laboratories in the U.S.A., U.K. and Canada.

Production ampersand marketing of radioisotopes: A vital market for rare earths ampersand specialty metals

International Nuclear Information System (INIS)

Fox, C.J.

1996-01-01

Isotopes that spontaneously emit alpha (α) or beta (β) particles, or gamma rays (γ), are said to be radioactive. The emission process, called open-quotes decay,close quotes is precisely what makes radioactive isotopes, known as open-quotes radioisotopes,close quotes useful in a variety of applications, including nuclear medicine, commercial sterilization, manufacturing, geophysics, agriculture, and research programs in these and various other fields. Until 1960, radioisotope production was limited to government-owned nuclear reactors and particle accelerators in universities and government laboratories, primarily because the enormous cost of building these facilities could only be supported by government budgets. During this time, a few private companies managed to secure commercial rights to exploit the production capabilities of these facilities. Today, these companies and a few government agencies still provide the basis of global commercial radioisotope supply

Production yield of produced radioisotopes from 100 MeV proton beam on lead target for shielding analysis of large accelerator

Energy Technology Data Exchange (ETDEWEB)

Oranj, Leila Mokhtari; Oh, Joo Hee; Jung, Nam Suk; Bae, O Ryun; Lee, Hee Seock [Div. of Advanced Nuclear Engineering, POSTECH, Pohang (Korea, Republic of)

2014-11-15

In this work, the production yield of major shielding material, a lead, was investigated using 100 MeV protons of KOMAC accelerator facility. For the analysis of the experimental data, the activity has been calculated using the FLUKA Monte Carlo code and analytical methods. The cross section data and the stopping power in the irradiated assembly were calculated by TALYS and SRIM codes in the analytical method, respectively. Consequently, the experimental production yield of produced radioisotopes was compared with the data that are based on Monte Carlo calculations and analytical studies. In this research, the {sup nat}Pb(p, x) reaction was studied using experimental measurements, Monte Carlo simulations and analytical methods. Rereading to the experimental measurements, we demonstrate that both Monte Carlo simulation and analytical methods could be useful tools for the estimation of production yield of this reaction.

Production yield of produced radioisotopes from 100 MeV proton beam on lead target for shielding analysis of large accelerator

International Nuclear Information System (INIS)

Oranj, Leila Mokhtari; Oh, Joo Hee; Jung, Nam Suk; Bae, O Ryun; Lee, Hee Seock

2014-01-01

In this work, the production yield of major shielding material, a lead, was investigated using 100 MeV protons of KOMAC accelerator facility. For the analysis of the experimental data, the activity has been calculated using the FLUKA Monte Carlo code and analytical methods. The cross section data and the stopping power in the irradiated assembly were calculated by TALYS and SRIM codes in the analytical method, respectively. Consequently, the experimental production yield of produced radioisotopes was compared with the data that are based on Monte Carlo calculations and analytical studies. In this research, the nat Pb(p, x) reaction was studied using experimental measurements, Monte Carlo simulations and analytical methods. Rereading to the experimental measurements, we demonstrate that both Monte Carlo simulation and analytical methods could be useful tools for the estimation of production yield of this reaction

Potential medical applications of the plasma focus in the radioisotope production for PET imaging

International Nuclear Information System (INIS)

Roshan, M.V.; Razaghi, S.; Asghari, F.; Rawat, R.S.; Springham, S.V.; Lee, P.; Lee, S.; Tan, T.L.

2014-01-01

Devices other than the accelerators are desired to be investigated for generating high energy particles to induce nuclear reaction and positron emission tomography (PET) producing radioisotopes. The experimental data of plasma focus devices (PF) are studied and the activity scaling law for External Solid Target (EST) activation is established. Based on the scaling law and the techniques to enhance the radioisotopes production, the feasibility of generating the required activity for PET imaging is studied. - Highlights: • Short lived radioisotopes for PET imaging are produced in plasma focus device. • The scaling law of the activity induced with plasma focus energy is established. • The potential medical applications of plasma focus are studied

Reactor-produced therapeutic radioisotopes

International Nuclear Information System (INIS)

Knapp, F.F. Jr.

2002-01-01

The significant worldwide increase in therapeutic radioisotope applications in nuclear medicine, oncology and interventional cardiology requires the dependable production of sufficient levels of radioisotopes for these applications (Reba, 2000; J. Nucl. Med., 1998; Nuclear News, 1999; Adelstein and Manning, 1994). The issues associated with both accelerator- and reactor-production of therapeutic radioisotopes is important. Clinical applications of therapeutic radioisotopes include the use of both sealed sources and unsealed radiopharmaceutical sources. Targeted radiopharmaceutical agents include those for cancer therapy and palliation of bone pain from metastatic disease, ablation of bone marrow prior to stem cell transplantation, treatment modalities for mono and oligo- and polyarthritis, for cancer therapy (including brachytherapy) and for the inhibition of the hyperplastic response following coronary angioplasty and other interventional procedures (For example, see Volkert and Hoffman, 1999). Sealed sources involve the use of radiolabeled devices for cancer therapy (brachytherapy) and also for the inhibition of the hyperplasia which is often encountered after angioplasty, especially with the exponential increase in the use of coronary stents and stents for the peripheral vasculature and other anatomical applications. Since neutron-rich radioisotopes often decay by beta decay or decay to beta-emitting daughter radioisotopes which serve as the basis for radionuclide generator systems, reactors are expected to play an increasingly important role for the production of a large variety of therapeutic radioisotopes required for these and other developing therapeutic applications. Because of the importance of the availability of reactor-produced radioisotopes for these applications, an understanding of the contribution of neutron spectra for radioisotope production and determination of those cross sections which have not yet been established is important. This

Radioisotope production by reactors and cyclotrons in Japan

International Nuclear Information System (INIS)

Murakami, Yukio

1978-01-01

Present status of radioisotope production in Japan and the increasing demand from various fields are generally reviewed. Future problems associated with the shortage of economical supply are also discussed. The first half of this report is devoted to general review of the increasing demand for various radioisotopes from increasing number of users. The present status and future trends of the distribution of users of specific radioisotopes and their demands are shown. The remaining half of this report reviews the production with reactors and cyclotrons. The Japanese reactors producing radioisotopes are limited to low flux (10 13 ) research reactors at JAERI. Some problems associated with the improvement of availability and with the organizational structure are discussed. As for the production with cyclotrons, available facilities and the method of production are explained in detail. For clinical use, especially for the production of short lived radioisotopes, the advantage of a small special purpose cyclotron at each medical organization is emphasized. (Aoki, K.)

Cyclotron for industrial production of radioisotopes: relevants characteristics

International Nuclear Information System (INIS)

Lima, Wanderley de

1997-01-01

The industrial production of radioisotopes requests cyclotrons with easy maintenance services, high productivity and low operation costs. To obtain this performance the experts on the have achieved excellent results, taking advantage of modern resources in calculation and modeling. Only by the maximum exploitation of the azimutal variation of the magnetic field, a physical concept introduced in 1967 with the isocronous cyclotrons, it was possible to construct cyclotrons with only 30% of the electrical consumption required by the former cyclotrons. On the other hand, the acceleration of negative ions enable the 100% accelerated beam utilization, without internal energy dissipation, obtaining beam intensities up to 1mA in continuous running which represents an increased factor of 15. Other construction parameters were optimized aiming at reliability and reduction in the components activation. Concerning energy consumption and the beam intensity supplied, a present cyclotron with 30 MeV and 300μA of protons current is 15 times more efficient than its precedent. (author). 6 refs., 1 fig., 2 tabs

Status on the compilation of nuclear data for medical radioisotopes produced by accelerators

International Nuclear Information System (INIS)

Gandarias-Cruz, D.; Okamoto, K.

1988-10-01

The status of data on excitation functions and thick target yields for medical radioisotopes produced by accelerators is summarized. Most of the information was extracted from the compiled data in EXFOR (EXCHANGE FORMAT) which is a common format used by the co-operating nuclear data centres in the world. The nuclear decay mode, half-life, production method, Q-value, maximum cross-section value and the energy at this maximum, are tabulated. For some commonly used reactions, the available excitation functions are plotted in graph. (author). 353 refs

Technical and economical availability of radioisotopes production in Brazil

International Nuclear Information System (INIS)

Lima, J.O.V.

1981-10-01

The technical and economical availability of radioisotopes production in Brazil by a low power research reactor, are done. The importance of radioisotope utilization and controled radiations, in areas such as medicine, industry and cost evaluation for the production in nuclear reactors. In the cost evaluation of a radioisotope production reactor, the studies developed by the Department of Nuclear Engineering of Universidade Federal de Minas Gerais - DEN/UFMG were used. The information analysis justify the technical and economical availability and the necessity of the radioisotopes production in Brazil. (E.G.) [pt

Radioisotope production at PUSPATI - five year programme

International Nuclear Information System (INIS)

Yusof Azuddin Ali; Abdul Rahman Mohamad Ali.

1983-01-01

Most of the basic laboratory facilities for radioisotopes production at PUSPATI will be commissioned by September 1983. Work on setting up of production and dispensing facilities is in progress as the nuclides being worked on are those that are commonly used in medical applications, such as Tc-99m, I-131, P-32 and other nuclides such as Na-24 and K-42. Kits for compounds labelled with Tc-99m such as Stannous Pyrophosphate, Sulfur Colloid and Stannous Glucoheptonate are being prepared. The irradiation facilities available now for radioisotope production at the PUSPATI TRIGA Reactor include a central thimble (flux density 1 x 10 13 n.cm -2 S -1 ) and a rotary specimen rack (flux density 0.2 x 10 13 n.cm -1 S -1 ). Irradiation schedules and target handling techniqes are discussed. Plans for radioisotope production at PUSPATI over the period of 1983-1987, based on present demand for radioisotope, are also explained. (author)

Radiation protection programme for a radioisotope production facility

International Nuclear Information System (INIS)

Makgato, Thutu Nelson

2015-02-01

The present project reviews reactor based radioisotope production facilities. An overview of techniques and methodologies used as well as laboratory facilities necessary for the production process are discussed. Specific details of reactor based production and processing of more commonly used industrial and pharmaceutical radioisotopes are provided. Ultimately, based on facilities and techniques utilized as well as the associated hazard assessment, a proposed radiation protection programme is discussed. Elements of the radiation protection programme will also consider lessons from recent incidents and accidents encountered in radioisotope production facilities. (au)

The production and application of radioisotopes

International Nuclear Information System (INIS)

O'Neill, W.P.; Evans, D.J.R.

1987-01-01

This paper outlines the historical evolution of radioisotopes from first concepts and discoveries to significant milestones in their production and the development of applications throughout the world. Regarding production, it addresses the methods that have been used at various stages during this evolution outlining the important findings that have led to further developments. With respect to radioisotope applications, the paper addresses the development of markets in industry, medicine, and agriculture and comments on the size of these markets and their rate of growth. Throughout, the paper highlights the Canadian experience and it also presents a Canadian view of emerging prospects and a forecast of how the future for radioisotopes might develop. (author)

Studies on the production and application of radioisotopes

Energy Technology Data Exchange (ETDEWEB)

Han, Hyon Soo; Park, K. B.; Kim, J. R.; Yoon, B. M.; Bang, H. S.; Shin, B. C.; Cho, W. K.; Park, U. J.; Park, C. D.; Lee, Y. G.; Suh, C. H.; Shin, H. Y.; Kim, D. S.; Hong, S. B.; Jun, S. S.; Min, E. S.; Jang, K. D.; Kim, J. K.; Kim, S. J.; Yang, S. Y.; Yang, S. H.; Chun, K. J.; Kang, H. Y.; Suh, K. S.; Goo, J. H.; Chung, S. H.; Lee, J. C.; Choi, J. L.; Lee, H. Y.; Bang, K. S.

1997-09-01

To produce radioisotopes utilizing the research reactor `HANARO`, development of RI production process, target fabrication, preparation of devices and tools for RI process, preparation of production facility for radiopharmaceuticals, test production for the established process, etc. have been carried out, respectively. Production processes for various kinds of radionuclides were developed and the settled methods were applied to test production using `HANARO`. The results of developed process are as follows: (1) I-131 dry distillation method. (2) Large scale production of Ir-192 sources (3) P-32 production process by distillation under reduced pressure (4) Cr-51 production process using enriched target. To irradiate the target for RI production in `HANARO`, target for neutron irradiation, loading/unloading devices, working table in service pool, remote handling tools, shield cask for irradiated target transfer, etc. were designed and fabricated. The function test of prepared targets and the safety analysis of shielding casks were carried out. License for practical use of the prepared casks were obtained from Ministry of Science and Technology. For production of medical radioisotopes, their production facilities were designed in detail and were installed in RIPF (Radioisotope Production Facility), with full reflection of the basic concept of the good manufacturing practice for radiopharmaceuticals. The constructed GMP facilities have started to be operated after authorization since Jun., 1997. Results of this study will be applied to mass production of radioisotopes in `HANARO` and are to contribute the advance of domestic medicine and industry related to radioisotopes. (author). 7 refs., 7 tabs., 4 figs.

Studies on the production and application of radioisotopes

International Nuclear Information System (INIS)

Han, Hyon Soo; Park, K. B.; Kim, J. R.; Yoon, B. M.; Bang, H. S.; Shin, B. C.; Cho, W. K.; Park, U. J.; Park, C. D.; Lee, Y. G.; Suh, C. H.; Shin, H. Y.; Kim, D. S.; Hong, S. B.; Jun, S. S.; Min, E. S.; Jang, K. D.; Kim, J. K.; Kim, S. J.; Yang, S. Y.; Yang, S. H.; Chun, K. J.; Kang, H. Y.; Suh, K. S.; Goo, J. H.; Chung, S. H.; Lee, J. C.; Choi, J. L.; Lee, H. Y.; Bang, K. S.

1997-09-01

To produce radioisotopes utilizing the research reactor 'HANARO', development of RI production process, target fabrication, preparation of devices and tools for RI process, preparation of production facility for radiopharmaceuticals, test production for the established process, etc. have been carried out, respectively. Production processes for various kinds of radionuclides were developed and the settled methods were applied to test production using 'HANARO'. The results of developed process are as follows: 1) I-131 dry distillation method. 2) Large scale production of Ir-192 sources 3) P-32 production process by distillation under reduced pressure 4) Cr-51 production process using enriched target. To irradiate the target for RI production in 'HANARO', target for neutron irradiation, loading/unloading devices, working table in service pool, remote handling tools, shield cask for irradiated target transfer, etc. were designed and fabricated. The function test of prepared targets and the safety analysis of shielding casks were carried out. License for practical use of the prepared casks were obtained from Ministry of Science and Technology. For production of medical radioisotopes, their production facilities were designed in detail and were installed in RIPF (Radioisotope Production Facility), with full reflection of the basic concept of the good manufacturing practice for radiopharmaceuticals. The constructed GMP facilities have started to be operated after authorization since Jun., 1997. Results of this study will be applied to mass production of radioisotopes in 'HANARO' and are to contribute the advance of domestic medicine and industry related to radioisotopes. (author). 7 refs., 7 tabs., 4 figs

Radioisotope production in fusion reactors

International Nuclear Information System (INIS)

Engholm, B.A.; Cheng, E.T.; Schultz, K.R.

1986-01-01

Radioisotope production in fusion reactors is being investigated as part of the Fusion Applications and Market Evaluation (FAME) study. /sup 60/Co is the most promising such product identified to date, since the /sup 60/Co demand for medical and food sterilization is strong and the potential output from a fusion reactor is high. Some of the other radioisotopes considered are /sup 99/Tc, /sup 131/l, several Eu isotopes, and /sup 210/Po. Among the stable isotopes of interest are /sup 197/Au, /sup 103/Rh and Os. In all cases, heat or electricity can be co-produced from the fusion reactor, with overall attractive economics

Structure and manual of radioisotope-production data base, ISOP

International Nuclear Information System (INIS)

Hata, Kentaro; Terunuma, Kusuo

1994-02-01

We planned on collecting the information of radioisotope production which was obtained from research works and tasks at the Department of Radioisotopes in JAERI, and constructed a proto-type data base ISOP after discussion of the kinds and properties of the information available for radioisotope production. In this report the structure and the manual of ISOP are described. (author)

Comparison of the production of medical radioisotopes on reactor and cyclotron

International Nuclear Information System (INIS)

Vucina, J.; Vuksanovic, Lj.; Dobrijevic, R.; Karanfilov, E.

1997-01-01

The production of radioisotopes for nuclear-medical applications can be performed either on nuclear reactor or on cyclotron. According to the nuclear reactions applied the radioisotopes of different physical characteristics can be produced. In the paper a comparison of the radioisotopes production given. Compared are the main steps in the production: choice of the nuclear reaction, targetry, irradiation and radiochemical separations performed on the irradiated target to isolate the desired radioisotope. The main characteristics of the produced radioisotopes are given and discussed. (author)

Radioisotope Production for Medical and Physics Applications

Science.gov (United States)

Mausner, Leonard

2012-10-01

Radioisotopes are critical to the science and technology base of the US. Discoveries and applications made as a result of the availability of radioisotopes span widely from medicine, biology, physics, chemistry and homeland security. The clinical use of radioisotopes for medical diagnosis is the largest sector of use, with about 16 million procedures a year in the US. The use of ^99Mo/^99mTc generator and ^18F make up the majority, but ^201Tl, ^123I, ^111In, and ^67Ga are also used routinely to perform imaging of organ function. Application of radioisotopes for therapy is dominated by use of ^131I for thyroid malignancies, ^90Y for some solid tumors, and ^89Sr for bone cancer, but production of several more exotic species such as ^225Ac and ^211At are of significant current research interest. In physics ^225Ra is of interest for CP violation studies, and the actinides ^242Am, ^249Bk, and ^254Es are needed as targets for experiments to create superheavy elements. Large amounts of ^252Cf are needed as a fission source for the CARIBU experiment at ANL. The process of radioisotope production is multidisciplinary. Nuclear physics input based on nuclear reaction excitation function data is needed to choose an optimum target/projectile in order to maximize desired isotope production and minimize unwanted byproducts. Mechanical engineering is needed to address issues of target heating, induced mechanical stress and material compatibility of target and claddings. Radiochemists are involved as well since chemical separation to purify the desired final radioisotope product from the bulk target and impurities is also usually necessary. Most neutron rich species are produced at a few government and university reactors. Other radioisotopes are produced in cyclotrons in the commercial sector, university/hospital based facilities, and larger devices at the DOE labs. The landscape of US facilities, the techniques involved, and current supply challenges will be reviewed.

Radioisotope detection and dating with accelerators

Energy Technology Data Exchange (ETDEWEB)

Mast, T S; Muller, R A [California Univ., Berkeley (USA). Lawrence Berkeley Lab.

1980-07-01

The status of the new technique of high energy mass spectrometry is reviewed. This sensitive method of measuring isotope concentrations has been applied to the detection of rare radioisotopes used for age estimation. The techniques used to select and identify the individual radioisotope atoms in a sample are described and then the status of the radioisotope measurements and their applications is reviewed.

Medical Radioisotope Production in a Power-Flattened ADS Fuelled with Uranium and Plutonium Dioxides

Directory of Open Access Journals (Sweden)

Gizem Bakır

2016-01-01

Full Text Available This study presents the medical radioisotope production performance of a conceptual accelerator driven system (ADS. Lead-bismuth eutectic (LBE is selected as target material. The subcritical fuel core is conceptually divided into ten equidistant subzones. The ceramic (natural U, PuO2 fuel mixture and the materials used for radioisotope production (copper, gold, cobalt, holmium, rhenium, thulium, mercury, palladium, thallium, molybdenum, and yttrium are separately prepared as cylindrical rods cladded with carbon/carbon composite (C/C and these rods are located in the subzones. In order to obtain the flattened power density, percentages of PuO2 in the mixture of UO2 and PuO2 in the subzones are adjusted in radial direction of the fuel zone. Time-dependent calculations are performed at 1000 MW thermal fission power (Pth for one hour using the BURN card. The neutronic results show that the investigated ADS has a high neutronic capability, in terms of medical radioisotope productions, spent fuel transmutation and energy multiplication. Moreover, a good quasiuniform power density is achieved in each material case. The peak-to-average fission power density ratio is in the range of 1.02–1.28.

Economic Contributions of Radioisotope Production Reactor in Korea

International Nuclear Information System (INIS)

Nam, Ji Hee; Kim, Seung Su; Moon, Kee Whan

2010-01-01

Radioisotopes (RIs) have been used extensively in the fields of industrial, the agricultural, and the medical applications. Especially the deficiency of radioisotopes such as Mo-99 and I-131 in the medical applications recently is becoming the main issue in our society. Radioisotope with the characteristics of public goods in some aspects is mainly playing as the intermediate inputs or goods in the process of the industrial production, with being expected to produce the economic benefits by creating the new demand in the market or enlarging the value added for the related goods and services. In this study, the contribution effects for Korean economy by the construction and operation of the reactor for radioisotope production would be evaluated the effects produced by the activities such as a RI supplies into domestic industry, the RI exports, the neutron transmutation doping services called NTD, and the exports of RI production reactors

Charged particle cross-section database for medical radioisotope production: diagnostic radioisotopes and monitor reactions. Final report of a co-ordinated research project

International Nuclear Information System (INIS)

2001-05-01

Medical applications of nuclear radiation are of considerable interest to the IAEA. Cyclotrons and accelerators, available in recent years in an increasing number of countries, are being used for the production of radioisotopes for both diagnostic and therapeutic purposes. The physical basis of this production is described through interaction of charged particles, such as protons, deuterons and alphas, with matter. These processes have to be well understood in order to produce radioisotopes in an efficient and clean manner. In addition to medical radioisotope production, reactions with low energy charged particles are of primary importance for two major applications. Techniques of ion beam analysis use many specific reactions to identify material properties, and in nuclear astrophysics there is interest in numerous reaction rates to understand nucleosynthesis in the Universe. A large number of medically oriented cyclotrons have been running in North America, western Europe and Japan for more than two decades. In recent years, 30-40 MeV cyclotrons and smaller cyclotrons (E p < 20 MeV) have been installed in several countries. Although the production methods are well established, there are no evaluated and recommended nuclear data sets available. The need for standardization was thus imminent. This was pointed out at three IAEA meetings. Based on the recommendations made at these meetings, the IAEA decided to undertake and organize the Co-ordinated Research Project (CRP) on Development of Reference Charged Particle Cross-Section Database for Medical Radioisotope Production. The project was initiated in 1995. It focused on radioisotopes for diagnostic purposes and on the related beam monitor reactions in order to meet current needs. It constituted the first major international effort dedicated to standardization of nuclear data for radioisotope production. It covered the following areas: Compilation of data on the most important reactions for monitoring light ion

Production of radioisotopes with BR2 facilities

International Nuclear Information System (INIS)

Fallais, C.J.; Morel de Westfaver, A.; Heeren, L.; Baugnet, J.M.; Gandolfo, J.M.; Boeykens, W.

1978-01-01

After a brief account on the isotopes production evolution in the industrialized countries the irradiation devices and the types of standardized capsules used in the BR2 reactor are described as well as the thermal neutron flux. Production of most important radioisotopes like 131 Iodine, 60 Cobalt, 192 Iridium and 99 Molybdenum and their main utilizations (uses)are described. The mean specific activities and the limit of use for different radioisotopes are reported. (A.F.)

KAERI's challenge to steady production of radioisotopes and radiopharmaceuticals

International Nuclear Information System (INIS)

Park, J.H.; Han, H.S.; Park, K.B.

2000-01-01

The Korea Atomic Energy Research Institute (KAERI) is a national organization in Korea, and has been doing many research and development works in radioisotope production and applications for more than 30 years. Now KAERI regularly produces radioisotopes (I-131, Tc-99m, Ho-166) for medical use and Ir-192 for industrial use. Various I-131 labeled compounds and more than 10 kinds of Tc-99m cold kits are also produced. Our multi-purpose reactor, named HANARO, has been operative since April of 1995. HANAKO is an open tank type reactor with 30 MW thermal capacity. This reactor was designed not only for research on neutron utilization but for production of radioisotopes. KAERI intended to maximize the radioisotope production capability. For this purpose, radioisotope production facilities (RIPF) have been constructed adjacent to the HANARO reactor building. There are four banks of hot cells equipped with manipulators and some of the hot cells were installed according to the KGMP standards and with clean rooms. In reviewing our RI production plan intensively, emphasis was placed on the development of new radiopharmaceuticals, development of new radiation sources for industrial and therapeutic use, and steady production of selected radioisotopes and radiopharmaceuticals. The selected items are Ho-166 based pharmaceuticals, fission Mo-99/Tc-99m generators. solution and capsules of I-131, and Ir-192 and Co-60 for industrial use. The status and future plan of KAERI's research and development program will be introduced, and will highlight programs for steady production. (author)

Accelerator mass spectrometry for measurement of long-lived radioisotopes.

Science.gov (United States)

Elmore, D; Phillips, F M

1987-05-01

Particle accelerators, such as those built for research in nuclear physics, can also be used together with magnetic and electrostatic mass analyzers to measure rare isotopes at very low abundance ratios. All molecular ions can be eliminated when accelerated to energies of millions of electron volts. Some atomic isobars can be eliminated with the use of negative ions; others can be separated at high energies by measuring their rate of energy loss in a detector. The long-lived radioisotopes (10)Be, (14)C,(26)A1, 36Cl, and (129)1 can now be measured in small natural samples having isotopic abundances in the range 10(-12) to 10(- 5) and as few as 10(5) atoms. In the past few years, research applications of accelerator mass spectrometry have been concentrated in the earth sciences (climatology, cosmochemistry, environmental chemistry, geochronology, glaciology, hydrology, igneous petrogenesis, minerals exploration, sedimentology, and volcanology), in anthropology and archeology (radiocarbon dating), and in physics (searches for exotic particles and measurement of halflives). In addition, accelerator mass spectrometry may become an important tool for the materials and biological sciences.

Production and application of radioisotopes - a Canadian perspective

International Nuclear Information System (INIS)

O'Neill, W.P.; Evans, D.J.R.

1988-01-01

This paper outlines the historical evolutions of radioisotopes from first concepts and discoveries to significant milestones in their production and the development of applications throughout the world. Regarding production, it addresses the methods that have been used at various stages during this evolution outlining the important findings that have led to further developments. With respect to radioisotope applications, the paper addresses the development of markets in industry, medicine, and agriculture and comments on the size of these markets and their rate of growth. Throughout, the paper highlights the Canadian experience and it also presents a Canadian view of emerging prospects and a forecast of how the future for radioisotopes might develop

Development of radioisotope production in the Philippines

Energy Technology Data Exchange (ETDEWEB)

Cabalfin, E G [Philippine Nuclear Research Institute, Quezon (Philippines)

1998-10-01

The Philippine Nuclear Research Institute (PNRI) started its activities on radioisotope production more than three decades ago, when the Philippine Research Reactor (PRR-1) started operating at its full rated power of 1 MW. Since then, several radionuclides in different chemical forms, were routinely produced and supplied for use in nuclear medicine, industry, agriculture, research and training, until the conversion of the PRR-1 to a 3 MW TRIGA type reactor. After the criticality test of the upgraded reactor, a leak was discovered in the pool liner. With the repair of the reactor still ongoing, routine radioisotope production activities have been reduced to dispensing of imported bulk {sup 131}I. In the Philippines, radioisotopes are widely used in nuclear medicine, with {sup 131}I and {sup 99m}Tc as the major radionuclides of interest. Thus the present radioisotope production program of PNRI is directed to meet this demand. With the technical assistance of the International Atomic Energy Agency (IAEA), PNRI is setting up a new {sup 131}I production facility. The in-cell equipment have been installed and tested using both inactive and active target, obtained from BATAN, Indonesia. In order to meet the need of producing {sup 99}Mo-{sup 99m}Tc generators, based on low specific activity reactor-produced {sup 99}Mo, research and development work on the preparation of {sup 99m}Tc gel generators is ongoing. (author)

Radioisotopes production for applications on the health; Produccion de radioisotopos para aplicaciones en la salud

Energy Technology Data Exchange (ETDEWEB)

Monroy G, F.; Alanis M, J., E-mail: fabiola.monroy@inin.gob.m [ININ, Departamento de Materiales Radiactivos, Carretera Mexico-Toluca s/n, 52750 Ocoyoacac, Estado de Mexico (Mexico)

2010-07-01

In the Radioactive Materials Department of the Instituto Nacional de Investigaciones Nucleares (ININ) processes have been studied and developed for the radioisotopes production of interest in the medicine, research, industry and agriculture. In particular five new processes have been developed in the last 10 years by the group of the Radioactive Materials Research Laboratory to produce: {sup 99}Mo/{sup 99m}Tc and {sup 188}W/{sup 188}Re generators, the radio lanthanides: {sup 151}Pm, {sup 147}Pm, {sup 161}Tb, {sup 166}Ho, {sup 177}Lu, {sup 131}I and the {sup 32}P. All these radioisotopes are artificial and they can be produced in nuclear reactors and some of them in particle accelerators. The radioisotope generators are of particular interest, as those of {sup 99}Mo/{sup 99m}Tc and {sup 188}W/{sup 188}Re presented in this work, because they are systems that allow to produce an artificial radioisotope of interest continually, in these cases the {sup 99m}Tc and the {sup 188}Re, without the necessity of having a nuclear reactor or an particle accelerator. They are compact systems armored and sure perfectly of manipulating that, once the radioactive material has decayed, they do not present radiological risk some for the environment and the population. These systems are therefore of supreme utility in places where it is not had nuclear reactors or with a continuous radioisotope supply, due to their time of decaying, for its cost or for logistical problems in their supply, like it is the case of many hospital centers, of research or industries in our country. (Author)

Medical radioisotopes production at the isochronous cyclotron in Alma-Ata

International Nuclear Information System (INIS)

Arzumanov, A.A.; Batischev, V.N.; Gladun, V.K.; Kochetkov, V.L.

1988-01-01

High efficiency cyclotron operations (up to 5200 hours of beam time a year) considerably increased the possibility to perform both fundamental and applied scientific work. There appeared possibility to accelerate protons in a wide energy range from 6 to 30 MeV and realize correspondingly the nuclear reactions up to (A, 3n). This paper reports that among different applied tasks performed at the cyclotron the special program of cyclotron production of short-lived medical radioisotopes iodine-123, thallium-201, cadmium-109 in the first place and some others to satisfy clinic needs of Alma-Ata and its region has special importance. In accordance with this program the preparation to produce iodine-123 is being held and regular production of Thallium chloride, thallium-201 pharmaceptical is started

Routes for the production of isotopes for PET with high intensity deuteron accelerators

Science.gov (United States)

Arias de Saavedra, F.; Porras, I.; Praena, J.

2018-04-01

Recent advances in accelerator science are opening new possibilities in different fields of physics. In particular, the development of compact linear accelerators that can provide charged particles of low-medium energy (few MeV) with high current (above mA) allows for the study of new possibilities in neutron production and for new routes for the production of radioisotopes. Keeping in mind how radioisotopes are actually produced in dedicated facilities, we have performed a study of alternative reactions to produce PET isotopes induced by low-energy deuterons. We have fitted the EXFOR cross sections data, used the fitted values of the stopping power by Andersen and Ziegler and calculated by numerical integration the production rate of isotopes for charged particles up to 20 MeV. The results for deuterons up to 3 MeV are compared with the ones from cyclotrons, which are able to provide higher energies to the charged projectiles but with lower intensities. Our results indicate that using linear accelerators may be a good alternative for producing PET isotopes, reducing the problem of neutron activation.

Facilities for the production and processing of radioisotopes

International Nuclear Information System (INIS)

Fourie, P.J.

1980-01-01

Radioisotopes which are used in South Africa are produced in the nuclear reactor SAFARI 1 of the AEB and the CSIR cyclotron in Pretoria or are being imported from various overseas manufactures. The safe and efficient production and use of radioisotopes is possible when being handled by sufficiently trained personnel using special designed equipment and facilities. The Isotope Production Centre is situated next to the reactor and waste treatment buildings. New production facilities shielded with lead and equipped with remote handling equipment are being erected and will be commissioned early during 1980 [af

Status and prospects on radioisotope production in Korea

International Nuclear Information System (INIS)

Han, H. S.; Cho, W. K.; Park, U. J.; Hong, Y. D.; Park, K. B.

2002-01-01

In Korea, radioisotopes has been produced using small-sized research reactors (TRIGA Mark II, III) from 1961 to 1995. The Korea Atomic Energy Research Institute (KAERI) completed the High-flux Advanced Neutron Application Reactor (HANARO) in 1995 and a radioisotope production facilities (RIPF) in 1997. Medical and industrial radionuclides such as 131 I, 99m Tc, 166 Ho, 192 Ir and 60 Co, are routinely produced utilizing HANARO. Several hundreds kilo curies of these nuclides were supplied to domestic users in 2001. The Korea Cancer Center Hospital (KCCH) first installed a cyclotron (MC-50) for neutron therapy and RI production in 1984. At present, the cyclotron routinely produced radionuclides such as 201 TI, 67 Ga, 123 I and 18 F. Also, it is capable of producing several radionuclides, including 111 In, 51 Cr, 124 I, 54 Mn, 22 Na, etc. Baby cyclotrons were installed in Seoul National University Hospital, Sam sung Medical Center and Asan Medical Center. The main purpose of the introduction of baby cyclotrons was to produce short-lived positron emitters such as 18 F, 15 O and 11 C for PET. Radioisotope production facilities were imported and installed as subsidiaries of cyclotron. In Korea, more than 60 kinds of radioisotopes are currently used in the field of their applications and most of them are imported form foreign vendors. For the quality assurance of final products such as radiopharmaceuticals and industrial sources, facilities for production should be installed and maintained in accordance with regulation rules and also the production system should be operated under quality management system. Since 1992 the Korean government has been encouraging Mid and Long Term Nuclear R and D Programs to enhance capability in nuclear technology development. In order to actively promote the utilization, research and development of technology applying radiation and RI, the Korean government established 'a comprehensive promotion plan for utilization, research and development

Production of radioisotopes by 1.5 m cyclotron and their utilization

International Nuclear Information System (INIS)

Niu Fang

1987-01-01

Radioisotopes characterized by nuclear property and uses can be produced on the accelerator, especially those playing an important role in scientific researches and biomedical uses. The status of Radioisotopes produced by 1.5 m cyclotron and their applications in our institute are summarized in this paper. The details of preparation and the results of use for radioactive sources, radiochemicals, radiopharmaceuticals of 57 Co, 109 Cd, 68 Ge- 68 Ga, and 167 Tm are given respectively. (author)

Development of radioisotope production in JAERI

International Nuclear Information System (INIS)

Yamabayashi, H.; Kato, H.; Umezawa, H.

1992-01-01

Since 1962, we have been developing methods and technology for producing a wide variety of processed radioisotopes and sealed radiation sources by using the JAERI's reactors, JRR-2, JRR-3, JRR-4 and JMTR, and providing the products to domestic users. At present, 29 nuclides and 31 products are on our list of processed radioisotopes. Some of those isotopes such as P-32, S-35, Cr-51 and short-lived nuclides are being produced regularly for distribution, but most of the rest are produced upon request. The radiation sources of Co-60 needles and Ir-192 pellets for industrial use and Gd-153 pellet, 7 kinds of Ir-192 and Au-198 grain for medical applications are produced and distributed routinely. (author)

Improvement of radioisotope production technology

International Nuclear Information System (INIS)

Li Yongjian

1987-01-01

The widespreading and deepgoing applications of radioisotopes results the increasing demands on both quality and quantity. This in turn stimulating the production technology to be improved unceasingly to meet the different requirements on availability, variety, facility, purity, specific activity and specificity. The major approaches of achieving these improvements including: optimizing mode of production; enhancing irradiation conditions; amelioration target arrangement; adapting nuclear process and inventing chemical processing. (author)

Radionuclide production for PET with a linear electrostatic accelerator

International Nuclear Information System (INIS)

Shefer, R.E.; Hughey, B.J.; Klinkowstein, R.E.; Welch, M.J.

1993-01-01

A new type of linear electrostatic accelerator for the production of short-lived radionuclides for PET has been developed at Science Research Laboratory. The tandem cascade accelerator (TCA) is a low energy (3.7 MeV) proton and deuteron accelerator which can generate the four short-lived PET radionuclides in the quantities required for clinical use. The compact size, low weight, low power consumption and reduced radiation shielding requirements of the TCA result in a significant reduction in capital and operating costs when compared with higher energy cyclotron-based systems. Radioisotope target for the production of O-15, F-18, N-13 and C-11 have been designed specifically for use with the low energy TCA beam. A simple to use PC-based computer control system allows fully automated system operation and advanced scheduling of isotope production. Operating experience with the TCA and its PET radionuclide targets is described

Radioisotope production

International Nuclear Information System (INIS)

1988-01-01

The trial production runs started in the previous report period were continued and have been extended to 67 Ga, 81 Rb/ 81m Kr and 111 In, the production of which will be taken over from the Pretoria cyclotron at the end of this year, when that machine is scheduled to be shut down. After commissioning of the target water cooling system and the helium cooling system for beam foil windows at the beginning of this year, these production runs could also be extended to high beam currents (up to 50 μA). Test consignments of a number of products have been supplied to various potential future users, and 123 I, in the form of Na 123 I capsules as well as 123 I-sodium hippurate, and 52 Fe-citrate have actually been used with success in trial diagnostic studies on patients. A procedure for labelling IPPA and 3-IPMPA with 123 I has been developed, while initial work has also been done on the radioiodination of monoclonal antifibrine antibodies. The last major facility needed for the commencement of the routine radioisotope production programme, namely the multiple-target facility, is now ready for installation in the production vault within the next few weeks, and routine production runs are expected to start in November 1988. 4 figs., 18 refs

Experience utilizing a 3.7 MeV tandem cascade accelerator (TCA) for PET radioisotope production

International Nuclear Information System (INIS)

Welch, M.J.; Gaehle, G.; Dence, C.S.

1994-01-01

A 3.7 MeV TCA was installed at Washington University in the Spring of 1993 for evaluation as a PET isotope production accelerator. The accelerator was installed in a specially designed suite consisting of the accelerator room, a open-quotes hot labclose quotes and a open-quotes cold labclose quotes. The accelerator has been utilized routinely for PET isotope production since it's installation. Although the major radionuclide produced utilizing the TCA is oxygen-15, techniques for the production of fluorine-18 and nitrogen-13 have been developed. The novel techniques used to produce usable quantities of these latter two isotopes will be discussed

Production of Radioisotopes and Radiopharmaceuticals at the Dalat Nuclear Research Reactor

International Nuclear Information System (INIS)

Duong Van Dong; Pham Ngoc Dien; Bui Van Cuong; Mai Phuoc Tho; Nguyen Thi Thu; Vo Thi Cam Hoa

2014-01-01

After reconstruction, the Dalat Nuclear Research Reactor (DNRR) was inaugurated on March 20th, 1984 with the nominal power of 500 kW. Since then the production of radioisotopes and labelled compounds for medical use was started. Up to now, DNRR is still the unique one in Vietnam. The reactor has been operated safely and effectively with the total of about 37,800 hrs (approximately 1,300 hours per year). More than 90% of its operation time and over 80% of its irradiation capacity have been exploited for research and production of radioisotopes. This paper gives an outline of the radioisotope production programme using the DNRR. The production laboratory and facilities including the nuclear reactor with its irradiation positions and characteristics, hot cells, production lines and equipment for the production of Kits for labelling with 99m Tc and for quality control, as well as the production rate are mentioned. The methods used for production of 131 I, 99m Tc, 51 Cr, 32 P, etc. and the procedures for preparation of radiopharmaceuticals are described briefly. Status of utilization of domestic radioisotopes and radiopharmaceuticals in Vietnam is also reported. (author)

Radioisotope Production Plan and Strategy of Kijang Research Reactor

Energy Technology Data Exchange (ETDEWEB)

Lee, Kye Hong; Lee, Jun Sig [Korea Atomic Energy Research Institute, Daejeon (Korea, Republic of)

2015-05-15

This reactor will be located at Kijang, Busan, Korea and be dedicated to produce mainly medical radioisotopes. Tc-99m is very important isotope for diagnosis and more than 80% of radiation diagnostic procedures in nuclear medicine depend on this isotope. There were, however, several times of insecure production of Mo-99 due to the shutdown of major production reactors worldwide. OECD/NEA is leading member countries to resolve the shortage of this isotope and trying to secure the international market of Mo-99. The radioisotope plan and strategy of Kijang Research Reactor (KJRR) should be carefully established to fit not only the domestic but also international demand on Mo-99. The implementation strategy of 6 principles of HLG-MR should be established that is appropriate to national environments. Ministry of Science, ICT and Future Planning and Ministry of Health and welfare should cooperate well to organize the national radioisotope supply structure, to set up the reasonable and competitive pricing of radioisotopes, and to cope with the international supply strategy.

Review of Compact Commercial Accelerator Products and Applications.

Science.gov (United States)

Jongen, Y.

1997-05-01

Historically, particle accelerators were developed initially for nuclear, then for particle physics research. From this research resulted applications of accelerators in the field of medicine and industry. These application-oriented accelerators are generally built commercially, and they often emphasize other qualities than the accelerators for research. The research applications frequently require energies or beam qualities at the limit of the existing technologies. They offer the largest flexibility in term of particles and beam properties, but are more complex, more expensive and often require large and highly qualified staff to operate and maintain them. In contrast, most applications are done with low to moderate energy protons or electrons, but often with large average beam power. The accelerators are generally specialized for a specific application, and are therefore very simple and inexpensive to operate. The author will review some applications in the field of medicine, such as the production of radio-isotopes for medical diagnostic or the production of electrons, protons or fast neutron beams for cancer therapy. In the industrial field, high power electron beam are used for sterilization and for the modification of materials. Log No. 1001

Production of radioisotopes within a plasma focus device

International Nuclear Information System (INIS)

Angeli, E.; Tartari, A.; Frignani, M.; Molinari, V.; Mostacci, D.; Rocchi, F.; Sumini, M. . E-mail address of corresponding author: domiziano.mostacci@mail.ing.unibo.it

2005-01-01

In recent years, research conducted in the US and in Italy has demonstrated production of radioisotopes in Plasma Focus (PF) devices, and particularly, on what could be termed 'endogenous' production, to wit, production within the plasma itself, as opposed to irradiation of targets. This technique relies on the formation of localized small plasma zones characterized by very high densities and fairly high temperatures. The conditions prevailing in these zones lead to high nuclear reaction rates, as pointed out in previous work by several authors. Further investigation of the cross sections involved has proven necessary to model the phenomena involved. In this paper, the present status of research in this field is reviewed, both with regards to cross section models and to experimental production of radioisotopes. Possible outcomes and further development are discussed. (author)

Prospective production of radioisotopes and radiopharmaceuticals in divisions of IPPE

International Nuclear Information System (INIS)

Terentyev, G.O.

2001-01-01

The first reason to commence the work on production of radioisotope production in IPPE, was the requirement of Russia medicine for original generators of technetium. The essential extension of their production in conditions of Moscow city has met the declaiming of the Moscow urban authorities. The important moment was that, in IPPE were objective possibilities to deployment the production of radioisotope production. Nowadays, nomenclature of the radioisotopes which have been produced in IPPE, constitutes 29 positions. The profile of production of radioisotope production was generated also. Restricted possibilities of the ray base, from one side, and the needs(requirement) of domestic medicine with other, in main have spotted this profile. The raw isotopes constitute a minority - on sales volumes ∼ 20 % (in main abroad), the defining part is constituted the form ready for the use by ∼ 80 % (in main in Russia). All 'know-how' is conditionally possible to divide into 3 categories: Base. It is technologies provided with an operating production sector, guaranteeing stable on quality production having a rather wide seller's market; Perspective. It is those technologies, in which the main stages of RESEARCH and DEVELOPMENT are fulfilled with positive result, but the working sites yet are not generated, and on the market are delivered only some samples of production. Are guessed RESEARCH AND DEVELOPMENT on perfecting the technology; Preparative. The technology, on which there are no regular orders, is not required of an individual working site. Sometimes it is rather precision operations, bound with usage of unique raw material, with a very stiff price of production. (authors)

Nuclear data for the production of radioisotopes in fusion materials irradiation facility

International Nuclear Information System (INIS)

Cheng, E.T.; Schenter, R.E.; Mann, F.M.; Ikeda, Y.

1991-01-01

The fusion materials irradiation facility (FMIF) is a neutron source generator that will produce a high-intensity 14-MeV neutron field for testing candidate fusion materials under reactor irradiation conditions. The construction of such a facility is one of the very important development stages toward realization of fusion energy as a practical energy source for electricity production. As a result of the high-intensity neutron field, 10 MW/m 2 or more equivalent neutron wall loading, and the relatively high-energy (10- to 20-MeV) neutrons, the FMIF, as future fusion reactors, also bears the potential capability of producing a significant quantity of radioisotopes. A study is being conducted to identify the potential capability of the FMIF to produce radioisotopes for medical and industrial applications. Two types of radioisotopes are involved: one is already available; the second might not be readily available using conventional production methods. For those radioisotopes that are not readily available, the FMIF could develop significant benefits for future generations as a result of the availability of such radioisotopes for medical or industrial applications. The current production of radioisotopes could help finance the operation of the FMIF for irradiating the candidate fusion materials; thus this concept is attractive. In any case, nuclear data are needed for calculating the neutron flux and spectrum in the FMIF and the potential production rates of these isotopes. In this paper, the authors report the result of a preliminary investigation on the production of 99 Mo, the parent radioisotope for 99m Tc

Current status of production and research of radioisotopes and radiopharmaceuticals in Indonesia

International Nuclear Information System (INIS)

Soenarjo, Sunarhadijoso; Tamat, Swasono R.

2000-01-01

The use of radioactive preparation in Indonesia has sharply increased during the past years, indicated by increase of the number of companies utilizing radioisotopes during 1985 to 1999. It has been clearly stressed in the BATAN's Strategic Plan for 1994-2014 that the production of radioisotopes and radiopharmaceuticals is one of five main industrial fields within the platform of the Indonesian nuclear industry. Research programs supporting the production of radioisotopes and radiopharmaceuticals as well as development of production technology are undertaken by the Research Center for Nuclear Techniques (RCNT) in Bandung and by the Radioisotope Production Center (RPC) in Serpong, involving cooperation with other research center within BATAN, universities and hospitals as well as overseas nuclear research institution. The presented paper describes production and research status of radioisotopes and radiopharmaceuticals in Indonesia after the establishment of P.T. Batan Teknologi in 1996, a government company assigned for activities related to the commercial application of nuclear technology. The reviewed status is divided into two short periods, i.e. before and after the Chairman Decree No. 73/KA/IV/1999 declaring new BATAN organizational structure. Subsequent to the Decree, all commercial requests for radioisotopes and radiopharmaceuticals are fulfilled by P.T. Batan Teknologi, while demands on novel radioactive preparations or new processing technology, as well as research and development activities should be fulfilled by the Center for the Development of Radioisotopes and Radiopharmaceuticals (CDRR) through non-commercial arrangement. The near-future strategic research programs to response to dynamic public demand are also discussed. The status of research cooperation with JAERI (Japan) is also reported. (author)

Cyclotron production of molecules labelled with short-lived radioisotopes β+ emitters (15O, 13N, 11C) and their clinical uses

International Nuclear Information System (INIS)

Bougharouat, B.

1981-01-01

Clinical use of three short-lived radioisotopes: 15 O, 13 N and 11 C is studied on two complementary aspects. A production and purification system is realized; detection instruments in medical use are studied. The production of labelled molecules with the three radiotracers 15 O, 13 N, 11 C from the target bombardment with charged and accelerated particles was studied [fr

Design study and heat transfer analysis of a neutron converter target for medical radioisotope production

International Nuclear Information System (INIS)

Masoud Behzad; Sang-In Bak; Seung-Woo Hong; Jong-Seo Chai; Yacine Kadi; Claudio Tenreiro; University of Talca, Talca

2014-01-01

A worldwide challenge in the near future will be to find a way of producing radioisotopes in sufficient quantity without relying on research reactors. The motivation for this innovative work on targets lies in the accelerator-based production of radioisotopes using a neutron converter target as in the transmutation by adiabatic resonance crossing concept. Thermal analysis of a multi-channel helium cooled device is performed with the computational fluid dynamics code CFX. Different boundary conditions are taken into account in the simulation process and many important parameters such as maximum allowable solid target temperature as well as uniform inlet velocity and outlet pressure changes in the channels are investigated. The results confirm that the cooling configuration works well; hence such a solid target could be operated safely and may be considered for a prototype target. (author)

Current utilization of research reactor on radioisotopes production in China

International Nuclear Information System (INIS)

Liu Yishu

2000-01-01

The main technical parameters of the four research reactors and their current utilization status in radioisotope manufacture and labeling compounds preparation are described. The radioisotopes, such as Co-60 sealed source, Ir-192 sealed source, γ-knife source, I-131, I-125, Sm-153, P-32 series products, In-113m generator, Tc-99m gel generator, Re-188 gel generator, C-14, Ba-131, Sr-89, 90 Y, etc., and their labeling compounds prepared from the reactor produced radionuclides, such as I-131-MIBG, I-131-Hippure, I-131-capsul, Sm-153-EDTMP, Re-186-HEDP, Re-186-HA, C-14-urea, and radioimmunoassay kits etc. are presented as well. Future development plan of radioisotopes and labeling compounds in China is also given. Simultaneously, the possibility and methods of bilateral or multilateral co-operation in utilization of research reactor, personnel and technology exchange of radioisotope production and labeling compounds is also discussed. (author)

Current utilization of research reactor on radioisotopes production in China

Energy Technology Data Exchange (ETDEWEB)

Liu Yishu [Nuclear Power Institute of China, Chengdu (China)

2000-10-01

The main technical parameters of the four research reactors and their current utilization status in radioisotope manufacture and labeling compounds preparation are described. The radioisotopes, such as Co-60 sealed source, Ir-192 sealed source, {gamma}-knife source, I-131, I-125, Sm-153, P-32 series products, In-113m generator, Tc-99m gel generator, Re-188 gel generator, C-14, Ba-131, Sr-89, {sup 90}Y, etc., and their labeling compounds prepared from the reactor produced radionuclides, such as I-131-MIBG, I-131-Hippure, I-131-capsul, Sm-153-EDTMP, Re-186-HEDP, Re-186-HA, C-14-urea, and radioimmunoassay kits etc. are presented as well. Future development plan of radioisotopes and labeling compounds in China is also given. Simultaneously, the possibility and methods of bilateral or multilateral co-operation in utilization of research reactor, personnel and technology exchange of radioisotope production and labeling compounds is also discussed. (author)

Current status of production and research of radioisotopes and radiopharmaceuticals in Indonesia

Energy Technology Data Exchange (ETDEWEB)

Soenarjo, Sunarhadijoso; Tamat, Swasono R. [Center for Development of Radioisotopes and Radiopharmaceuticals, National Nuclear Energy Agency (BATAN), Kawasan Puspiptek, Serpong, Tangerang (Indonesia)

2000-10-01

The use of radioactive preparation in Indonesia has sharply increased during the past years, indicated by increase of the number of companies utilizing radioisotopes during 1985 to 1999. It has been clearly stressed in the BATAN's Strategic Plan for 1994-2014 that the production of radioisotopes and radiopharmaceuticals is one of five main industrial fields within the platform of the Indonesian nuclear industry. Research programs supporting the production of radioisotopes and radiopharmaceuticals as well as development of production technology are undertaken by the Research Center for Nuclear Techniques (RCNT) in Bandung and by the Radioisotope Production Center (RPC) in Serpong, involving cooperation with other research center within BATAN, universities and hospitals as well as overseas nuclear research institution. The presented paper describes production and research status of radioisotopes and radiopharmaceuticals in Indonesia after the establishment of P.T. Batan Teknologi in 1996, a government company assigned for activities related to the commercial application of nuclear technology. The reviewed status is divided into two short periods, i.e. before and after the Chairman Decree No. 73/KA/IV/1999 declaring new BATAN organizational structure. Subsequent to the Decree, all commercial requests for radioisotopes and radiopharmaceuticals are fulfilled by P.T. Batan Teknologi, while demands on novel radioactive preparations or new processing technology, as well as research and development activities should be fulfilled by the Center for the Development of Radioisotopes and Radiopharmaceuticals (CDRR) through non-commercial arrangement. The near-future strategic research programs to response to dynamic public demand are also discussed. The status of research cooperation with JAERI (Japan) is also reported. (author)

Present status of radioisotope production in JAERI

International Nuclear Information System (INIS)

Yamabayashi, Hisamichi

1994-01-01

Since 1962, the technology for producing a wide variety of processed radioisotopes and sealed radiation sources has been developed by using the reactors, JRR-1, JRR-2, JRR-3, JRR-4 and JMTR, and the products have been offered to domestic users. At present, 31 products of 29 nuclides are on the list of processed radioisotopes. Some of those isotopes such as P-32, S-35, Cr-51 and short lived nuclides are produced for regular distribution, but the rest are produced upon request. The radiation sources of Co-60 needles for industrial use, Ir-192 pellets for the nondestructive inspection of pipelines, Gd-153 pellets for the diagnosis of born mineral and seven kinds of brachy therapy Ir-192 and Au-198 grains are produced and distributed regularly. The organic compounds labeled with H-3 and C-14 are widely used. In fiscal year 1992, 34 batches and total amount 12 TBq of processed radioisotopes and 100 batches, 1.2 PBq of radiation sources were produced as scheduled. The development of the techniques for producing the sources emitting high energy β ray used for the diagnosis and treatment of cancer is in progress. The method of producing new isotopes is developed. (K.I.)

Production and application of radioisotopes in Asian Countries

International Nuclear Information System (INIS)

He Youfeng

1997-01-01

Production and application of radioisotopes in some Asian countries including Bangladesh, India, Indonesia, Iran, Japan, Republic of Korea, Malaysia, Pakistan, Philippines, Thailand, Uzbekistan, and Viet Nam are introduced

Decontamination of radioisotope production facility

International Nuclear Information System (INIS)

Daryoko, M.; Yatim, S.; Suseno, H.; Wiratmo, M.

1998-01-01

The strippable coating method use phosphoric glycerol and irradiated latex as supporting agents have been investigated. The investigation used some decontaminating agents: EDTA, citric acid, oxalic acid and potassium permanganate were combined with phosphoric glycerol supporting agent, then EDTA Na 2 , sodium citric, sodium oxalic and potassium permanganate were combined with irradiated latex supporting agent. The study was needed to obtain the representative operating data, will be implemented to decontamination the Hot Cell for radioisotope production. The experiment used 50x50x1 mm stainless steel samples and contaminated by Cs-137 about 1.1x10 -3 μCi/cm 2 . This samples according to inner cover of Hot Cell material, and Hot Cell activities. The decontamination factor results of the investigation were: phosphoric glycerol as supporting agent, about 20 (EDTA as decontaminating agent) to 47 (oxalic acid as decontaminating agent), and irradiated latex as supporting agent, about 11.5 (without decontamination agent) to 27 (KMnO 4 as decontaminating agent). All composition of the investigation have been obtained the good results, and can be implemented for decontamination of Hot Cell for radioisotope production. The irradiated latex could be recommended as supporting agent without decontaminating agent, because it is very easy to operate and very cheap cost. (author)

Medical radioisotope production - the Australian experience

Energy Technology Data Exchange (ETDEWEB)

Druce, M. [Australian Nuclear Science and Technology Organisation, Menai (Australia)

1996-12-31

The Australian government, through its instrumentality, the Australian Nuclear Science and Technology Organization (ANSTO), owns and operates a 10-MW Dido-class research reactor at Lucas Heights on the southern outskirts of Sydney. This is the only operating nuclear reactor in Australia. It was built in 1958 and has a maximum flux of 1 x 10{sup 14} n/cm{sup 2}{center_dot}s. ANSTO also jointly owns and operates a 30-MeV IBA negative ion cyclotron at Camperdown in central Sydney, which began operation in 1992. ANSTO is predominantly a research organization; however, radioisotopes are commercially produced through Australian Radioisotopes (ARI), an ANSTO business entity. Seventy-four people are employed by ARI, which is a vertically integrated organization, i.e., everything from target preparation to sale of products is undertaken.

Production capabilities in US nuclear reactors for medical radioisotopes

Energy Technology Data Exchange (ETDEWEB)

Mirzadeh, S.; Callahan, A.P.; Knapp, F.F. Jr. (Oak Ridge National Lab., TN (United States)); Schenter, R.E. (Westinghouse Hanford Co., Richland, WA (United States))

1992-11-01

The availability of reactor-produced radioisotopes in the United States for use in medical research and nuclear medicine has traditionally depended on facilities which are an integral part of the US national laboratories and a few reactors at universities. One exception is the reactor in Sterling Forest, New York, originally operated as part of the Cintichem (Union Carbide) system, which is currently in the process of permanent shutdown. Since there are no industry-run reactors in the US, the national laboratories and universities thus play a critical role in providing reactor-produced radioisotopes for medical research and clinical use. The goal of this survey is to provide a comprehensive summary of these production capabilities. With the temporary shutdown of the Oak Ridge National Laboratory (ORNL) High Flux Isotope Reactor (HFIR) in November 1986, the radioisotopes required for DOE-supported radionuclide generators were made available at the Brookhaven National Laboratory (BNL) High Flux Beam Reactor (HFBR). In March 1988, however, the HFBR was temporarily shut down which forced investigators to look at other reactors for production of the radioisotopes. During this period the Missouri University Research Reactor (MURR) played an important role in providing these services. The HFIR resumed routine operation in July 1990 at 85 MW power, and the HFBR resumed operation in June 1991, at 30 MW power. At the time of the HFBR shutdown, there was no available comprehensive overview which could provide information on status of the reactors operating in the US and their capabilities for radioisotope production. The obvious need for a useful overview was thus the impetus for preparing this survey, which would provide an up-to-date summary of those reactors available in the US at both the DOE-funded national laboratories and at US universities where service irradiations are currently or expected to be conducted.

Production capabilities in US nuclear reactors for medical radioisotopes

International Nuclear Information System (INIS)

Mirzadeh, S.; Callahan, A.P.; Knapp, F.F. Jr.; Schenter, R.E.

1992-11-01

The availability of reactor-produced radioisotopes in the United States for use in medical research and nuclear medicine has traditionally depended on facilities which are an integral part of the US national laboratories and a few reactors at universities. One exception is the reactor in Sterling Forest, New York, originally operated as part of the Cintichem (Union Carbide) system, which is currently in the process of permanent shutdown. Since there are no industry-run reactors in the US, the national laboratories and universities thus play a critical role in providing reactor-produced radioisotopes for medical research and clinical use. The goal of this survey is to provide a comprehensive summary of these production capabilities. With the temporary shutdown of the Oak Ridge National Laboratory (ORNL) High Flux Isotope Reactor (HFIR) in November 1986, the radioisotopes required for DOE-supported radionuclide generators were made available at the Brookhaven National Laboratory (BNL) High Flux Beam Reactor (HFBR). In March 1988, however, the HFBR was temporarily shut down which forced investigators to look at other reactors for production of the radioisotopes. During this period the Missouri University Research Reactor (MURR) played an important role in providing these services. The HFIR resumed routine operation in July 1990 at 85 MW power, and the HFBR resumed operation in June 1991, at 30 MW power. At the time of the HFBR shutdown, there was no available comprehensive overview which could provide information on status of the reactors operating in the US and their capabilities for radioisotope production. The obvious need for a useful overview was thus the impetus for preparing this survey, which would provide an up-to-date summary of those reactors available in the US at both the DOE-funded national laboratories and at US universities where service irradiations are currently or expected to be conducted

Solid targets for production of radioisotopes with cyclotron

International Nuclear Information System (INIS)

Paredes G, L.; Balcazar G, M.

1999-01-01

The design of targets for production of radioisotopes and radiopharmaceuticals of cyclotron to medical applications requires a detailed analysis of several variables such as: cyclotron operation conditions, choice of used materials as target and their physicochemical characteristics, activity calculation, the yielding of each radioisotope by irradiation, the competition of nuclear reactions in function of the projectiles energy and the collision processes amongst others. The objective of this work is to determine the equations for the calculation for yielding of solid targets at the end of the proton irradiation. (Author)

Hospital-based proton linear accelerator for particle therapy and radioisotope production

Science.gov (United States)

Lennox, Arlene J.

1991-05-01

Taking advantage of recent advances in linear accelerator technology, it is possible for a hospital to use a 70 MeV proton linac for fast neutron therapy, boron neutron capture therapy, proton therapy for ocular melanomas, and production of radiopharmaceuticals. The linac can also inject protons into a synchrotron for proton therapy of deep-seated tumors. With 180 μA average current, a single linac can support all these applications. This paper presents a conceptual design for a medical proton linac, switchyard, treatment rooms, and isotope production rooms. Special requirements for each application are outlined and a layout for sharing beam among the applications is suggested.

Reactor production and processing of radioisotopes for therapeutic applications in nuclear medicine

International Nuclear Information System (INIS)

Knapp, F.F. Jr.; Mirzadeh, S.; Beets, A.L.

1995-01-01

Nuclear reactors continue to play an important role in providing radioisotopes for nuclear medicine. Many reactor-produced radioisotopes are ''neutron rich'' and decay by beta-emission and are thus of interest for therapeutic applications. This talk discusses the production and processing of a variety of reactor-produced radioisotopes of current interest, including those produced by the single neutron capture process, double neutron capture and those available from beta-decay of reactorproduced radioisotopes. Generators prepared from reactorproduced radioisotopes are of particular interest since repeated elution inexpensively provides many patient doses. The development of the alumina-based W-188/Re-188 generator system is discussed in detail

Administration of radioisotope production

Energy Technology Data Exchange (ETDEWEB)

NONE

1964-01-15

Current developments in atomic energy, and the administrative problems to which they give rise, were surveyed in a seminar on 'Atomic Energy for Atomic Energy Administrators' held at IAEA headquarters from 30 September to 4 October 1963. The ground covered included protection against radiation, isotopes and radiation sources, research reactors, nuclear power, legal matters, technical and scientific administration, the role of the universities, and the Agency's part in assistance to developing countries. The possibilities and limitations of radioisotope production from research reactors were discussed by Dr. G. B. Cook, of the Division of Research and Laboratories, IAEA in this paper.

Administration of radioisotope production

International Nuclear Information System (INIS)

1964-01-01

Current developments in atomic energy, and the administrative problems to which they give rise, were surveyed in a seminar on 'Atomic Energy for Atomic Energy Administrators' held at IAEA headquarters from 30 September to 4 October 1963. The ground covered included protection against radiation, isotopes and radiation sources, research reactors, nuclear power, legal matters, technical and scientific administration, the role of the universities, and the Agency's part in assistance to developing countries. The possibilities and limitations of radioisotope production from research reactors were discussed by Dr. G. B. Cook, of the Division of Research and Laboratories, IAEA in this paper.

Radioisotope production in Malaysia

Energy Technology Data Exchange (ETDEWEB)

Wan Awang, Wan Anuar [Medical Technology Div., Malaysian Inst. for Nuclear Technology Research (MINT) (Malaysia)

1998-10-01

Production of Mo-99 by neutron activation of Mo-99 in Malaysia began as early as 1984. Regular supply of the Tc-99m extracted from it to the hospitals began in early 1988 after going through formal registration with the Malaysian Ministry of Health. Initially, the weekly demand was about 1.2 Ci of Mo-99 which catered the needs of 3 nuclear medicine centres. Sensitive to the increasing demand of Tc-99m, we have producing our own Tc-99m generator from imported TeO{sub 2} because irradiation TeO{sub 2} with our reactor give low yield of I-131. We have established the production of radioisotope for industrial use. By next year, Sm-153 EDTMP will be produce after we have license from our competent authority. (author)

Transmission factors for neutrons produced by radioisotopes production used in PET

International Nuclear Information System (INIS)

Hernandez G, D.; Cruzate, J.A.

1996-01-01

The dose transmission factor for normal concrete and the neutrons produced in the 18 O(p,n) 18 F and 13 C(p,n) 13 N reactions are presented in this paper. These transmission factors permit to simplify the calculation of the necessary accelerator shielding to be used in the radioisotope production for positron emission tomography. The energy distributions of the neutrons resulting from the irradiation of thick targets, with 10 to 13 MeV protons, were determined using the thin target cross sections, the energy loss per path length and the energy balance of the reaction (Q-equation). The one dimensional discrete ordinate transport code ANISN and the conversion coefficients from fluence to dose, presented in the ICRP Publication 51 were employed to obtain the transmission factors. (authors). 12 refs., 3 figs., 2 tabs

Recent progress in radioisotope production in Vietnam

Energy Technology Data Exchange (ETDEWEB)

So, Le Van [Radioisotope Dept., Nuclear Research Institute, Dalat (Viet Nam)

1998-10-01

This is a report on the recent progress in radioisotope production in Vietnam. Using a nuclear research reactor of 500 KW with continuous operation cycles of 100 hours a month, the production of some important radioisotopes used in nuclear medicine and research was routinely carried out. More than 80 per cent of irradiation capacity of reactor for radioisotope production were exploited. The radioactivity of more than 150 Ci of {sup 131}I, {sup 99}Mo-{sup 99m}Tc, {sup 32}P, {sup 51}Cr, {sup 153}Sm, {sup 46}Sc, {sup 192}Ir was produced annually. Radiopharmaceuticals such as {sup 131}I-Hippuran and in-vivo Kits for {sup 99m}Tc labelling were also prepared routinely and regularly. More than 10 in-vivo Kits including modern radiopharmaceuticals such as HmPAO kit were supplied to hospitals in Vietnam. The research on the improvement of dry distillation technology for production of {sup 131}I was carried out. As a result obtained a new distillation apparatus made from glass was successfully put to routine use in place of expensive quartz distillation furnace. We have also continued the research programme on the development of {sup 99m}Tc generators using low power research reactors. Gel technology using Zr- and Ti- molybdate gel columns for {sup 99m}Tc generator production was developed and improved continually. Portable {sup 99m}Tc generator using Zr-({sup 99}Mo) molybdate gel column and ZISORB adsorbent column for {sup 99m}Tc concentration were developed. The ZISORB adsorbent of high adsorption capacity for {sup 99}Mo and other parent radionuclides was also studied for the development purpose of alternative technology of {sup 99m}Tc and other different radionuclide generator systems. The studies on the preparation of therapeutic radiopharmaceuticals labelling with {sup 153}Sm and {sup 131}I such as {sup 153}Sm-EDTMP, {sup 131}I-MIBG were carried out. (author)

Present situation of the production and use of radioisotopes in France

International Nuclear Information System (INIS)

Fisher, Charlie

1974-01-01

As the sole large scale producer of radioisotopes in France, the Commissariat a l'Energie Atomique is keeping up pace with all developments in medical, biological and industrial areas. This production will reach the turnover close to 40 million F in 1973. About 65% of the products will go to medical market, 10% to biology and the remaining 25% to industry. As medical products, many radioisotopes are used for in-vivo diagnosis, while radioimmunology techniques are well known in in-vitro diagnosis. There has been very few noticeable development in therapeutics. Also there is steadily increasing demand for 14 C, 3 H and 13 C-labelled materials which are used to study metabolism of natural substances and drugs. The industrial utilization of radioisotopes in France is developed by CEA as well as several industrial companies. Trend must be analyzed for the different segments of the market which includes tracer utilization, instrumentation, large source technology such as sterilization of medical supplies, activation analysis and isotopic generators. (Wakatsuki, Y.)

Preparing for Harvesting Radioisotopes from FRIB

Energy Technology Data Exchange (ETDEWEB)

Peaslee, Graham F. [Hope College, Holland, MI (United States); Lapi, Suzanne E. [Washington Univ., St. Louis, MO (United States)

2015-02-02

The Facility for Rare Isotope Beams (FRIB) is the next generation accelerator facility under construction at Michigan State University. FRIB will produce a wide variety of rare isotopes by a process called projectile fragmentation for a broad range of new experiments when it comes online in 2020. The accelerated rare isotope beams produced in this facility will be more intense than any current facility in the world - in many cases by more than 1000-fold. These beams will be available to the primary users of FRIB in order to do exciting new fundamental research with accelerated heavy ions. In the standard mode of operation, this will mean one radioisotope will be selected at a time for the user. However, the projectile fragmentation process also yields hundreds of other radioisotopes at these bombarding energies, and many of these rare isotopes are long-lived and could have practical applications in medicine, national security or the environment. This project developed new methods to collect these long-lived rare isotopes that are by-products of the standard FRIB operation. These isotopes are important to many areas of research, thus this project will have a broad impact in several scientific areas including medicine, environment and homeland security.

Twenty years of radioisotope production from Institute of Atomic Energy reactors

International Nuclear Information System (INIS)

Lun, Xiao

1980-01-01

The heavy water reactor in People's Republic of China went critical in November, 1958, and the radioisotope development work began since then. The thermal power of the reactor was 7 MW, and the maximum thermal neutron flux was 1.2 x 10 14 n/cm 2 /sec. Since 1967, it was operated at 10 MW. The first radioisotope product was 24 Na, using Na 2 CO 3 as a target, while the first chemically processed product was an electroplated reference source of 60 Co. The first processed radiochemical was the carrier-free H 2 SO 4 of 35 S. Since then, 131 I and 32 P for medical uses, colloidal 198 Au, colloidal Cr 32 PO 4 , chemicals containing 203 Hg, organic compounds labelled with 125 I, 131 I, 3 H and 14 C and smoke detectors have been produced to date. In addition, 22 Na, 54 Mn, 57 Co, 88 Y, 109 Cd have been prepared from a cyclotron. Now about 140 kinds of products can be supplied, and 60% of the users are the hospitals with nuclear medicine department. The present status of the kinds and production figures of nuclear medicines, radiopharmaceuticals, labelled compounds, radiation sources, and some works in progress are reported. General aspects of the application of radioisotopes in China are also described. Radioisotopes have been applied to agriculture, industry, medicine, and sciences such as physics, chemistry, biology and geography. (Wakatsuki, Y.)

Application of radiation and radioisotopes in life science

International Nuclear Information System (INIS)

Nakanishi, Tomoko M.

2005-01-01

Radiation and Radioisotopes have been played an important role in the wide range of life science, from the field study, such as fertilizer or pesticide development or production of new species, to gene engineering researches. Many mutants through radiation have been provided to the market and the usage of radioactive tracers was an effective tool to study plant physiology. It has been granted that the contribution of radioisotopes has been accelerated the development of the gene engineering technology, which is now overwhelming all the other usages of radiation or radioisotopes. However, because of the difficulty to get social acceptance for gene modified plants, the orientation of the life science is now changing towards, so called ''post genome era''. Therefore, from the point of radiation or radioisotope usage, new application methods are needed to develop new type of researches. We present how (1) neutron activation analysis, (2) neutron radiography and (3) positron emission tomography are promising to study living plant physiology. Some of these techniques are not necessarily new methods but with a little modification, they show new aspects of plant activity. (author)

Study of surface potential contamination in radioisotope and radiopharmaceutical production facilities and alternative solutions

International Nuclear Information System (INIS)

Suhaedi Muhammad; Rimin Sumantri; Farida Tusafariah; Djarwanti Rahayu Pipin Soedjarwo

2013-01-01

Radioisotope and radiopharmaceutical production facilities that exist in their operations around the world in the form of radiological impacts of radiation exposure, contamination of surface and air contamination. Given the number of existing open source in radioisotope and radiopharmaceutical production facility, then the possibility of surface contamination in the work area is quite high. For that to protect the safety and health of both workers, the public and the environment, then the licensee must conduct an inventory of some of the potential that could result in contamination of surfaces in radioisotope and radiopharmaceutical production facilities. Several potential to cause surface contamination in radioisotope and radiopharmaceutical production facilities consist of loss of resources, the VAC system disorders, impaired production facilities, limited resources and lack of work discipline and radioactive waste handling activities. From the study of some potential, there are several alternative solutions that can be implemented by the licensee to address the contamination of the surface so as not to cause adverse radiological impacts for both radiation workers, the public or the environment. (author)

Radioisotope production at the cyclotron in Rio de Janeiro, Brazil

International Nuclear Information System (INIS)

Silva, A.G. da; Lemos, O.F.; Britto, J.L.O. de; Osso, J.A.; Bastos, M.A.V.; Braghirolli, A.M.S.; Chamma, D.F.S.; Newton, G.W.A.; Weinreich, R.

1982-01-01

A radioisotope production laboratory has been installed at Instituto de Engenharia Nuclear in Rio de Janeiro. It is intended primarily for processing short-lived radioisotopes produced by a multiparticle, variable energy, isochronous, compact CV-28 Cyclotron and for preparation of radiopharmaceuticals and labelled molecules. Carrier-free iodine-123, indium-111, thalium-201, bromine-77 and gallium-67 with high purity have been produced. An irradiated target transport system has been built. Special targets that can dissipate high surface power densities are being developed. Each radioisotope is processed in a remotely controlled cell equiped with electric and pneumatic systems as well as manipulators ans tongs. Quality control is achieved by atomic absorption spectrophotometry, spot tests, gamma-ray spectroscopy and thin-layer chromatography. Biological tests in mice have confirmed the good quality of the radiopharmaceuticals. (Author) [pt

LANL Activities Supporting Electron Accelerator Production of 99Mo for NorthStar Medical Radioisotopes, LLC

International Nuclear Information System (INIS)

Dale, Gregory E.; Kelsey, Charles T. IV; Woloshun, Keith A.; Holloway, Michael A.; Olivas, Eric R.; Dalmas, Dale A.; Romero, Frank P.; Hurtle, Kenneth P.

2012-01-01

Summary of LANL FY12 Activities are: (1) Preparation, performance, and data analysis for the FY12 accelerator tests at ANL - (a) LANL designed and installed a closed-loop helium target cooling system at ANL for the FY12 accelerator tests, (b) Thermal test was performed on March 27, (c) 24 h production test to follow the accelerator upgrade at ANL; (2) Local target shielding design and OTR/IR recommendations - (a) Target dose rate and activation products were calculated with MCNPX, (b) 206 Pb(γ,2n) 204m Pb vs 204g Pb branching ratio unpublished, will measure using the LANL microtron, (c) OTR system nearing final configuration, (d) IR prototype system demonstrated during the recent thermal test at ANL; (3) Target housing lifetime estimation - Target housing material specifications and design to be finalized following the thermal test, lifetime not believed to be an issue; and (4) Target cooling system reliability - Long duration system characterizations will begin following the thermal test.

Economical and technical feasibility study of some radioisotopes production for medical application

International Nuclear Information System (INIS)

Souza, A.L.A.B. de.

1985-01-01

The economical and technical feasibility study of the production in reactors of some radioisotopes most used in medicine, are presented. The clinical applications of each radioisotope as well as its radioactive concentrations and specific activities are related. Irradiation procedures based in the foregoing data are given. Part of the study is dedicated to quality control. (M.A.C.) [pt

A radioisotope production cyclotron designed to minimize dose

International Nuclear Information System (INIS)

Szlavik, F.F.; Moritz, L.E.

1992-01-01

This paper describes a radioisotope production cyclotron which has been designed to minimize the dose to personnel during operation and maintenance. The design incorporates lessons learned from the operation of a CP42 cyclotron and has resulted in a reduction of the dose by a factor of more than 10. (author)

Manual for reactor produced radioisotopes

International Nuclear Information System (INIS)

2003-01-01

Radioisotopes find extensive applications in several fields including medicine, industry, agriculture and research. Radioisotope production to service different sectors of economic significance constitutes an important ongoing activity of many national nuclear programmes. Radioisotopes, formed by nuclear reactions on targets in a reactor or cyclotron, require further processing in almost all cases to obtain them in a form suitable for use. Specifications for final products and testing procedures for ensuring quality are also an essential part of a radioisotope production programme. The International Atomic Energy Agency (IAEA) has compiled and published such information before for the benefit of laboratories of Member States. The first compilation, entitled Manual of Radioisotope Production, was published in 1966 (Technical Reports Series No. 63). A more elaborate and comprehensive compilation, entitled Radioisotope Production and Quality Control, was published in 1971 (Technical Reports Series No. 128). Both served as useful reference sources for scientists working in radioisotope production worldwide. The 1971 publication has been out of print for quite some time. The IAEA convened a consultants meeting to consider the need for compiling an updated manual. The consultants recommended the publication of an updated manual taking the following into consideration: significant changes have taken place since 1971 in many aspects of radioisotope production; many radioisotopes have been newly introduced while many others have become gradually obsolete; considerable experience and knowledge have been gained in production of important radioisotopes over the years, which can be preserved through compilation of the manual; there is still a need for a comprehensive manual on radioisotope production methods for new entrants to the field, and as a reference. It was also felt that updating all the subjects covered in the 1971 manual at a time may not be practical considering the

The Texas A&M Radioisotope Production and Radiochemistry Program

International Nuclear Information System (INIS)

Akabani, Gamal

2016-01-01

The main motivation of the project at Texas A&M University was to carry out the production of critically needed radioisotopes used in medicine for diagnostics and therapy, and to establish an academic program in radionuclide production and separation methods. After a lengthy battle with the Texas A&M University Radiation Safety Office, the Texas Department of State Health Services granted us a license for the production of radionuclides in July 2015, allowing us to work in earnest in our project objectives. Experiments began immediately after licensing, and we started the assembly and testing of our target systems. There were four analytical/theoretical projects and two experimental target systems. These were for At-211 production and for Zn-62/Cu-62 production. The theoretical projects were related to the production of Mo-99/Tc-99m using a) a subcritical aqueous target system and b) production of Tc-99m from accelerator-generated Mo-99 utilizing a photon-neutron interaction with enriched Mo-100 targets. The two experimental projects were the development of targetry systems and production of At-211 and Zn-62/Cu-62 generator. The targetry system for At-211 has been tested and production of At-211 is chronic depending of availability of beam time at the cyclotron. The installation and testing of the targetry system for the production of Zn-62/Cu-62 has not been finalized. A description of the systems is described. The academic program in radionuclide production and separation methods was initiated in the fall of 2011 and, due to the lack of a radiochemistry laboratory, it was suspended. We expect to re-start the academic program at the Texas A&M Institute for Preclinical Studies under the Molecular Imaging Program.

The Texas A&M Radioisotope Production and Radiochemistry Program

Energy Technology Data Exchange (ETDEWEB)

Akabani, Gamal [Texas A & M Univ., College Station, TX (United States)

2016-08-31

The main motivation of the project at Texas A&M University was to carry out the production of critically needed radioisotopes used in medicine for diagnostic and therapy, and to establish an academic program in radionuclide production and separation methods. After a lengthy battle with the Texas A&M University Radiation Safety Office, the Texas Department of State Health Services granted us a license for the production of radionuclides in July 2015, allowing us to work in earnest in our project objectives. Experiments began immediately after licensing, and we started the assembly and testing of our target systems. There were four analytical/theoretical projects and two experimental target systems. These were for At-211 production and for Zn- 62/Cu-62 production. The theoretical projects were related to the production of Mo-99/Tc-99m using (a) a subcritical aqueous target system and (b) production of Tc-99m from accelerator-generated Mo-99 utilizing a photon-neutron interaction with enriched Mo-100 targets. The two experimental projects were the development of targetry systems and production of At-211 and Zn-62/Cu-62 generator. The targetry system for At-211 has been tested and production of At-211 is chronic depending of availability of beam time at the cyclotron. The installation and testing of the targetry system for the production of Zn-62/Cu-62 has not been finalized. A description of the systems is described. The academic program in radionuclide production and separation methods was initiated in the fall of 2011; due to the lack of a radiochemistry laboratory, it was suspended. We expect to re-start the academic program at the Texas A&M Institute for Preclinical Studies under the Molecular Imaging Program.

The Texas A&M Radioisotope Production and Radiochemistry Program

International Nuclear Information System (INIS)

Akabani, Gamal

2016-01-01

The main motivation of the project at Texas A&M University was to carry out the production of critically needed radioisotopes used in medicine for diagnostic and therapy, and to establish an academic program in radionuclide production and separation methods. After a lengthy battle with the Texas A&M University Radiation Safety Office, the Texas Department of State Health Services granted us a license for the production of radionuclides in July 2015, allowing us to work in earnest in our project objectives. Experiments began immediately after licensing, and we started the assembly and testing of our target systems. There were four analytical/theoretical projects and two experimental target systems. These were for At-211 production and for Zn- 62/Cu-62 production. The theoretical projects were related to the production of Mo-99/Tc-99m using (a) a subcritical aqueous target system and (b) production of Tc-99m from accelerator-generated Mo-99 utilizing a photon-neutron interaction with enriched Mo-100 targets. The two experimental projects were the development of targetry systems and production of At-211 and Zn-62/Cu-62 generator. The targetry system for At-211 has been tested and production of At-211 is chronic depending of availability of beam time at the cyclotron. The installation and testing of the targetry system for the production of Zn-62/Cu-62 has not been finalized. A description of the systems is described. The academic program in radionuclide production and separation methods was initiated in the fall of 2011; due to the lack of a radiochemistry laboratory, it was suspended. We expect to re-start the academic program at the Texas A&M Institute for Preclinical Studies under the Molecular Imaging Program.

The Texas A&M Radioisotope Production and Radiochemistry Program

Energy Technology Data Exchange (ETDEWEB)

Akabani, Gamal [Texas A & M Univ., College Station, TX (United States). Dept. of Nuclear Engineering. Dept. of Veterinary Integrative Biosciences

2016-10-28

The main motivation of the project at Texas A&M University was to carry out the production of critically needed radioisotopes used in medicine for diagnostics and therapy, and to establish an academic program in radionuclide production and separation methods. After a lengthy battle with the Texas A&M University Radiation Safety Office, the Texas Department of State Health Services granted us a license for the production of radionuclides in July 2015, allowing us to work in earnest in our project objectives. Experiments began immediately after licensing, and we started the assembly and testing of our target systems. There were four analytical/theoretical projects and two experimental target systems. These were for At-211 production and for Zn-62/Cu-62 production. The theoretical projects were related to the production of Mo-99/Tc-99m using a) a subcritical aqueous target system and b) production of Tc-99m from accelerator-generated Mo-99 utilizing a photon-neutron interaction with enriched Mo-100 targets. The two experimental projects were the development of targetry systems and production of At-211 and Zn-62/Cu-62 generator. The targetry system for At-211 has been tested and production of At-211 is chronic depending of availability of beam time at the cyclotron. The installation and testing of the targetry system for the production of Zn-62/Cu-62 has not been finalized. A description of the systems is described. The academic program in radionuclide production and separation methods was initiated in the fall of 2011 and, due to the lack of a radiochemistry laboratory, it was suspended. We expect to re-start the academic program at the Texas A&M Institute for Preclinical Studies under the Molecular Imaging Program.

Production, control and utilization of radioisotopes including radiopharmaceuticals

International Nuclear Information System (INIS)

Muenze, R.

1985-05-01

From April 29th to May 5th, 1984 27 participants from 21 developing countries stayed within an IAEA Study Tour ('Production, Control and Utilization of Radioisotopes including Radiopharmaceuticals') in the GDR. In the CINR, Rossendorf the reactor, the cyclotron, the technological centre as well as the animal test laboratory were visited. The participants were made familiar by 10 papers with the development, production and control of radiopharmaceuticals in the CINR, Rossendorf. (author)

Tailoring medium energy proton beam to induce low energy nuclear reactions in ⁸⁶SrCl₂ for production of PET radioisotope ⁸⁶Y.

Science.gov (United States)

Medvedev, Dmitri G; Mausner, Leonard F; Pile, Philip

2015-07-01

This paper reports results of experiments at Brookhaven Linac Isotope Producer (BLIP) aiming to investigate effective production of positron emitting radioisotope (86)Y by the low energy (86)Sr(p,n) reaction. BLIP is a facility at Brookhaven National Laboratory designed for the proton irradiation of the targets for isotope production at high and intermediate proton energies. The proton beam is delivered by the Linear Accelerator (LINAC) whose incident energy is tunable from 200 to 66 MeV in approximately 21 MeV increments. The array was designed to ensure energy degradation from 66 MeV down to less than 20 MeV. Aluminum slabs were used to degrade the proton energy down to the required range. The production yield of (86)Y (1.2+/-0.1 mCi (44.4+/-3.7) MBq/μAh) and ratio of radioisotopic impurities was determined by assaying an aliquot of the irradiated (86)SrCl2 solution by gamma spectroscopy. The analysis of energy dependence of the (86)Y production yield and the ratios of radioisotopic impurities has been used to adjust degrader thickness. Experimental data showed substantial discrepancies in actual energy propagation compared to energy loss calculations. Copyright © 2015 Elsevier Ltd. All rights reserved.

Production of Medical Isotopes with Electron Linacs

Energy Technology Data Exchange (ETDEWEB)

Rotsch, D A; Alford, K.; Bailey, J. L.; Bowers, D. L.; Brossard, T.; Brown, M. A.; Chemerisov, S. D.; Ehst, D.; Greene, J.; Gromov, R. G.; Grudzinski, J.J.; Hafenrichter, L.; Hebden, A. S.; Henning, W.; Heltemes, T. A.; Jerden, J.; Jonah, C. D.; Kalensky, M.; Krebs, J. F.; Makarashvili, V.; Micklich, B.; Nolen, J.; Quigley, K. J.; Schneider, J. F.; Smith, N. A.; Stepinski, D. C.; Sun, Z.; Tkac, P.; Vandegrift, G. F.; Virgo, M J; Wesolowski, K. A.; Youker, A. J.

2017-06-01

Radioisotopes play important roles in numerous areas ranging from medical treatments to national security and basic research. Radionuclide production technology for medical applications has been pursued since the early 1900s both commercially and in nuclear science centers. Many medical isotopes are now in routine production and are used in day-to-day medical procedures. Despite these advancements, research is accelerating around the world to improve the existing production methodologies as well as to develop novel radionuclides for new medical appli-cations. Electron linear accelerators (linacs) represent a unique method for the production of radioisotopes. Even though the basic technology has been around for decades, only recently have electron linacs capable of producing photons with sufficient energy and flux for radioisotope production become available. Housed in Argonne Nation-al Laboratory’s Low Energy Accelerator Facility (LEAF) is a newly upgraded 55 MeV/25-kW electron linear ac-celerator, capable of producing a wide range of radioiso-topes. This talk will focus on the work being performed for the production of the medical isotopes 99Mo (99Mo/99mTc generator), 67Cu, and 47Sc.

Radiation protection and dosimetry problems around medium energy accelerators

Energy Technology Data Exchange (ETDEWEB)

Pavlovic, R; Pavlovic, S; Markovic, S [Inst. of Nuclear Sciences Vinca, Belgrade (Yugoslavia); Boreli, F [Fac. of Electrical Engineering, Belgrade (Yugoslavia)

1996-12-31

In the Institute of Nuclear Sciences `VINCA`, the Accelerator Installation `TESLA`, which is an ion accelerator facility consisting of an isochronous cyclotron `VINCY`, a heavy ion source, a D{sup -} / H{sup -} ion source, three low energy and five high energy experimental channels is now under construction. The Tesla Accelerator Installation should by the principal facility for basic and applied research in physics, chemistry, biology, and material science, as well as for production of radioisotopes, medical diagnostics and therapy with radioisotopes and accelerated particle beams. Some problems in defining radiation protection and safety programme, particularly problems in construction appropriate shielding barriers at the Accelerator Installation `TESLA` are discussed in this paper. (author) 1 fig., 9 refs.

Measurement cross sections for radioisotopes production

International Nuclear Information System (INIS)

Garrido, E.

2011-01-01

New radioactive isotopes for nuclear medicine can be produced using particle accelerators. This is one goal of Arronax, a high energy - 70 MeV - high intensity - 2*350 μA - cyclotron set up in Nantes. A priority list was established containing β - - 47 Sc, 67 Cu - β + - 44 Sc, 64 Cu, 82 Sr/ 82 Rb, 68 Ge/ 68 Ga - and α emitters - 211 At. Among these radioisotopes, the Scandium 47 and the Copper 67 have a strong interest in targeted therapy. The optimization of their productions required a good knowledge of their cross-sections but also of all the contaminants created during irradiation. We launched on Arronax a program to measure these production cross-sections using the Stacked-Foils' technique. It consists in irradiating several groups of foils - target, monitor and degrader foils - and in measuring the produced isotopes by γ-spectrometry. The monitor - nat Cu or nat Ni - is used to correct beam loss whereas degrader foils are used to lower beam energy. We chose to study the nat Ti(p,X) 47 Sc and 68 Zn(p,2p) 67 Cu reactions. Targets are respectively natural Titanium foil - bought from Goodfellow - and enriched Zinc 68 deposited on Silver. In the latter case, Zn targets were prepared in-house - electroplating of 68 Zn - and a chemical separation between Copper and Gallium isotopes has to be made before γ counting. Cross-section values for more than 40 different reactions cross-sections have been obtained from 18 MeV to 68 MeV. A comparison with the Talys code is systematically done. Several parameters of theoretical models have been studied and we found that is not possible to reproduce faithfully all the cross-sections with a given set of parameters. (author)

Operation status and prospect of radioisotope production facility in HANARO

International Nuclear Information System (INIS)

Kim, Minjin; Jung, H.S.

2012-01-01

At the RIPF at HANARO, Radioisotopes for industrial and medical purpose are produced and research and development for various radioisotopes are carried out. Major products include Ir-192 for NDT, I-131 for treatment and diagnosis of thyroid cancer, Mo-99/Tc-99m Generator for imaging diagnosis of cancer. Production of radioisotope and radiopharmaceutical is being increased every year. Due to world-wide unstableness in the supply of Mo-99, a technology to produce (n,γ)Mo-99 generator at HANARO had been developed as a short term countermeasure. It will be available by the end of 2012. As a long term countermeasure, we are trying to build a new fully dedicated isotope reactor that will produce Fission Mo-99. At present, utilization of RIPF at HANARO is being increased. However when the construction of a new dedicated isotope reactor is completed in 2016, the role of the existing facility and new facility should be established accordingly so that none of the facilities are idling. In the near future, when the prospect of a utilization plan is completed, we expect an opportunity to present the result. (author)

Radioisotope tracer study in an aniline production reactor

International Nuclear Information System (INIS)

Pant, H.J.; Yelgoankar, V.N.; Mendhekar, G.N.

1995-01-01

A radioisotope tracer study was carried out in an aniline production reactor to investigate the cause of poor heat transfer from tube side to shell side in an aniline production (ANPO) reactor. The results of the study indicated that more than 50% of the shell volume was reduced due to deposition of the process material (i.e. fouling) on the shell walls and may be the cause of poor heat transfer in the reactor. (author). 2 refs., 2 figs

Radioisotope production and distribution in Australia

International Nuclear Information System (INIS)

Brough, J.

1986-01-01

The high quality of radioactive products and services, provided by the Commercial Products Unit of Australian Atomic Energy Agency for industrial and medical applications are discussed. The production program has changed from research driven to being market driven. The Commission in fact not only manufactures radioisotopes and radiopharmaceuticals but also acts as a Centralized Dispensing Service for over sea products. The advantages associated with centralize distribution are discussed. The delivery arrangements and the existed problems are explained. With the unique experience, assistance and advice are provided for many years now to Nuclear Energy Unit at PUSPATI via staff training programs and many visits by the Commission staff to assist in the commissioning of the facilities in which enables PUSPATI to provide Malaysia and surrounding neighbour countries (on a smaller scale) with the similar type of service that the Commission does within Australia. (A.J.)

Research trends in radioisotopes: a scientometric analysis

International Nuclear Information System (INIS)

Sagar, Anil; Kademani, B.S.; Bhanumurthy, K.; Ramamoorthy, N.

2014-01-01

Radioisotopes or radionuclides are radioactive forms of elements and are usually produced in research reactors and accelerators. They have wide ranging applications in healthcare, industry, food and agriculture, and environmental monitoring. Following over five decades of vast experience accumulated, radioisotope technology has developed to a high degree of sophistication and it is estimated that about 200 radioisotopes are in regular use. This paper attempts to highlight the publication status and growth of radioisotope research across the world and make quantitative and qualitative assessment by way of analyzing the following features of research output based on Web of Science database during the period 1993-2012. (author)

Operational aspects of the radiological control in a radioisotopes plant production

International Nuclear Information System (INIS)

Corahua, A.

1996-01-01

The purpose of this paper is to inform about the results obtained in the control operations carried out by the radioprotection area of the radioisotopes plant production during 1994 and then were compared with the limits established by the regulations of radiological radioprotection. In the general inter-texture of the activities that are developed in the radioisotopes plant production, the carried out controls are: area monitoring, air monitoring, personnel monitoring, monitoring in the expedition of radioactive material and monitoring and control in the evacuation of solid and liquid wastes. The result obtained in the present paper states that the doses received by the exposed occupationally staff are below the allowed limits. (author). 3 refs

Summary report of the consultants' meeting on nuclear data for production of therapeutic radioisotopes

International Nuclear Information System (INIS)

Haight, R.C.; Paviotti-Corcuera, R.

2002-04-01

This report summarizes the presentations, recommendations and conclusions of the Consultants' Meeting on Nuclear Data for Production of Therapeutic Radioisotopes. The purpose of this meeting was to discuss scientific and technical matters related to the subject and to advise the IAEA Nuclear Data Section (NDS) on the need and possible formation of a Coordinated Research Programme (CRP). Accurate and complete knowledge of nuclear data are essential for the production of radionuclides for therapy to achieve the specific activity and purity required for efficient and safe clinical application. The Consultants recommended updating and completing the data for production of radionuclides that are recognized to be important in therapy. In addition, the consultants recommend investigating other radionuclides that have a potential interest and for which there exists a medical rationale for therapeutic use. To date no serious effort has been devoted to evaluation of nuclear data for the reactor and accelerator production of therapeutic radionuclides. The IAEA is in the unique and privileged position to address this important public health related problem. Therefore, the consultants highly recommend the formation of a CRP with the title: 'Nuclear Data for Production of Therapeutic Radionuclides.' (author)

Research reactor production of radioisotopes for medical use

International Nuclear Information System (INIS)

Mani, R.S.

1985-01-01

More than 70% of all radioisotopes applied in medical diagnosis and research are currently produced in research reactors. Research reactors are also an important source of certain radioisotopes, such as 60 Co, 90 Y, 137 Cs and 198 Au, which are employed in teletherapy and brachytherapy. For regular medical applications, mainly 29 radionuclides produced in research reactors are used. These are now produced on an 'industrial scale' by many leading commercial manufacturers in industrialized countries as well as by national atomic energy establishments in developing countries. Five main neutron-induced reactions have been employed for the regular production of these radionuclides, namely: (n,γ), (n,p), (n,α), (n,γ) followed by decay, and (n, fission). In addition, the Szilard-Chalmers process has been used in low- and medium-flux research reactors to enrich the specific activity of a few radionuclides (mainly 51 Cr) produced by the (n,γ) reaction. Extensive work done over the last three decades has resulted in the development of reliable and economic large-scale production methods for most of these radioisotopes and in the establishment of rigorous specifications and purity criteria for their manifold applications in medicine. A useful spectrum of other radionuclides with suitable half-lives and low to medium toxicity can be produced in research reactors, with the requisite purity and specific activity and at a reasonable cost, to be used as tracers. Thanks to the systematic work done in recent years by many radiopharmaceutical scientists, the radionuclides of several elements, such as arsenic, selenium, rhenium, ruthenium, palladium, cadmium, tellurium, antimony, platinum, lead and the rare earth elements, which until recently were considered 'exotic' in the biomedical field, are now gaining attention. (author)

Recent progress in development of radioisotope production

Energy Technology Data Exchange (ETDEWEB)

Yoon, Byung Mok [HANARO Center, Korea Atomic Energy Research Institute, Taejon (Korea, Republic of)

1998-10-01

The Korea multipurpose research reactor, HANARO(Hi-flux Advanced Neutron Application Reactor) is designed and constructed to obtain high density neutron flux (max. 5x10{sup 14} n/cm{sup 2}{center_dot}sec) with relatively low thermal output (30 MW) in order to utilize for various studies such as fuel and material test, radioisotope production, neutron activation analysis, neutron beam experiment, neutron transmutation doping, etc. HANARO has 32 vertical channels (3 in-core, 4 out-core, 25 reflector) and 7 horizontal channels. KAERI has constructed 4 concrete hot cells for production of Co-60, Ir-192, etc. and 6 lead hot cells for production of medical RIs(I-131, Mo-99, etc.). Other 11 lead hot cells will be completed by Feb. 1998 for production of Sm-153, Dy-165, Ho-166, etc. Clean room facilities were installed for production of radiopharmaceuticals. (author)

Study on application of radiation and radioisotopes -Development of the radioisotope production facilities for the HANARO

Energy Technology Data Exchange (ETDEWEB)

Lee, Ji Bok; Woo, Jong Sub; Kang, Byung Woi; Baek, Sam Tae; Jeong, Un Soo; Park, Yong Chul; Jeon, Young Keon; Chang, Chun Ik; Lee, Bong Jae [Korea Atomic Energy Research Institute, Taejon (Korea, Republic of)

1995-08-01

Development and construction of the lead hot cell for radioisotope production and related facility. 1. Fabrication and installation of the lead H/C system. 2. Development and installation of the hydraulic transfer system. 3. Development of the radiation monitoring system. 4. Fabrication and installation of the fire extinguishing system in the H/C. 5. Fabrication and installation of the fume hood. 4 tabs.,10 figs. (Author).

Construction Status of the Beamline for Radio-Isotope Production in the Korea Multi-purpose Accelerator Complex

Energy Technology Data Exchange (ETDEWEB)

Chung, B. H.; Yoon, S. P.; Seol, K. T.; Kim, H. S.; Kwon, H. J.; Cho, Y. S. [Korea Atomic Energy Research Institute, Daejeon (Korea, Republic of)

2015-10-15

The 100-MeV beamline consist of 5 target room, a TR 103 as one of these is operating beamline, and a TR 101 as the other beamline is under construction as shown in Fig. 1. The TR 101 as beamline target room will be used for the high value-added medical isotope production and increased utilization of the proton accelerator. The optical system of the beamline consisted of dipole and quadrupole, and it included beam position monitor (BPM) and current transformer (CT) for beam diagnostics. The beamline was inserted into the carbon block and the aluminum collimator, the end of pipe as beam window was used for the aluminum to reduce the radioactive of materials. The target transfer equipment is being installed for RI production. The RI Beamline was aligned using the laser tracker, and vacuum leak was not detected by the helium leak detector. This facility is expected to the high value-added medical isotope production and increased utilization of the proton accelerator.

Securing a better future for all: Nuclear techniques for global development and environmental protection. NA factsheet on radioisotope production and radiation technology contributing to better health care and a cleaner environment

International Nuclear Information System (INIS)

2012-01-01

Radioisotope and radiation technology finds numerous applications in a wide variety of fields, most importantly in medicine, industry, agriculture and the environment. However, in order to take full advantage of the benefits offered by this technology, it is essential to provide the necessary infrastructure as well as qualified personnel. The IAEA strives to promote worldwide availability of products and facilities in order to offer the benefits of radioisotope products and radiation technology to developing countries. In particular, the IAEA helps Member States to achieve self-sufficiency in the production of radioisotopes and radiopharmaceuticals, strengthen quality assurance practices and regulatory compliance as well as facilitate human resources development. The multipronged need based approach includes providing advice, assistance and capacity building support for: Development, production and quality assurance of reactor and accelerator based medical isotopes and radiopharmaceuticals for both the diagnosis and treatment of diseases, especially cancer; Establishment of irradiation facilities and utilization of gamma radiation, electron beam and X ray technology for varied applications, including tackling pollutants, wastewater treatment, sterilization of medical products, disinfestation of food grains, and synthesis and characterization of advanced materials; Application of radiation and isotopes in industrial process management.

Activity calculation of radioisotopes in HFETR

International Nuclear Information System (INIS)

Liu Shuiqing

1996-12-01

The activity calculating method and formulas of seven kinds of radioisotopes for High Flux Engineering Test REactor (HFETR) are given. The perturbation of targets to neutron fluence rate is considered while targets are put into the neutron fluence rate field of reactor core. All perturbing factors of seven kinds of radioisotopes being used in HFETR are presented. After considering the perturbation, the calculating accuracy of radioisotope activity has been raised 10%. The given method and formulas have ended the history of all activities estimated by experiences, except for that of 60 Co, in the radioisotope production of HFETR. The conclusions are also useful and instructive for the production of radioisotopes in HFETR. (8 tabs.)

Radioisotopes In Animal Production Research

International Nuclear Information System (INIS)

Eduvie, L.O.

1994-05-01

Animal productivity may be measured among others, in terms of two important physiological processes of reproduction and growth each of which involves a number of integrated disciplines. Both physiological processes are controlled by interactions of genotype and environment. Reproduction essentially involves complex physiological processes controlled by secretions of endocrine glands known as hormones. On the other hand growth is determined largely by availabilty of essential nutrients. In order to achieve good reproductive and growth rates adequate and constant nutrition for livestock include pasture, cereals, tubers and their by-products as well as industrial by-products. While reproduction is essential to provide the required number and replacement of livestock, growth guarantees availability of meat. Another aspect of livestock production is disease control. An animal needs a good health to adequately express its genetic make up and utilize available nutrition. Research in animal production is aimed at improving all aspects of productivity of livestock which include reproduction, growth, milk production, egg production, good semen etc. of livestock. In order to achieve this an understanding of the biochemical and physiological processes occurring in the animal itself, and in the feedstuff fed to the animal as well as the aetiology and control of diseases affecting the animal among other factors, is desirable. A number of methods of investigation have evolved with time. These include colorimetry, spectrophotometry, chromatography, microscopy and raidoisotopic tracer methods. While most of these methods are cumbersome and use equipment with low precision, radioisotopic tracer methods utilize equipment with relatively high precision

Study of solid target preparation for developing I-124, Pd-103, Cu-64 radioisotopes based cyclotron

Energy Technology Data Exchange (ETDEWEB)

Kim, Jae Hong; Park, Hyun; Lee, Ji Sub; Lee, Dong Hoon; Chun, Kwon Soo [Korea Institute of Radiological and Medical Sciences, Seoul (Korea, Republic of); Choi, Hee Dong [Seoul National Univ., Seoul (Korea, Republic of)

2005-07-01

The decay characteristics of I-124, Pd-103 and Cu-64 radioisotopes produced by cyclotron have considered useful agents for diagnostic imaging or therapy. Numbers of radioisotopes used in medical applications or promised for development are produced with solid targets. The aims of developing solid targets are to obtain large quantities of radionuclides from accelerators. The scope of the study is to develop optimized target system and chemical procedures of these radioisotopes. In order to increase the availability of the radionuclides, the investigation for the design of the solid target and different procedures yielding efficient production of high specific activity will be carrying. In this work, we will present the issue of the primary target design concept.

99Mo production by 100Mo(n,2n)99Mo using accelerator neutrons

International Nuclear Information System (INIS)

Sato, Nozomi; Kawabata, Masako; Nagai, Yasuki; Hashimoto, Kazuyuki; Hatsukawa, Yuichi; Saeki, Hideya; Motoishi, Shoji; Kin, Tadahiro; Konno, Chikara; Ochiai, Kentaro; Takakura, Kosuke; Minato, Futoshi; Iwamoto, Osamu; Iwamoto, Nobuyuki; Hashimoto, Shintaro

2013-01-01

We proposed a new route to produce a medical radioisotope 99 Mo by the 100 Mo(n,2n) 99 Mo reaction using accelerator neutrons. A high-quality 99 Mo with a minimum level of radioactive waste can be obtained by the proposed reaction. The decay product of 99 Mo, 99m Tc, is separated from 99 Mo by the sublimation method. The proposed route could bring a major breakthrough in the solution of ensuring a constant and reliable supply of 99 Mo. (author)

Americium-241 radioisotope thermoelectric generator development for space applications

International Nuclear Information System (INIS)

Ambrosi, Richard; Williams, Hugo; Samara-Ratna, Piyal

2013-01-01

Space nuclear power systems are under development in the UK in collaboration with European partners as part of a European Space Agency (ESA) programme. Radioisotope thermoelectric generators (RTG) are an important element of this new capability in Europe. RTG systems being developed in Europe are targeting the 10 W electric to 50 W electric power generation range adopting a modular scalable approach to the design. Radiogenic decay heat from radioisotopes can be converted to electrical power by using appropriate semiconductor based thermoelectric materials. The plan for Europe is to develop radioisotope space nuclear power systems based on both thermoelectric and Stirling power conversion systems. Although primarily focused on delivering up to 50 W of electrical power, the European radioisotope thermoelectric system development programme is targeting americium-241 as a fuel source and is maximizing the use of commercially available thermoelectric manufacturing processes in order to accelerate the development of power conversion systems. The use of americium provides an economic solution at high isotopic purity and is product of a separation process from stored plutonium produced during the reprocessing of civil nuclear fuel. A laboratory prototype that uses electrical heating as a substitute for the radioisotope was developed to validate the designs. This prototype has now been tested. This paper outlines the requirements for a European americium-241 fuelled RTG, describes the most recent updates in system design and provides further insight into recent laboratory prototype test campaigns. (author)

Americium-241 radioisotope thermoelectric generator development for space applications

Energy Technology Data Exchange (ETDEWEB)

Ambrosi, Richard; Williams, Hugo; Samara-Ratna, Piyal, E-mail: rma8@le.ac.uk [University of Leicester, (United Kingdom); and others

2013-07-01

Space nuclear power systems are under development in the UK in collaboration with European partners as part of a European Space Agency (ESA) programme. Radioisotope thermoelectric generators (RTG) are an important element of this new capability in Europe. RTG systems being developed in Europe are targeting the 10 W electric to 50 W electric power generation range adopting a modular scalable approach to the design. Radiogenic decay heat from radioisotopes can be converted to electrical power by using appropriate semiconductor based thermoelectric materials. The plan for Europe is to develop radioisotope space nuclear power systems based on both thermoelectric and Stirling power conversion systems. Although primarily focused on delivering up to 50 W of electrical power, the European radioisotope thermoelectric system development programme is targeting americium-241 as a fuel source and is maximizing the use of commercially available thermoelectric manufacturing processes in order to accelerate the development of power conversion systems. The use of americium provides an economic solution at high isotopic purity and is product of a separation process from stored plutonium produced during the reprocessing of civil nuclear fuel. A laboratory prototype that uses electrical heating as a substitute for the radioisotope was developed to validate the designs. This prototype has now been tested. This paper outlines the requirements for a European americium-241 fuelled RTG, describes the most recent updates in system design and provides further insight into recent laboratory prototype test campaigns. (author)

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1983

International Nuclear Information System (INIS)

Baker, D.A.

1984-08-01

This document lists DOE's radioisotope production and distribution activities by its facilities at Argonne National Laboratory; Pacific Northwest Laboratory; Idaho Operations Office; Los Alamos National Laboratory; Oak Ridge National Laboratory; Savannah River Plant; and UNC Nuclear Industries, Inc. The information is divided into five sections: isotope suppliers, facility contacts, and isotopes or services supplied; lists of customers, suppliers and isotopes purchased; list of isotopes purchased cross-referenced to customer codes; geographic locations of radioisotope customers; and radioisotope sales and transfers - FY 1983

Occupational radioprotection in the cyclotron laboratory radioisotope production at IEN

International Nuclear Information System (INIS)

Fajardo, P.W.; Teixeira, M.V.; Santos, I.H.T.; Pujol Filho, S.V.

1990-07-01

The Cyclotron of the Instituto de Engenharia Nuclear is operated mainly for radioisotope production, neutron production studies and irradiation damage analysis. The risks associated to the activities developed in these laboratories are exposition to beta, neutron and gama radiation and contamination. The radioprotection program adapted are presented briefly and the results of the air and surface contamination analysis, liquid efluents and dose equivalent of the workers in 1988 are shown. (author) [pt

Experiences in radioisotope production in the German Democratic Republic with special reference to radiopharmaceuticals

International Nuclear Information System (INIS)

Muenze, R.

1988-01-01

Radioisotope production has been carried out in the German Democratic Republic for 30 years. Based on a 10 MW research reactor, a cyclotron and certain irradiation facilities at units of national nuclear power stations, a widespread assortment of radioisotopes is produced with emphasis to radiopharmaceuticals as the main materials. Domestic production covers the national demand in these products where the production is technologically feasible under our conditions. A complete supply of the users in the country (more than 7000 licences) is accomplished by an intense co-operation with neighbouring countries, including mutual assistance in reactor shut down periods and supply with special radioactive materials and products. International co-operation within the framework of the IAEA takes place, mainly as scientific and technological assistance to many developing countries. (author)

Radioisotope applications in industry and environment: Indian scenario

International Nuclear Information System (INIS)

Pant, H.J.

2016-01-01

Applications of radioisotopes and radiation technology in industry, medicine and agriculture form an important part of India's programme of using nuclear technology for societal benefits. Radioisotope production in India started on a modest scale soon after 1 MW APSARA reactor at Trombay, Mumbai became critical in 1956. The scope of activities expanded thereafter. With the commissioning of 40 MW CIRUS reactor in 1960, the setting up of modern radioisotope processing laboratories in late sixties and the production of cobalt-60 in power reactors in megacurie quantities in late seventies made India self-sufficient in radioisotope production. The radioisotope production received a major boost in 1985 with the commissioning of high flux 100 MW DHRUVA reactor, which provided opportunity to extend the range of radioisotopes available in the country both in quantity as well in specific activity. The CIRUS reactor has been shutdown in year 2010 and 1 MW APSARA reactor is presently being upgraded to 5 MW. Today, The DHRUVA reactor operating at its full capacity is being used for production of 100 different radioisotopes those are used in industry, agriculture and medicine. (author)

Computational investigation of 99Mo, 89Sr, and 131I production rates in a subcritical UO2(NO32 aqueous solution reactor driven by a 30-MeV proton accelerator

Directory of Open Access Journals (Sweden)

Z. Gholamzadeh

2015-12-01

Full Text Available The use of subcritical aqueous homogenous reactors driven by accelerators presents an attractive alternative for producing 99Mo. In this method, the medical isotope production system itself is used to extract 99Mo or other radioisotopes so that there is no need to irradiate common targets. In addition, it can operate at much lower power compared to a traditional reactor to produce the same amount of 99Mo by irradiating targets. In this study, the neutronic performance and 99Mo, 89Sr, and 131I production capacity of a subcritical aqueous homogenous reactor fueled with low-enriched uranyl nitrate was evaluated using the MCNPX code. A proton accelerator with a maximum 30-MeV accelerating power was used to run the subcritical core. The computational results indicate a good potential for the modeled system to produce the radioisotopes under completely safe conditions because of the high negative reactivity coefficients of the modeled core. The results show that application of an optimized beam window material can increase the fission power of the aqueous nitrate fuel up to 80%. This accelerator-based procedure using low enriched uranium nitrate fuel to produce radioisotopes presents a potentially competitive alternative in comparison with the reactor-based or other accelerator-based methods. This system produces ∼1,500 Ci/wk (∼325 6-day Ci of 99Mo at the end of a cycle.

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1982

International Nuclear Information System (INIS)

Richards, M.P.

1983-08-01

The radioisotope production and distribution activities by facilities at Argonne National Laboratory, Pacific Northwest Laboratory, Brookhaven National Laboratory, Hanford Engineering Development Laboratory, Idaho Operations Office, Los Alamos Scientific Laboratory, Oak Ridge National Laboratory, Savannah River Laboratory, and UNC Nuclear Industries, Inc. are listed. The information is divided into five sections: isotope suppliers, facility, contacts, and isotopes or services supplied; alphabetical list of customers, and isotopes purchased; alphabetical list of isotopes cross-referenced to customs numbers; geographical location of radioisotope customers; and radioisotope sales and transfers-FY 1982

submitter Development of a Superconducting Magnet for a Compact Cyclotron for Radioisotope Production

CERN Document Server

Garcia-Tabares, Luis; Calero, Jesus; Gutierrez, Jose L; Munilla, Javier; Obradors, Diego; Perez, Jose M; Toral, Fernando; Iturbe, Rafael; Minguez, Leire; Gomez, Jose; Rodilla, Elena; Bajko, Marta; Michels, Matthias; Berkowitz, Daniel; Haug, Friedrich

2016-01-01

The present paper describes the development process of a low critical temperature superconducting magnet to be installed in a compact cyclotron producing single-dose radioisotopes for clinical and preclinical applications. After a brief description of the accelerator, the magnet development process is described, starting from the magnetic, mechanical, quench, and thermal calculations, continuing with the designing process, particularly the support structure of the magnet and the cryogenic supply system, to finish with the fabrication and the first tests than have been performed.

Charged particle accelerators for practice

International Nuclear Information System (INIS)

Arzumanov, A.A.

1988-01-01

Characteristics of some accelerators operating in the world are given, capabilities of accelerator technique are demonstrated. Examples of wide application of accelerators in radiation-chemical technology as well as for defectoscopy of massive metal products and impurity ion implantation when producing semiconductor elements are presented. Works on nuclear filter production are characterized by high efficiency. Wide application of synchrotron radiation is described. Various accelerators can be applied during element analysis in geology, metallurgy, ecology. Application of accelerators ''in particular, cyclotrons for radioisotope production as well as in radiotherapy in medicine appears to be important. An isochronous cyclotron with controlled ion energy, at which applied works concerning a number of considered trends in the field of radiation physics and radiation physical metallurgy, element analysis, radiation resistance of electronic circuits and components are conducted, is in operation at the IYaPh of the Kazakh Academy of Sciences. Production of tallium-201 for cardiologic invstigations deserves a special attention. An electrostatic heavy ion accelerator which allows one to produce the beams of accelerated ions of elements from hydrogen to uranium is under commissioning

The MAPLE-X concept dedicated to the production of radio-isotopes

International Nuclear Information System (INIS)

Heeds, W.

1985-06-01

MAPLE is a versatile new Canadian multi-purpose research reactor concept that meets the nuclear aspirations of developing countries. It is planned to convert the NRX reactor at Chalk River Nuclear Laboratories into MAPLE-X as a demonstration prototype of this concept and thereafter to dedicate its operation to the production of radio-isotopes. A description of MAPLE-X and details of molybdenum-99 production are given

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1979

International Nuclear Information System (INIS)

Burlison, J.S.

1980-06-01

The fifteenth edition of the radioisotope customer list was prepared at the request of the Division of Financial Services, Office of the Assistant Secretary for Environment, Department of Energy (DOE). This document lists DOE's radioisotope production and distribution activities by its facilities at Argonne National Laboratory; Pacific Northwest Laboratory; Brookhaven National Laboratory; Hanford Engineering Development Laboratory; Idaho Operations Office; Los Alamos Scientific Laboratory; Mound Facility; Oak Ridge National Laboratory; Rocky Flats Area Office; Savannah River Laboratory; and UNC Nuclear Industries, Inc. The information is divided into five sections: Isotope suppliers, facility, contracts and isotopes or services supplied; alphabetical list of customers, and isotopes purchased; alphabetical list of isotopes cross-referenced to customer numbers; geographical location of radioisotope customers; and radioisotope sales and transfers-FY 1979

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1981

International Nuclear Information System (INIS)

Burlison, J.S.

1982-09-01

The seventeenth edition of the radioisotope customer list was prepared at the request of the Office of Health and Environmental Research, Office of Energy Research, Department of Energy (DOE). This document lists DOE's radioisotope production and distribution activities by its facilities at Argonne National Laboratory: Pacific Northwest Laboratory; Brookhaven National Laboratory; Hanford Engineering Development Laboratory; Idaho Operations Office; Los Alamos Scientific Laboratory; Mound Facility; Oak Ridge National Laboratory; Savannah River Laboratory; and UNC Nuclear Industries, Inc. The information is divided into five sections: (1) isotope suppliers, facility, contracts and isotopes or services supplied; (2) alphabetical list of customers, and isotopes purchased; (3) alphabetical list of isotopes cross-referenced to customer numbers; (4) geographical location of radioisotope customers; and (5) radioisotope sales and transfers-FY 1980

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1980

International Nuclear Information System (INIS)

Burlison, J.S.

1981-08-01

The sixteenth edition of the radioisotope customer list was prepared at the request of the Office of Health and Environmental Research, Office of energy Research, Department of Energy (DOE). This document lists DOE's radioisotope production and distribution activities by its facilities at Argonne National Laboratory; Pacific Northwest Laboratory; Brookhaven National Laboraory; Hanford Engineering Development Laboratory; Idaho Operations Office; Los Alamos Scientific Laboratory; Mound Facility; Oak Ridge National Laboratory; Savannah River Laboratory; and UNC Nuclear Industries, Inc. The information is divided into five sections: (1) isotope suppliers, facility, contracts and isotopes or services supplied; (2) alphabetical list of customers, and isotopes purchased; (3) alphabetical list of isotopes cross-referenced to customer numbers; (4) geographical location of radioisotope customers; and (5) radioisotope sales and transfers-FY 1980

Radioisotope production for medical and non-medical application at the Nuclear Energy Unit (UTN)

International Nuclear Information System (INIS)

Mohamad Awang; Zulkifli Mohamad Hashim; Yusof Azuddin Ali

1986-01-01

Radioisotopes are produced by using a low power research reactor, TRIGA MARK II situated at UTN. Products intended for use as radiopharmaceuticals undergo a more stringent precaution. The solvent extraction technique used to separate 99 m TC from the radioactive solution of Potassium molybdate (K 2 99 Mo0 4 ) is explained in detail. The specific activity of 99Mo obtained at a neutron flux of 2.5 x 10 12 n/cm 2 , s ranges from 1.75 mCi 99 Mo/g MoO 3 to 6.25 mCi 99 Mo/g MoO 3 . However, the specific activity of 99 Mo obtained could be increased by a factor of 6 using the central thimble facility. There are 14 radioisotopes being currently produced. Commonly used cold kits for 99m TC labelling are also produced. Sn-MDP kit for bone scintigraphy is prepared under aseptic environment and freeze-drived. Products are terminally sterilized using γ-irradiation. Uptake studies done on laboratory animals indicate good bone uptake. A few radioisotopes and radiopharmaceuticals products to be produced by UTN in future are reviewed. (author)

A prototype on-line work procedure system for radioisotope thermoelectric generator production

International Nuclear Information System (INIS)

Kiebel, G.R.

1991-09-01

An on-line system to manage work procedures is being developed to support radioisotope thermoelectric generator (RTG) assembly and testing in a new production facility. This system implements production work procedures as interactive electronic documents executed at the work site with no intermediate printed form. It provides good control of the creation and application of work procedures and provides active assistance to the worker in performing them and in documenting the results. An extensive prototype of this system is being evaluated to ensure that it will have all the necessary features and that it will fit the user's needs and expectations. This effort has involved the Radioisotope Power Systems Facility (RPSF) operations organization and technology transfer between Westinghouse Hanford Company (Westinghouse Hanford) and EG ampersand G Mound Applied Technologies Inc. (Mound) at the US Department of Energy (DOE) Mound Site. 1 ref

Revisiting homogeneous suspension reactors for production of radioisotopes

International Nuclear Information System (INIS)

Pasqualini, E.E.

2010-01-01

Some 50 years ago in Geneva Conferences I, II and III (1955. 1958 and 1964) on the Peaceful Uses of Atomic Energy, and also in Vienna Symposium on Reactor Experiments (1961), several papers where presented by different countries referring to advances in homogeneous suspension reactors. In particular the Dutch KEMA Suspension Test Reactor (KSTR) was developed, built and successfully operated in the sixties and seventies. It was a 1MWth reactor in which a suspension (6 microns spheres) of mixed UO 2 /ThO 2 in light water was circulated in a closed loop through a sphere-shaped vessel. One of the basic ideas on these suspension reactors was to apply the fission recoil separation effect as a means of purification of the fuel: the non-volatile fission products can be adsorbed in dispersed active charcoal and removed from the liquid. Undoubtedly, this method can present some advantages and better yields for the production of Mo-99 and other short lived radioisotopes, since they have to be extracted from a liquid in which practically no uranium is present. Details are mentioned of the different aspects that have been taken into account and which ones could be added in the corresponding actualization of suspension reactors for radioisotope production. In recent years great advances have been made in nanotechnology that can be used in the tailoring of fuel particles and adsorbent media. Recently, in CNEA Buenos Aires, a new facility has been inaugurated and is being equipped and licensed for laboratory experiments and preparative synthesis of nuclear nanoparticles. RA-6 and RA-3 experimental reactors in Argentina can be used for in-pile testing. (author)

Economic Feasibility Study for the Utilization of Egyptian Reactor (ETRR-2) in Radioisotope Production

International Nuclear Information System (INIS)

El-Kolaly, M; El-Gameel, E.A.

2011-01-01

The present study was carried out to discus the economic feasibility study of local radioisotope production in Egyptian Atomic Energy Authority. This study was divided into three sections; the first section included the marketing study which based on the expectation of the local demand and surplus production to export from 99 Mo production. The second section discussed the financial analysis and provided a model for calculating the cost per operation hour and per curie from production. The financial analysis discussed the profitable analysis and project sensitivity to change in cost and revenue. The third section discussed the effect of this project on the national return as the national income, employment, social rate of return and trade balance. This study was carried out according to the method adopted by the International Bank for Development taking into consideration the impact of applying radioisotope production technology on the society.

The Radioisotopes production in tunisia, presentation of the CNSTN project

International Nuclear Information System (INIS)

Ounalli, Leila

2013-01-01

radioisotopes production are much sought worldwide. There is a universal lack of these specialists. Regarding this situation, there is an urgency to collect the right conditions which allow the organization of a Master's degree in radio-pharmacy, radio-biology and radiochemistry. The projects of complementarities between Arab countries via the Arabic Agency of the Atomic Energy, the collaboration with the International Atomic Energy Agency and the Technical French Cooperation of the Atomic Energy Commission are useful to combine efforts for better training of the staff. (Author)

Charged particle radioisotope production at Instituto de Engenharia Nuclear - IEN

International Nuclear Information System (INIS)

Lemos Junior, O.F.

1992-05-01

A variable energy isochronous cyclotron (CV-28) was installed in 1974 at the Instituto de Engenharia Nuclear in Rio de Janeiro, with the purpose, among others, of irradiating suitable targets to produce radioisotopes for medical diagnostic studies. This papers is an overview of the work done in the last two decades and reports the present status on the production of iodine-123 and gallium-67. (author)

Application of radioisotopes in pharmaceutical research

International Nuclear Information System (INIS)

Khujaev, S.

2004-01-01

Full text: To use of radioisotopes in the processes of receiving radiopharmaceutical diagnostic means it is widely know [1]. Radioactivity labeled chemical compounds, pharmacological kinetics of which allows one solving a concrete diagnostic problem in an organism are used in radio pharmaceutics. In spite of this choice of the radioisotope, possessing the most favorable nuclei-physical characteristics for it to be detected and minimization of beam loadings, be of great importance. Development of a method of introduction of a radioisotope also has important value, as it is included into chemical structure of a radiopharmaceutical preparation. One more way of use of radioisotopes in pharmaceutics is their use as a radioactive mark at a stage of creation of a new medical product. And in this case, all those moments, which are listed above, take place. Preparations labeling by radioisotopes are used basically for their studying pharmacological kinetics. In Institute of nuclear physics AS RU, in recent years, works are done on studying pharmacological kinetics of some new medical products, which have been synthesized in the Tashkent pharmaceutical institute. These preparations are on the basis of microelements with a complex set of properties possessing expressed biological activity and have great value in pharmaceutical science of Republic of Uzbekistan. Reception of labeled compounds of all preparations was carried out by a method of introduction of a radioisotope at a stage of their synthesis. The work presents the results of researches on synthesis and study of pharmacological kinetics of radioactively labeled preparations - PIRACIN, labeled by radioisotope 69m Zn; FERAMED, labeled by radioisotope 59 Fe; COBAVIT, labeled by radioisotope 57 Co; VUC, labeled by radioisotope 57 Co

Radioisotope research and development at Los Alamos National Laboratory

International Nuclear Information System (INIS)

Peterson, E.J.

1993-01-01

Throughout its fifty year history, Los Alamos National Laboratory has conducted research and development in the production, isolation, purification, and application of radioactive isotopes. Initially this work supported the weapons development mission of the Laboratory. Over the years the work has evolved to support basic and applied research in many diverse fields, including nuclear medicine, biomedical studies, materials science, environmental research and the physical sciences. In the early 1970s people in the Medical Radioisotope Research Program began irradiating targets at the Los Alamos Meson Physics Facility (LAMPF) to investigate the production and recovery of medically important radioisotopes. Since then spallation production using the high intensity beam at LAMPF has become a significant source of many important radioisotopes. Los Alamos posesses other facilities with isotope production capabilities. Examples are the Omega West Reactor (OWR) and the Van de Graaf Ion Beam Facility (IBF). Historically these facilities have had limited availability for radioisotope production, but recent developments portend a significant radioisotope production mission in the future

High-intensity cyclotrons for radioisotope production and accelerator driven systems

Energy Technology Data Exchange (ETDEWEB)

Jongen, Y.; Vandeplassche, D.; Kleeven, W.; Beeckman, W.; Zaremba, S.; Lannoye, G.; Stichelbaut, F

2002-04-22

IBA recently proposed a new method to extract high-intensity positive ion beams from a cyclotron based on the concept of auto-extraction. We review the design of a 14 MeV, multi-milliampere cyclotron using this new technology. IBA is also involved in the design of the accelerator system foreseen to drive the MYRRHA facility, a multipurpose neutron source developed jointly by SCK-CEN and IBA.

Internal dosimetry from IPEN workers involved in the medical radioisotopes production

International Nuclear Information System (INIS)

Cesar, R.B.P.; Mesquita, C.H. de

1988-01-01

The internal dose from IPEN workers involved in the medical radioisotopes products is related. In the workers population, six groups were classified: development and research, routine production, quality control, package, radioprotection supervision and maintenance. The internal doses were calculated according to the methodology described by the ICRP-30, using resuls from a whole-body counter. The results described were obtained from 970 whole-body radioactivity measurements during the last three years (1985 a 1987). (author) [pt

Applications of Particle Accelerators in Medical Physics

OpenAIRE

Cuttone, G

2008-01-01

Particle accelerators are often associated to high energy or nuclear physics. As well pointed out in literature [1] if we kindly analyse the number of installation worldwide we can easily note that about 50% is mainly devoted to medical applications (radiotherapy, medical radioisotopes production, biomedical research). Particle accelerators are also playing an important indirect role considering the improvement of the technical features of medical diagnostic. In fact the use of radionuclide f...

Studies of radioisotope production with an AVF cyclotron in TIARA

Energy Technology Data Exchange (ETDEWEB)

Sekine, Toshiaki [Japan Atomic Energy Research Inst., Takasaki, Gunma (Japan). Takasaki Radiation Chemistry Research Establishment

1997-03-01

The production of radioisotopes to be used mainly for nuclear medicine and biology is studied with an AVF cyclotron in TIARA. A production method of no-carrier-added {sup 186}Re with the {sup 186}W(p,n){sup 186}Re reaction has been developed; this product may be used as a therapeutic agent in radioimmunotherapy due to the adequate nuclear and chemical properties. For the study of the function of plants using a positron-emitter two-dimensional imaging system, a simple method of producing the positron emitter {sup 18}F in water was developed by taking advantage of a highly-energetic {alpha} beam from the AVF cyclotron. (author)

Radioisotope conveyor ash meter

International Nuclear Information System (INIS)

Savelov, V.D.

1994-01-01

Radioisotope conveyor ash meter realizes persistent measuring of ashiness of coal and products of its enrichment on the belt conveyor without contact. The principle of ash meter acting is based on functional dependence of the gamma radiation flows backscattering intensity of radioisotope sources from the ash volume content in the controlled fuel. Facility consists from the ashiness transducer and the processing and control device

An INVAP perspective on the production of medical radioisotopes: past and present

International Nuclear Information System (INIS)

Salvatore, M.

2009-01-01

This presentation gives a perspective on medical radionuclide production methods from INVAP, Argentina. INVAP is a company headquartered in Argentina and is involved amongst other activities in nuclear, medical and scientific equipment. It describes INVAP's involvement in research reactor projects in a number of countries around the world. The paper describes a number of turn-key facilities for the production of radioisotopes for medicine, industry and research activities.

Aspects of occupational radioprotection in laboratories for radioisotopes production

International Nuclear Information System (INIS)

Fajardo, Patricia Wieland; Santos, Ilka Helena Taam.

1990-10-01

Some aspects of the radiation protection program implemented in the radioisotope production laboratories at the Nuclear Engineering Institute (IEN), are presented. This program evolves external and internal monitoring, radiation level measurements, and surface and air contamination monitoring. Comparing the results obtained in 1987, 1988 and 1989 with the corresponding limits established by Brazilian National Nuclear Energy Commission, it can be seen that the radiation protection program is suitable for those places with high risks of radiation contamination. (author). 2 refs., 2 figs., 2 tabs

List of ERDA radioisotope (customers with summary of radioisotope shipments FY 1975

International Nuclear Information System (INIS)

Simmons, J.L.; Gano, S.R.

1976-01-01

The twelfth edition of the ERDA radioisotope customer list has been prepared at the request of the Division of Biomedical and Environmental Research. The purpose of this document is to list the FY 1975 commercial radioisotope production and distribution activities of USERDA facilities at Argonne National Laboratory, Battelle, Pacific Northwest Laboratories, Brookhaven National Laboratory, United Nuclear Inc., Idaho Operations Office, Hanford Engineering Development Laboratory, Mound Laboratory, Oak Ridge National Laboratory, and Savannah River Plant

Ashing vs. electric generation in accelerator driven system

International Nuclear Information System (INIS)

Solanilla, Roberto B.

1999-01-01

Accelerator Driven Systems have been conceived as an alternative for the processing of the radioactive wastes contained in spent fuel elements from nuclear power plants. These systems are formed by the coupling of a nuclear reactor - preferably a subcritical reactor - with a particle accelerator providing particles with energy in the order of the GeV. The long-lived fission products and actinides of the spent fuels are transformed by nuclear reactions in stable isotopes or in short-lived radioisotopes. The basic parameters for the electric energy production of the different systems are analysed. (author)

Science opportunities at high power accelerators like APT

International Nuclear Information System (INIS)

Browne, J.C.

1996-01-01

This paper presents applications of high power RF proton linear accelerators to several fields. Radioisotope production is an area in which linacs have already provided new isotopes for use in medical and industrial applications. A new type of spallation neutron source, called a long-pulse spallation source (LPSS), is discussed for application to neutron scattering and to the production and use of ultra-cold neutrons (UCN). The concept of an accelerator-driven, transmutation of nuclear waste system, based on high power RF linac technology, is presented along with its impact on spent nuclear fuels

Modelling study on production cross sections of {sup 111}In radioisotopes used in nuclear medicine

Energy Technology Data Exchange (ETDEWEB)

Kara, Ayhan; Korkut, Turgay [Sinop Univ. (Turkey). Faculty of Engineering; Yigit, Mustafa [Aksaray Univ. (Turkey). Faculty of Science and Arts; Tel, Eyyup [Osmaniye Korkut Ata Univ. (Turkey). Faculty of Science and Arts

2015-07-15

Radiopharmaceuticals are radioactive drugs used for diagnosis or treatment in a tracer quantity with no pharmacological action. The production of radiopharmaceuticals is carried out in the special research centers generally using by the cyclotron systems. Indium-111 is one of the most useful radioisotopes used in nuclear medicine. In this paper, we calculated the production cross sections of {sup 111}In radioisotope via {sup 111-114}Cd(p,xn) nuclear reactions up to 60 MeV energy. In the model calculations, ALICE/ASH, TALYS 1.6 and EMPIRE 3.2 Malta nuclear reaction code systems were used. The model calculation results were compared to the experimental literature data and TENDL-2014 (TALYS-based) data.

Accelerator business in Japan expanding

International Nuclear Information System (INIS)

Anon.

1992-01-01

Accelerators have become to be used increasingly in Japan in such fields as medicine, physics research and industry. This has caused stiff competition for market share by the manufacturers of accelerators. Electron beam accelerators for industrial use provide an indispensable means for adding values to products, for example, electric cables with incombustible insulators. Linear accelerators for the nondestructive inspection of nuclear components have been widely installed at equipment manufacturing plants. Active efforts have been exerted to develop small synchrotron radiation accelerators for next generation electronic industry. Cyclotrons for producing short life radioisotopes for medical diagnosis and electron beam accelerators for radiation therapy are also used routinely. The suppliers of accelerators include the companies manufacturing heavy electric machinery, heavy machinery and the engineering division of steelmakers. Accelerator physics is being formed, but universities do not yet offer the course regarding accelerators. Accelerator use in Japan and the trend of accelerator manufacturers are reported. (K.I.)

Radioisotope Dating with Accelerators.

Science.gov (United States)

Muller, Richard A.

1979-01-01

Explains a new method of detecting radioactive isotopes by counting their accelerated ions rather than the atoms that decay during the counting period. This method increases the sensitivity by several orders of magnitude, and allows one to find the ages of much older and smaller samples. (GA)

Use of radioisotopes in Japan

International Nuclear Information System (INIS)

Foeldiak, G.

1974-01-01

A survey of the following general data on the use of radioisotopes in Japan is given (from the material of the 11th Japan Conference on Radioisotopes): 1. number of the organizations using radioactive isotopes, grouped according to special working fields and instruments; 2. amount of the unsealed sources (Ci) used in the different special working fields in 1971, 4. amount of the sealed sources (Ci) used between 1966 and 1971. 5. number of the institutions using sealed sources, grouped according to special working fields (March, 1972), 6. number of the accelerators applied, grouped according to special working fields (March, 1972), 7. number of the nuclear instruments in the education and research institutes (March, 1972), 8. amount of the collected radioactive waste material between 1960 and 1971 (number of containers). (K.A.)

Radioisotopes and radiopharmaceuticals catalogue

International Nuclear Information System (INIS)

2002-01-01

The Chilean Nuclear Energy Commission (CCHEN) presents its radioisotopes and radiopharmaceuticals 2002 catalogue. In it we found physical characteristics of 9 different reactor produced radioisotopes ( Tc-99m, I-131, Sm-153, Ir-192, P-32, Na-24, K-42, Cu-64, Rb-86 ), 7 radiopharmaceuticals ( MDP, DTPA, DMSA, Disida, Phitate, S-Coloid, Red Blood Cells In-Vivo, Red Blood Cells In-Vitro) and 4 labelled compounds ( DMSA-Tc99m, DTPA-Tc99m, MIBG-I131, EDTMP-Sm153 ). In the near future the number of items will be increased with new reactor and cyclotron products. Our production system will be certified by ISO 9000 on March 2003. CCHEN is interested in being a national and an international supplier of these products (RS)

Investigation of the radionuclide inventory and the production yields of the target stacks at the PEFP radioisotope production facility

International Nuclear Information System (INIS)

Yoon, Sang-Pil; Hong, In-Seok; Cho, Yong-Sub

2010-01-01

The Proton Engineering Frontier Project (PEFP) will construct a radioisotope production facility by using the nuclear reaction between the 100-MeV proton beam and the solid target. For investigating the radionuclide inventory and the production yield of the radioisotope production facility, we have optimized the thickness of the prototype target stacks by using a SRIM calculation. The target stacks consist of RbCl encapsulated in inconel alloy, Zn metal, and Ga metal encapsulated in niobium. Typical beam parameters were 300 μA and 95 hours. An inventory of all generated radionuclide activities is mandatory in order to prepare the operation scenario and design the hot cell. The Monte Carlo code MCNPX was used to investigate what radionuclide is generated. The obtained radionuclide inventory indicated that about 100 radionuclides were generated and that the total radioactivity of the irradiated target stacks was 1324.1 Ci at the end of the bombardment. The production yields of Sr-82, Cu-67, and Ge-68 were 3.79 Ci, 2.74 Ci, and 1.23 Ci at the end of the bombardment.

List of ERDA radioisotope customers with summary of radioisotope shipments, FY 1976

International Nuclear Information System (INIS)

Simmons, J.L.

1977-03-01

The thirteenth edition of the ERDA radioisotope customer list has been prepared at the request of the Office of Program Coordination, Office of the Assistant Administrator. The purpose of the document is to list the FY 1976 commercial radioisotope production and distribution activities of ERDA facilities at Argonne National Laboratory, Battelle, Pacific Northwest Laboratories, Brookhaven National Laboratory, Hanford Engineering Development Laboratory, Idaho Operations Office, Los Alamos Scientific Laboratory, Mound Laboratory, Oak Ridge National Laboratory, Savannah River Laboratory, and United Nuclear Industries, Inc

Basic Research and Feasibility Study of Radioisotope Production using 100 MeV Proton Beam

International Nuclear Information System (INIS)

Yoo, K. H.; Yoon, K. S.; Cho, W. J.; Park, S. I.; Han, H. S.; Yang, S. D.; Jeon, K. S.; Kim, J. H.; Yang, T. K.

2010-04-01

Results of the project are various nuclei, such as 82 Rb, 68 Ga, 67 Cu, 22 Na and so on, can be produced by irradiating 100 MeV proton beam, by irradiating proton beam to the nat Ga target, the 68 Ge, mother nucleus of positron emitting 68 Ga, is produced based on the nat Ga(p,x) 68 Ge reaction, the target system for the high-energy of proton beam can produce more than 2 species of radioisotope at the same time by employing tandem targets, 68 Ge/ 68 Ga generator, 82 Sr(25.34d)/ 82 Rb generator - 67 Cu production method, 70 Zn electroplating technology based on the electrochemistry, the container, whose weight is about 3 ton, is made by depleted uranium and because of the unstable situation for the supply and demand of reactor produced radioisotope, the need for the cyclotron produced radioisotopes is dramatically increased all over the world.

Modernization of the Radioisotopes Production Laboratory of the La Reina Nuclear Center in Chile: Incorporating advanced concepts of safety and good manufacturing practices

International Nuclear Information System (INIS)

Lagos Espinoza, Silvia

2014-01-01

A radioisotopes and radiopharmaceuticals production laboratory was established in Chile in the 1960s for research activities. From 1967 until January 2012, it was dedicated to the manufacturing of radioisotopes and radiopharmaceuticals for medical diagnosis and treatment purposes. In 2012, modernization of the facility’s design and technology began as part of the IAEA technical cooperation project, Modernizing the Radioisotopes Production Laboratory of La Reina Nuclear Centre by Incorporating Advanced Concepts of Safety and Good Manufacturing Practices, (CHI4022)

Production of medical radioisotopes in the ORNL High Flux Isotope Reactor (HFIR) for cancer treatment and arterial restenosis therapy after PTCA

International Nuclear Information System (INIS)

Knapp, F.F. Jr.; Beets, A.L.; Mirzadeh, S.; Alexander, C.W.; Hobbs, R.L.

1998-01-01

The High Flux Isotope Reactor (HFIR) at the Oak Ridge National Laboratory (ORNL) represents an important resource for the production of a wide variety of medical radioisotopes. In addition to serving as a key production site for californium-252 and other transuranic elements, important examples of therapeutic radioisotopes which are currently routinely produced in the HFIR for distribution include dysprosium-166 (parent of holmium-166), rhenium-186, tin-117m and tungsten-188 (parent of rhenium-188). The nine hydraulic tube (HT) positions in the central high flux region permit the insertion and removal of targets at any time during the operating cycle and have traditionally represented a major site for production of medical radioisotopes. To increase the irradiation capabilities of the HFIR, special target holders have recently been designed and fabricated which will be installed in the six Peripheral Target Positions (PTP), which are also located in the high flux region. These positions are only accessible during reactor refueling and will be used for long-term irradiations, such as required for the production of tin-117m and tungsten-188. Each of the PTP tubes will be capable of housing a maximum of eight HT targets, thus increasing the total maximum number of HT targets from the current nine, to a total of 57. In this paper the therapeutic use of reactor-produced radioisotopes for bone pain palliation and vascular brachytherapy and the therapeutic medical radioisotope production capabilities of the ORNL HFIR are briefly discussed

Impact of chemistry on production and utilization of radioisotopes and related products

International Nuclear Information System (INIS)

Ramamoorthy, N.

2011-01-01

The year 2011, declared as the International Year of Chemistry (IYC), commemorates the centenary of the award of Nobel Prize in Chemistry to Madam Curie for her pioneering work on the discovery of Radium and Polonium. Her invaluable discovery and her other research pursuits, as well as other subsequent discoveries in nuclear sciences, including by her daughter and son-in-law - Irene Curie and Frederic Joliot - who in 1935 discovered the phenomenon of artificially induced radioactivity (that later bagged the Nobel Prize), led to several noteworthy applications. The author, as a member of 'Indian radioisotope family' and the DAE programmes on radioisotopes and related radiation technology since August 1972, narrates in this article a series of select chemistry-related milestones that enabled vital developments in the production of isotope products and their applications. Ingenious and often simple chemistry-based solutions instituted by the researchers stand out in the enormous progress achieved over the years and highly significant practical applications rendered a reality. Appropriate examples can be cited from both the Indian scenario and international developments over the past nearly four decades. The long list will include inter alia the following: change of eluent from dilute nitric acid to normal saline to obtain medical-grade pertechnetate from molybdate adsorbed an acidic alumina (ushering in 99m Tc generators for (radio)pharmacy use); premixing a reducing agent like stannous chloride with ligand and freeze-drying the mixture - 'lyophilised kit' - (providing an easy access to 99m Tc radiopharmaceuticals); introduction of an iodine atom in place of an aryl hydrogen as a non-isotopic label in organic compound of interest (birth of radioiodinated compounds for biomedical use); bifunctional chelates designed to link radiometals with biological or pharmaceutical compound (radiolabeled biological analogues for medical use); nucleophilic substitution by fluoride

Design of radioisotope power systems facility

International Nuclear Information System (INIS)

Eschenbaum, R.C.; Wiemers, M.J.

1991-01-01

Radioisotope power systems currently produced for the U.S. Department of Energy Office of Special Applications by the Mound Laboratory at Miamisburg, Ohio, have been used in a variety of configurations by the Department of Defense and the National Aeronautics and Space Administration. A forecast of fugure radioisotope power systems requirements showed a need for an increased production rate beyond the capability of the existing Mound Laboratory. Westinghouse Hanford Company is modifying the Fuels and Materials Examination Facility on the Hanford Site near Richland, Washington, to install the new Radioisotope Power Systems Facility for assembling future radioisotope power systems. The facility is currently being prepared to assemble the radioisotope thermoelectric generators required by the National Aeronautics and Space Administration missions for Comet Rendezvous Asteroid Flyby in 1995 and Cassini, an investigation of Saturn and its moons, in 1996

Single atom counting with accelerators

Energy Technology Data Exchange (ETDEWEB)

Woelfli, W [Eidgenoessische Technische Hochschule, Zurich (Switzerland)

1984-02-01

Direct detection of radioisotopes with conventional mass spectrometers is possible when the potential background atoms, in particular stable isotopes of the same mass (isobars) or molecules of similar mass are present in sufficiently low concentrations. Most of the long lived radioisotopes of interest for dating purposes however, occur in such small concentrations that their peak in the mass spectrum is obscured by the stable isobar and molecule distributions. The key idea of the new AMS technique which allows us to measure directly such small concentrations is the acceleration of the sample atoms to MeV energies and to use various filter processes and particle identification techniques developed for nuclear physics research to eliminate the isobaric and molecular interferences. The detection methods used for each radioisotope depend on the dominant background atoms and these in turn depend on the specific accelerator used. The problems encountered in transforming an existing particle accelerator into a high precision dating tool are considerable and have been solved only recently for one type of accelerator, notably the tandem Van de Graaff. For this reason the description of the AMS method and some of its applications is restricted to this type of accelerator only.

Homogeneous aqueous solution nuclear reactors for the production of Mo-99 and other short lived radioisotopes

International Nuclear Information System (INIS)

2008-09-01

Technetium-99m ( 99m Tc), the daughter of Molybdenum-99 ( 99 Mo), is the most commonly used medical radioisotope in the world. It accounts for over twenty-five million medical procedures each year worldwide, comprising about 80% of all radiopharmaceutical procedures. 99 Mo is mostly prepared by the fission of uranium-235 targets in a nuclear reactor with a fission yield of about 6.1%. Currently over 95% of the fission product 99 Mo is obtained using highly enriched uranium (HEU) targets. Smaller scale producers use low enriched uranium (LEU) targets. Small quantities of 99 Mo are also produced by neutron activation through the use of the (n, γ) reaction. The concept of a compact homogeneous aqueous reactor fuelled by a uranium salt solution with off-line separation of radioisotopes of interest ( 99 Mo, 131 I) from aliquots of irradiated fuel solution has been cited in a few presentations in the series of International Conference on Isotopes (ICI) held in Vancouver (2000), Cape Town (2003) and Brussels (2005) and recently some corporate interest has also been noticeable. Calculations and some experimental research have shown that the use of aqueous homogeneous reactors (AHRs) could be an efficient technology for fission radioisotope production, having some prospective advantages compared with traditional technology based on the use of solid uranium targets irradiated in research reactors. This review of AHR status and prospects by a team of experts engaged in the field of homogeneous reactors and radioisotope producers yields an objective evaluation of the technological challenges and other relevant implications. The meeting to develop this report facilitated the exchange of information on the 'state of the art' of the technology related to homogeneous aqueous solution nuclear reactors, especially in connection with the production of radioisotopes. This publication presents a summary of discussions of a consultants meeting which is followed by the technical

Radioisotopes for therapy: an overview

International Nuclear Information System (INIS)

Venkatesh, Meera

2006-01-01

Radionuclides made great impact in the history of nuclear sciences both at the end of 19th century with the discoveries of Becquerel and madame Curie and later in 1934, when Frederic Joliet and Irene Curie demonstrated the production of the first artificial radioisotopes, 30 P, by bombardment of 27 Al by alpha particles. The subsequent invention of cyclotron and setting up of nuclear reactor opened the floodgate for production of artificial radionuclides. Currently, majority of radionuclides are made artificially by transforming a stable nuclide into an unstable state and thus far over 2500 radionuclides have been produced artificially. Use of radionuclides in various fields immediately followed their production and last century has witnessed tremendous growth in the applications of radiation and radioisotopes, in diverse fields such as medicine, industry, agriculture, food preservation, water resource management, environmental studies, etc. While radiation and radioisotopes are used both for diagnosis as well as for therapy in the field of medicine, therapeutic applications are among the earliest, which began as an empirical science in the beginning and developed into a well structured modality with time. (author)

The status of the tandem accelerator ANTARES

Energy Technology Data Exchange (ETDEWEB)

Fallon, J.; Boldeman, J.; Cohen, D.; Tuniz, C.; Ellis, P. [Australian Nuclear Science and Technology Organisation, Lucas Heights, NSW (Australia)

1996-12-31

The ANTARES facility at the Lucas Heights Research Laboratories has now operated for 4 years. A research program in Accelerator Mass Spectrometry, lon Beam Analysis and small scale radioisotope production has been pursued. During the same period, the accelerator has been significantly upgraded from the configuration which existed at Rutgers University, NJ, USA, before shipment to Australia in 1989. AMS measurement techniques of several long lived isotopes have been developed for environmental, industry and biomedical applications. Both the experimental program and the engineering developments are discussed further.

The status of the tandem accelerator ANTARES

Energy Technology Data Exchange (ETDEWEB)

Fallon, J; Boldeman, J; Cohen, D; Tuniz, C; Ellis, P [Australian Nuclear Science and Technology Organisation, Lucas Heights, NSW (Australia)

1997-12-31

The ANTARES facility at the Lucas Heights Research Laboratories has now operated for 4 years. A research program in Accelerator Mass Spectrometry, lon Beam Analysis and small scale radioisotope production has been pursued. During the same period, the accelerator has been significantly upgraded from the configuration which existed at Rutgers University, NJ, USA, before shipment to Australia in 1989. AMS measurement techniques of several long lived isotopes have been developed for environmental, industry and biomedical applications. Both the experimental program and the engineering developments are discussed further.

Radioisotope instruments

CERN Document Server

Cameron, J F; Silverleaf, D J

1971-01-01

International Series of Monographs in Nuclear Energy, Volume 107: Radioisotope Instruments, Part 1 focuses on the design and applications of instruments based on the radiation released by radioactive substances. The book first offers information on the physical basis of radioisotope instruments; technical and economic advantages of radioisotope instruments; and radiation hazard. The manuscript then discusses commercial radioisotope instruments, including radiation sources and detectors, computing and control units, and measuring heads. The text describes the applications of radioisotop

Evaluation of Radioisotope Production Process of 153Sm and 153Sm-EDTMP Radiopharmaceuticals

International Nuclear Information System (INIS)

Kadarisman; Sri Hastini; Yayan Tahyan; Abidin; Dadang Hafid; Enny Lestari

2007-01-01

Experiments on the process of 153 Sm radioisotope and labeling of 153 Sm-EDTMP radiopharmaceuticals were carried out. This experiments included preparation of Sm 2 O 3 target, dissolution of post irradiation, determination of radioactivity concentration of 153 Sm radioisotope, radionuclide purity, EDTMP labeling, determination of radiochemical purity and pH. In these experiments the total radioactivity 153 Sm product is round about 2845.83 mCi to 36963.31 mCi, or with the radioactivity concentration between 474 mCi/ml to 6160.55 mCi/ml in the SmCl 3 solution form, each its volume is 6.0 ml, and the samarium content is 5.76 mg/ml, and the radionuclide purity of 153 Sm is 100 %. All of the 153 Sm- EDTMP radiopharmaceuticals product are fulfilled requirements the radioactivity concentration, Sm content, radiochemical purity and pH. The radioactivity concentration of 153 Sm-EDTMP radiopharmaceuticals is 37.50 mCi/ml (minimum) to 283.50 mCi/ml (highest). The pH 7.5 were 8 products, and the rest are pH 8.5. Radiochemical purity of 153 Sm-EDTMP are round about 90.00 % to 99.44 %. (author)

Production of radioisotopes at the Boris Kidric Institute of Nuclear Sciences at Vinca, Yugoslavia

International Nuclear Information System (INIS)

Teofilovski, C.

1969-01-01

The investigations in order to master the production of radioisotopes were commenced simultaneously with the beginning of RA nuclear reactor construction at Vinca, in 1956. A new organization division - Laboratory for chemistry of high activity accepting beside other problems also the programme for mastering the regular production of radioactive material was formed in 1959. Various problems during the realization of this programme have been solved, starting with the staff training for work with radioactive material on the high level activity (to 7500 Ci/source), construction and equipment of the laboratory area for safe work, up to development of the whole series of chemical-technological procedures and techniques for regular production of various radioactive products, as well as the methods for their chemical, radiometric and pharmaceutical control. Owing to the successful realization of this programme, the Institute 'Boris Kidric' supplies to-day regularly 110 organizations in the country with various radioactive products, applied in medicine, industry and research. The annual product of the radioactive solutions of radioisotopes J-131, Au-198, P-32, S-35 etc., amounts to about 75 Ci, radiographic sources Ir-192 and Co-60 to 2000 Ci and Co-60 sources for teletherapy and the other applications to many thousand curies (author) [sr

Fixing tools of targets for radioisotope production in the RA10

International Nuclear Information System (INIS)

Peirone, M.; Coleff, A.; Chasseur, A.

2012-01-01

The RA-10 project is about the design and construction of a reactor for radioisotopes production and scientific research in the nuclear area. Most of the reactor design comes from INVAP SE, however some of the design job was performed in CNEA, i.e. the so called Outer Core Experimental Devices (DEEN) and their interfaces with the Reflector Tank were designed in CNEA and the documentation of the basic design was recently released (author)

Radioisotope techniques in oil wells

International Nuclear Information System (INIS)

Jain, Prabuddha

1998-01-01

Radioisotope techniques are quite useful in oil exploration and exploitation. Nuclear logging offers a way of gathering information on porosity, permeability, fluid saturations, hydrocarbon types and lithology. Some of the interesting applications in well drilling are determining depth of filtrate invasion, detection of lost circulation, drill-bit erosion control; primary cement measurements and well completions such as permanent tubular markers, perforation position marking, detection of channeling behind casing and gravel pack operations. Radioisotopes have been successfully used in optimizing production processes such as production profiling injection profiling, corrosion measurements and well to well tracer tests. (author)

Abstracts of the third conference on radioisotopes and their applications

International Nuclear Information System (INIS)

2002-10-01

The Third Uzbekistan Conference on radioisotopes and their applications was held on 8-10 October, 2002 in Tashkent, Uzbekistan. The specialists discussed various aspects of modern problems of radiochemistry, radioisotope production, technology of radioisotopes and compounds, activations analysis applications, radionuclides, radioimmunoassays, application of radioisotopes in industry, medicine, biology and agriculture. More than 80 talks were presented in the meeting

Radioisotope Power Sources

International Nuclear Information System (INIS)

Culwell, J. P.

1963-01-01

The radioisotope power programme of the US Atomic Energy Commission has brought forth a whole new technology of the use of radioisotopes as energy sources in electric power generators. Radioisotope power systems are particularly suited for remote applications where long-lived, compact, reliable power is needed. Able to perform satisfactorily under extreme environmental conditions of temperature, sunlight and electromagnetic radiations, these ''atomic batteries'' are attractive power sources for remote data collecting devices, monitoring systems, satellites and other space missions. Radioisotopes used as fuels generally are either alpha or beta emitters. Alpha emitters are the preferable fuels but are more expensive and less available than beta fuels and are generally reserved for space applications. Beta fuels separated from reactor fission wastes are being used exclusively in land and sea applications at the present. It can be expected, however, that beta emitters such as stiontium-90 eventually will be used in space. Development work is being carried out on generators which will use mixed fission products as fuel. This fuel will be less expensive than the pure radioisotopes since the costs of isotope separation and purification are eliminated. Prototype thermoelectric generators, fuelled with strontium-90 and caesium-137, are now in operation or being developed for use in weather stations, marine navigation aids and deep sea monitoring devices. A plutonium-238 thermoelectric generator is in orbit operating as electric power source in a US Navy TRANSIT satellite. Generators are under development for use on US National Aeronautics and Space Administration missions. The large quantities of radioactivity involved in radioisotope power sources require that special attention be given to safety aspects of the units. Rigid safety requirements have been established and extensive tests have been conducted to insure that these systems can be employed without creating undue

Radioisotopes and their applications in highway testings

International Nuclear Information System (INIS)

Saxena, S.C.

1974-01-01

Applications of radioisotopes in highway testing are described. Radioisotopic methods have been used to determine : (1) moisture and density of soil and base materials for compaction control, (2) magnesium oxide content of cement, (3) permeability of bituminous coverings and (4) field density of freshly laid hot bituminous concrete surface. Possible uses of nuclear explosives for production of aggregates and of radioisotopes for determination of deflection in the design of flexible pavements are indicated. (M.G.B.)

Markets for reactor-produced non-fission radioisotopes

International Nuclear Information System (INIS)

Bennett, R.G.

1995-01-01

Current market segments for reactor produced radioisotopes are developed and reported from a review of current literature. Specific radioisotopes studied in is report are the primarily selected from those with major medical or industrial markets, or those expected to have strongly emerging markets. Relative market sizes are indicated. Special emphasis is given to those radioisotopes that are best matched to production in high flux reactors such as the Advanced Test Reactor (ATR) at the Idaho National Engineering Laboratory or the High Flux Isotope Reactor (HFIR) at the Oak Ridge National Laboratory. A general bibliography of medical and industrial radioisotope applications, trends, and historical notes is included

Solid targets for production of radioisotopes with cyclotron; Blancos solidos para produccion de radioisotopos con ciclotron

Energy Technology Data Exchange (ETDEWEB)

Paredes G, L.; Balcazar G, M. [Instituto Nacional de Investigaciones Nucleares, Direccion de Investigacion Tecnologica, A.P. 18-1027, 11801 Mexico D.F. (Mexico)

1999-07-01

The design of targets for production of radioisotopes and radiopharmaceuticals of cyclotron to medical applications requires a detailed analysis of several variables such as: cyclotron operation conditions, choice of used materials as target and their physicochemical characteristics, activity calculation, the yielding of each radioisotope by irradiation, the competition of nuclear reactions in function of the projectiles energy and the collision processes amongst others. The objective of this work is to determine the equations for the calculation for yielding of solid targets at the end of the proton irradiation. (Author)

RSG-Gas Based Radioisotopes And Sharing Program For Regional Back Up Supply

International Nuclear Information System (INIS)

Soenardjo, Sunarhadijoso; Tamat, Swasono R.; Suparman, Ibon; Purwadi, Bambang

2003-01-01

As the owner of the reactors used for radioisotope production, BATAN needs to increase the effectiveness of the reactor operation cost that can be achieved by simultaneously exploiting all the existing irradiation facility, supported by full utilization of the radioisotopes produced. On the other hand, the domestic demand of radioisotopes is much lower than the production capability but sometimes the request is compulsory to be suspended due to reactor operation schedule. As this condition is mostly similar to that of several countries of RCA Member States, a sharing program for regional back up supply seems to be a positive thought to support expectation on the effectiveness of reactor operation cost and the continuity of radioisotope product services as well as the utilization of radioisotopes produced. Based on radioactivity achieved in each production batch at the present, 131 I, 99 Mo, 153 Sm, 125 I and 32 p radioisotopes may be offered for back up supply program. Due to consideration on conformity of user demands with reactor operation and radiochemical processing costs, the concept of back up supply program should performed first by means of full utilization of the available products and not by increasing reactor operation frequency. An information and communication network system, therefore, is absolutely needed to support information exchange between the radioisotope producer, members of back up supply program and radioisotope customers

Abstracts of the second conference on radioisotopes and their applications

Energy Technology Data Exchange (ETDEWEB)

NONE

2000-10-01

The Second Uzbekistan Conference on radioisotopes and their applications was held on 3-5 October, 2000 in Tashkent, Uzbekistan. The specialists discussed various aspects of modern problems of radiochemistry, radioisotope production, technology of radioisotopes and compounds, activations analysis applications, radionuclides, radioimmunoassays, application of radioisotopes in industry, medicine, biology and agriculture. More than 80 talks were presented in the meeting. (A.A.D.)

Radiation protection at radioisotope processing facilities

International Nuclear Information System (INIS)

Hillier, L.R.; Decaire, R.

2002-01-01

MDS Inc. is Canada's largest diversified health and life sciences company and provides health care services and products to prevent, diagnose and treat disease. MDS Nordion Inc. is a subsidiary of MDS Inc. and is located in Ottawa, Ontario. It provides much of the world's supply of radioisotopes used in nuclear medicine primarily to diagnose, but also to treat disease. MDS Nordion is composed of three major production divisions at its Ottawa location and serves customers in three major markets. These are primarily: radioisotopes used in nuclear medicine (Nuclear Medicine Division), radiation processing for sterilization of medical equipment and supplies, and food (Ion Technologies Division), and teletherapy equipment used in cancer treatment (Therapy Systems Division). MDS Nordion supplies customers in over 100 countries, exporting more than 95 percent of its product processed in Canada. Every year, 15 to 20 million diagnostic imaging tests are carried out in hospitals around the world, using radioisotopes supplied by MDS Nordion. In addition, 150 to 200 million cubic feet (that's enough to cover an entire CFL field - including the end zones - stacked over half a kilometer high) of single use medical products are sterilized using MDS Nordion supplied equipment. MDS Nordion receives medical isotopes from AECL, Chalk River Laboratories and processes the material to purify and quantify the radioisotope product. Sealed sources, comprised of cobalt 60, are supplied from CANDU reactors. Production processes include ventilated shielded cells with remote manipulators, gloveboxes and fumehoods, to effectively control the safety of the workplace and the environment, and to prevent contamination of the products. The facilities are highly regulated by the Canadian Nuclear Safety Commission (CNSC) for safety and environmental protection. Products are also regulated by Health Canada and the US-Food and Drug Administration (FDA). (author)

The order for enforcing the law concerning prevention from radiation hazards due to radioisotopes

International Nuclear Information System (INIS)

1981-01-01

This rule is established under the provisions of the law on the prevention of radiation injuries by radioisotopes, and the former ordinance No. 14, 1958, is hereby totally amended. Radioisotopes under the law are the isotopes which emit radiation, and of which the concentration exceeds the levels defined by the Director General of the Science and Technology Agency, their compounds or the substances containing these compounds, excluding those defined in the atomic energy act and other particular laws. The apparatuses fitted with radioisotopes under the law are electron capture detectors for gas chromatography. The radiation emitting installations under the law are cyclotron, synchrotron, synchro-cyclotron, linear accelerator, betatron, Van de Graaff accelerator, Cockcroft-Walton's accelerator, etc. The permission of usage under the law shall be obtained for each works or enterprise. Persons who intend to get the permission shall file the application for them attaching the documents describing expected period of usage and other papers specified by the Director General. The total quantity of radioisotopes sealed tightly for each works or enterprise under the law shall be 100 milli-curie. The design of apparatus for the prevention of radiation injuries, the capacities of storage facilities regularly inspected, the period of regular inspection, the confirmation of transport and disposal and fees to be paid, etc. are defined, respectively. (Okada, K.)

76 FR 63668 - Guidelines for Preparing and Reviewing Licensing Applications for the Production of Radioisotopes

Science.gov (United States)

2011-10-13

..., Research and Test Reactors Projects Branch, Division of Policy and Rulemaking, Office of Nuclear Reactor... NUCLEAR REGULATORY COMMISSION [NRC-2011-0135] Guidelines for Preparing and Reviewing Licensing Applications for the Production of Radioisotopes AGENCY: Nuclear Regulatory Commission. ACTION: Draft interim...

Preparation of an annual report for a consolidated radioisotope licence

International Nuclear Information System (INIS)

1985-01-01

A consolidated radioisotope licence is a single license issued by the Atomic Energy Control Board (AECB) to an institution having many users of radioactive materials. The licence is issued when the institution has fulfilled the requirements set by the AECB and has implemented policies and procedures which will ensure the maintenance of an effective radiation safety program. The consolidated licence is retained only if the results of AECB inspections are satisfactory -- or remedial action is taken promptly -- and if the institution reports regularly about the status of its radiation safety program. One aspect of this reporting procedure is an annual report. This guide describes the information that the AECB requires in the annual report. The guide applies primarily to universities and research institutions where a wide variety of radioisotope uses take place. The guide does not affect most other institutions or facilities, either because the nature and extent of their operations with radioactive materials do not lend themselves to consolidated licensing or because they are not licensed by the Radioisotopes and Transportation Division. (For example, this guide does not apply to reactors, to accelerators, or to waste management or uranium mining or refining facilities.) The information in the annual report should be specific to the consolidated radioisotope licence. Incidents, staff exposures, and waste associated with accelerators, research reactors, and waste management facilities should be excluded from this report unless they affected activities under the consolidated licence

A proton-driven, intense, subcritical, fission neutron source for radioisotope production

Energy Technology Data Exchange (ETDEWEB)

Jongen, Y. [Chemin du Cyclotron, Louvain-la-Neuve (Belgium)

1995-10-01

{sup 99m}Tc, the most frequently used radioisotope in nuclear medicine, is distributed as {sup 99}Mo=>{sup 99m}Tc generators. {sup 99}Mo is a fission product of {sup 235}U. To replace the aging nuclear reactors used today for this production, the author proposes to use a spallation neutron source, with neutron multiplication by fission. A 150 MeV, H{sup {minus}} cyclotron can produce a 225 kW proton beam with 50% total system energy efficiency. The proton beam would hit a molten lead target, surrounded by a water moderator and a graphite reflector, producing around 0.96 primary neutron per proton. The primary spallation neutrons, moderated, would strike secondary targets containing a subcritical amount of {sup 235}U. The assembly would show a k{sub eff} of 0.8, yielding a fivefold neutron multiplication. The thermal neutron flux at the targets location would be 2 {times} 10{sup 14} n/cm{sup 2}.s, resulting in a fission power of 500 to 750 kW. One such system could supply the world demand in {sup 99}Mo, as well as other radioisotopes. Preliminary indications show that the cost would be lower than the cost of a commercial 10 MW isotope production reactor. The cost of operation, of disposal of radiowaste and of decommissioning should be significantly lower as well. Finally, the non-critical nature of the system would make it more acceptable for the public than a nuclear reactor and should simplify the licensing process.

TESLA accelerator installation

International Nuclear Information System (INIS)

Neskovic, N.; Ostojic, R.; Susini, A.; Milinkovic, Lj.; Ciric, D.; Dobrosavljevic, A.; Brajuskovic, B.; Cirkovic, S.; Bojovic, B.; Josipovic, M.

1992-01-01

The TESLA accelerator Installation is described. Its main parts are the VINCY Cyclotron, the multiply charged heavy-ion mVINIS Ion Source, and the negative light-ion pVINIS Ion Source. The Installation should be the principal installation of a regional center for basic and applied research in nuclear physics, atomic physics, surface physics and solid state physics, for production of radioisotopes, for research and therapy in nuclear medicine. The first extraction of the ion beam from the Cyclotron is planned for 1995. (R.P.) 3 refs.; 1 fig

Studies on application of radiation and radioisotopes

International Nuclear Information System (INIS)

Kim, Jae Rok; Lee, Ji Bok; Lee, Yeong Iil; Jin, Joon Ha; Beon, Myeong Uh; Park, Kyeong Bae; Han, Heon Soo; Jeong, Yong Sam; Uh, Jong Seop; Kang, Kyeong Cheol; Cho, Han Ok; Song, Hui Seop; Yoon, Byeong Mok; Jeon, Byeong Jin; Park, Hong Sik; Kim, Jae Seong; Jeong, Un Soo; Baek, Sam Tae; Cho, Seong Won; Jeon, Yeong Keon; Kim, Joon Yeon; Kwon, Joong Ho; Kim, Ki Yeop; Yang, Jae Seung; No, Yeong Chang; Lee, Yeong Keun; Shin, Byeong Cheol; Park, Sang Joon; Hong, Kwang Pyo; Cho, Seung Yeon; Kang, Iil Joon; Cho, Seong Ki; Jeong, Yeong Joo; Park, Chun Deuk; Lee, Yeong Koo; Seo, Chun Ha; Han, Kwang Hui; Shin, Hyeon Young; Kim, Jong Kuk; Park, Soon Chul; Shin, In Cheol; Lee, Sang Jae; Lee, Ki Un; Lim, Yong Taek; Park, Eung Uh; Kim, Dong Soo; Jeon, Sang Soo

1993-05-01

With the completion of construction of KMRR, the facility and technology of radiation application will be greatly improved. This study was performed as follows; (1) Studies on the production and application of radioisotopes. (2) The development of radiation processing technology. (3) The application of Irradiation techniques for food preservation and process improvement. (4) Studies on the radiation application for the development of genetic resources (5) Development of the radioisotope (RI) production facilities for Korea Multipurpose Research Reactor (KMRR)

The radioisotopes and radiations program

International Nuclear Information System (INIS)

1982-01-01

This program of the National Atomic Energy Commission of Argentina refers to the application and production of radionuclides, their compounds and sealed sources. The applications are carried out in the medical, agricultural, cattle raising and industrial areas and in other engineering branches. The sub-program corresponding to the production of radioactive materials includes the production of radioisotopes and of sealed sources, and an engineering service for radioactive materials production and handling facilities. The sub-program of applications is performed through several groups or laboratories in charge of the biological and technological applications, intensive radiation sources, radiation dosimetry and training of personnel or of potential users of radioactive material. Furthermore, several aspects about technology transfer, technical assistance, manpower training courses and scholarships are analyzed. Finally, some legal aspects about the use of radioisotopes and radiations in Argentina are pointed out. (M.E.L.) [es

Development and application of industrial radioisotope instruments in China

International Nuclear Information System (INIS)

Lu Yanxiao

1994-09-01

Industrial radioisotope instruments are emerging as advanced monitoring, controlling and automation tools for industries in China. Especially the on-line analysis systems based on radioisotope instruments, referred to as nucleonic control systems (NCS), have more and more important role in the modernization and optimization of industrial processes. Over nearly four decades significant progress has been made in the development and application of radioisotope instruments in China. After a brief review of the history of radioisotope instruments, the state of the art of this kind of instruments and recent examples of their applications are given. Technical and economic benefits have resulted from the industrial applications of radioisotope instruments and the sales of products of their own in marketing. It is expected that along with the high speed growth of national economy, there will be greater demand for radioisotope instruments and nucleonic control systems in Chinese industry to promote the technological transformation and progress of traditional industries and to establish high-tech industries with technology-intensive products. Sustained efforts for the research and development of radioisotope instrument should be made to up-grade domestic instruments and to satisfy the needs of the smaller scale industries more common in China for low cost systems. (1 fig., 2 tabs.)

Twenty years of Korea radioisotope association history

International Nuclear Information System (INIS)

2005-09-01

This contents has two parts. The first part describes the present and post of Korea radioisotope association which are about the foundation of the association, organization, main projects and vision of the association. The second part is about the use and the prospect of radiation and radioisotope in Korea, which shows the plan of expansion of use of radiation and radioisotope, the prospect and present condition in fields such as medical, industry and farming, product and distribution, research and development of human resources, system and management of safety of radiation.

Production and radiochemical separation of 203Pb radioisotope for nuclear medicine

International Nuclear Information System (INIS)

Szuecs, Z.; Takacs, S.; Andrasi, D.; Kovacs, B.

2012-01-01

Complete text of publication follows. The heavy metal pollution due to their industrial production, waste repository or accident as the cyanide spill in river Tisza in 2002, increase the scientific interest for using an ideal trace isotope for monitoring these type of events. The lead is one of the most toxic and commonly used heavy metal, its poisoning is often deadly because very difficult to recognize and identify. The neuro-scientific study of biodegradation effect of lead could be an impressive scientific field of application of 203 Pb radioisotope. However the targeted radionuclide therapy especially the α-emitting radioisotope therapy is also strongly interested to find an ideal tracer for the 213 Bi and 212 Pb therapy. Therefore the 203 Pb is a potential radioisotope for this role due to its radiation behaviour and as heavy metal element. The 203 Tl(p,n) 203 Pb nuclear reaction was chosen for the production. The irradiation was done at the compact cyclotron of Atomki with proton beam 14.5 MeV energy and beam current of 7 μAs. The thickness of the target material was 840 μm, the irradiation time was 3 hours and the produced activity was 40 MBq at EOB. It corresponds to 1.87 MBq/μAh physical yield of the reaction which correlating with the cross section curve. A new technique was developed for target preparation. The metal Tl was pressed into a copper backing and covered with a HAWAR foil with thickness of 11 μm. The covering foil saved the surface of the Tl from the oxidation and also transferred the dissipating heat to the cooling He gas. The back side of the target was cooled with pressured cold water. The irradiated Tl target was pressed out from the copper backing, which had only the thickness of 0.2 mm. Then the Thallium was dissolved in nitric acid. The excess acid was evaporated slowly. The nitrate form was transferred to chloride form by 8 mol/dm 3 HCl and the Thallium was kept in 3+ oxidation stage by hydrogen peroxide. The separation was

Automatized target devices for radioisotope production at the RITs cyclotron

International Nuclear Information System (INIS)

Bogdanov, P.V.; Ivanov, V.V.; Karasev, B.G.

1981-01-01

An automation target device intended for isotope production on the internal beam of the RITs cyclotron is decribed. The target device comprises the following main units: target head, vacuum lock, charging device, transport system for bringing the target for charging; mechanism of target discharge transport device, control interlocking and signalling control system of target radiation power. The automation target device permits radioisotope production on the cyclotron in commercial scales with automation substitution of irradiated targets. The time of substitution of one of six targets makes up only 5 min. The time of charging a new group of targets to the charge device - 60 min. Contact of the personnel with irradiated targets is practically excluded and the necessity of entering the cyclotron room for maintenance of the plant is reduced to the minimum [ru

Industrial and medical applications of accelerators with energies less than 20 MeV

International Nuclear Information System (INIS)

Duggan, J.L.

1983-01-01

In this paper the medical and industrial application of small accelerators is reviewed. Most of the material is taken from the Seventh Conference on the Application of Accelerators in Research and Industry, which was held in Denton, Texas in November of 1982. The areas covered include medical linacs, cyclotron design and production of medical radioisotopes, radiation processing, ion implantation for the metallurgical and semiconductor industries, oil and mineral exploration, trace, surface and bulk analysis, and unique accelerators for all of the above applications

Applications of Particle Accelerators in Medical Physics

CERN Document Server

Cuttone, G

2008-01-01

Particle accelerators are often associated to high energy or nuclear physics. As well pointed out in literature [1] if we kindly analyse the number of installation worldwide we can easily note that about 50% is mainly devoted to medical applications (radiotherapy, medical radioisotopes production, biomedical research). Particle accelerators are also playing an important indirect role considering the improvement of the technical features of medical diagnostic. In fact the use of radionuclide for advanced medical imaging is strongly increasing either in conventional radiography (CT and MRI) and also in nuclear medicine for Spect an PET imaging. In this paper role of particle accelerators for medical applications will be presented together with the main solutions applied.

Radioisotopic control and automation of food mills

International Nuclear Information System (INIS)

Pertsovskij, E.S.; Sakharov, Eh.V.; Dolinin, V.A.

1980-01-01

Domestic and foreign experience in application of radioisotope devices to process control in fool industry, is described. The diagrams of devices to block and account the production in systems of process monitoring and control are considered. The methods of determining chemical composition of substances are discussed, as sell as the devices used for those purposes and based on recording β-and γ-radiation absorption by substance. The methods for determining dust and smoke content in premises using radioisotope devices. Level indicators, moisture gages and densitimeters usedf ctol level humidity, density and concentration of food products in the process of production are described [ru

Transport of radioisotopes

International Nuclear Information System (INIS)

Aoki, Shigefumi

1978-01-01

Presently the amount of radioisotopes increased very much and the application spread to wide fields in Japan. Since facilities using radioisotopes are distributed to every place in the country, every transport means such as airplanes, automobiles, railways, ships and mail are employed. The problems in the transport of radioisotopes include too much difference in the recognition of criticality among the persons concerning the transportation and treatment, knowledges of shielding and energy difference in the types of radiation and handling of sealed and unsealed sources and the casks for transport. IAEA established the latest regulation on the package of radioisotopes in 1973, and in Japan, the related regulations will be revised according to the IAEA's regulation in near future. The present status in the inspection at the time of shipment, supervision, and the measures to the accidents are described for the transport means of airplanes, ships and automobiles. Finally, concerning the insurance for cargo, the objects of the insurance for radioisotopes include either the radioisotopes contained in casks for transportation or radioisotopes only. Generally, radioisotopes are accepted in all-risk condition including casks and limited to the useful radioisotopes for peaceful use. (Wakatsuki, Y

Radioisotope production with a medical cyclotron

International Nuclear Information System (INIS)

Silvester, D.J.

1974-01-01

The cyclotron of Hammersmith hospital in England was completed and started the operation in 1955. The feature is in its design operable at high beam current, reaching 500μA in internal beam and 300μA in external beam. In 1960's, twelve nuclides of radioactive pharmaceuticals were produced with the cyclotron. C-11, N-13 and O-15 have been used in the form of radioactive gases such as CO or H 2 O to test lung functions. F-18 has been used for bone scanning. K-43 is employed in the research of electrolyte balancing together with Na-24 and Br-77. Fe-52 is utilized in iron ion researches as a tracer. Cs-129 is highly evaluated as an isotope for imaging cardiac clogging part. Radioisotopes must be much more used in the examination of in vivo metabolic function. For this purpose, peculiarly labelled compounds should be further developed. It is welcome that the persons paying attention to the medical prospect of cyclotrons are increasing. The author hopes to continue his endeavour to find new products made with the cyclotron for human welfare. (Wakatsuki, Y.)

The efficient importation and distribution of radioisotopes. Suggestions for the most economic importation of radioisotopes

Energy Technology Data Exchange (ETDEWEB)

NONE

1963-08-01

In the course of their work in many Member States, IAEA technical assistance experts have sometimes encountered difficulties in connection with the importation of radioactive isotopes. In some countries they have been consulted as to the possible improvement of import procedures. The purpose of this publication is to summarize the experience that has been gained in the hope that it may be useful both to scientists who wish to import radioisotopes for their work and to public officials who are concerned with the administrative and financial aspects of the problem. This question is of considerable importance because many countries have only limited resources of scientific man-power and foreign exchange and hence it is essential, if these resources are to be utilized fully, that efficient importing procedures be established. Furthermore, the success or failure of technical assistance activities may depend on whether radioisotopes needed for the project can be efficiently imported. Although the data summarized in this publication are based mainly on the experience of medical users of radioisotopes, they are equally applicable to their uses in other fields such as agriculture and hydrology. This publication covers the subject of importation and distribution of radioisotopes, and concludes with a brief section on the domestic production of short-lived radioisotopes in research reactors.

The efficient importation and distribution of radioisotopes. Suggestions for the most economic importation of radioisotopes

International Nuclear Information System (INIS)

1963-01-01

In the course of their work in many Member States, IAEA technical assistance experts have sometimes encountered difficulties in connection with the importation of radioactive isotopes. In some countries they have been consulted as to the possible improvement of import procedures. The purpose of this publication is to summarize the experience that has been gained in the hope that it may be useful both to scientists who wish to import radioisotopes for their work and to public officials who are concerned with the administrative and financial aspects of the problem. This question is of considerable importance because many countries have only limited resources of scientific man-power and foreign exchange and hence it is essential, if these resources are to be utilized fully, that efficient importing procedures be established. Furthermore, the success or failure of technical assistance activities may depend on whether radioisotopes needed for the project can be efficiently imported. Although the data summarized in this publication are based mainly on the experience of medical users of radioisotopes, they are equally applicable to their uses in other fields such as agriculture and hydrology. This publication covers the subject of importation and distribution of radioisotopes, and concludes with a brief section on the domestic production of short-lived radioisotopes in research reactors

Proposal for an irradiation facility at the TAEK SANAEM Proton Accelerator Facility

Science.gov (United States)

Demirköz, B.; Gencer, A.; Kiziloren, D.; Apsimon, R.

2013-12-01

Turkish Atomic Energy Authority's (TAEK's) Proton Accelerator Facility in Ankara, Turkey, has been inaugurated in May 2012 and is under the process of being certified for commercial radio-isotope production. Three of the four arms of the 30 MeV cyclotron are being used for radio-isotope production, while the fourth is foreseen for research and development of novel ideas and methods. The cyclotron can vary the beam current between 12 μA and 1.2 mA, sufficient for irradiation tests for semiconductor materials, detectors and devices. We propose to build an irradiation facility in the R&D room of this complex, open for use to the international detector development community.

Diffusion of Implanted Radioisotopes in Solids

CERN Multimedia

2002-01-01

Implantation of radioisotopes into metal and semiconductor samples is performed. The implanted isotope or its decay-product should have a half-life long enough for radiotracer diffusion experiments. Such radioisotopes are utilized to investigate basic diffusion properties in semiconductors and metals and to improve our understanding of the atomic mechanisms of diffusion. For suitably chosen systems the combination of on-line production and clean implantation of radioisotopes at the ISOLDE facility opens new possibilities for diffusion studies in solids. \\\\ \\\\ The investigations are concentrated on diffusion studies of $^{195}$Au in amorphous materials. The isotope $^{195}$Au was obtained from the mass 195 of the mercury beam. $^{195}$Hg decays into $^{195}$Au which is a very convenient isotope for diffusion experiments. \\\\ \\\\ It was found that $^{195}$Au is a slow diffusor in amorphous Co-Zr alloys, whereas Co is a fast diffusor in the same matrix. The ``asymmetry'' in the diffusion behaviour is of considerab...

Preliminary definition of the design of a nuclear reactor for research and radioisotope production using natural uranium and heavy water

International Nuclear Information System (INIS)

Llagostera Beltran, J.I.

1982-01-01

A study was conducted about the evolution of the Brazilian importations of radioisotopes, from the beginning of the 70's since they have been increasingly used in the Country. In view of the limited production capacity of radioactive isotopes now existing in Brazil, a nuclear reactor type (natural uranium and heavy water) was defined, for research and production of radioisotopes, wich, besides providing, at least partially, the Brazilian needs of said isotopes, permits a large national participation in its project, construction and operating maintenance. The processes for heavy water production have been analyzed and it could be detected what is the best alternative for the production thereof, in low scale, in Brazil. The options concerning the definition of the main components of the reactor were justified and its most important features were determined, in relation to the neutronic and thermal aspects, being so defined its most significant parameters. The annual quantities were estimated, in terms of total and specific activity, for the radioisotopes that could be obtained by means of the proposed reactor, which, by now, are participating, to a large extent, in the total of Brazilian importation of radioactive isotopes. (Author) [pt

77 FR 21592 - Guidelines for Preparing and Reviewing Licensing Applications for the Production of Radioisotopes

Science.gov (United States)

2012-04-10

... Licensing of Non-Power Reactors: Format and Content,'' for the production of radioisotopes and NUREG-1537, Part 2, ``Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors... by searching on http://www.regulations.gov under Docket ID NRC-2011-0135. You may submit comments by...

Medical applications of accelerators

CERN Document Server

Rossi, Sandro

1998-01-01

At Present, about five thousands accelerators are devoted to biomedical applications. They are mainly used in radiotherapy, research and medical radioisotopes production. In this framework oncological hadron-therapy deserves particular attention since it represents a field in rapid evolution thanks to the joint efforts of laboratories with long experiences in particle physics. It is the case of CERN where the design of an optimised synchrotron for medical applications has been pursued. These lectures present these activities with particular attention to the new developments which are scientifically interesting and/or economically promising.

Radio-isotope production scale-up at the University of Wisconsin

Energy Technology Data Exchange (ETDEWEB)

Nickles, Robert Jerome [Univ of Wisconsin

2014-06-19

Our intent has been to scale up our production capacity for a subset of the NSAC-I list of radioisotopes in jeopardy, so as to make a significant impact on the projected national needs for Cu-64, Zr-89, Y-86, Ga-66, Br-76, I-124 and other radioisotopes that offer promise as PET synthons. The work-flow and milestones in this project have been compressed into a single year (Aug 1, 2012- July 31, 2013). The grant budget was virtually dominated by the purchase of a pair of dual-mini-cells that have made the scale-up possible, now permitting the Curie-level processing of Cu-64 and Zr-89 with greatly reduced radiation exposure. Mile stones: 1. We doubled our production of Cu-64 and Zr-89 during the grant period, both for local use and out-bound distribution to ≈ 30 labs nationwide. This involved the dove-tailing of beam schedules of both our PETtrace and legacy RDS cyclotron. 2. Implemented improved chemical separation of Zr-89, Ga-66, Y-86 and Sc-44, with remote, semi-automated dissolution, trap-and-release separation under LabView control in the two dual-mini-cells provided by this DOE grant. A key advance was to fit the chemical stream with miniature radiation detectors to confirm the transfer operations. 3. Implemented improved shipping of radioisotopes (Cu-64, Zr-89, Tc-95m, and Ho-163) with approved DOT 7A boxes, with a much-improved FedEx shipping success compared to our previous steel drums. 4. Implemented broad range quantitative trace metal analysis, employing a new microwave plasma atomic emission spectrometer (Agilent 4200) capable of ppb sensitivity across the periodic table. This new instrument will prove essential in bringing our radiometals into FDA compliance needing CoA’s for translational research in clinical trials. 5. Expanded our capabilities in target fabrication, with the purchase of a programmable 1600 oC inert gas tube furnace for the smelting of binary alloy target materials. A similar effort makes use of our RF induction furnace, allowing

Accelerated product development

NARCIS (Netherlands)

Langerak, F.; Seth, J.N.; Malhotra, N.K.

2011-01-01

Accelerated product development is a competitive strategy that seeks to reduce the development cycle time of new products. However, there has been little theoretical advancement and empirical model testing in the identification of the conditions under which cycle time reduction is appropriate, the

US Department of Energy radioisotope customers with summary of radioisotope shipments, FY 1988

International Nuclear Information System (INIS)

Van Houten, N.C.

1989-06-01

Pacific Northwest Laboratory (PNL) prepared this edition of the radioisotope customer list at the request of the Office of Health and Environmental Research (ER-73), Office of Energy Research, US Department of Energy (DOE). This is the 25th report in a series dating from 1964. This report covers DOE radioisotope sales and distribution activities by its facilities to domestic, foreign and other DOE facilities for FY 1988. The report is divided into five sections: radioisotope suppliers, facility contacts, and radioisotopes or services supplied; a list of customers, suppliers, and radioisotopes purchased; a list of radioisotopes purchased cross-referenced to customer numbers; geographic locations of radioisotope customers; and radioisotope sales and transfers -- FY 1988. Radioisotopes not previously reported in this series of reports were argon-37, arsenic-72, arsenic-73, bismuth-207, gadolinium-151, rhenium-188, rhodium-101, selenium-72, xenon-123 and zirconium-88. The total value of DOE radioisotope sales for FY 1988 was $11.1 million, an increase of 3% from FY 1987

US Department of Energy radioisotope customers with summary of radioisotope shipments, FY 1988

Energy Technology Data Exchange (ETDEWEB)

Van Houten, N.C.

1989-06-01

Pacific Northwest Laboratory (PNL) prepared this edition of the radioisotope customer list at the request of the Office of Health and Environmental Research (ER-73), Office of Energy Research, US Department of Energy (DOE). This is the 25th report in a series dating from 1964. This report covers DOE radioisotope sales and distribution activities by its facilities to domestic, foreign and other DOE facilities for FY 1988. The report is divided into five sections: radioisotope suppliers, facility contacts, and radioisotopes or services supplied; a list of customers, suppliers, and radioisotopes purchased; a list of radioisotopes purchased cross-referenced to customer numbers; geographic locations of radioisotope customers; and radioisotope sales and transfers -- FY 1988. Radioisotopes not previously reported in this series of reports were argon-37, arsenic-72, arsenic-73, bismuth-207, gadolinium-151, rhenium-188, rhodium-101, selenium-72, xenon-123 and zirconium-88. The total value of DOE radioisotope sales for FY 1988 was $11.1 million, an increase of 3% from FY 1987.

Radioisotopes preparation with GA Siwabessy for application in health/medical

International Nuclear Information System (INIS)

Sunarhadijoso-Soenarjo

2003-01-01

The Center for Development of Radioisotopes and Radiopharmaceuticals (CDRR) has to improve its role and potency to comply domestic demand in radioisotope preparations. The radioisotopes are used as both primary radioisotopes and labeled compounds, especially for medical diagnosis and therapy as radiopharmaceutical preparations. The implementation of capability in production of radioisotopes and radiopharmaceuticals is fully affected by the readiness of operational function of supporting facilities in regard to maintain safety system, process and personnel as well. For those reasons, activities program has been carried out with the aims of : (a). To faithful capability in production of GA Siwabessy reactor based radioisotopes, labeled compounds and radiopharmaceutical kits, (b). To optimize normal operational function of supporting facilities and utilities, and (c). To perform invention and modification of heater and temperature control units on the air handling unit (AHU) system. Some kinds of radioactive products are dominant during the year of 2002, i.e. 153 SmCl 3 , Na 2 99 MoO 4 and Na 186 ReO 4 primary radioisotopes and 153 Sm-EDTMP labeled compound. The main utilization of the products is for research and development of processing technology and medical application as diagnostic or therapeutic agent. The operational function of supporting facilities and utilities was well performed meeting the requirement of the users. Some units of the systems partially showed degradation of working performance but it did not cause trouble in security and safety of the system, process and personnel. A heater device completed with control system has been installed as a modified part of AHU system and has been tested successfully. The operation of the heater device is significantly influential to the air temperature and humidity in working area. The required air condition, e.g. 22 - 25 o C of temperature and 40 - 50 % of humidity, can be complied on the blower motor

Cost-benefit aspects of radioisotope methods

International Nuclear Information System (INIS)

Jankowski, L.

1986-01-01

The cost-benefit relations in the complex application of radioisotpe techniques increased in the last years to up to 1/10 to 1/15. The most essential cause of this trend is the increase of the capacity of production processes, controlled and automatized by means of radioisotopes, and the solution of qualitatively new technological problems of a high economic relevance. A collection of statistical data about the expediture and benefit of different radioisotopes techniques is presented. (author)

Packaging and transport of radioisotopes

International Nuclear Information System (INIS)

Taylor, C.B.G.

1976-01-01

The importance of radioisotope traffic is emphasized. More than a million packages are being transported each year, mostly for medical uses. The involvement of public transport services and the incidental dose to the public (which is very small) are appreciably greater than for movements connected with the nuclear fuel cycle. Modern isotope packages are described, and an outline given of the problems of a large radioisotope manufacturer who has to package many different types of product. Difficulties caused by recent uncoordinated restrictions on the use of passenger aircraft are mentioned. Some specific problems relating to radioisotope packaging are discussed. These include the crush resistance of Type A packages, the closure of steel drums, the design of secure closures for large containers, the Type A packaging of liquids, leak tightness criteria of Type B packages, and the use of 'unit load' overpacks to consign a group of individually approved packages together as a single shipment. Reference is made to recent studies of the impact of radioisotope shipments on the environment. Cost/benefit analysis is important in this field - an important public debate is only just beginning. (author)

Production and Use of Short-Lived Radioisotopes from Reactors. Vol. II. Proceedings of a Seminar on the Practical Applications of Short-Lived Radioisotopes Produced in Small Research Reactors

International Nuclear Information System (INIS)

1963-01-01

There are many radioisotope applications in which it is important that the radiation should rapidly fall to an insignificant level once the initial intense activity has served its purpose. Such applications include diagnostic tests in medicine, where it is essential to reduce the radiation dose to the patient to a minimum, non-destructive testing methods which must be applied without contaminating the material or product concerned, and repeated routine tests which are possible only if the residual activity from the previous test is negligible. All these applications call for radionuclides whose half- lives are measured in hours or even minutes. Similarly, in the new but increasingly important technique of activation analysis, whereby the quantities of elements present in a material can be determined by irradiating the material in a reactor and assaying the radionuclides produced, the latter are mainly short-lived and must be measured immediately. While the production of long-lived radionuclides can most economically be left to the large reactors at the main radioisotope centres, short-lived isotopes must be produced, or materials activation performed, in a reactor at or near the place of intended use or analysis; this, then, represents one of the most important uses for the large number of small reactors which have been installed in recent years, or will come into operation in the near future, in many parts of the world. Since in many countries the new problems of producing, separating and applying short-lived radioisotopes are being faced for the first time, the International Atomic Energy Agency believed it would be valuable to survey the state of the art by convening an international Seminar on Practical Applications of Short-lived Radioisotopes produced in Small Research Reactors at its Vienna headquarters in November, 1962. This Seminar provided an opportunity for the producers and users of short-lived radioisotopes from many countries to meet and discuss the

Production and Use of Short-Lived Radioisotopes from Reactors. Vol. II. Proceedings of a Seminar on the Practical Applications of Short-Lived Radioisotopes Produced in Small Research Reactors

Energy Technology Data Exchange (ETDEWEB)

NONE

1963-03-15

There are many radioisotope applications in which it is important that the radiation should rapidly fall to an insignificant level once the initial intense activity has served its purpose. Such applications include diagnostic tests in medicine, where it is essential to reduce the radiation dose to the patient to a minimum, non-destructive testing methods which must be applied without contaminating the material or product concerned, and repeated routine tests which are possible only if the residual activity from the previous test is negligible. All these applications call for radionuclides whose half- lives are measured in hours or even minutes. Similarly, in the new but increasingly important technique of activation analysis, whereby the quantities of elements present in a material can be determined by irradiating the material in a reactor and assaying the radionuclides produced, the latter are mainly short-lived and must be measured immediately. While the production of long-lived radionuclides can most economically be left to the large reactors at the main radioisotope centres, short-lived isotopes must be produced, or materials activation performed, in a reactor at or near the place of intended use or analysis; this, then, represents one of the most important uses for the large number of small reactors which have been installed in recent years, or will come into operation in the near future, in many parts of the world. Since in many countries the new problems of producing, separating and applying short-lived radioisotopes are being faced for the first time, the International Atomic Energy Agency believed it would be valuable to survey the state of the art by convening an international Seminar on Practical Applications of Short-lived Radioisotopes produced in Small Research Reactors at its Vienna headquarters in November, 1962. This Seminar provided an opportunity for the producers and users of short-lived radioisotopes from many countries to meet and discuss the

Radiation protection in cyclotron and radioisotope production laboratories of IEN - (Instituto de Engenharia Nuclear - CNEN)

International Nuclear Information System (INIS)

Fajardo, P.W.; Silva, J.J.G.

1988-01-01

The Cyclotron at Instituto de Engenharia Nuclear is used for the radioisotope production, neutron production and irradiation damages analysis, etc. The risks associated with the operation and maintenance of cyclotron and the neutron radiation of wide energy spectrum, external and internal contamination. A summary of the radioprotection program for these areas are show and the results obtained from the air and surface analysis, liquid efluents and equivalentes doses of workers of the several activities are given. (Author) [pt

Production and world-wide distribution of radioisotopes and allied products from NTP at Pelindaba, South Africa

International Nuclear Information System (INIS)

Louw, P.A.

2001-01-01

Nuclear Technology Products (NTP) a business division of the South African Nuclear Energy Corporation Ltd. (NECSA) is today a leading supplier of a range or radioisotope and supporting products to markets throughout the world. To achieve this status in the face of large technological, logistical and business barriers to entry has required the development of integrated and effective processes from a diverse and unconsolidated range of expertise and other resources. The various facilities and competencies established at NECSA over a period of 40 years had as their objective the accomplishment of strictly non-commercial strategic imperatives. Major emphasis was placed at Pelindaba on development of the capability to beneficiate the country's resources of uranium which are extracted as a by-product of gold mining. Fuel enrichment processes (using a method unique to NECSA) and nuclear fuel fabrication facilities were developed and commissioned during the period 1975 - 1990 and substantial quantities of enriched and depleted uranium material was produced. A small amount of locally produced, highly enriched fuel has been used to power the 20 MW SARARI -1 Research Reactor at Pelindaba which has been in operation since 1965. Major political and economic changes affecting South Africa gave rise, in the late 1980s, to the necessity for a fundamental strategic reorientation of NECSA. Over a period of time the fuel enrichment and fabrication programmes were terminated and ever greater emphasis was placed on development of businesses from established, diverse facilities and competencies with the objective of promoting increased financial independence and long term viability for the organisation. It was at this time that NTP the business responsible for production and marketing of radiation-based products at NECSA, was established. The various developments which facilitated the capacity of NTP to accede to its current position as a significant and growing provider of

Radioisotopes - where have we got to, where are we going ?

International Nuclear Information System (INIS)

Taylor, C.B.G.

1986-01-01

Rapid growth has been achieved and there are remarkable possibilities in various fields of radioisotopes and radiation. New applications in molecular biology, in nuclear medicine, and in biotechnology are opening further opportunities for the use of radioisotopes. In the industrial field too there is growth, as microprocessor techniques extend the usefulness of radioisotope methods. And radiation engineering is a success story of its own, as ever-increasing use is made of radiation processing and sterilization, and new horizons open for food irradiation. This paper begins by recalling how isotope technology developed from the research laboratory to become the industry-scale activity it is today. A section is devoted to describing the development of a new radioisotope industry during the period from the 1930s through 1960s, focusing on the growth in the areas of nuclear medicine, radiotherapy, isotope gauging and tracing, production control, industrial processing, and production of radioisotopes. After a brief review of the present it looks into the future to suggest the directions in which new developments may lie. In particular, remarkable growth is expected in such areas as molecular biology, biotechnology, radiography, gauging, process control, radiation processing, and radiation sterilization. A review is also made of the transport and disposal of radioisotopes. (Nogami, K.)

List of DOE radioisotope customers with summary of radioisotope shipments FY 1978

International Nuclear Information System (INIS)

Burlison, J.S.; Laidler, R.I.

1979-05-01

The purpose of the document is to list DOE's radioisotopes production and distribution activities by its facilities at Argonne National Laboratory; Pacific Northwest Laboratory; Brookhaven National Laboratory; Hanford Engineering Development Laboratory; Idaho Operations Office; Los Alamos Scientific Laboratory; Mound Facility; Oak Ridge National Laboratory; Savannah River Laboratory; and UNC Nuclear Industries, Inc

Solid targetry at the TESLA Accelerator Installation

CERN Document Server

Comor, J J; Rajcevic, M; Kosutic, D; Spasic, M; Vidovic, A; Duricic, J; Nedeljkovic, N

2002-01-01

According to the concept of the TESLA Accelerator Installation, the channel for production of radioisotopes has to routinely produce sup 2 sup 0 sup 1 Tl, sup 1 sup 1 sup 1 In, sup 6 sup 7 Ga, sup 1 sup 2 sup 3 I and sup 1 sup 8 F, and a number of other radionuclides for experimental purposes. The production of sup 1 sup 2 sup 3 I and sup 1 sup 8 F will be performed in dedicated, commercial target stations, while a versatile solid target irradiation system is designed for the routine and experimental production of all other radioisotopes. The solid target station is designed to accept targets for both the 7 deg. and 90 deg. irradiation geometry. The targets used for the routine production will be prepared by electroplating on a silver substrate. They can be irradiated with a 1.5 kW beam using the 7 deg. geometry. The cooling of these targets is enhanced by fins on the back of the silver substrate designed so that the highest temperature on the surface of the target does not exceed 110 deg. C. The irradiation ...

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1986

International Nuclear Information System (INIS)

Lamar, D.A.

1988-01-01

Data were collected and compiled on radioisotopes produced and sold by Department of Energy (DOE) facilities, and on services rendered by DOE facilities. Compiled data were published and distributed in the document list of DOE Radioisotope Customers with Summary of Radioisotope Shipments, FY 1986, PNL-6361, October 1987. The DOE facilities that supplied information for the compilation were Argonne National Laboratory, Brookhaven National Laboratory, Hanford Engineering Development Laboratory, Idaho National Engineering Laboratory, Los Alamos National Laboratory, Oak Ridge National Laboratory, Pacific Northwest Laboratory, Savannah River Plant, and UNC Nuclear Industries, Inc. (Hanford). The data provided were reported in several different ways: (1) a list of radioisotopes and services provided by each facility; (2) a list of radioisotope customers, the supplying DOE facility, and the radioisotope or service provided to each customer; and (3) a list of the quantity and value of each radioisotope or service sold by each DOE facility. The sales information covered foreign customers, domestic private customers, and domestic DOE customers

High purity materials as targets for radioisotope production: Needs ...

Indian Academy of Sciences (India)

Unknown

lity of high purity target materials, natural or enriched, are crucial for any successful radioisotope pro- gramme. Selection ... and blockages detection in buried pipelines are rendered ..... from reputed international suppliers with analysis report.

High intensity accelerator for a wide range of applications

International Nuclear Information System (INIS)

Conard, E.M.

1994-01-01

When looking at commercial applications of accelerators from a market point of view, it appears that a common accelerator design could meet different users' needs. This would benefit both the manufacturer and the user by multiplying the number of machines sold, thus lowering their cost and improving their quality. These applications include: radioisotope production for medical imaging (positron emission tomography), industrial imaging and non-destructive testing (e.g. neutron radiography, explosive and drug detection in luggage or freight). This paper investigates the needs of the various applications and defines their common denominator to establish suitable specifications (type of particles, energy, intensity). Different accelerator types (cyclotrons, linear accelerators and electrostatic machines) are reviewed and compared on performance and estimated costs. A high intensity tandem accelerator design is studied in more detail as it seems the most appropriate candidate. ((orig.))

Proton linac for hospital-based fast neutron therapy and radioisotope production

International Nuclear Information System (INIS)

Lennox, A.J.; Hendrickson, F.R.; Swenson, D.A.; Winje, R.A.; Young, D.E.

1989-09-01

Recent developments in linac technology have led to the design of a hospital-based proton linac for fast neutron therapy. The 180 microamp average current allows beam to be diverted for radioisotope production during treatments while maintaining an acceptable dose rate. During dedicated operation, dose rates greater than 280 neutron rads per minute are achievable at depth, DMAX = 1.6 cm with source to axis distance, SAD = 190 cm. Maximum machine energy is 70 MeV and several intermediate energies are available for optimizing production of isotopes for Positron Emission Tomography and other medical applications. The linac can be used to produce a horizontal or a gantry can be added to the downstream end of the linac for conventional patient positioning. The 70 MeV protons can also be used for proton therapy for ocular melanomas. 17 refs., 1 fig., 1 tab

Reviews of accelerator science and technology

CERN Document Server

Chou, Weiren

2008-01-01

Particle accelerators are a major invention of the 20th century. In the last eight decades, they have evolved enormously and have fundamentally changed the way we live, think and work. Accelerators are the most powerful microscopes for viewing the tiniest inner structure of cells, genes, molecules, atoms and their constituents such as protons, neutrons, electrons, neutrinos and quarks. This opens up a whole new world for materials science, chemistry and molecular biology.Accelerators with megawatt beam power may ultimately solve a critical problem faced by our society, namely, the treatment of nuclear waste and the supply of an alternative type of energy. There are also tens of thousands of small accelerators all over the world. They are used every day for medical imaging, cancer therapy, radioisotope production, high-density chip-making, mass spectrometry, cargo x-ray/gamma-ray imaging, detection of explosives and illicit drugs, and weapons. This volume provides a comprehensive review of this driving and fas...

Excitation functions and production of arsenic radioisotopes for environmental toxicology and biomedical purposes

International Nuclear Information System (INIS)

Basile, D.; Birattari, C.; Bonard, M.; Salomone, A.; Goetz, L.; Sabbioni, E.

1981-01-01

Many arsenic radionuclides have come to be used as tracers in biology and in the study of environmental pollution of both water and soil. In nuclear medicine, radioactive 74 As has been employed as a positron emitter for the localization of brain tumors, cerebral occlusive vascular lesions, arterious-venous malformations, etc. The aim of the work described was to study the excitation functions for the production of the arsenic radioisotopes from targets of natural germanium via nuclear reactions (p, xn). (author)

Annual Technical Progress Report of Radioisotope Power Systems Materials Production and Technology Program Tasks for October 1, 2006 Through September 30, 2007

Energy Technology Data Exchange (ETDEWEB)

King, James F [ORNL

2008-04-01

The Office of Radioisotope Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. For the Cassini Mission, ORNL produced carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS) used in the generators. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. This report reflects program guidance from the Office of Radioisotope Power Systems for fiscal year (FY) 2007. Production activities for prime quality (prime) CBCF insulator sets, iridium alloy blanks and foil, and CVS are summarized in this report. Technology activities are also reported that were conducted to improve the manufacturing processes, characterize materials, or to develop information for new radioisotope power systems.

Radioisotope thermoelectric generators for implanted pacemakers

Energy Technology Data Exchange (ETDEWEB)

Pustovalov, A.A.; Bovin, A.V.; Fedorets, V.I.; Shapovalov, V.P.

1986-08-01

This paper discusses the development and application of long-life lithium batteries and the problems associated with miniature radioisotope thermoelectric generators (RITEG) with service lives of 10 years or longer. On eof the main problems encountered when devising a radioisotope heat source (RHS) for an RITEG is to obtain biomedical /sup 238/PuO/sub 2/ with a specific neutron yield of 3.10/sup 3/-4.10/sup 3/ (g /SUP ./ sec)/sup -1/, equivalent to metallic Pu 238, and with a content of gamma impurities sufficient to ensure a permissible exposure a permissible exposure does rate (EDR) of a mixture of neutron and gamma radiation. After carrying out the isotope exchange and purifying the initial sample of its gamma impurity elements, the authors obtain biomedical Pu 238 satisfying the indicated requirements king suitable for use in the power packs of medical devices. Taking the indicated specifications into account, the Ritm-1o and gamma radioisotope heat sources were designed, built, tested in models and under natural conditions, and then into production as radioisotope thermoelectric generators designed to power the electronic circuits of implanted pacemakers. The Ritm-MT and Gemma radioisotope thermoelectric generators described are basic units, which can be used as self-contained power supplies for electronic equipment with power requirements in the micromilliwatt range.

Actual and future situations of the use of radioisotopes

International Nuclear Information System (INIS)

Paredes G, L.C.

2005-01-01

It is anticipated to medium term, an increase in the demand of the radioisotopes for medicine, industry and research, as well as the application of new radioisotopes derived from the development of new radiopharmaceuticals products for diagnosis and therapy applications. The personal and clinical dosimetry will have to be prepared for the new challenges. (Author)

Industrial radioisotope economics. Findings of the study group

International Nuclear Information System (INIS)

1965-01-01

Within twenty years of the availability of radioisotopes in quantity the use of these as tracers has been widely applied in scientific research and in industrial process and product control. Industry spends millions of dollars on these new techniques. Since the overall attitude of industry is to favour methods that involve rapid financial returns the economic benefits must be considerable. In promoting the peaceful uses of atomic energy, the IAEA is actively interested in the international exchange of experience in all applications of radioisotopes. This has been demonstrated by a number of scientific conferences where new results of direct importance to the industrial use of radioisotopes have been presented. In 1963 the IAEA also published literature survey on radioisotope applications described in the scientific literature up to 1960, classified according to industry. However, the available scientific literature was found insufficient to determine the extent of the use of radioisotopes and the economic benefits derived from it. Therefore, further fact-finding efforts were necessary. The IAEA thus decided to carry out an International Survey on the Use of Radioisotopes in Industry. In 1962 the IAEA's highly industrialized Member States Were invited to participate in the Survey; 25 declared their willingness to do so and in due course submitted their national reports. These included information on how radioisotopes were used by industry in each country and indicated the size and form of the economic advantages, primarily in terms of savings made by industry. The findings from the Survey were discussed at a Study Group Meeting on Radioisotope Economics, held in Vienna in March 1964. Forty participants from 22 countries were nominated for this Study Group. The program of the meeting was divided in three parts: (1) experience of the International Survey on the use of radioisotopes in industry; (2) present use of radioisotopes, technical and economic aspects; (3

Control of radioisotopes and radiation sources in Indonesia

International Nuclear Information System (INIS)

Ridwan, M.

2001-01-01

Radioisotopes and radiation sources are extensively used in Indonesia in medicine, industry, mining, agriculture and research. These materials are controlled by the regulatory authority, according to established legal procedures. The Nuclear Energy Control Board of Indonesia (BAPETEN), which was established in 1998 through the Nuclear Energy Act No. 10/1997, is entrusted with the control of any application of nuclear energy, including the application of radioisotopes and radiation sources, through regulation, licensing and inspection. The control is aimed to assure welfare, security and peace, the safety and health of workers and the public, and environmental protection. The number of licences issued to date is around 2400, consisting of 1600 licences for radioisotopes and radiation sources used in hospitals, 347 in radiography, 256 in industry, 53 in mining, and the rest in many other areas such as research and agriculture. A licence can cover one or more radioisotopes or radiation sources, depending on the location of the user institution. These radioisotopes and radiation sources are Co-60, Cs-137, Ir-192, Ra-226, Am-241, Sr-90, Kr-85, Pm-147, linear accelerator and X-ray, and short half-life radioisotopes such as I-125, I-131 and Tc-99m. There are 10 LINACs, 27 X-ray medicines, 61 radioisotope devices for Co-60 and Cs-137, and 10 mHDR Ir-192 for therapeutic purposes currently used in Indonesia and some Ra-226 in storage. Any activity related to the application of nuclear energy is required to be conducted in a manner which observes safety and security. According to the legal requirements, each user has to employ at least one radiation safety officer. To improve the control of the application of radiation sources and radioactive material in the country, BAPETEN introduced some new approaches to the users, including regular dialogues with radiation safety officers and the management of the users, requalification for radiation protection officers twice in five

Some advances in medical applications of low energy accelerators

Science.gov (United States)

Valković, V.; Moschini, G.

1991-05-01

Medical applications of low energy accelerators include: the use of nuclear analytical methods and procedures for laboratory studies and routine measurements; material productions and modifications to meet special requirements; radioisotope productions and their applications in radiopharmaceuticals as well as in positron emission tomography; and radiotherapy with ions, based on improved understanding of the interaction of charged particles with living tissue. Some of the recent advances in these fields are critically summarized. The plan for an improved charged particle facility in a hospital environment dedicated to applications in biology and medicine is presented.

Application of radioisotope methods of investigation and control techniques in tube production

International Nuclear Information System (INIS)

Chizh, V.A.; Drabkin, L.A.

1975-01-01

Various spheres of radioactive isotopes application of closed and open type in tube production are described. Due to the usage of radioactive indicator method in combination with physicochemical methods and metallography new data are obtained in the theory and practice of tube centrifugal casting, rolling and pressing. Adsorption properties of lubricants and element distribution in the joint weld region of the big diameter tubes are investigated. The application of radioactive isotopes as ionizing radiation source made it possible to develop some radioisotope methods and instruments for tube wall thickness and the wall thickness difference control. Short characteristics of such instruments are given

Cosmogenic radioisotopes in Gebel Kamil meteorite

Science.gov (United States)

Taricco, C.; Colombetti, P.; Bhandari, N.; Sinha, N.; Di Martino, M.; Vivaldo, G.

2012-04-01

Recently a small (45 m in diameter) and very young (radioisotope activity generated by cosmic rays in the meteoroids as they travel through the interplanetary space before falling on the Earth. From the 26Al activity measurement and its depth production profiles, we infer (i) that the radius of the meteoroid should be about 1 m, constraining to 30-40 ton the range of pre-atmospheric mass previously proposed and (ii) that the fragment should have been located deeply inside the meteoroid, at a depth > 0.7 m. The 44Ti activity is under the detection threshold of the apparatus; using the depth production profiles of this radioisotope and its half-life T1/2 = 59.2 y, we deduce an upper limit to the date of fall.

Practical applications of short-lived radioisotopes

Energy Technology Data Exchange (ETDEWEB)

NONE

1963-01-15

The advantages of the use of short-lived radioisotopes in agriculture, food industry and medicine as well as some industrial uses are discussed. Methods for isotope production in small research reactors and laboratories are presented

Validation of FLUKA calculated cross-sections for radioisotope production in proton-on-target collisions at proton energies around 1 GeV

CERN Document Server

Felcini, M

2006-01-01

The production cross-sections of several radioisotopes induced by 1 GeV protons impinging on different target materials have been calculated using the FLUKA Monte Carlo and compared to measured cross-sections. The emphasis of this study is on the production of alpha and beta/gamma emitters of interest for activation evaluations at a research complex, such as the EURISOL complex, using several MW power proton driver at an energy of 1 GeV. The comparisons show that in most of the cases of interest for such evaluations, the FLUKA Monte Carlo reproduces radioisotope production cross-sections within less than a factor of two with respect to the measured values. This result implies that the FLUKA calculations are adequately accurate for proton induced activation estimates at a 1 GeV high power proton driver complex.

Chemical Process for Treatment of Tellurium and Chromium Liquid Waste from I-131 Radioisotope Production

International Nuclear Information System (INIS)

Zainus-Salimin; Gunandjar; Dedy-Harsono; Hendro; Sugeng-Purnomo; Mohammad-Faruq; Zulfakhri

2000-01-01

The I-131 radioisotope is used in nuclear medicine for diagnosis and therapy. The I-131 radioisotope is produced by wet distillation at Bandung Nuclear Research Center and generated about 4,875 Itr of liquid waste containing 2,532.8 ppm of tellurium and 1,451.8 ppm chromium at pH 1. Considering its negative impact to the environment caused by toxic behaviour of tellurium and chromium, it is necessary to treat chemically that's liquid waste. The research of chemical treatment of tellurium and chromium liquid waste from I-131 radioisotope production has been done. The steps of process are involved of neutralisation with NaOH, coagulation-flocculation process for step I using Ca(OH) 2 coagulant for precipitation of sulphate, sulphite, oxalic, chrome Cr 3+ , and coagulation-flocculation process for step II using BaCI 2 coagulant for precipitation of chrome Cr 6+ and tellurium from the supernatant of coagulation in step I. The best result of experiment was achieved at 0.0161 ppm of chromium concentration on the supernatant from coagulation-flocculation of step I using 3.5 g Ca(OH) 2 for 100 ml of liquid waste, and 0.95 ppm of tellurium concentration on the final supernatant from coagulation-flocculation by of step II using 0.7 g BaCI 2 for supernatant from coagulation of step I. (author)

Extension of the irradiation system at TIARA for production of radioisotopes to be used in plant physiology

International Nuclear Information System (INIS)

Ishioka, N.S.; Watanabe, S.; Fujimaki, S.; Sakamoto, K.; Matsuhashi, S.

2005-01-01

A target irradiation system for radioisotope production at the TIARA AVF cyclotron facility has been improved for extending physiological studies of plants. Experiments using a position imaging technique require a variety of positron-emitting radioisotopes and their labelled compounds. Therefore, a compact revolver equipped with six target cambers for gas and liquid targets were newly constructed, in addition to the original target irradiation system consisting of two solid target chambers and one gas target chamber, placed on the movable table. The control system was also reconstructed with a local area network for communication between the control station beside the irradiation port and the hot laboratory. Use of this system enables us to produce routinely positron-emitting tracers for plant physiology. (author)

Development of radioisotope preparation and application technology

Energy Technology Data Exchange (ETDEWEB)

Han, Hyon Soo; Park, K. B.; Bang, H. S. [and others

2000-04-01

The purpose of this project is to develop RI production technology utility 'HANARO' and to construct a sound infra-structure for mass production and supply to domestic users. The developed contents and results are as follows: two types of rig for irradiation in reactor core were designed and manufactured. The safety of OR rig during irradiation was identified through various test and it is used for RI production. The prepared IR rig will be used to performance tests for safety. We prepared two welders and welding jigs for production of sealed sources, and equipments for quality control of the welded materials. Production processes and apparatus Cr-51, P-32, I-125 and Sr-89, were developed. Developed results would be used for routine production and supply of radioisotopes. The automatic Tc-99m extraction apparatus was supplied to Libya under IAEA support. For approval on special form radioactive material of the developed Ir-192 source assembly and projector documents were prepared and submitted to MOST. The high dose rate Ir-192 source(diameter 1.1 mm, length 5.2 mm) for RALS and the laser welding system for its fabrication were developed. Production technologies of Ir-192 sources for destructive test and medical therapy were transferred to private company for commercial supply. The chemical immobilization method based on the self-assemble monolayer of {omega}-functionalized thiol and the sensing scheme based on the beta-emitter labeling method were developed for the fabrication radioimmuno-sensors. Results of this study will be applied to mass production of radioisotopes 'HANARO' and are to contribute the advance of domestic medicine and industry related to radioisotopes.

Development of radioisotope preparation and application technology

International Nuclear Information System (INIS)

Han, Hyon Soo; Park, K. B.; Bang, H. S. and others

2000-04-01

The purpose of this project is to develop RI production technology utility 'HANARO' and to construct a sound infra-structure for mass production and supply to domestic users. The developed contents and results are as follows: two types of rig for irradiation in reactor core were designed and manufactured. The safety of OR rig during irradiation was identified through various test and it is used for RI production. The prepared IR rig will be used to performance tests for safety. We prepared two welders and welding jigs for production of sealed sources, and equipments for quality control of the welded materials. Production processes and apparatus Cr-51, P-32, I-125 and Sr-89, were developed. Developed results would be used for routine production and supply of radioisotopes. The automatic Tc-99m extraction apparatus was supplied to Libya under IAEA support. For approval on special form radioactive material of the developed Ir-192 source assembly and projector documents were prepared and submitted to MOST. The high dose rate Ir-192 source(diameter 1.1 mm, length 5.2 mm) for RALS and the laser welding system for its fabrication were developed. Production technologies of Ir-192 sources for destructive test and medical therapy were transferred to private company for commercial supply. The chemical immobilization method based on the self-assemble monolayer of ω-functionalized thiol and the sensing scheme based on the beta-emitter labeling method were developed for the fabrication radioimmuno-sensors. Results of this study will be applied to mass production of radioisotopes 'HANARO' and are to contribute the advance of domestic medicine and industry related to radioisotopes

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1984

International Nuclear Information System (INIS)

Baker, D.A.

1985-08-01

This edition of the radioisotope customer list was prepared at the request of the Office of Health and Environmental Research (ER-73), Office of Energy Research, Department of Energy (DOE). This document describes radioisotope distribution from DOE facilities to private firms including foreign and other DOE facilities. The information is divided into five sections: (1) isotope suppliers, facility contacts, and isotopes or services supplied; (2) customers, suppliers, and isotopes purchased; (3) isotopes purchased cross-referenced with customer numbers; (4) geographic locations of radioisotope customers; and (5) radioisotope sales and transfers - FY 1984

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1984

Energy Technology Data Exchange (ETDEWEB)

Baker, D.A.

1985-08-01

This edition of the radioisotope customer list was prepared at the request of the Office of Health and Environmental Research (ER-73), Office of Energy Research, Department of Energy (DOE). This document describes radioisotope distribution from DOE facilities to private firms including foreign and other DOE facilities. The information is divided into five sections: (1) isotope suppliers, facility contacts, and isotopes or services supplied; (2) customers, suppliers, and isotopes purchased; (3) isotopes purchased cross-referenced with customer numbers; (4) geographic locations of radioisotope customers; and (5) radioisotope sales and transfers - FY 1984.

Accelerator mass spectrometry and associated facilities at Inter-University Accelerator Centre, New Delhi, India

International Nuclear Information System (INIS)

Kumar, Pankaj; Bohra, Archna; Ojha, S.; Gargari, S.; Joshi, R.; Roonwal, G.S.; Chopra, S.; Pattanaik, J.K.; Balakrishnan, S.

2011-01-01

Accelerator Mass Spectrometry (AMS) facility at Inter-University Accelerator Centre (IUAC) is developed by upgrading its existing 15UD Pelletron accelerator. Since last two decades Pelletron is mainly used for nuclear physics, materials science, atomic physics, radiation biology and accelerator mass spectrometry is recent development. In addition, a chemistry laboratory in clean room for the chemical processing of samples for AMS studies has also been established. At present the AMS facility is used for 10 Be, 26 Al measurements and soon other long lived radio-isotopes will also be used

Radioisotopes as Political Instruments, 1946-1953.

Science.gov (United States)

Creager, Angela N H

2009-01-01

The development of nuclear "piles," soon called reactors, in the Manhattan Project provided a new technology for manufacturing radioactive isotopes. Radioisotopes, unstable variants of chemical elements that give off detectable radiation upon decay, were available in small amounts for use in research and therapy before World War II. In 1946, the U.S. government began utilizing one of its first reactors, dubbed X-10 at Oak Ridge, as a production facility for radioisotopes available for purchase to civilian institutions. This program of the U.S. Atomic Energy Commission was meant to exemplify the peacetime dividends of atomic energy. The numerous requests from scientists outside the United States, however, sparked a political debate about whether the Commission should or even could export radioisotopes. This controversy manifested the tension in U.S. politics between scientific internationalism as a tool of diplomacy, associated with the aims of the Marshall Plan, and the desire to safeguard the country's atomic monopoly at all costs, linked to American anti-Communism. This essay examines the various ways in which radioisotopes were used as political instruments-both by the U.S. federal government in world affairs, and by critics of the civilian control of atomic energy-in the early Cold War.

Therapy with high LET Radioisotopes: Can sufficient levels of attractive Auger and alpha emitters be produced to make their use practical?

International Nuclear Information System (INIS)

Knapp, F.F. Jr.; Mirzadeh, S.; Stabin, M.; Brill, A.B.

2005-01-01

Because of localized energy deposition within a very small volume, cellular targeted therapy with high linear energy transfer (LET) Auger-electron and alpha-particle emitting radioisotopes is of great interest. While the energy deposition from alpha particles usually encompasses several cell diameters, the dose from Auger electrons is confined to a single cell. Two major challenges for broader use of Alpha and Auger emitters are the efficient and cost effective routine production of sufficient levels of these radioisotopes, and the availability of targeting molecules to which the radioisotopes can be attached for cellular delivery of sufficient levels of activity for effective therapy. Examples of several Alpha-and Auger-emitting radioisotopes of current interest are presented. Alpha- and Auger electron-emitting radioisotopes can be produced in accelerators (A) and nuclear reactors (R), and several alpha emitter congeners (i.e. thorium-229) can be obtained from uranium decay products. The challenge for reactor production, is the availability and exploitation of methods - other then the usual radiative (n,γ) production route which will provide no-carrier-added (nca) or the high specific activity radioisotopes of interest. The submitted manuscript has been authored by a contractor of the U.S. Government under contract DE-AC05-00OR22725. Accordingly, the U.S. Government retains a nonexclusive, royalty-free license to publish or reproduce the published form of this contribution, or allow others to do so, for U.S. Government purposes High LET radioisotopes of current interest which are in the initial stages of development and/or which demonstrate practical use in clinical trials include several alpha-emitters, in particular bismuth-213 - and also the actinium-225 parent - astatine-211 and bismuth-212. Extensive experimental studies have been reported with Auger iododeoxyuridine (IdUR) radiolabeled with the iodine-125 emitter-labeled. However, development of production

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1985

Energy Technology Data Exchange (ETDEWEB)

Baker, D.A.

1986-08-01

This document describes radioisotope distribution from DOE facilities to private firms including foreign and other DOE facilities. The information is divided into five sections: (1) isotope suppliers, facility contacts, and isotopes or services supplied; (2) customers, suppliers, and isotopes purchased; (3) isotopes purchased cross-referenced with customer numbers; (4) geographic locations of radioisotope customers; and (5) radioisotope sales and transfer - FY 1985.

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1985

International Nuclear Information System (INIS)

Baker, D.A.

1986-08-01

This document describes radioisotope distribution from DOE facilities to private firms including foreign and other DOE facilities. The information is divided into five sections: (1) isotope suppliers, facility contacts, and isotopes or services supplied; (2) customers, suppliers, and isotopes purchased; (3) isotopes purchased cross-referenced with customer numbers; (4) geographic locations of radioisotope customers; and (5) radioisotope sales and transfer - FY 1985

High heat flux cooling for accelerator targets

International Nuclear Information System (INIS)

Silverman, I.; Nagler, A.

2002-01-01

Accelerator targets, both for radioisotope production and for high neutron flux sources generate very high thermal power in the target material which absorbs the particles beam. Generally, the geometric size of the targets is very small and the power density is high. The design of these targets requires dealing with very high heat fluxes and very efficient heat removal techniques in order to preserve the integrity of the target. Normal heat fluxes from these targets are in the order of 1 kw/cm 2 and may reach levels of an order of magnitude higher

Improvement of animal production through research using radioisotopes and radiation

International Nuclear Information System (INIS)

1976-01-01

High birth rates coupled with greater longevity continue to increase the.world's population, especially in the less developed countries. The prevention of undernutrition and ultimately starvation will only be averted by increased food production and more efficient use of that food. At the same time people who have largely subsisted upon plant food diets and whose standards of living are rising, want to increase the use of animal products in order to upgrade their diets. To provide this high quality food animal scientists must find ways of increasing the supply especially in the less developed countries. Since most of the available pasture lands are presently being fully utilized or overgrazed, improved efficiency of the present herds and use of agroindustrial wastes are the only methods left to increase production significantly. The use of radioisotopes and radiation in research are making major contributions to the understanding of the processes necessary to achieve better animal production. In order to provide a forum for exchange of information in this field, the FAO/IAEA Joint Division of Atomic Energy in Food and Agriculture organized an international symposium, held in Vienna, from 2?6 February, on the use of nuclear techniques in animal production. Among the topics discussed at the symposium were: Soil-plant-animal relations regarding minerals, Trace elements in animal nutrition, Calcium, phosphorus and magnesium metabolism, Protein (nitrogen) metabolism - ruminants Protein (nitrogen) metabolism - non-ruminants Nuclear techniques in the control of parasitic infections Animal endocrinology with special emphasis on radioimmunoassays

Improvement of animal production through research using radioisotopes and radiation

Energy Technology Data Exchange (ETDEWEB)

NONE

1976-07-01

High birth rates coupled with greater longevity continue to increase the.world's population, especially in the less developed countries. The prevention of undernutrition and ultimately starvation will only be averted by increased food production and more efficient use of that food. At the same time people who have largely subsisted upon plant food diets and whose standards of living are rising, want to increase the use of animal products in order to upgrade their diets. To provide this high quality food animal scientists must find ways of increasing the supply especially in the less developed countries. Since most of the available pasture lands are presently being fully utilized or overgrazed, improved efficiency of the present herds and use of agroindustrial wastes are the only methods left to increase production significantly. The use of radioisotopes and radiation in research are making major contributions to the understanding of the processes necessary to achieve better animal production. In order to provide a forum for exchange of information in this field, the FAO/IAEA Joint Division of Atomic Energy in Food and Agriculture organized an international symposium, held in Vienna, from 2?6 February, on the use of nuclear techniques in animal production. Among the topics discussed at the symposium were: Soil-plant-animal relations regarding minerals, Trace elements in animal nutrition, Calcium, phosphorus and magnesium metabolism, Protein (nitrogen) metabolism - ruminants Protein (nitrogen) metabolism - non-ruminants Nuclear techniques in the control of parasitic infections Animal endocrinology with special emphasis on radioimmunoassays.

Application of radioisotopes in entomology

International Nuclear Information System (INIS)

Saour, G.

1995-01-01

Radioisotope techniques are effective in entomology and studies on insects physiology. The study presents the use of radioisotopes in pest control programs: Methods of insects irradiation and the concept of biological half-life of the radioisotopes in comparison with physical half-life are explained. Main radioisotopes used in entomology are: 3 H, 14 Ca, 32 P, 35 S, 38 Cl. Other radioisotopes contributing to studies on insects are: 198 Au, 134 Cs, 131 I, 86 Rb, 65 Zn, 59 Fe, 45 Ca, 24 Na, 22 Na. Radiation doses specific to each radioisotopes are given in tables. As an example of the application of radioisotopes in pest control: the determination of insects population density by means of releasing irradiated male insects than chasing them; studying of reproduction activity of Agrotis ipsilon; studying of egg laying of Heliocoverpa armigera moth. 15 refs. 2 figs. 2 tabs

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1986

International Nuclear Information System (INIS)

Lamar, D.A.

1987-10-01

This document describes radioisotope distribution from DOE facilities to private firms including foreign and other DOE facilities. The information is divided into five sections: (1)isotope suppliers, facility contact, and isotopes or services supplied; (2) customers, suppliers, and isotopes purchased; (3) isotopes purchased cross-referenced with customer numbers; (4) geographic locations of radioisotope customers; and (5) radioisotope sales and transfers for fiscal year 1986

Transmutation of fission products through accelerator

International Nuclear Information System (INIS)

Nakamura, H.; Tani, S.; Takahashi, T.; Yamamura, O.

1995-01-01

The transmutation of fission products through particle accelerators has been studied under the OMEGA program. The photonuclear reaction has also been investigated to be applied to transmuting long-lived fission products, such as Cesium and Strontium, which have difficulties on reaction with neutrons due to its so small cross section. It is applicable for the transmutation if the energy balance can be improved with a monochromatic gamma rays in the range of the Giant Dipole Resonance generated through an excellent high current electron linear accelerator. The feasibility studies are being conducted on the transmutation system using it through an electron accelerator. (authors)

Medical Radioisotope Scanning, Vol. II. Proceedings of the Symposium on Medical Radioisotope Scanning

International Nuclear Information System (INIS)

1964-01-01

Medical applications of radioisotopes continue to grow in number and importance and medical centres in almost all countries of the world are now using radioactive materials both in the diagnosis and treatment of disease. An increasing proportion of these applications involves studies of the spatial distribution of radioactive material within the human body, for which purpose highly specialized scanning methods have been elaborated. By these methods it is possible to study the position, size and functional state of different organs, to detect tumours, cysts and other abnormalities and to obtain much useful information about regions of the body that are otherwise inaccessible, except by surgery. Progress in scanning methods in recent years has been very rapid and there have been many important advances in instrumentation and technique. The development of new forms of the gamma camera and of colour-scanning techniques are but two examples of recent improvements. The production of new radioisotopes and new labelled compounds has further extended the scope of these methods. To survey these new advances the International Atomic Energy Agency held a Symposium on Medical Radioisotope Scanning in Athens from 20-24 April 1964. The scientific programme of the meeting covered all aspects of scanning methods including theoretical principles, instrumentation, techniques and clinical applications. The World Health Organization assisted in the selection of papers by providing a consultant to the selection committee. The meeting followed the earlier IAEA/WHO Seminar on Medical Radioisotope Scanning in Vienna in 1959, which was attended by 36 participants and at which 14 papers were presented. Some idea of the growth of interest in the subject may be gained from the fact that the Symposium was attended by 160 participants from 26 countries and 4 international organizations, and that 58 papers were presented. The published proceedings, comprising two volumes, contain all the

Evaluation of the OSCAR-4/MCNP calculation methodology for radioisotope production in the SAFARI-1 reactor

International Nuclear Information System (INIS)

Karriem, Z.; Zamonsky, O.M.

2014-01-01

The South African Nuclear Energy Corporation SOC Ltd (Necsa) is a state owned nuclear facility which owns and operates SAFARI-1, a 20 MW material testing reactor. SAFARI-1 is a multi-purpose reactor and is used for the production of radioisotopes through in-core sample irradiation. The Radiation and Reactor Theory (RRT) Section of Necsa supports SAFARI-1 operations with nuclear engineering analyses which include core-reload design, core-follow and radiation transport analyses. The primary computer codes that are used for the analyses are the OSCAR-4 nodal diffusion core simulator and the Monte Carlo transport code MCNP. RRT has developed a calculation methodology based on OSCAR-4 and MCNP to simulate the diverse in-core irradiation conditions in SAFARI-1, for the purpose of radioisotope production. In this paper we present the OSCAR-4/MCNP calculation methodology and the software tools that were developed for rapid and reliable construction of MCNP analysis models. The paper will present the application and accuracy of the methodology for the production of yttrium-90 ( 90 Y) and will include comparisons between calculation results and experimental measurements. The paper will also present sensitivity analyses that were performed to determine the effects of control rod bank position, representation of core depletion state and sample loading configuration, on the calculated 90 Y sample activity. (author)

Production and supply of radioisotopes with reactors in north america and europe current status and future prospects

International Nuclear Information System (INIS)

Trevena, I.

1994-01-01

Reactors have played a key pole in the production of radioactive isotopes for medical applications for the past 50 years. This paper reviews current and future capabilities for the production and supply of radioactive isotopes used in nuclear medicine. It focuses primarily on the supply of fission product molybdenum-99, which is used to produce technetium-99m, the radioisotope most widely employed in nuclear medicine procedures. The significant infrastructure required for the production and supply of molybdenum-99 is detailed, and the capabilities of the major commercial suppliers in North America and Europe are discussed. Plans for increasing production capabilities in the future are also reviewed. (author)

Laser acceleration

Science.gov (United States)

Tajima, T.; Nakajima, K.; Mourou, G.

2017-02-01

The fundamental idea of Laser Wakefield Acceleration (LWFA) is reviewed. An ultrafast intense laser pulse drives coherent wakefield with a relativistic amplitude robustly supported by the plasma. While the large amplitude of wakefields involves collective resonant oscillations of the eigenmode of the entire plasma electrons, the wake phase velocity ˜ c and ultrafastness of the laser pulse introduce the wake stability and rigidity. A large number of worldwide experiments show a rapid progress of this concept realization toward both the high-energy accelerator prospect and broad applications. The strong interest in this has been spurring and stimulating novel laser technologies, including the Chirped Pulse Amplification, the Thin Film Compression, the Coherent Amplification Network, and the Relativistic Mirror Compression. These in turn have created a conglomerate of novel science and technology with LWFA to form a new genre of high field science with many parameters of merit in this field increasing exponentially lately. This science has triggered a number of worldwide research centers and initiatives. Associated physics of ion acceleration, X-ray generation, and astrophysical processes of ultrahigh energy cosmic rays are reviewed. Applications such as X-ray free electron laser, cancer therapy, and radioisotope production etc. are considered. A new avenue of LWFA using nanomaterials is also emerging.

Laser acceleration

International Nuclear Information System (INIS)

Tajima, T.; Nakajima, K.; Mourou, G.

2017-01-01

The fundamental idea of LaserWakefield Acceleration (LWFA) is reviewed. An ultrafast intense laser pulse drives coherent wakefield with a relativistic amplitude robustly supported by the plasma. While the large amplitude of wake fields involves collective resonant oscillations of the eigenmode of the entire plasma electrons, the wake phase velocity ∼ c and ultra fastness of the laser pulse introduce the wake stability and rigidity. A large number of worldwide experiments show a rapid progress of this concept realization toward both the high-energy accelerator prospect and broad applications. The strong interest in this has been spurring and stimulating novel laser technologies, including the Chirped Pulse Amplification, the Thin Film Compression, the Coherent Amplification Network, and the Relativistic Mirror Compression. These in turn have created a conglomerate of novel science and technology with LWFA to form a new genre of high field science with many parameters of merit in this field increasing exponentially lately. This science has triggered a number of worldwide research centers and initiatives. Associated physics of ion acceleration, X-ray generation, and astrophysical processes of ultrahigh energy cosmic rays are reviewed. Applications such as X-ray free electron laser, cancer therapy, and radioisotope production etc. are considered. A new avenue of LWFA using nano materials is also emerging.

Linacs for medical isotope production

International Nuclear Information System (INIS)

Pramudita, A.

2012-01-01

This paper reviews efforts on using high energy (25-30 MeV) and high power (10-20 kW) electron linacs and lower energy (7 MeV) proton linacs for medical radioisotope production. Using high energy x-rays from the electron linacs, PET (Positron Emission Tomography) radioisotopes are produced through photonuclear reactions such as 19 F(γ,n) 18 F, which also allow production of other PET radionuclides 11 C, 13 N, and 15 O. Other mostly used medical radionuclides 99m Tc can also be obtained by using the electron linacs, through photofission or photonuclear reactions. Proton linacs for PET have also been recently developed and the product has been available in the market since 2005. The linacs have been tested for 18 F production. As a proton accelerator, the target systems and nuclear reactions are similar to the ones used in PET cyclotrons. (author)

Application of radioisotopes in entomology

Energy Technology Data Exchange (ETDEWEB)

Saour, G [Atomic Energy Commission, Damascus (Syrian Arab Republic). Dept. of Radiation Agriculture

1995-10-01

Radioisotope techniques are effective in entomology and studies on insects physiology. The study presents the use of radioisotopes in pest control programs: Methods of insects irradiation and the concept of biological half-life of the radioisotopes in comparison with physical half-life are explained. Main radioisotopes used in entomology are:{sup 3}H, {sup 14}Ca, {sup 32}P, {sup 35}S, {sup 38}Cl. Other radioisotopes contributing to studies on insects are: {sup 198}Au, {sup 134}Cs, {sup 131}I, {sup 86}Rb, {sup 65}Zn, {sup 59}Fe, {sup 45}Ca, {sup 24}Na, {sup 22}Na. Radiation doses specific to each radioisotopes are given in tables. As an example of the application of radioisotopes in pest control: the determination of insects population density by means of releasing irradiated male insects than chasing them; studying of reproduction activity of Agrotis ipsilon; studying of egg laying of Heliocoverpa armigera moth. 15 refs. 2 figs. 2 tabs.

Applications of radioisotopes in medicine

International Nuclear Information System (INIS)

Sivaprasad, N.

2012-01-01

The application of radioisotopes in medicine is many folds. They can be classified into two main groups. (a) The radioisotope tagged labeled compounds suitable for safe administration in the body for diagnosis of various diseases of vital organs such as brain, kidney, thyroid etc and for treatment known as radiotherapy (b) The sealed source of radioisotopes for utilizing the radiation emitted from the radioisotope for treatment, particularly for radiation therapy of cancer. The former application of radioisotope in the field of medicine has led to the formation of special branch of medicine termed Nuclear Medicine - the branch of medicine deals with the use of radioisotope in the from of radiopharmaceuticals for investigation, diagnosis and treatment of diseases. Radioisotopes in the form of radiolabelled compound and bio-chemicals that are pharmaceutically and radiologically safe for administration in the body for diagnosis and treatment are called radiopharmaceuticals. The radiopharmaceuticals are the results of world-wide effort to bring nuclear energy in a tangible form for diagnosis and treatment. Radioisotopes as radiopharmaceuticals thus constitute one of the key requirements for nuclear medicine investigation and radiotherapy. In the case of sealed radioisotope source the radiation emitted by the radioactive source is utilized for the treatment and this mode of treatment is called radiation therapy where no radioactive substance is administrated into the body. This does not form the part of nuclear medicine

Some important applications of accelerators in medicine and industry

International Nuclear Information System (INIS)

Jongen, Y.

1996-01-01

Accelerators, and cyclotrons in particular, have long been dedicated to research. Nowadays, they are industrial devices heavily used in various fields. The Belgian company Ion Beam Applications, probably the largest private company manufacturing cyclotrons, has largely contributed to the dissemination of this technology into the medical and radio-pharmaceutical community. This paper will present different applications of cyclotrons in these fields, from radioisotope production to radiotherapy, based on IBA's experience since 1986, date of construction of the CYCLONE 30 prototype, a cyclotron that revolutionized cyclotron technology for medicine and industry. Possible industrial applications of cyclotrons will also be mentioned, together with applications of another type of accelerator recently introduced in the market by IBA: the Rhodotron. (author)

Short-lived cyclotron-produced radioisotopes: Medi-Physics, Inc.'s commitment

International Nuclear Information System (INIS)

Kramer, H.H.

1985-01-01

Medi-Physics, Inc., is a major US supplier of short-lived cyclotron-produced radioisotopes for radiopharmaceuticals, as well as routinely producing and distributing the greatest number of 123 I radiopharmaceuticals. The present commercial production capacity for 123 I is more than ten times the theoretical need for existing procedures and is more than adequate for the research and development of new radiopharmaceuticals. However, production capacity is only one component of many that are required to supply a radioisotope for human use. These components are summarized in this paper

Present and future prospects of accelerator mass spectrometry

International Nuclear Information System (INIS)

Kutschera, W.

1987-04-01

Accelerator Mass Spectrometry (AMS) has become a powerful technique for measuring extremely low abundances (10 -10 to 10 -15 relative to stable isotopes) of long-lived radioisotopes with half-lives in the range from 10 2 to 10 8 years. With a few exceptions, tandem accelerators turned out to be the most useful instruments for AMS measurements. Both natural (mostly cosmogenic) and man-made (anthropogenic) radioisotopes are studied with this technique. In some cases very low concentrations of stable isotope are also measured. Applications of AMS cover a large variety of fields including anthropology, archaeology, oceanography, hydrology, climatology, volcanology, minerals exploration, cosmochemistry, meteoritics, glaciology, sedimentary processes, geochronology, environmental physics, astrophysics, nuclear and particle physics. Present and future prospects of AMS are discussed as an interplay between the continuous development of new techniques and the investigation of problems in the above mentioned fields. Typical factors to be considered are energy range and type of accelerator, and the possibilities of dedicated versus partial use of new or existing accelerators

Development of indigenous technology at CNEN in the fields of nuclear medicine, nuclear detectors, instrumentation, radioisotope production and application of nuclear techniques

International Nuclear Information System (INIS)

Mafra, O.

1990-01-01

The main objectives of the program developed at CNEN in the field of nuclear medicine, nuclear detectors, instrumentation, radioisotope production and application of nuclear technique are described. (E.G.) [pt

Utilization of the Dalat Research Reactor for Radioisotope Production, Neutron Activation Analysis, Research and Training

International Nuclear Information System (INIS)

Nguyen Nhi Dien; Duong Van Dong; Cao Dong Vu; Nguyen Xuan Hai

2013-01-01

The Dalat Nuclear Research Reactor (DNRR) is a 500 kW pool type reactor loaded with a mixed core of HEU (36% enrichment) and LEU (19.75% enrichment) fuel assemblies. The reactor is used as a neutron source for the purposes of radioisotopes production, neutron activation analysis, basic and applied research and training. The reactor is operated mainly in continuous runs of 108 hours for cycles of 3–4 weeks for the above mentioned purposes. The current status of safety, operation and utilization of the reactor is given and some aspects for improvement of commercial products and services of the DNRR are also discussed in this paper. (author)

Radioisotope battery for particular application

International Nuclear Information System (INIS)

Shen Tianjian; Liang Daihua; Cai Jianhua; Dai Zhimin; Xia Huihao; Wang Jianhua; Sun Sen; Yu Guojun; Wang Xiao; Wang Dongxing; Liu Xin

2010-01-01

Radioisotope battery, as a new type of power source, was developed in 1960s. It is advantageous in terms of long working life, high reliability, flexibility to rugged environment, maintenance free, and high capacity rate, hence its unique applications in space, isolated terrestrial or ocean spots, deep waters, and medicine. In this paper, we analysz the primary performances and classification of radioisotope thermoelectric generator, as well as characteristic, basic principle,and structure of radioisotope thermoelectric generator (RTG), which is the most popular in application of radioisotope battery in space, undersea, terrestrial and medicine. A prospect for development and application of radioisotope battery in the 21 st century is given, too. (authors)

Radioisotope programme in India: past, present and future

International Nuclear Information System (INIS)

Kohli, A.K.

2012-01-01

One of the major discoveries of the 20th century is the discovery of artificial radioactivity. This distinctive discovery in human history transformed atoms of one element to another. Until then, chemical reactions used to be concerned only with changes occurring outside the nucleus. The field of nuclear science came into existence with discovery of X-rays by Wilhelm Roentgen in 1895, radioactivity emitted by Uranium salt by Henri Becquerel in 1896 and pioneering work carried out by Madame Curie and Pierre Curie. India's atomic energy programme was envisaged, founded and developed by the great visionary Dr. Homi Jehangir Bhabha. Since then Department of Atomic Energy (DAE) of Government of India has been engaged in developing technologies for use of radiation in all possible fields for the benefit of society. The most common sources of radiation are radioisotopes. Radioisotopes are produced by nuclear reactors either by utilizing available excess neutrons for activation of stable elements or by separating useful fission products from the spent fuel. In India, the production of radioisotopes started with the commissioning of APSARA reactor in 1956. Initially, APSARA was operated at low power, and radioisotopes could be produced only on a small scale. All these operations had to be called out with remote handling or in the safe glove boxes keeping in view the radiation levels associated with the samples. In due course, the reactor reached full power and remotely operated processing equipment required for handling the radioisotopes were set up. Isotopes such as Iodine-131, Phosphorous-32, Gold-198 and Sodium-24 were produced and extracted in purified form in small quantities. These were given to KEM Hospital and Bombay Hospital at Mumbai, Vallabhbhai Patel Chest Institute and Safdarjung Hospital in Delhi, mainly for exploratory experiments

Radioisotope measurement system

International Nuclear Information System (INIS)

Villanueva Ruibal, Jose

2007-01-01

A radioisotope measurement system installed at L.M.R. (Ezeiza Atomic Center of CNEA) allows the measurement of nuclear activity from a wide range of radioisotopes. It permits to characterize a broad range of radioisotopes at several activity levels. The measurement hardware as well as the driving software have been developed and constructed at the Dept. of Instrumentation and Control. The work outlines the system's conformation and its operating concept, describes design characteristics, construction and the error treatment, comments assay results and supplies use advices. Measuring tests carried out employing different radionuclides confirmed the system performing satisfactorily and with friendly operation. (author) [es

The future of medical radioisotope supply

International Nuclear Information System (INIS)

Peykov, Pavel

2014-01-01

The NEA and its High-level Group on the Security of Supply of Medical Radioisotopes (HLG-MR) have been actively examining the causes of supply shortages of the most widely used isotope in medical diagnostic imaging, technetium-99m ( 99m Tc), and its parent isotope molybdenum-99 ( 99 Mo). As a result of this examination, the HLG-MR has developed a policy approach that includes principles and supporting recommendations to address the causes of these supply shortages. Six policy principles were agreed by the HLG-MR in March 2011. These are implementation of full-cost recovery and outage reserve capacity (ORC) for 99 Mo production, a government role in the market, conversion to low-enriched uranium targets, international collaboration and periodic reviews of the supply chain. This article describes progress made in the implementation of the six principles and examines the projected global capacity for medical radioisotope production in the near future. (author)

Treatment of Radioactive Waste Generated from the Production of Molybdenum-99 Radioisotope

International Nuclear Information System (INIS)

Aisyah; Herlan Martono

2007-01-01

The 99 Mo is produced as the parent radionuclide for 99m Tc radioisotope which is used as medical radiodiagnostic for certain disease. In Indonesia 99 Mo is produced by irradiating target of high enriched U in the reactor. The characteristics of radioactive waste from the production of 99 Mo depend on the U enrichment of the target and the irradiation time. The characteristic of the radioactive waste can be directly determined by laboratory analysis or by ORIGEN 2 code. Producing 99 Mo from high enriched uranium target will produce radioactive waste containing 235 U, 238 U and fission product, while from low enriched uranium target will produce radioactive waste containing large amount of 239 Pu. Plutonium-239 is a long half life actinide that need to be separated from the fission product due to a different treatment is required. The fission product, after it is allowed to decay then needs to be categorized as low or medium level waste, while 239 Pu are categorized as transuranic waste. The disposal of low and medium level waste are stored in near surface disposal, while the disposal of transuranic waste is stored in a geologic formation. (author)

Radioisotopes as Political Instruments, 1946–1953

Science.gov (United States)

Creager, Angela N. H.

2009-01-01

The development of nuclear “piles,” soon called reactors, in the Manhattan Project provided a new technology for manufacturing radioactive isotopes. Radioisotopes, unstable variants of chemical elements that give off detectable radiation upon decay, were available in small amounts for use in research and therapy before World War II. In 1946, the U.S. government began utilizing one of its first reactors, dubbed X-10 at Oak Ridge, as a production facility for radioisotopes available for purchase to civilian institutions. This program of the U.S. Atomic Energy Commission was meant to exemplify the peacetime dividends of atomic energy. The numerous requests from scientists outside the United States, however, sparked a political debate about whether the Commission should or even could export radioisotopes. This controversy manifested the tension in U.S. politics between scientific internationalism as a tool of diplomacy, associated with the aims of the Marshall Plan, and the desire to safeguard the country’s atomic monopoly at all costs, linked to American anti-Communism. This essay examines the various ways in which radioisotopes were used as political instruments—both by the U.S. federal government in world affairs, and by critics of the civilian control of atomic energy—in the early Cold War. PMID:20725612

Annual Technical Progress Report of Radioisotope Power System Materials Production and Technology Program Tasks for October 1, 2002 Through September 30, 2003

Energy Technology Data Exchange (ETDEWEB)

King, J.F.

2004-05-18

The Office of Space and Defense Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. For the Cassini Mission, for example, ORNL was involved in the production of carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS). This report has been divided into three sections to reflect program guidance from the Office of Space and Defense Power Systems for fiscal year (FY) 2003. The first section deals primarily with maintenance of the capability to produce flight quality (FQ) CBCF insulator sets, iridium alloy blanks and foil, and CVS. In all three cases, production maintenance is assured by the manufacture of limited quantities of FQ components. The second section deals with several technology activities to improve the manufacturing processes, characterize materials, or to develop technologies for new radioisotope power systems. The last section is dedicated to studies related to the production of {sup 238}Pu.

CAS Accelerators for Medical Applications in Vösendorf, Austria

CERN Multimedia

CERN Accelerator School

2015-01-01

The CERN Accelerator School (CAS) and MedAustron jointly organised a course on Accelerators for Medical Applications in Vösendorf, Austria between 26 May and 5 June 2015. The course was held at the Eventhotel Pyramide on the outskirts of Vienna, and was attended by 76 participants from 29 countries, coming from as far away as Canada, China, Lithuania, Thailand, Ukraine and Russia.       The intensive programme comprised 37 lectures. The emphasis was on using charged particle beams for cancer therapy and the programme began by covering the way in which particles interact with biological material, how this translates into the dose needed for treatment and how this dose is best delivered. The different accelerator options for providing the particles needed were then presented in some detail. The production of radioisotopes and how these are used for diagnostics and therapy was also covered, together with a look at novel acceleration techniques that may play a role i...

A new radioisotope facility for Thailand

International Nuclear Information System (INIS)

Horlock, K.

1997-01-01

The Thai Office of Atomic Energy for Peace (OAEP) is planning a new Nuclear Research Centre which will be located at Ongkharak, a greenfield site some 100 km North of Bangkok. General Atomics (GA) has submitted a bid for a turnkey contract for the core facilities comprising a Reactor to be supplied by GA, an Isotope Production Facility supplied by ANSTO and a Waste Processing and Storage Facility to be supplied by Hitachi through Marubeni. The buildings for these facilities will be provided by Raytheon, the largest constructor of nuclear facilities in the USA. The proposed Isotope Facility will consist of a 3000 m 2 building adjacent to the reactor with a pneumatic radioisotope transfer system. Hot cells, process equipment and clean rooms will be provided, as well as the usual maintenance and support services required for processing radiopharmaceutical and industrial products. To ensure the highest standards of product purity the processing areas will be supplied with clean air and operated at slightly positive pressure. The radioisotopes to be manufactured include Phosphorus 32 (S-32 [n,p]P-32), I-131(Te-130 [n,g]Te-131[p]I-131) for bulk, diagnostic capsules and therapeutic capsules, Iridium 192 (Ir-191[n,g]Ir-192) wire for radiotherapy and discs for industrial radiography sources and bulk Iodine 125 (Xe-124[n,g]Xe-125[β]I-125 for radioimmunoassay. The bid includes proposals for training OAEP staff during design and development at ANSTO's radioisotope facilities, and during construction and commissioning in Thailand. The entire project is planned to take four years with commencement anticipated in early 1997. The paper will describe the development of the design of the hot-cells, process equipment, building layout and ventilation and other services

Control of the technological processes at ''Azovstal'' plant using radioisotope devices

Energy Technology Data Exchange (ETDEWEB)

Nosochenko, O V; Overchenko, Z V; Karpov, O I; Deryabina, G N

1980-05-01

Considered is the state of radioisotope control of the technological process at 'Azovstal' plant which has permitted to increase the quality of metal and of metal production. With the help of radioisotope densimeter PR-1024 carried out is the control of the density of the lime solution used for hearth spraying at pig iron casting. A system of automatic correction of skip coke supply according to indications of moisture gauges ''Neutron 3-1'' is implemented at blast furnaces. A radioisotope thickness gauge of hot rolling is positioned on the section of finishing stand of thick-sheet plant, its operation is based on the ..gamma.. radiation weakening in dependence on sheet thickness. The introduction of thickness gauges in the automatized system of rolling control is planned. A radioisotope device ''Paza 2'' for measuring of continuous ingot skin thickness is tested successively at the plant. Gamma-relay devices are used to control the level of loose materials in bunkers. Noted is the prospects of using radioisotopic means of control and automatization of technological processes in ferrous matallurgy.

Applications of radioisotopes in industry and healthcare in Vietnam

International Nuclear Information System (INIS)

Dien, N.N.; Quang, N.H.

1997-01-01

Nowadays, in Vietnam radioisotopes have been used very widely in various socio-economic branches, especially in industry and healthcare. Applications of radioisotopes have significant meaning in economic development, people health protection, as well as in scientific research. In this paper, the present status and main applications of radiation and radioactive isotopes in industry and healthcare in Vietnam are reported. In order to control and monitor industrial processes, nucleonic control systems and radioactive tracer techniques have been utilized. Actually, sealed source applications are popular in Vietnam industry. A number of nuclear control devices and gauges have been used in the various industrial factories, such as liquid level gauges in steel industry, cement and beverage factories; density and moisture gauges in paper industry, etc. Tracer technique and sealed source applications have also been utilized in industrial production plants and in trouble-shooting in the petroleum industry. For medicine purposes, two departments of nuclear medicine were primarily established at the beginning of the 1970s. At the present time, a number of nuclear medicine departments have been set up and they have been equipped with advanced equipment. Main activities are focused on thyroid function studies, nuclear cardiology, brain scans, gastrointestinal studies, bone scans, etc. Since march 1984 Dalat nuclear research reactor of nominal power of 500 kW has been reconstructed and put into operation. This reactor is unique in Vietnam and has become an important scientific tool for development of nuclear techniques and radioisotope applications for socio-economic progress. Thanks to this important scientific tool, a variety of radioisotopes for medicine and industry applications as well as for scientific research has been produced. Utilization of the Dalat research reactor for radioisotope production is also summarized in this paper

Applications of radioisotopes in industry and healthcare in Vietnam

Energy Technology Data Exchange (ETDEWEB)

Dien, N.N.; Quang, N.H. [Nucealr Research Institute, Dalat, (Viet Nam)

1997-10-01

Nowadays, in Vietnam radioisotopes have been used very widely in various socio-economic branches, especially in industry and healthcare. Applications of radioisotopes have significant meaning in economic development, people health protection, as well as in scientific research. In this paper, the present status and main applications of radiation and radioactive isotopes in industry and healthcare in Vietnam are reported. In order to control and monitor industrial processes, nucleonic control systems and radioactive tracer techniques have been utilized. Actually, sealed source applications are popular in Vietnam industry. A number of nuclear control devices and gauges have been used in the various industrial factories, such as liquid level gauges in steel industry, cement and beverage factories; density and moisture gauges in paper industry, etc. Tracer technique and sealed source applications have also been utilized in industrial production plants and in trouble-shooting in the petroleum industry. For medicine purposes, two departments of nuclear medicine were primarily established at the beginning of the 1970s. At the present time, a number of nuclear medicine departments have been set up and they have been equipped with advanced equipment. Main activities are focused on thyroid function studies, nuclear cardiology, brain scans, gastrointestinal studies, bone scans, etc. Since march 1984 Dalat nuclear research reactor of nominal power of 500 kW has been reconstructed and put into operation. This reactor is unique in Vietnam and has become an important scientific tool for development of nuclear techniques and radioisotope applications for socio-economic progress. Thanks to this important scientific tool, a variety of radioisotopes for medicine and industry applications as well as for scientific research has been produced. Utilization of the Dalat research reactor for radioisotope production is also summarized in this paper

Career opportunities in the applications of radiation and radioisotopes

International Nuclear Information System (INIS)

Morganstern, K.H.

1975-01-01

The application of radiation and radioisotopes is finally coming into its own after a long and hesitant gestation period. Overshadowed since the inception of the ''Nuclear Age'' by nuclear power generation, this area nevertheless provides real and challenging opportunities involving many different technical specialties and professional skills. Career opportunities are becoming available in those areas involving the use of radioactive isotopes in research, medicine, and industrial process control, and the employment of large radiation outputs, from either accelerator or isotopes, for industrial process applications

Nuclear data for production of therapeutic radionuclides. Summary report of second research coordination meeting

International Nuclear Information System (INIS)

Sublet, J.-Ch.; Capote Noy, R.

2004-11-01

A summary is given of the Second Research Coordination Meeting on Nuclear Data for Production of Therapeutic Radionuclides. The new library of evaluated cross section will cover the reactor and/or accelerator production of therapeutic radionuclides to appropriate specific activities and purity along with the relevant decay data. There are a significant number of radioisotopes in use or being proposed for therapeutic applications. As a consequence of the work undertaken during the course of this CRP, the resulting completeness and accuracy of the nuclear data for the production of these nuclides to appropriate specific activities and purity along with the re-definition of their decay data should be adequate for safe and efficient medical applications. The radioisotopes to be considered in the CRP were divided into two categories: Established Radioisotopes (therapeutic radioisotopes that have established clinical uses) and Emerging Radioisotopes (less-commonly used but potentially interesting radioisotopes for which medical applications have been demonstrated). Experimental data compilations and selection and preliminary evaluations for each of the reactions were extensively discussed during the meeting. The recommendations for both established and emerging radionuclides, and validation/testing of the cross section library are summarized. Technical discussions and the resulting work plan of the Coordinated Research Programme are summarized for every reaction path to be evaluated, along with actions and deadlines. Participants' contributions to the RCM are also attached. (author)

Comparison between Radioisotopic and Non-radioisotopic Polymerase Chain Reaction-Single Strand Conformation Polymorphism (PCR-SSCP) Procedures in the Detection of Mutations at the rpoB Gene Associated with Rifampicin Resistance in Mycobacterium tuberculosis

International Nuclear Information System (INIS)

Lee, H.; Bang, H.E.; Johnson, R.; Jordaan, A.M.; Victor, T.C. . E-mail : tv@sun.ac.za; Dar, L.; Khan, B.K.; Cho, S.N. . E-mail : raycho@yonsei.ac.kr

2006-01-01

Rapid and sensitive detection of mutations at the rpoB gene of Mycobacterium tuberculosis would be of great importance for proper management of tuberculosis (TB) patients and control of multi-drug resistant TB. Polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) using both radioisotopic and non-radioisotopic methods have been widely used for detecting such mutations. However, the silver staining method, which is the most frequently employed in PCR-SSCP, has been reported to be producing results of varying sensitivity. Radioisotope-based methods have shown greater sensitivity in detecting the rpoB mutations than the silver staining method. The primary objective of this study was therefore to compare the radioisotopic method with the silver staining method detection of mutations of rpoB gene by PCR-SSCP in the same laboratory. Purified DNAs from M. tuberculosis H37Rv were serially diluted and used for PCR amplification with and without radionuclides. The PCR products were then detected by silver staining and autoradiography methods. In addition, clinical isolates were analyzed by PCR-SSCP. The radioisotopic method showed about four-fold increase in the detection of PCR products over ethidium bromide staining in agarose gel. When compared with silver staining, the radioisotopic method gave a sensitivity of more than 10-fold in detecting PCR products and about 8-fold in PCR-SSCP. Radioisotope-based detection methods provided a clearer resolution in PCR-SSCP than the silver staining method when applied to clinical isolates of M. tuberculosis. Radioisotope-based detection method was shown to be more sensitive than non-isotope-based method in detecting PCR products and mutations at the rpoB gene of M. tuberculosis by PCR-SSCP. It may be noted that mutations in the rpoB gene as a marker have significant clinical importance because of the increasing number of MDR-TB cases in the world. It is especially relevant to MDR and Extreme Drug Resistance TB

Rhenium radioisotopes for therapeutic radiopharmaceutical development

International Nuclear Information System (INIS)

Knapp, F.F. Jr.; Beets, A.L.; Pinkert, J.; Kropp, J.; Lin, W.Y.; Wang, S.Y.

2001-01-01

Rhenium-186 and rhenium-188 represent two important radioisotopes which are of interest for a variety of therapeutic applications in oncology, nuclear medicine and interventional cardiology. Rhenium-186 is directly produced in a nuclear reactor and the 90 hour half-life allows distribution to distant sites. The relatively low specific activity of rhenium-186 produced in most reactors, however, permits use of phosphonates, but limits use for labelled peptides and antibodies. Rhenium-188 has a much shorter 16.9 hour half-life which makes distribution from direct reactor production difficult. However, rhenium-188 can be obtained carrier-free from a tungsten-188/rhenium-188 generator, which has a long useful shelf-life of several months which is cost-effective, especially for developing regions. In this paper we discuss the issues associated with the production of rhenium-186- and rhenium-188 and the development and use of various radiopharmaceuticals and devices labelled with these radioisotopes for bone pain palliation, endoradiotherapy of tumours by selective catheterization and tumour therapy using radiolabelled peptides and antibodies, radionuclide synovectomy and the new field of vascular radiation therapy. (author)

The PSI/ETH tandem accelerator facility

Energy Technology Data Exchange (ETDEWEB)

Synal, H.A.; Doebeli, M.; Fuhrmann, H.; Kubik, P.W.; Nebiker, P.W. [Paul Scherrer Inst. (PSI), Villigen (Switzerland)] [and others

1997-09-01

The 1996 operation of the PSI/ETH tandem accelerator at ETH Hoenggerberg is summarised with a detailed compilation of the beam time statistics and the statistics of AMS samples for the different radioisotopes and for the major fields of research. (author) 2 tab.

Accelerator mass spectrometry of heavy elements: /sup 36/Cl to /sup 205/Pb

Energy Technology Data Exchange (ETDEWEB)

Henning, W

1987-08-25

Measurements are discussed in which the technique of accelerator mass spectrometry was applied to problems involving heavy radioisotopes. These measurements, which depend on the ion energies that can be reached with the new heavy-ion accelerator facilities, were performed at the Argonne tandem linac accelerator system (ATLAS) and at the UNILAC accelerator at GSI. The topics include a discussion of measurements of long nuclear lifetimes, of radioisotope detection of interest to solar neutrino experiments, and of a determination of the /sup 41/Ca concentration in natural samples of terrestrial origin by making use of isotopic pre-enrichment in an isotope separator. A long-known method of isobar separation, employing a gas-filled magnetic field region, has been revived for some of these measurements and its characteristics and advantages are briefly reviewed.

Cyclotrons for isotope production

International Nuclear Information System (INIS)

Milton, B.F.; Stevenson, N.R.

1995-06-01

Cyclotrons continue to be efficient accelerators for radioisotope production. In recent years, developments in the accelerator technology have greatly increased the practical beam current in these machines while also improving the overall system reliability. These developments combined with the development of new isotopes for medicine and industry, and a retiring of older machines indicates a strong future for commercial cyclotrons. In this paper we will survey recent developments in the areas of cyclotron technology, and isotope production, as they relate to the new generation of commercial cyclotrons. We will also discuss the possibility of systems capable of extracted energies up to 100 MeV and extracted beam currents of up to 2.0 mA. (author). 6 refs., 2 tabs., 3 figs

Introduction: the changing face of accelerator target physics and chemistry

International Nuclear Information System (INIS)

Sunderland, J.J.

1992-01-01

The explosive growth of the small accelerator industry, an offshoot of the expansion of both clinical and research PET imaging, is driving a changing perspective in the field of accelerator targetry. To meet the new demands placed on targetry by the increasingly active and demanding PET institutions it has become necessary to design targets capable of producing large amounts of the four common positron-emitting radionuclides ( 15 O, 13 N, 11 C, 18 F) with unfailing reliability and simplicity. The economic clinical and research survival of PET absolutely relies upon these capabilities. In response to this perceived need, the lion's share of the effort in the field of target physics and chemistry is being directed toward the profuse production of these four common radioisotopes. (author)

Present status and prospect of radiation and radioisotopes in China

International Nuclear Information System (INIS)

Zhou, Yong-Tian

1986-01-01

Production and application of radioisotopes in China started almost thirty years ago. At present there are 20 units producing more than 700 radioisotope products. This report outlines the present status and prospect of radiation and radioisotopes in some major areas. Remarkable achievements have been made in agriculture using nuclear technology. More than 70 new varieties or strains of cultivated plants have been bred by inducing mutation through irradiation. A new variety of silkworm bred by irradiation has unique characteristics such as high and stable yield. Application of radioisotopes in medical research and clinical practice began in 1956 and radionuclides have been progressively used in diagnosis and treatment of diseases. The most common radionuclide used in therapy is iodine-131 for hyperthyroidism. Isotope-tracer technique and activation analysis play an important role in the study of traditional Chinese medicine. Isotope methods in China have been used in many industrial branches, such as textile, plastic and printing, but not very widely now. The nation has produced more than 2,000 sets of nuclear radiation measuring instruments, which become important parts of industrial automation control. The radiation processing research started in the end of 1950's. Food irradiation research has been going on in a good cooperation of different branches. Now China is planning to set up some plants to produce gamma irradiated disposal syringes and other medical devices. (Nogami, K.)

Symposium on isotope production and applications

International Nuclear Information System (INIS)

1981-01-01

This report contains the papers delivered at the symposium on isotope production and applications, held at Pelindaba, Pretoria, South Africa. The following topics were discussed: facilities for the production of radioisotopes at Pelindaba; the role of the chemist in the development and production of radioisotopic preparations; quality control of radioisotopic products; applications of radioisotopes in medicine; concepts and current status of nuclear imaging; industrial and research applications of radioisotopic tracers and radioisotopic radiation sources; radiation processing using intense radioisotopic radiation sources; a review of current and future radioisotope production activities at the Council for Scientific and Industrial Research

Radioisotope application to studies of copper electrolytic refining

International Nuclear Information System (INIS)

Shul'ts, U.; Lange, Kh.; Gajdel', B.

1976-01-01

Silver and selenium behaviour was studied using sup(110m)Ag and 75 Se radioisotopes in the copper electrolysis process. sup(110m)Ag and 75 Se distribution in the electrorefining products was also studied. It was found that Ag/Se mass ratio affected greatly the silver content in the copper cathode. It was found that the tracer technique made it possible to determine 0,1gSe/tCu and 1gAg/t Cu simultaneously and accurately with small material and time expenses. Using sup(110m)Ag radioisotope, the reduction in electrolyte silver content dependent on time may be determined quickly and accurately

Specific features of the desion of a cyclotron for radioisotope production

International Nuclear Information System (INIS)

Akulova, N.V.; Bogdanov, P.V.; Ivanov, V.V.

1979-01-01

Results of development of an isochronous cyclotron for commercial production of Co 57 and Ga 67 isotopes are described. The accelerator is intended for proton acceleration up to 25 MeV at 1000-1500 mA intensity of inner beam and 200 mA intensity of external beam. An axial ion source with a hot cathode will be used in the cyclotron. Outer diameter of armour type electromagnet is 3130 mm, mass - 75 t, diameter of poles-150 cm and mean induction of magnetic field in a working gap amounts to 12 kgs. Accelerating chamber vessel is made of steel in the form of thick-wall hollow cylinder having 3130 mm outer diameter, 330 mm thickness and 380 mm height. Resonance system represents a quarter-wave line operating on 16.6 MHZ-frequency. Vacuum system is designed to produce and maintain residual pressure of 6.7x10 -4 Pa and 2.7x10 -3 Pa in the accelerating chamber which can be provided with two NDM-2 ion-getter pumps with an arc evaporator. The suggested constructive solution for electromagnet, accelerating chamber of the cyclotron and pumping system permitted to arrange the accelerator on the whole and to considerably decrease the level of ionizing radiations inside the chamber [ru

Equipment for nuclear medical centers, production capabilities of Rosatom enterprises

International Nuclear Information System (INIS)

Gavrish, Yu. N.; Koloskov, S. A.; Smirnov, V. P.; Strokach, A. P.

2015-01-01

Analysis of the capabilities of the State Corporation Rosatom enterprises on the development and production of diagnostic and therapeutic equipment for nuclear medicine centers is presented. Prospects of the development of accelerator equipment for the production of a wide range of radioisotope products are shown, and the trends of its development are determined. A comparative analysis of the technical parameters of domestic tomographs and devices for brachytherapy with foreign counterparts is given

Equipment for nuclear medical centers, production capabilities of Rosatom enterprises

Science.gov (United States)

Gavrish, Yu. N.; Koloskov, S. A.; Smirnov, V. P.; Strokach, A. P.

2015-12-01

Analysis of the capabilities of the State Corporation Rosatom enterprises on the development and production of diagnostic and therapeutic equipment for nuclear medicine centers is presented. Prospects of the development of accelerator equipment for the production of a wide range of radioisotope products are shown, and the trends of its development are determined. A comparative analysis of the technical parameters of domestic tomographs and devices for brachytherapy with foreign counterparts is given.

Medical radioisotopes for the next century

International Nuclear Information System (INIS)

Carr, S.W.

1999-01-01

Radioisotopes are widely used in medicine (Nuclear Medicine) for diagnosis, palliation and therapy of heart disease, cancer, muscoskeletal and neurological conditions. The radioisotopes used are both reactor and cyclotron produced. The utilisation is currently growing and is expected to continue to grow over the next 10-20 years. The combination of radioisotope and delivery vehicle can be designed to meet the intended end use. This paper will deal with the main approaches to the use of radioisotopes for Nuclear medicine ad future prospects for the area

Industrial Applications of radioisotopes and radiation technology and Agency's role

International Nuclear Information System (INIS)

Ramamoorthy, N.; Haji-Saeid, M.

2004-01-01

Applications of radioisotopes and radiation technology are contributing significantly in many areas of science and technology, industry and environment, towards sustainable development, improving the quality of life and cleaner and safer national industries. There are three major classes impacting industrial scale operations, namely, (a) radiation processing/treatment, (b) radiotracer and sealed source techniques to monitor industrial processes/columns/vessels and (c) industrial gamma radiography and tomography. Radiation processing applying gamma sources and electron accelerators for material treatment/modification is an established technology. There are over 160 gamma industrial irradiators and 1300 industrial electron accelerators in operation worldwide. Development of new materials, especially for health care and environment protection, and advanced products (for electronics, solar energy systems, biotechnology etc) are the main objectives of R and D activity in radiation processing technology. The International Atomic Energy Agency (IAEA, Agency) is involved in supporting both the development and transfer of radiation technology. Thanks to Agency's efforts, advanced radiation processing centres have been established in many Member States (MS), e.g. Malaysia, Egypt, Iran, Poland, Brazil, Hungary. Hydrogel dressing for wounds, radiation vulcanised latex, degraded natural polymer are examples of useful product outcomes. Demonstration of effective treatment of flue gas in pilot plant as well as industrial scale and industrial wastewater in pilot plant scale has shown promise for tackling industrial emissions/effluents using electron beam machines. Industrial radiotracer and gamma sealed source techniques are largely used for analyzing industrial process systems. Initially used as trouble-shooting measures, they play a vital role in process parameter optimization, improved productivity, on-line monitoring and could lead to even pre-commissioning benchmarking. Gamma

Industrial Applications of radioisotopes and radiation technology and Agency's role

International Nuclear Information System (INIS)

Ramamoorthy, N.; Haji-Saeid, M.

2004-01-01

Full text: Applications of radioisotopes and radiation technology are contributing significantly in many areas of science and technology, industry and environment, towards sustainable development, improving the quality of life and cleaner and safer national industries. There are three major classes impacting industrial scale operations, namely, (a) radiation processing/treatment, (b) radiotracer and sealed source techniques to monitor industrial processes/columns/vessels and (c) industrial gamma radiography and tomography. Radiation processing applying gamma sources and electron accelerators for material treatment/modification is an established technology. There are over 160 gamma industrial irradiators and 1300 industrial electron accelerators in operation worldwide. Development of new materials, especially for health care and environment protection, and advanced products (for electronics, solar energy systems, biotechnology etc) are the main objectives of R and D activity in radiation processing technology. The International Atomic Energy Agency (IAEA, Agency) is involved in supporting both the development and transfer of radiation technology. Thanks to Agency's efforts, advanced radiation processing centres have been established in many Member States (MS), e.g. Malaysia, Egypt, Iran, Poland, Brazil, Hungary. Hydrogel dressing for wounds, radiation vulcanised latex, degraded natural polymer are examples of useful product outcomes. Demonstration of effective treatment of flue gas in pilot plant as well as industrial scale and industrial wastewater in pilot plant scale has shown promise for tackling industrial emissions/effluents using electron beam machines. Industrial radiotracer and gamma sealed source techniques are largely used for analyzing industrial process systems. Initially used as trouble-shooting measures, they play a vital role in process parameter optimization, improved productivity, on-line monitoring and could lead to even pre

Radioisotopes in industry

International Nuclear Information System (INIS)

Popple, B.N.

1977-01-01

The author explains clearly what is radiography, enumerates four major factors in considering a practical source to use namely half-life, penetrating power, half value layer and specific activity and also the advantages and disadvantages in using isotopes. Common radioisotopes used in industrial radiography are iridium, cesium, cobalt and thulium. Main uses of the radioisotopes are for radiographic testing like welding castings, forgoings etc.; thickness, level or density measurement and tracing. (RTD)

Present and future prospects of accelerator mass spectrometry

Energy Technology Data Exchange (ETDEWEB)

Kutschera, W

1988-05-20

Accelerator mass spectrometry (AMS) has become a powerful technique for measuring extremely low abundances (10/sup -10/ to 10/sup -15/ relative to stable isotopes) of long-lived radioisotopes with half-lives in the range from 10/sup 2/ to 10/sup 8/ years. With a few exceptions, tandem accelerators turned out to be the most useful instruments for AMS measurements. Both natural (mostly cosmogenic) and manmade (anthropogenic) radioisotopes are studied with this technique. In some cases very low concentrations of stable isotopes are also measured. Applications of AMS cover a large variety of fields including anthropology, archaeology, oceanography, hydrology, climatology, volcanology, mineral exploration, cosmochemistry, meteoritics, glaciology, sedimentary processes, geochronology, environmental physics, astrophysics, nuclear and particle physics. Present and future prospects of AMS will be discussed as an interplay between the continuous development of new techniques and the investigation of problems in the above mentioned field. Depending on the specific problem to be investigated, different aspects of an AMS system are of importance. Typical factors to be considered are energy range and type of accelerator, and the possibilities of dedicated versus partial use of new or existing accelerators.

Radioisotope requirements and usage in the radiopharmaceutical industry

International Nuclear Information System (INIS)

Langton, M.A.

1995-01-01

Radioisotopes are used extensively in many different productive and beneficial human endeavors. Amersham International, a U.K.-based company originating in the British Scientific Civil Service during World War II, has been actively involved in many of these activities for more than 50 yr. Today they are one of the world's largest suppliers of radioactive compounds and scaled radiation sources for use in industrial quality and safety assurance, life science research, and medicine. This paper outlines one of these applications: the use of radioisotopes as radiopharmaceuticals. Radiopharmaceuticals are radioactive nuclides and labeled compounds that have been developed for the diagnosis and treatment of (human) disease. They are manufactured via highly controlled processes and have gone through regulatory scrutiny and approval far in excess of other radioisotopes used in other applications. Radiopharmaceuticals can be conveniently split into two categories. One type is simply an active analog that mimics the physiological behavior of its inactive counterpart in the body. The other involves an actual pharmacological compound that exhibits the desired physiological behavior, which is then labeled with a radionuclide suitable for either imaging or the delivery of a therapeutic radiation dose as appropriate but which plays no part in the mechanism of action of the drug. The latter type, which is the more common of the two, can be supplied either as an active compounded product or as a open-quotes cold kit,close quotes which is then labeled with the appropriate radiopharmaceutical-grade radionuclide to yield the final product

Radioisotope applications on fluidized catalytic cracking units

International Nuclear Information System (INIS)

Charlton, J.S.

1997-01-01

Radioisotopes are used to trace the flow of all the phases of Fluidized Catalytic Cracking process in oil refineries. The gaseous phases, steam, hydrocarbon vapour and air, are generally traced using a noble-gas isotope, 41 Ar, 79 Kr or 85 Kr. An appropriate tracer for the catalyst is produced by irradiating a catalyst sample in a nuclear reactor. The activation products, 140 La and 24 Na provide appropriate radioactive 'labels' for the catalyst, which is reinjected into the FCC. An advantage of this approach is that it facilitates the study of the behaviour of different particle size fractions. Radioisotopes as sealed sources of gamma radiation are used to measure catalyst density variations and density distributions in critical parts of the unit. An important trend in radioisotope applications is the increasing use of the information they produce as inputs to or as validation of, mathematical process models. In line with the increasing sophistication of the models, the technology is undergoing continuous refinement. Developments include the investigation of more efficient, more convenient tracers, the introduction of systems to facilitate more rapid and comprehensive data acquisition and software refinements for enhanced data analysis

Annual Technical Progress Report of Radioisotope Power System Materials Production and Technical Program Tasks for October 1, 2005 through September 30, 2006

Energy Technology Data Exchange (ETDEWEB)

None

2007-04-02

The Office of Space and Defense Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. For the Cassini Mission, ORNL produced carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS) used in the generators. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. This report reflects program guidance from the Office of Space and Defense Power Systems for fiscal year (FY) 2006. Production activities for prime quality (prime) CBCF insulator sets, iridium alloy blanks and foil, and CVS are summarized in this report. Technology activities are also reported that were conducted to improve the manufacturing processes, characterize materials, or to develop information for new radioisotope power systems.

Annual Technical Progress Report of Radioisotope Power System Materials Production and Technology Programs Tasks for October 1, 2005, through September 30, 2006

Energy Technology Data Exchange (ETDEWEB)

None

2006-09-30

The Office of Space and Defense Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. For the Cassini Mission, ORNL produced carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS) used in the generators. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. This report reflects program guidance from the Office of Space and Defense Power Systems for fiscal year (FY) 2006. Production activities for prime quality (prime) CBCF insulator sets, iridium alloy blanks and foil, and CVS are summarized in this report. Technology activities are also reported that were conducted to improve the manufacturing processes, characterize materials, or to develop information for new radioisotope power systems.

ANNUAL TECHNICAL PROGRESS REPORT OF RADIOISOTOPE POWER SYSTEM MATERIALS PRODUCTION AND TECHNOLOGY PROGRAM TASKS FOR OCTOBER 1, 2005 THROUGH SEPTEMBER 30, 2006

Energy Technology Data Exchange (ETDEWEB)

King, James F [ORNL

2007-04-01

The Office of Space and Defense Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. For the Cassini Mission, ORNL produced carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS) used in the generators. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. This report reflects program guidance from the Office of Space and Defense Power Systems for fiscal year (FY) 2006. Production activities for prime quality (prime) CBCF insulator sets, iridium alloy blanks and foil, and CVS are summarized in this report. Technology activities are also reported that were conducted to improve the manufacturing processes, characterize materials, or to develop information for new radioisotope power systems.

Cyclotron Development and Technical Aspects on Accelerator Based Laboratory Development

International Nuclear Information System (INIS)

Sunarhadijoso

2000-01-01

BATAN is planning to establish an accelerator-based laboratory at P3TM Yogyakarta as an effort in the development and use of accelerator technology for improving industrial performance and public welfare. This paper reviews several aspects of cyclotron technology and describes the combination of a linear accelerator - cyclotron system as an alternative to be considered in the planing of the laboratory. The progress of cyclotron technology is discussed covering three generations, i.e. conventional cyclotron, synchrocyclotron and AVF cyclotron generations. The planning should not consider the accelerator application for radioisotope production because it is established in Serpong with the existing negative ion cyclotron. The proposed facility at P3TM may comprise two linear accelerators coupled with a positive ion cyclotron of synchrocyclotron generation. In fact, the attachment of the synchrocyclotron unit is flexible and it can be installed subsequently if the higher energy particle beam, which can not be produced by the linear accelerators, is extremely needed. Some technical aspects related to ion beam application, building construction and infrastructure, human resources, and specification of function test are discussed for additional information in the implementation of the planning. (author)

Use of radioisotopes in agriculture: DNA based molecular markers in crop improvement

International Nuclear Information System (INIS)

Sivaramakrishnan, S.; Seetharama, N.; Kannan, Seetha

2001-01-01

Agriculture has always benefited from the use of radioisotopes in many ways. In the beginning radioisotopes were mostly used for physiological studies to measure photosynthetic efficiency, nutrient uptake, and for mutation breeding. Radioisotopes have now become a part of the biotechnological tools that are being increasingly used in improving crops and production systems. The tools of biotechnology are being increasingly used to hasten breeding and address problems of biotic and abiotic stresses. Some of the non-radioactive methods have replaced radiotracer techniques and thus led to automation often at high cost. However, still there remain many applications where radioisotopes seem almost indispensable. For some of the applications like comparative genome mapping, the confirmation of transgenics, and establishment of gene copy number, use of RFLP with radioisotopes is essential. The following research areas at ICRISAT use radioisotopes: (1) physiological basis of adaptation to abiotic stresses (ii) development and use of appropriate DNA markers crop improvement; (iii) characterization of cytoplasmic male sterile systems and genetic diversity of breeding materials, land races and the wild relatives and (iv) molecular basis of disease resistance; (v) comparative genome mapping across cereals, (vi) isolation and characterization of genes of potential value to genetic improvement and (vii) verification of genetic transformation events. (author)

Container for gaseous samples for irradiation at accelerators

International Nuclear Information System (INIS)

Kupsch, H.; Riemenschneider, J.; Leonhardt, J.

1985-01-01

The invention concerns a container for gaseous samples for the irradiation at accelerators especially to generate short-lived radioisotopes. The container is also suitable for storage and transport of the target gas and can be multiply reused

Stabilization and shutdown of Oak Ridge National Laboratory's Radioisotopes Production Facility

International Nuclear Information System (INIS)

Eversole, R.E.

1992-01-01

The Oak Ridge National Laboratory (ORNL) has been involved in the production and distribution of a variety of radioisotopes for medical, scientific and industrial applications since the late 1940s. Production of these materials was concentrated in a number of facilities primarily built in the 1950s and 1960s. Due to the age and deteriorating condition of these facilities, it was determined in 1989 that it would not be cost effective to upgrade these facilities to bring them into compliance with contemporary environmental, safety and health standards. The US Department of Energy (DOE) instructed ORNL to halt the production of isotopes in these facilities and maintain the facilities in safe standby condition while preparing a stabilization and shutdown plan. The goal was to place the former isotope production facilities in a radiologically and industrially safe condition to allow a 5-year deferral of the initiation of environmental restoration (ER) activities. In response to DOE's instructions, ORNL identified 17 facilities for shutdown, addressed the shutdown requirements for each facility, and prepared and implemented a three-phase, 4-year plan for shutdown of the facilities. The Isotopes Facilities Shutdown Program (IFSP) office was created to execute the stabilization and shutdown plan. The program is entering its third year in which the actual shutdown of the facilities is initiated. Accomplishments to date have included consolidation of all isotopes inventory into one facility, DOE approval of the IFSP Environmental Assessment (EA), and implementation of a detailed management plan for the shutdown of the facilities

Production of medical radioisotope 153Sm in the Tehran Research Reactor (TRR) through theoretical calculations and practical tests

International Nuclear Information System (INIS)

Forughi, Sh.; Hamidi, S.; Khalafi, H.; Sheibani, Sh.; Shahidi, A.

2013-01-01

Highlights: ► Production of 153 Sm isotope by neutron activation in a nuclear reactor was studied. ► Optimal parameters for weight and irradiation time were found. ► This study led to an empirical correction factor (kf). ► Kf enhanced the production procedure of the 153 Sm radioisotope. ► The results led to nearly 60% decrease in the amount of material used in the production process. - Abstract: The feasibility of producing 2000–3000 mCi 153 Sm by irradiation of 152 Sm in 5 MW TRR was studied via TRR core simulation. In this study the cross-section of 152 Sm (n,γ) 153 Sm reaction from ENDF/B library was used. The effective activation cross section for production of 153 Sm is obtained using the neutron spectra in different irradiation channel of the core. The activity of the simulated samples is calculated using the obtained fluxes and cross sections. Then samples were prepared and irradiated under different conditions and fluxes. The final production’s specific activity was measured by the standard dose calibrator ISOMED 1010. By comparison of the theoretical calculations and actual measurements, an empirical correction factor (K f ) was obtained, which is helpful in production procedure of the 153 Sm radioisotope. The optimal weight of the samples and irradiation time was studied according to the flux calculations based on the location of the sample and saturated activity calculation. In order to test the proposed conditions, samples were prepared and were irradiated under the proposed conditions. According to the compared results with the initial irradiation condition, the new proposed sample which weighed 4 mg of Sm 2 O 3 is acceptable for the labeling, therefore this study led to nearly 60% decrease in the amount of material used in the production process

List of ERDA radioisotope customers with summary of radioisotope shipments, FY-1974

International Nuclear Information System (INIS)

Simmons, J.L.; Mandell, S.

1974-01-01

The eleventh edition of the AEC radioisotope customer list has been prepared at the request of the Division of Biomedical and Environmental Research. The purpose of this document is to list the FY 1974 commercial radioisotope production and distribution activities of USAEC facilities at Argonne National Laboratory, Battelle, Pacific Northwest Laboratories, Brookhaven National Laboratory, United Nuclear Inc., Idaho Operations Office, Hanford Engineering Development Laboratory, Mound Laboratory, Oak Ridge National Laboratory, and Savannah River Plant. The information is divided into four sections. Section I is an alphabetical list of domestic and foreign customers and their addresses. Each customer has been designated a number according to its alphabetical position which provides a means of cross-referencing in the following sections. The isotopes purchased are listed after the address of the customer and the laboratory supplying each isotope is indicated by a letter set off by parentheses. Section II is an alphabetical list of isotopes, cross-referenced to customer numbers and again divided into the domestic and foreign categories. This section provides a quick idea of the amount of companies purchasing a particular isotope. If more information is needed, the reader can locate the customer by number and determine the laboratory supplying the isotope. The third section is an alphabetical list of states and countries, also cross-referenced to customer numbers, indicating geographical concentrations of isotope users. Section IV summarizes the FY 1974 radioisotope shipment activities of USAEC laboratories in a comprehensive table providing an alphabetical listing of the isotopes and their suppliers. The shipments, quantities and dollars are broken down for each isotope under the Domestic, Foreign, and Project (AEC facilities) categories, and the total figures for each isotope are also provided. (U.S.)

Radioisotope techniques for process optimisation and control in the offshore oil and gas industries

International Nuclear Information System (INIS)

Charlton, J.S.

2002-01-01

For over fifty years, radioisotope technology has been used by the oil industry to solve problems and to help optimise process operations. The widespread development of offshore oil and gas fields has brought, and continues to bring, new challenges and, in response, new or modified applications of radioisotope technology have been introduced. This paper presents case studies, which illustrate the use of radioisotopes, both in the sub-sea environment and on the offshore production platforms. On the platform, radioisotope techniques applied singly or in combination, have been applied to the performance assessment of oil/gas separation and gas dehydration units. Novel nucleonic instrumentation has been developed for the control of three-phase separators. Sub-sea, radioactive tracers and/or sealed sources have been used to investigate the integrity of submerged structures and to troubleshoot pipeline problems. The continuing expansion in the use of this technology stems from industry increasing awareness of its versatility and from the fact that the benefits it confers can be obtained at a relatively modest cost. Examples of economic benefit described in the paper are associated with production enhancements derived from the ability of radioisotope technology to measure performance and diagnose problems on line, without disrupting process operations in any way. (Author)

Design of a 1 MeV 3He+ RFQ for the SAIC PET accelerator facility

International Nuclear Information System (INIS)

Cornelius, W.D.; Young, P.E.

1993-01-01

The novel design of a 1 MeV 3 He + radiofrequency quadrupole (RFQ) accelerator is discussed. This RFQ is the first segment of an accelerator for the production of radioisotopes for positron emission tomography (PET) applications. This RFQ is unusual in that two specific innovations were incorporated into the design. The mechanical design is a hybrid of conventional four-vane and four-rod geometries. This hybridization reduces the physical dimensions of the accelerator without sacrificing too much in rf efficiency and has the added benefit of reducing the sensitivity to mechanical alignment errors. In addition, the beam dynamics of the last few cells was modified to tailor the output beam parameters to improve the beam transport through the next accelerator section. The details of the mechanical structure, the mechanical and electrical alignment experiences, and a comparison of the theoretical and experimental performance of this accelerator are also discussed. (orig.)

Radioactive wastes from Angra-1 plant and radioisotope production to medical and industrial uses

International Nuclear Information System (INIS)

Meldonian, Nelson L.; Mattos, Luis A.T. de

1997-01-01

Based on false premises, critics point of view have frequently lead part of Brazilian public opinion to impeach the validity of nuclear energy applications.The critics allege that social implications discredit those applications. In this context, treated as if not known theirs diverse characteristics, great noise has been created about radioactive wastes related to diverse nuclear industry processes. Due to the great misunderstanding on the subject, this paper presents the characteristics and destinations of radioactive wastes related to nucleoelectric generation and to radioisotopes production in Brazil. Even so someone could point out that those characteristics are diverse, we discuss in a comparative way the benefits of those two kinds of nuclear applications. (author). 5 refs., 6 tabs

CAS CERN Accelerator School: Cyclotrons, linacs and their applications. Proceedings

International Nuclear Information System (INIS)

Turner, S.

1996-01-01

These proceedings present the lectures given at the eighth specialized course organized by the CERN Accelerator School (CAS), the topic this time being 'Cyclotrons, Linacs and Their Applications'. Following an introductory lecture on linacs, the fundamental features of electron, ion and induction linacs are described together with their RF systems and particle sources. Cyclotrons are then introduced followed by details of their different types, their magnet and RF design, and their injection and extraction systems, with a glance towards exotic and possible future machines. Chapters are then presented on the use of linacs and cyclotrons for medical, fission, fusion and material applications, as well as for isotope production. Finally, descriptions of the design of a radioisotope facility, the matching of accelerators to their task and the computational tools used in their design are included. (orig.)

CAS CERN Accelerator School: Cyclotrons, linacs and their applications. Proceedings

Energy Technology Data Exchange (ETDEWEB)

Turner, S [ed.

1996-03-04

These proceedings present the lectures given at the eighth specialized course organized by the CERN Accelerator School (CAS), the topic this time being `Cyclotrons, Linacs and Their Applications`. Following an introductory lecture on linacs, the fundamental features of electron, ion and induction linacs are described together with their RF systems and particle sources. Cyclotrons are then introduced followed by details of their different types, their magnet and RF design, and their injection and extraction systems, with a glance towards exotic and possible future machines. Chapters are then presented on the use of linacs and cyclotrons for medical, fission, fusion and material applications, as well as for isotope production. Finally, descriptions of the design of a radioisotope facility, the matching of accelerators to their task and the computational tools used in their design are included. (orig.).

Role of radioisotopes in the study of insect pests

International Nuclear Information System (INIS)

Mansour, M.

2013-01-01

Although the use of nuclear techniques, particularly radioisotopes, in entomological research is less than a century old, the contribution of radioisotopes to the science of studying insects (Entomology) is indispensable. In fact, radioisotopes provided a very important and sometimes a unique tool for solving many research problems in entomology. This article discusses the most important and widely used applications of radioisotopes in studying insect pests. In particular, it concentrates on the subject of radioisotopes used in entomological research, methods of labeling insect with radioisotopes, half life of radioisotopes, and the role of radioisotopes in physiological, ecological, biological and behavioral studies of insects. (author)

An overview of computer models for pollutant transfer through the atmosphere, with special consideration for radioisotopes

International Nuclear Information System (INIS)

Zivanovic, M.; Djukanovic, J.; Davidovic, M.; Cekerevac, D.; Stankovic, S.

2011-01-01

Modern society is intrinsically connected with usage and production of radioisotopes, both for military and civilian applications. During the march of 2007, there were 443 active nuclear plants, unknown quantity of nuclear weapons and a huge number of industrial, medical and other facilities that possess and use radioisotopes for various purposes. With the widespread usage of radioisotopes, there comes a danger of accidental or planed release into the biosphere. This paper gives an overview of the models that can be used for prognosis or reconstruction of radioisotope transfer through the atmosphere in case of accidental or planned release [sr

Recent developments in radiation equipment and radioisotopes

International Nuclear Information System (INIS)

Beddoes, J.M.

1978-09-01

A review is given of the technology of the uses of radiation equipment and radioisotopes, in which field Canada has long been a world leader. AECL Commercial Products has pioneered many of the most important applications. The development and sale of Co-60 radiation teletherapy units for cancer treatment is a familiar example of such an application and Commercial Products dominates the world market. Another such example is the marketing of Mo-99, which is produced in the NRX and NRU reactors at Chalk River, and from which the short-lived daughter Tc-99 is eluted as required for use in in-vivo diagnosis. New products coming into use for this purpose include Tl-201, I-123, Ga-67 and In-111, all produced in the TRIUMF cyclotron in Vancouver, while I-125 continues to be in demand for in-vitro radioimmunoassays. Radioisotopes continue to play an important part in manufacturing, where their well-known uses include controlling thickness, contents, etc., in production, and industrial radiography. The application of large industrial irradiators for the sterilization of medical products is now a major world industry for which Commercial Products is the main manufacturer. Isotopes are also used in products such as smoke detectors. Isotopes continue to find extensive use as tracers, both in industrial applications and in animal and plant biology studies. Some more recent uses include pest control by the Σsterile maleΣ technique and neutron activation and delayed neutron counting in uranium assay. The review concludes with an account of the development and prospects of AECL Commercial Products. (author)

The Current Utilization and Future Demand of Radiopharmaceutical and Radioisotopes in Malaysia

International Nuclear Information System (INIS)

Ibrahim Ijang; Zakaria Ibrahim; Bohari Yaacob

2013-01-01

Radioisotope and pharmaceutical kits play an important role in nuclear medicine for non-invasive diagnosis and treatment of various cancers and cardiovascular disease. Our aim was to survey the current utilization and future demand of radiopharmaceuticals and radioisotopes in Malaysia. The survey methodology technique was done using questionnaire administration modes. The survey was done for four month duration from government hospitals that have nuclear medicine department. The most frequent pharmaceutical kits used in hospitals were Methylene Diphosphonic acid (MDP) for bone imaging and Diethylene Triamine Pantacetic acid (DTPA). Similarly radioisotopes widely used were Tc-99m and Iodine 131.Therefore if produced of Tc-99m by Nuclear Malaysia can improved in term of high quality products, Nuclear Malaysia could be the sole supplier of this product to hospitals in Malaysia. Similarly pharmaceutical kits especially MDP and DTPA, Nuclear Malaysia has the expertise and knowledge to supply these kits to the hospital. (author)

Radioisotope Power Supply, Phase I

Data.gov (United States)

National Aeronautics and Space Administration — Between 1998 and 2003, Hi-Z Technology developed and built a 40 mW radioisotope power supply (RPS) that used a 1 watt radioisotope heater unit (RHU) as the energy...

The production of radionuclides for nuclear medicine from a compact, low-energy accelerator system.

Science.gov (United States)

Webster, William D; Parks, Geoffrey T; Titov, Dmitry; Beasley, Paul

2014-05-01

The field of nuclear medicine is reliant on radionuclides for medical imaging procedures and radioimmunotherapy (RIT). The recent shut-downs of key radionuclide producers have highlighted the fragility of the current radionuclide supply network, however. To ensure that nuclear medicine can continue to grow, adding new diagnostic and therapy options to healthcare, novel and reliable production methods are required. Siemens are developing a low-energy, high-current - up to 10 MeV and 1 mA respectively - accelerator. The capability of this low-cost, compact system for radionuclide production, for use in nuclear medicine procedures, has been considered. The production of three medically important radionuclides - (89)Zr, (64)Cu, and (103)Pd - has been considered, via the (89)Y(p,n), (64)Ni(p,n) and (103)Rh(p,n) reactions, respectively. Theoretical cross-sections were generated using TALYS and compared to experimental data available from EXFOR. Stopping power values generated by SRIM have been used, with the TALYS-generated excitation functions, to calculate potential yields and isotopic purity in different irradiation regimes. The TALYS excitation functions were found to have a good agreement with the experimental data available from the EXFOR database. It was found that both (89)Zr and (64)Cu could be produced with high isotopic purity (over 99%), with activity yields suitable for medical diagnostics and therapy, at a proton energy of 10MeV. At 10MeV, the irradiation of (103)Rh produced appreciable quantities of (102)Pd, reducing the isotopic purity. A reduction in beam energy to 9.5MeV increased the radioisotopic purity to 99% with only a small reduction in activity yield. This work demonstrates that the low-energy, compact accelerator system under development by Siemens would be capable of providing sufficient quantities of (89)Zr, (64)Cu, and (103)Pd for use in medical diagnostics and therapy. It is suggested that the system could be used to produce many other

Medical research with radioisotopes in Greece

Energy Technology Data Exchange (ETDEWEB)

Belcher, E H [Post-graduate Medical School, Hammersmith, London (United Kingdom)

1961-07-15

An important program of research into the nature and causes of congenital haemolytic anaemias, notably the disease known as Mediterranean anaemia or Thalassaemia, which is a serious medical problem in the Mediterranean countries, is at present being carried out in the Department of Clinical Therapeutics of the University of Athens under a research contract awarded by the International Atomic Energy Agency. This program is concerned with diseases in which there is an inherited defect or abnormality in the production of haemoglobin, the iron-containing pigment of the red blood cells which is responsible for the carriage of oxygen in the blood. Two techniques have been widely used in the studies at the University of Athens. In the first of these, a radioisotope of iron, iron-59, is used to follow iron metabolism and haemoglobin production. Iron metabolism in the body is concerned largely with the synthesis and breakdown of haemoglobin, which consists of a protein, globin, linked to an iron containing substance, haeme. The second technique makes use of a radioisotope of chromium, chromium-51, to study the fate of the red cells in the blood. By performing simultaneous studies with iron- 59 and chromium-51, a detailed picture of haemoglobin synthesis and red cell production and destruction can be built up. Such investigations have been invaluable in establishing the characteristic patterns of different congenital haemolytic anaemias.

Survey of industrial radioisotope savings

International Nuclear Information System (INIS)

1965-01-01

Only three decades after the discovery of artificial radioactivity and two after radioisotopes became available in quantity, methods employing these as sources or tracers have found widespread use, not only in scientific research, but also in industrial process and product control. The sums spent by industry on these new techniques amount to millions of dollars a year. Realizing the overall attitude of industry to scientific progress - to accept only methods that pay relatively quickly - one can assume that the economic benefits must be of a still larger order of magnitude. In order to determine the extent to which radioisotopes are in daily use and to evaluate the economic benefits derived from such use, IAEA decided to make an 'International Survey on the Use of Radioisotopes in Industry'. In 1962, the Agency invited a number of its highly industrialized Member States to participate in this Survey. Similar surveys had been performed in various countries in the 1950's. However, the approaches and also the definition of the economic benefits differed greatly from one survey to another. Hence, the Agency's approach was to try to persuade all countries to conduct surveys at the same time, concerning the same categories of industries and using the same terms of costs, savings, etc. In total, 24 Member States of the Agency agreed to participate in the survey and in due course they submitted contributions. The national reports were discussed at a 'Study Group Meeting on Radioisotope Economics', convened in Vienna in March 1964. Based upon these discussions, the national reports have been edited and summarized. A publication showing the administration of the Survey and providing all details is now published by the Agency. From the publication it is evident that in general the return of technical information was quite high, of the order of 90%, but, unfortunately the economic response was much lower. However, most of the reports had some bearing on the economic aspects

Present status of research on radiation utilization in 1994 at JAERI. Utilization of irradiation and RI production and utilization

International Nuclear Information System (INIS)

1994-10-01

In Japan Atomic Energy Research Institute, Takasaki Radiation Chemistry Research Establishment is in charge of the utilization of irradiation, and Tokai Research Establishment is in charge of the production and utilization of radioisotopes. As for the utilization of irradiation the development of new polymers, the development of environment preservation technology such as flue gas treatment, and by using various ion beams from four accelerators, the development of the materials used for space environment, nuclear fusion and new functional materials, the research on the radiation application to biotechnology, the development of the production and utilization of new radioisotopes have been carried out. As for the production and utilization of radioisotopes, the development of new products and new utilization techniques, the technology of producing and using a large amount of tritium, and the research on the chemical behavior of tritium have been carried out. The international cooperations have been promoted positively. In this report, the research activities in 1994 are described. (K.I.)

B cell increases and ex vivo IL-2 production as secondary endpoints for the detection of sensitizers in non-radioisotopic local lymph node assay using flow cytometry.

Science.gov (United States)

Jung, Kyoung-Mi; Jang, Won-Hee; Lee, Yong-Kyoung; Yum, Young Na; Sohn, Soojung; Kim, Bae-Hwan; Chung, Jin-Ho; Park, Young-Ho; Lim, Kyung-Min

2012-03-25

Non-radioisotopic local lymph node assay (LLNA) using 5-bromo-2'-deoxyuridine (BrdU) with flow cytometry (FCM) is gaining attention since it is free from the regulatory issues in traditional LLNA (tLLNA) accompanying in vivo uses of radioisotope, (3)H-thymidine. However, there is also concern over compromised performance of non-radioisotopic LLNA, raising needs for additional endpoints to improve the accuracy. With the full 22 reference substances enlisted in OECD Test Guideline No. 429, we evaluated the performance of LLNA:BrdU-FCM along with the concomitant measurements of B/T cell ratio and ex vivo cytokine production from isolated lymph node cells (LNCs) to examine the utility of these markers as secondary endpoints. Mice (Balb/c, female) were topically treated with substances on both ears for 3 days and then, BrdU was intraperitoneally injected on day 5. After a day, lymph nodes were isolated and undergone FCM to determine BrdU incorporation and B/T cell sub-typing with B220+ and CD3e+. Ex vivo cytokine production by LNCs was measured such as IL-2, IL-4, IL-6, IL-12, IFN-γ, MCP-1, GM-CSF and TNFα. Mice treated with sensitizers showed preferential increases in B cell population and the selective production of IL-2, which matched well with the increases in BrdU incorporation. When compared with guinea pig or human data, BrdU incorporation, B cell increase and IL-2 production ex vivo could successfully identify sensitizers with the accuracy comparable to tLLNA, suggesting that these markers may be useful for improving the accuracy of LLNA:BrdU-FCM or as stand-alone non-radioisotopic endpoints. Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Licensing of digital Instrumentation and Control in Radioisotope Production Facility

International Nuclear Information System (INIS)

Abdel-Aziz, L.Kh.; Lashin, R.; Mostafa, W.

2012-01-01

In spite of the rapid development of digital I and C systems in all major industries, it has for several reasons been slower in nuclear power plants. The most important reason is that only a few new plants have been ordered worldwide during the last ten years. A second reason is connected to the efforts needed in providing adequate evidence that the digital I and C system can be used in safety and safety related applications. This issue is connected to the effort needed in obtaining adequate assurance that the digital I and C will fulfill its intended function and contain no unintended function in all possible operational states during its entire life cycle. This paper presents an acceptance criteria for licensing a digital instrumentation and control system in a Radioisotope Production Facility(1), which is under commissioning. The acceptance criteria ensure that the I and C systems are designed to reach the highest degree of reliability with respect to the function they perform, operators will have clear and accessible availability to data on every plant parameter, and also ensure that the safety objectives have been covered

Production of platinum radioisotopes at Brookhaven Linac Isotope Producer (BLIP

Directory of Open Access Journals (Sweden)

Smith Suzanne V.

2017-01-01

Full Text Available The accelerator production of platinum isotopes was investigated at the Brookhaven Linac Isotope Producer (BLIP. In this study high purity natural platinum foils were irradiated at 53.2, 65.7, 105.2, 151.9, 162.9 and 173.3.MeV. The irradiated foils were digested in aqua regia and then converted to their hydrochloride salt with concentrated hydrochloric acid before analyzing by gamma spectrometry periodically for at least 10 days post end of bombardment. A wide range of platinum (Pt, gold (Au and iridium (Ir isotopes were identified. Effective cross sections at BLIP for Pt-188, Pt-189, Pt-191 and Pt-195m were compared to literature and theoretical cross sections determined using Empire-3.2. The majority of the effective cross sections (<70 MeV confirm those reported in the literature. While the absolute values of the theoretical cross sections were up to a factor of 3 lower, Empire 3.2 modeled thresholds and maxima correlated well with experimental values. Preliminary evaluation into a rapid separation of Pt isotopes from high levels of Ir and Au isotopes proved to be a promising approach for large scale production. In conclusion, this study demonstrated that with the use of isotopically enriched target material accelerator production of selected platinum isotopes is feasible over a wide proton energy range.

Support housing for radioisotope generation

International Nuclear Information System (INIS)

Fries, B.A.

1976-01-01

A support housing for on-site radioisotope generation is disclosed in which the formation of a short-lived daughter radioisotope from its longer-lived parent features countercurrent batch flow of the eluting reagent interior of the housing. 6 claims, 4 drawing figures

Progress update on the development of the 3He linac for PET isotope production

International Nuclear Information System (INIS)

Young, P.; Sun, D.; Larson, D.; Pasquinelli, R.; Anderson, K.; Bieniosek, F.; Schmidt, C.W.; Popovic, M.; McCrory, E.; Webber, R.; Link, J.; Krohn, K.; Bida, J.

1996-01-01

In 1995, Fermilab and SAIC formed a collaboration with partners from the University of Washington (UW) and the Biomedical Research Foundation of Northwest Louisiana (BRF) to explore an innovative approach to the production of radioisotopes. The accelerator system that is being developed accelerates 3 He to 10.5 MeV and then delivers this beam to the target to produce the short lived radioisotopes of interest to the PET community ( 18 F, 15 0, 13 N, 11 C). Research is being conducted to investigate the contribution that this promising approach can make to clinical and research PET. The accelerator system has several very interesting aspects. These innovations include multiple RFQ accelerators configured in series, a gas stripper jet to doubly charge the low energy (1 MeV) 3 He beam, and an isochronous matching section to manipulate the transverse and maintain the longitudinal profile of the beam (without the use of an RF buncher) in the charge doubler transition section between RFQ's. This paper updates the progress of the PET 3 He RFQ accelerator, the current status of the design, and some of the interesting ongoing research. (author)

Progress update on the development of the 3He linac for PET isotope production

International Nuclear Information System (INIS)

1996-09-01

In 1995, Fermilab and SAIC formed a collaboration with partners from the University of Washington (UW) and the Biomedical Research Foundation of Northwest Louisiana (BRF) to explore an innovative approach to the production radioisotopes. The accelerator system that is being developed accelerates 3 He to 10.5 MeV and then delivers this beam to the target to produce the short lived radioisotopes of interest to the PET community ( 18 F, 15 0, 13 N, 11 C). Research is being conducted to investigate the contribution that this promising approach can make to clinical and research PET. The accelerator system has several very interesting aspects. These innovations include multiple RFQ accelerators configured in series, a gas stripper jet to doubly charge the low energy (I MeV) 3 He beam, and an isochronous matching section to manipulate the transverse and maintain the longitudinal profile of the beam (without the use of an RF buncher) in the charge doubler transition section between RFQ'S. This paper updates the progress of the PET 3 He RFQ accelerator, the current status of the design, and some of the interesting ongoing research

Preliminary Determination of Activation Products for a Varian Truebeam Linear Accelerator.

Science.gov (United States)

Waller, Edward; Ram, Rohan; Steadman, Ian

2017-09-01

Medical linear accelerators used to treat various forms of cancers are operated at a number of different energies. A by-product of the high-energy photons produced by accelerators is activation of components within the machine itself and its surrounding bunker. The activation products pose radiological and regulatory challenges during the operation of the accelerator as well as when it is time for final decommissioning. The Varian TrueBeam is a new state-of-the-art linear accelerator now operating in the Canadian market. There is currently limited information on the production of its activation products and the resulting impacts on operation and decommissioning. In this paper, activation products in the Varian TrueBeam accelerator are experimentally determined by performing gamma spectroscopy using a portable high purity germanium detector. A total of 10 isotopes are identified for the conditions tested, which include Na, Al, Mn, Ni, Cu, Cu, Br, Sb, Sb, W. The half-lives of these isotopes range from 2.3 min to 60.2 d. These preliminary results indicate that a decommissioning case similar to other radiotherapy accelerators can be made.

Modular Stirling Radioisotope Generator

Science.gov (United States)

Schmitz, Paul C.; Mason, Lee S.; Schifer, Nicholas A.

2016-01-01

High-efficiency radioisotope power generators will play an important role in future NASA space exploration missions. Stirling Radioisotope Generators (SRGs) have been identified as a candidate generator technology capable of providing mission designers with an efficient, high-specific-power electrical generator. SRGs high conversion efficiency has the potential to extend the limited Pu-238 supply when compared with current Radioisotope Thermoelectric Generators (RTGs). Due to budgetary constraints, the Advanced Stirling Radioisotope Generator (ASRG) was canceled in the fall of 2013. Over the past year a joint study by NASA and the Department of Energy (DOE) called the Nuclear Power Assessment Study (NPAS) recommended that Stirling technologies continue to be explored. During the mission studies of the NPAS, spare SRGs were sometimes required to meet mission power system reliability requirements. This led to an additional mass penalty and increased isotope consumption levied on certain SRG-based missions. In an attempt to remove the spare power system, a new generator architecture is considered, which could increase the reliability of a Stirling generator and provide a more fault-tolerant power system. This new generator called the Modular Stirling Radioisotope Generator (MSRG) employs multiple parallel Stirling convertor/controller strings, all of which share the heat from the General Purpose Heat Source (GPHS) modules. For this design, generators utilizing one to eight GPHS modules were analyzed, which provided about 50 to 450 W of direct current (DC) to the spacecraft, respectively. Four Stirling convertors are arranged around each GPHS module resulting in from 4 to 32 Stirling/controller strings. The convertors are balanced either individually or in pairs, and are radiatively coupled to the GPHS modules. Heat is rejected through the housing/radiator, which is similar in construction to the ASRG. Mass and power analysis for these systems indicate that specific

Radioisotope dating beyond 50,000 years BP

International Nuclear Information System (INIS)

Beukens, R.P.

1980-01-01

A counting method for radiocarbon dating has been developed by the Toronto-Rochester-General Ionex group over the past two years using electrostatic tandem-accelerators as part of a mass spectrometer. The method uses very small samples of 1 mg or less and reaches high accuracy after counting for only a few hours. In principle this 14 C method can be used to date samples up to 100,000 years old but severe problems are anticipated with respect to sample contamination, particularly beyond 70,000 years BP. The counting method can also be applied to the detection of longer lived radioisotopes created in the upper atmosphere by the interaction of cosmic radiation, such as 36 Cl, 26 Al and 10 Be. (author)

Over-the-road shock and vibration testing of the radioisotope thermoelectric generator transportation system

International Nuclear Information System (INIS)

Becker, D.L.

1997-01-01

Radioisotope Thermoelectric Generators (RTG) convert heat generated by radioactive decay into electricity through the use of thermocouples. The RTGs have a long operating life, are reasonably lightweight, and require little or no maintenance, which make them particularly attractive for use in spacecraft. However, because RTGs contain significant quantities of radioactive materials, normally plutonium-238 and its decay products, they must be transported in packages built in accordance with Title 10, Code of Federal Regulations, Part 71 (10 CFR 71). To meet these regulations, a RTG Transportation System (RTGTS) that fully complies with 10 CFR 71 has been developed, which protects RTGs from adverse environmental conditions during normal conditions of transport (e.g., shock, vibration, and heat). To ensure the protection of RTGs from shock and vibration loadings during transport, extensive over-the-road testing was conducted on the RTG'S to obtain real-time recordings of accelerations of the air-ride suspension system trailer floor, packaging, and support structure. This paper provides an overview of the RTG'S, a discussion of the shock and vibration testing, and a comparison of the test results to the specified shock response spectra and power spectral density acceleration criteria

Analysis of status of radiation/radioisotopes utilization

Energy Technology Data Exchange (ETDEWEB)

Park, Chan Hee; Lee, Seung Hyun; Kim, Na Kyung; Kim, Kon Wuk [Business Innovation Office, Korean Association for Radiation Application, Seoul (Korea, Republic of)

2017-03-15

The use of radiation and radioisotopes in Korea has been increasing each year, and its impact on economy and industry is expected to be increasing progressively following the development of industrial technology and the expansion of their usage. To establish and supporting policies for industries using radiation and radioisotopes, it is necessary to check the status of related industries accurately, as well as to gather data required to establish plans for industrial development by studying both revenues and economic scale (contributing to revenue). o analyze the status of utilization, surveys were carried out on 6,621 organizations engaged in nuclear operations handling radiation and radioisotopes pursuant to the Nuclear Safety Act as of end 2014, on 33,471 medical institutions using radiation generators for medical and diagnostic purposes pursuant to the Medical Service Act, and on 2,218 organizations using radiation generators for animal diagnostics pursuant to the Veterinary License Act. he overall status of the domestic radiation market including the number of user organizations, that of employees, and the size of distributions (imports, productions, and exports) with which the scale of domestic radiation market can be judged showed a growth trend compared to the previous year, though the number of employees for radiation operation in industrial sector, research sector, education sector, military sector, and power plants (nuclear power plants) and the size of imports was reduced somewhat. t is expected that data acquired through periodic surveys on the status of utilization would be utilized practically in establishing governmental policies related to the promotion of usage of radiation and radioisotopes, and also be utilized widely in cultivating and developing the industry efficiently to invigorate the related industries.

Analysis of status of radiation/radioisotopes utilization

International Nuclear Information System (INIS)

Park, Chan Hee; Lee, Seung Hyun; Kim, Na Kyung; Kim, Kon Wuk

2017-01-01

The use of radiation and radioisotopes in Korea has been increasing each year, and its impact on economy and industry is expected to be increasing progressively following the development of industrial technology and the expansion of their usage. To establish and supporting policies for industries using radiation and radioisotopes, it is necessary to check the status of related industries accurately, as well as to gather data required to establish plans for industrial development by studying both revenues and economic scale (contributing to revenue). o analyze the status of utilization, surveys were carried out on 6,621 organizations engaged in nuclear operations handling radiation and radioisotopes pursuant to the Nuclear Safety Act as of end 2014, on 33,471 medical institutions using radiation generators for medical and diagnostic purposes pursuant to the Medical Service Act, and on 2,218 organizations using radiation generators for animal diagnostics pursuant to the Veterinary License Act. he overall status of the domestic radiation market including the number of user organizations, that of employees, and the size of distributions (imports, productions, and exports) with which the scale of domestic radiation market can be judged showed a growth trend compared to the previous year, though the number of employees for radiation operation in industrial sector, research sector, education sector, military sector, and power plants (nuclear power plants) and the size of imports was reduced somewhat. t is expected that data acquired through periodic surveys on the status of utilization would be utilized practically in establishing governmental policies related to the promotion of usage of radiation and radioisotopes, and also be utilized widely in cultivating and developing the industry efficiently to invigorate the related industries

Present status of research on Re-186 radiopharmaceuticals at Radioisotope Production Center

Energy Technology Data Exchange (ETDEWEB)

Mutalib, A [Radioisotope Production Center, National Atomic Energy Agency Kawasan PUSPIPTEK, Serpong (Indonesia)

1998-10-01

Rhenium shows a close chemical similarity to technetium and is suitable for radiotherapy because the {beta}-emitting radionuclides {sup 186}Re (t{sub 1/2} 90 h, E{sub {beta}} = 1.1 MeV, E{sub {gamma}} = 137 keV) and {sup 188}Re (t{sub 1/2} = 17 h, E{sub {beta}} = 2.1 MeV). The {gamma}-emission associated with decay of {sup 186}Re is also useful in scintigraphy. The research on {sup 186}Re radiopharmaceuticals at Radioisotope Production Center has been carried out since April 1997. Interest in radioimmunotherapy (RIT) led us to the development of labeling antibodies with rhenium isotopes. Although there are several methods for coupling radiometal to antibody, we prefer an indirect labeling method in which a bifunctional chelating agent is used for coupling of {sup 186}Re to monoclonal antibodies. In this report we outline the study on the preparation of {sup 186}Re DMSA-TFP as precursor for labeling with monoclonal antibody. (author)

Contributions and Future of Radioisotopes in Medical, Industrial and Space Applications

Science.gov (United States)

Tingey, G. L.; Dix, G. P.; Wahlquist, E. J.

1990-11-01

There are 333 isotopes that have a half-life between 1 day and 100,000 years that have a wide variety of applications including public health, medicine,industrial technology, food technology and packaging, agriculture, energy supply, and national security. This paper provides an overview of some of the most extensive applications of radioisotopes including some observations of future uses. Examples are discussed that indicate that the use of radioisotopes is almost unlimited and will continue to grow. There is a growing need for future applications development and production. 12 refs., 1 tab. (BM)

Contributions and future of radioisotopes in medical, industrial and space applications

International Nuclear Information System (INIS)

Tingey, G.L.; Dix, G.P.; Wahlquist, E.J.

1990-11-01

There are 333 isotopes that have a half-life between 1 day and 100,000 years that have a wide variety of applications including public health, medicine,industrial technology, food technology and packaging, agriculture, energy supply, and national security. This paper provides an overview of some of the most extensive applications of radioisotopes including some observations of future uses. Examples are discussed that indicate that the use of radioisotopes is almost unlimited and will continue to grow. There is a growing need for future applications development and production. 12 refs., 1 tab. (BM)

Contributions and future of radioisotopes in medical, industrial, and space applications

Science.gov (United States)

Tingey, G. L.; Dix, G. P.; Wahlquist, E. J.

1990-11-01

There are 333 isotopes that have a half-life between 1 day and 100,000 years that have a wide variety of applications including public health, medicine, industrial technology, food technology and packaging, agriculture, energy supply, and national security. This paper provides an overview of some of the most extensive applications of radioisotopes including some observations of future uses. Examples are discussed that indicate that the use of radioisotopes is almost unlimited and will continue to grow. There is a growing need for future applications development and production.

Management of radioactive wastes arising from the use of Australian radioisotopes

International Nuclear Information System (INIS)

Costello, J.M.

1986-01-01

The medical, industrial and research use of radioisotopes in Australia has given rise to approximately 30 m 3 of solid radioactive waste containing about 5 TBq of radioactivity. This waste is stored at State hospitals, universities and research centres. A further 10 m 3 of waste containing 300 GBq of radioactivity is stored by the Commonwealth at the St Mary's Munitions Filling factory. About 700 m 3 of waste containing 1.5 PBq of radioactivity resulting from operation of the HIFAR nuclear reactor and the production of radioisotopes is in storage at the Lucas Heights Research Establishment. The source, nature and rate of arising of these wastes is reviewed, together with national developments in waste classification, storage procedures and eventual disposal. Some research at Lucas Heights on the conditioning of radioisotope waste to facilitate disposal is briefly noted

Radioisotopes in the treatment of cancer

Energy Technology Data Exchange (ETDEWEB)

NONE

1962-01-15

Radiation treatment of malignant growths is not, of course, a novel procedure; both radium implants and X-rays generated at medium voltages (up to 250 kV) have been used all over the world for many years. However, large scale production of radioisotopes in atomic reactors has made radiotherapy available for the first time in less developed areas of the world. Moreover, the treatment has been simplified and, in many cases, made more effective

Notification determining details of technical standards concerning transport of radioisotopes or goods contaminated by radioisotopes outside works or enterprises

International Nuclear Information System (INIS)

1981-01-01

This rule is established under the provisions of the regulation for the execution of the law on the prevention of radiation injuries by radioisotopes. Terms are used in this rule for the same meanings as in the regulation. The concentration of radioisotopes to which the technical standards for transport outside enterprises are not applied is 0.002 micro-curie per gram. The radioisotopes which can be transported as L type transported goods are defined in detail, excluding explosive or spontaneously igniting radioisotopes. The quantity limit of radioisotopes which can be transported as A type transported goods is the values A 1 and A 2 defined in this rule. The permissible surface density defined by the Director General of the Science and Technology Agency are 1/100,000 micro-curie per cm 2 for the radioisotopes emitting alpha-ray, and 1/10,000 micro-curie per cm 2 for the radioisotopes which do not emit alpha-ray. The leak quantity of radioisotopes specified by the Director General is 1/1,000,000 of A 2 value for BM type transported goods and 1/1,000 of A 2 value for BU type goods. The test conditions for each type of transported goods, dangerous goods, the limit of the number of transported goods and signs are stipulated, respectively. Permissible exposure dose is 1.5 rem a year for persons other than radiation workers. (Okada, K.)

14 MV pelletron accelerator and superconducting ECR ion source

International Nuclear Information System (INIS)

Gupta, A.K.

2015-01-01

The BARC-TIFR 14UD Pelletron Accelerator at Mumbai has completed more than two and a half decade of successful operation. The accelerator is primarily used for basic research in the fields of nuclear, atomic and molecular, condensed matter physics and material science. The application areas include accelerator mass spectrometry, production of track-etch membranes, radioisotopes production, radiation damage studies and secondary neutron production for cross section measurement etc. Over the years, numerous developmental activities have been carried out in-house that have resulted in improving the overall performance and uptime of the accelerator and has also made possible to initiate variety of application oriented programmes. Since the SF 6 pressure vessels have been in operation for about 29 years, a comprehensive refurbishment and retrofitting work is carried out to comply with the safety recommendations. Recently, the beam trials were conducted with 18 GHz superconducting ECR (Electron Cyclotron Resonance) Ion Source system at Van-de-Graaff as per BARC Safety Council permission. Various ion beams with different charge states were extracted and mass analyzed and the beam quality was measured by recording their transverse emittance in situ. Experimental measurements pertaining to projectile X-rays Spectroscopy were carried out using variety of ion beams at variable energies. The superconducting Linac booster provides additional acceleration to the ions from Pelletron injector up to A ∼60 region with E∼5 MeV/A. In order to cover the entire mass range of the elements across the periodic table, an ECR based heavy ion accelerator was initiated under plan project. This heavy ion accelerator essentially comprises of a superconducting ECR ion source, room temperature RFQ (Radio Frequency Quadrupole) followed by superconducting Niobium resonators as accelerating elements. This talk will provide an overview of the developmental activities and the safety features

Annual report 1991 of Munich University and Technical University Accelerator Laboratory

International Nuclear Information System (INIS)

1992-01-01

The experimental work in the Accelerator Laboratory contains investigations of nuclear reactions and nuclear structure, studies of atom physics and the application of nuclear physics methods in physics and in interdisciplinary research. These applications are acceleration mass spectrometry to detect traces of radio-isotopes and material analysis with particle beams. The development of apparatus in the fields of accelereator construction, ion sources and targets are at the heart of the laboratory and help to establish its reputation. They are of the greatest importance for the education of students. The development stage for the superconducting post-accelerator TRITRON is complete and prototypes of the magnets and resonators were successfully tested and operated. The mass-production of all the components is under way or already finished. The standard injector for the tandem axxelerator and an injector for accelerator mass spectroscopy with stable isotopes are being newly designed. The experimental work is supplemented by the calculations of our theoretical collagues of core reaction mechanisms, core de-excitation and the Cerenkov radiation of core structures and transition strengths, by relativistic Hartree-Fock calculations and by star model calculations. (orig.) [de

The safe handling of radioisotopes

Energy Technology Data Exchange (ETDEWEB)

NONE

1964-12-31

A narrative account of a minor contamination accident in a laboratory is used to demonstrate the important role of radiation protection measures in radioisotope work and the necessity of giving proper regard to such measures. It is primarily directed towards the research scientists and medical workers using radioisotopes on a relatively small scale

REVISS / MAYAK: A new partnership in radioisotope supply

International Nuclear Information System (INIS)

Bennett, N.; Chikshov, A.I.; Malykh, Y.A.

1997-01-01

REVISS Services (UK) Limited, the joint venture company formed between Amersham International plc, Production Association MAYAK and Techsnabexport brings together the scientific, manufacturing, marketing and distribution skills and facilities which enable REVISS to be not just a major supplier of radioisotopes and other associated products and services, but the supplier with the largest product range. The paper describes the history and the development of MAYAK and reviews its manufacturing facilities and capabilities and also how MAYAK has moved from being a secret military organisation to become a major and successful commercial organisation

VEDs for charged particle accelerators: Indian scenario

International Nuclear Information System (INIS)

Bhandari, R.K.

2012-01-01

In the initial times after their invention, the charged particle accelerators have, primarily, been used for fundamental studies on nuclei and atoms. From the first modern accelerator, the cathode ray tube, used by J.J. Thomson for the discovery of electron, very recently the gigantic 27 km circumference Large Hadron Collider (LHC) is operational in the search of Higg's boson and related physics issues. Particle accelerators have emerged as powerful microscopes for investigating the finest details of cells, genes, molecules, atoms, protons, neutrons, muons, electrons, quarks and, possibly, still undiscovered even more fundamental constituents of the universe, such as dark matter and dark energy. Several noble prize winning discoveries have been made using accelerators. Accelerators are now being used in a wide area of industrial and medical applications. They are used for the production of radioisotopes for medical imaging, cancer therapy, food sterilization, treatment of waste water, sterilization of medical equipment, material modification, mass spectroscopy, cargo scanning, fabrication of semiconductors etc. Ongoing effort towards the development of accelerators with megawatt beam power is showing hope for a cleaner source of nuclear energy and treatment of nuclear waste. Several tens of thousands of accelerators are presently operational in the world for basic research and applications. Development of new accelerators has several times been driven by new technologies and materials and sometimes they have driven the technological developments towards cutting edge. Some examples are ultra-high vacuum in large volumes, superfluid helium in cryogenics, cryocoolers, superconducting magnets and RF cavities, high power vacuum electronic devices, global control systems, superfast computing and communication networks, giant data storage/processing systems etc. India has been pursuing a fairly robust programme of accelerator development at various institutions. It

Production expansion continues to accelerate

International Nuclear Information System (INIS)

Anon.

1992-01-01

This paper reports that Saudi Arabian Oil Co. (Saudi Aramco) is continuing its accelerated Crude Oil Expansion Program initiated in 1989 that aims at achieving a 10 million bpd productive capacity by 1995. In addition to major engineering, construction and renovation work related to production expansion, Saudi Aramco drilling and workover operations have been markedly expanded. Since January 1991, rig activity has doubled. As an indication of aging of Saudi production, projects include modernizing current injection water treatment facilities, installing a new seawater injection plant on the Persian Gulf, installing dewatering facilities in a number of locations and installing a pilot gas lift project. In addition, equipment orders indicate the new discoveries south of Riyadh may also need the assistance of water injection from inception of production

IEA-R1 Nuclear Research Reactor: 58 Years of Operating Experience and Utilization for Research, Teaching and Radioisotopes Production

Energy Technology Data Exchange (ETDEWEB)

Cardenas, Jose Patricio Nahuel; Filho, Tufic Madi; Saxena, Rajendra; Filho, Walter Ricci [Nuclear and Energy Research Institute, IPEN-CNEN/SP, Instituto de Pesquisas Energeticas e Nucleares - IPEN-CNEN/SP, Av. Prof. Lineu Prestes 2242 Cid Universitaria CEP: 05508-000- Sao Paulo-SP (Brazil)

2015-07-01

IEA-R1 research reactor at the Instituto de Pesquisas Energeticas e Nucleares (Nuclear and Energy Research Institute) IPEN, Sao Paulo, Brazil is the largest power research reactor in Brazil, with a maximum power rating of 5 MWth. It is being used for basic and applied research in the nuclear and neutron related sciences, for the production of radioisotopes for medical and industrial applications, and for providing services of neutron activation analysis, real time neutron radiography, and neutron transmutation doping of silicon. IEA-R1 is a swimming pool reactor, with light water as the coolant and moderator, and graphite and beryllium as reflectors. The reactor was commissioned on September 16, 1957 and achieved its first criticality. It is currently operating at 4.5 MWth with a 60-hour cycle per week. In the early sixties, IPEN produced {sup 131}I, {sup 32}P, {sup 198}Au, {sup 24}Na, {sup 35}S, {sup 51}Cr and labeled compounds for medical use. During the past several years, a concerted effort has been made in order to upgrade the reactor power to 5 MWth through refurbishment and modernization programs. One of the reasons for this decision was to produce {sup 99}Mo at IPEN. The reactor cycle will be gradually increased to 120 hours per week continuous operation. It is anticipated that these programs will assure the safe and sustainable operation of the IEA-R1 reactor for several more years, to produce important primary radioisotopes {sup 99}Mo, {sup 125}I, {sup 131}I, {sup 153}Sm and {sup 192}Ir. Currently, all aspects of dealing with fuel element fabrication, fuel transportation, isotope processing, and spent fuel storage are handled by IPEN at the site. The reactor modernization program is slated for completion by 2015. This paper describes 58 years of operating experience and utilization of the IEA-R1 research reactor for research, teaching and radioisotopes production. (authors)

Quarterly Technical Progress Report of Radioisotope Power System Materials Production and Technology Program tasks for January 2000 through March 2000

International Nuclear Information System (INIS)

Moore, J.P.

2000-01-01

The Office of Space and Defense Power Systems (OSDPS) of the Department of Energy (DOE) provides radioisotope Power Systems (BPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of .I 997 to study the planet Saturn. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. For the Cassini Mission, for example, ORNL was involved in the production of carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVSs) and weld shields (WSs). This quarterly report has been divided into three sections to reflect program guidance from OSDPS for fiscal year (FY) 2000. The first section deals primarily with maintenance of the capability to produce flight quality carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, clad vent sets (CVSs), and weld shields (WSs). In all three cases, production maintenance is assured by the manufacture of limited quantities of flight quality (FQ) components. The second section deals with several technology activities to improve the manufacturing processes, characterize materials, or to develop technologies for two new RPS. The last section is dedicated to studies of the potential for the production of 238Pu at OBNL

Radioisotope techniques for problem-solving on refineries

International Nuclear Information System (INIS)

Charlton, J.S.; Webb, M.

1994-01-01

Increasingly, refineries worldwide are recognizing the value of radioisotope technology in studying the operation of on-line plant. Using case studies, this paper illustrates the versatility of radioisotope techniques in a wide range of investigations: the density-profiling of distillation columns; the investigation of leaks on feed/effluent exchangers; on-line flowrate measurement; underground leakage detection. The economic benefits deriving from radioisotope applications are indicated

International topical meeting on nuclear research applications and utilization of accelerators. Book of abstracts

International Nuclear Information System (INIS)

2009-01-01

Applications of particle accelerators cover a number of areas, from strategic and applied research, safety and security, environmental applications, materials research and analytical sciences, to radioisotope production and radiation processing. Accelerator based techniques and pulsed neutron sources are expected to lead to new initiatives in materials research of relevance for both the nuclear and non-nuclear fields. Material science studies with the use of accelerators, neutron beams and other nuclear analytical methods are relevant to the development of advanced reactors, nuclear fuel cycle needs and fusion research. In this regard, a better understanding of the irradiation effects in materials for energy and non-energy applications is needed, and is reflected in accelerator techniques for modification and analysis of materials for nuclear technologies. Accelerator applications for innovative nuclear systems aiming at rad-waste transmutation (e.g., accelerator driven systems) are being pursued in many countries. Research and development using accelerators involves a broad spectrum of skills to build a cadre of trained experts in nuclear techniques in IAEA Member States, and to generate knowledge for innovative methodologies and tools. The present conference is also being held in cooperation with the American Nuclear Society (ANS), which successfully organized the series of accelerator applications conferences known as AccApp. The ANS series of topical meetings has provided a forum for the global exchange of scientific and technical knowledge on a wide variety of related topics since the first AccApp took place in 1997 in Albuquerque, USA. The last conference which was held in 2007 in Pocatello, USA, was jointly organized by the ANS and the IAEA. The main objectives of the conference are to promote exchange of information among IAEA Member States representatives/delegates and to discuss new trends in accelerator applications including nuclear materials research

Deuteron nuclear data for the design of accelerator-based neutron sources: Measurement, model analysis, evaluation, and application

Science.gov (United States)

Watanabe, Yukinobu; Kin, Tadahiro; Araki, Shouhei; Nakayama, Shinsuke; Iwamoto, Osamu

2017-09-01

A comprehensive research program on deuteron nuclear data motivated by development of accelerator-based neutron sources is being executed. It is composed of measurements of neutron and gamma-ray yields and production cross sections, modelling of deuteron-induced reactions and code development, nuclear data evaluation and benchmark test, and its application to medical radioisotopes production. The goal of this program is to develop a state-of-the-art deuteron nuclear data library up to 200 MeV which will be useful for the design of future (d,xn) neutron sources. The current status and future plan are reviewed.

Advanced Radioisotope Power Conversion Technology Research and Development

Science.gov (United States)

Wong, Wayne A.

2004-01-01

NASA's Radioisotope Power Conversion Technology program is developing next generation power conversion technologies that will enable future missions that have requirements that cannot be met by either the ubiquitous photovoltaic systems or by current Radioisotope Power System (RPS) technology. Performance goals of advanced radioisotope power systems include improvement over the state-of-practice General Purpose Heat Source/Radioisotope Thermoelectric Generator by providing significantly higher efficiency to reduce the number of radioisotope fuel modules, and increase specific power (watts/kilogram). Other Advanced RPS goals include safety, long-life, reliability, scalability, multi-mission capability, resistance to radiation, and minimal interference with the scientific payload. NASA has awarded ten contracts in the technology areas of Brayton, Stirling, Thermoelectric, and Thermophotovoltaic power conversion including five development contracts that deal with more mature technologies and five research contracts. The Advanced RPS Systems Assessment Team includes members from NASA GRC, JPL, DOE and Orbital Sciences whose function is to review the technologies being developed under the ten Radioisotope Power Conversion Technology contracts and assess their relevance to NASA's future missions. Presented is an overview of the ten radioisotope power conversion technology contracts and NASA's Advanced RPS Systems Assessment Team.

Regulations concerning the radionuclides uses in France; Reglementation de l'utilisation des radioisotopes en France

Energy Technology Data Exchange (ETDEWEB)

Vergne, J [Commissariat a l' Energie Atomique, Saclay (France). Centre d' Etudes Nucleaires; Bugnard, L [Institut national d' Hygiene (France)

1955-07-01

The progress in the uses of radioisotopes has been conditioned by increasing the number of trained workers and researchers and developing theoretical teaching in universities since 1950 in France as well as developing a national control of the distribution and uses of radioisotopes. With the large diffusion and development of radioisotopes uses and applications, new rules and regulations came to control the importation, exportation, transport and utilization of radioisotopes. In the first part, it described the different French laws since 1934 and their successive modifications which ruled on the production, manipulation and utilization of radioisotopes. An inter-ministerial committee was created in 1952 to advise and inform of all the questions related to the preparation, importation, exportation, possession and distribution of radioisotopes. The transport regulations are in constant evolution and has got to meet with international recommendations. It distinguished three different type of transport: road, river and railway transport, postal transport and finally air transport. All the different transports have their specific packaging, maximum transportable quantity, maximum material intensity and labelling requirements. The regulations about customs duties are specified as well as the administrative formalities for non natural radioisotopes importation. Since 1950, diseases caused by irradiation to natural or artificial radioactive materials are recognised as professional diseases and a table of the actual regulations is presented. (M.P.)

Discrete radioisotopic relays of a cyclic action

International Nuclear Information System (INIS)

Klempner, K.S.; Vasil'ev, A.G.

1975-01-01

A functional diagram of discrete radioisotopic relay equipment (RRP) with cyclic action was examined. An analysis of its rapid action and reliability under stationary conditions and transition regimes is presented. A structural diagram of radioisotopic relay equipment shows three radiation detectors, a pulse standardizer, an integrator and a power amplifier with a threshold cut-off device. It was established that the basic properties of the RRP - rapid action and reliability - are determined entirely by the counting rate of the average frequency of pulses from the radiation detector, n 0 and n 1 , in the 0 and 1 states (absence of current in the electromagnetic relay winding and activation of the winding of the output relay), capacities N 1 and N 2 of the dual counters, and the frequency of the transition threshold, f, of the generator. Formulas are presented which allow making engineering calculations for determining the optimum RRP parameters. High speed and reliability are shown, which are determined by the production purposes of the relay

Research and development for the application of radioisotope technology in SINR

International Nuclear Information System (INIS)

Zhang Jiahua

1987-01-01

A brief systematic account on the research and development for the application of radioisotope technology in Shanghai Institute of Nuclear Research (SINR) is presented. It comprehensively covers the following categories: 1. Radioisotopes produced by cyclotron; 2. Radioisotope-labelled compounds; 3. Radioisotope as source of energy converter; 4. Induced-radioisotope generation as a means for elemental analysis--the activation analysis; 5. Radioisotope equipped with electronic instrument for various application; and 6. Special usage of some radioisotopes

Determination of the optimal conditions for simultaneous production of 73SE and 75SE radioisotopes in a 30 MeV cyclotron

International Nuclear Information System (INIS)

Pejman Rowshanfazad; Amirreza Jalilian; Mahsheed Sabet

2004-01-01

Purpose: 73 Se and 75 Se radioisotopes are widely used in medicine, industry and agriculture. 75 Se is used in high activity brachytherapy (1), assessment of pancreatic exocrine function (2, 3), study of bile acids and evaluation of illeal function (4, 5, 6), industrial radiography (7, 8) and as a tracer in the assessment of chemical, biochemical, biophysical processes, metabolic research and agricultural studies. 73 Se is used in pancreas scanning (9), hyperthyroidism diagnosis(10), adrenal scanning (11), tumor detection (12, 13, 14), detection of brain dopamine receptors (15), parathyroid tumor detection (10) and detection of brain blood flow (16). These radioisotopes were selected to be produced in the country according to their wide range of applications. The idea of simultaneous production of 73 Se and 75 Se arouse after the completion of primary studies. Important physical characteristics of these radioisotopes are shown in table l. Methods: 1 Selection of the Best Reaction. Various nuclear reactions which may be used for the production of 73 Se and 75 Se are shown in table 2 (17, 18, 19). Among the above reactions, those which use α and 3 He as the projectile particles were discarded since high energy and high intensity beams of α and 3 He are not available in the country at present. Those reactions which used 74 Se and 76 Se as the target material could not be used, since these isotopes have low isotopic values (0.87% and 9.02% respectively), and their chemical separation processes are difficult, expensive and time-taking, due to the equal chemical properties of the product and the target material (20). Thus 75 As(p, n) 75 Se seemed to be the most appropriate reaction for the production of 75 Se. The 75 As(d, 4n) 73 Se reaction is not as suitable as 75 As(p, 3n) 73 Se, because of the lower radionuclidic purity of the product (18). Thus the best reaction for the production of 73 Se was determined to be 75 As(p, 3n) 73 Se. There was no need for an isotopic

IPENS's social role in scientific and technological development of radioisotope and radiopharmaceutical production - (1950 -1980)

International Nuclear Information System (INIS)

Gordon, Ana Maria P.L.

2009-01-01

Some facts and figures are present in the existent interaction between the Instituto de Pesquisas Energeticas e Nucleares (IPEN) and the medical community. Among other characteristics, the IPEN has a permanent seat in the Biology and Nuclear Medicine Society and, the present Radiopharmacy Center, has had the continuous concern, since the Instituto de Energia Atomica (IEA) creation until today (2009), to perform an excellent approach with the medical faculty. In the past, some physicians would complete their courses in Europe and in the United States of America, and there noticed the importance of radioisotopes applications in medicine, mainly, in the beginning of these activities, with the I-131. Returning to Brazil, they requested that the former IEA, today IPEN researchers used the research reactor IEA-R1, installed in Sao Paulo, at Universidade Sao Paulo (USP) campus, for radioisotopes production. Then, in the late 1959, the first production line from the I-131 took place. The IPEN starts to accomplish what was planned as one of its targets, at the act of its official creation on August 31, 1956. From 1961 on, there was a continuous flux of I-131 and other radiopharmaceuticals production. The recovery and analysis of these happenings, in the Brazilian society cultural historic context, were partially published in different previous works. Nevertheless, history is dynamic and gains new interpretations, in the present research, from the reading of novel research sources, both primary and secondary, not explores so far - reports, interviews with IPEN researchers and papers published or divulged in meetings, either scientific or bureaucratic. This research is part of project supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), with the aim, among others, of contributing for the analysis of the transformations occurred in all of the IPEN research lines, plus the social role of this institution for science and technology development. The

Accelerator physics and nuclear energy education in INRNE-BAS

International Nuclear Information System (INIS)

Tonev, D.; Goutev, N.; Georgiev, L. S.

2015-01-01

Presently Bulgaria has no research nuclear facility, neither a research reactor, nor an accelerator. With the new cyclotron laboratory in Sofia the Institute for Nuclear Research and Nuclear Energy at the Bulgarian Academy of Sciences will restart the experimental research program not only in the fi eld of nuclear physics, but also in many interdisciplinary fields related to nuclear physics. The cornerstone of the cyclotron laboratory is a cyclotron TR24, which provides a proton beam with a variable energy between 15 and 24 MeV and current of up to 0.4 mA. The TR24 accelerator allows for the production of a large variety of radioisotopes for medical applications and development of radiopharmaceuticals. The new cyclotron facility will be used for research in radiopharmacy, radiochemistry, radiobiology, nuclear physics, solid state physics, applied research, new materials and for education in all these fields including especially nuclear energy. Keywords: Cyclotron, PET/CT, radiopharmacy

Cyclotron production of molybdenum-99 via proton-induced uranium-238 fission

International Nuclear Information System (INIS)

Lagunas-Solar, M.C.; Zeng, N.X.; Mirshad, I.; Castaneda, C.M.

1996-01-01

Technetium-99m ( 99m Tc; 6.02 h) is the most widely used radioisotope in nuclear medicine worldwide. It is currently supplied from elutions of a 99 Mo → 99m Tc generator and used for regional distribution or locally for institutional use. The parent 99 Mo (66.02 h) radioactivities are being produced commercially in reactors using the 235 U(n, fission) 99 Mo (preferred method) or the 98 Mo(n,γ) 99 Mo (less desirable) methods. The production of 99 Mo is based on the operation of a small number of nuclear reactors, most of which have reached decommissioning age. Two new reactors to be dedicated to radioisotope production are now being planned in Canada. Accelerator-based methods for producing 99 Mo and/or 99m Tc would then provide new alternatives to the current reliance on reactor-based technologies

Recent research activities and future subjects on stable- and radio-isotopes of chlorine in environment

International Nuclear Information System (INIS)

Kushita, Kouhei

2001-12-01

This report reviews the recent studies on the stable- and radio-isotopes of chlorine from a viewpoint of environmental science, partly including historic references on this element. First, general properties, occurrence, and utilization of chlorine are described. Secondly, current status and research works on chlorine-compounds, which attract special attention in recent years as environmentally hazardous materials, are reported. Thirdly, research works on stable chlorine isotopes, 35 Cl and 37 Cl, are described with a focus laid on the newly-developed techniques; isotopic ratio mass spectrometry (IRMS) and thermal ionization mass spectrometry (TIMS). Fourthly, recent research works on chlorine radioisotopes, 36 Cl etc., are described, focusing on the development of accelerator mass spectrometry (AMS) and its application to geochemistry and others. Finally, taking account of the above-mentioned recent works on Cl isotopes, possible future research subjects are discussed. (author)

Recent research activities and future subjects on stable- and radio-isotopes of chlorine in environment

Energy Technology Data Exchange (ETDEWEB)

Kushita, Kouhei [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment

2001-12-01

This report reviews the recent studies on the stable- and radio-isotopes of chlorine from a viewpoint of environmental science, partly including historic references on this element. First, general properties, occurrence, and utilization of chlorine are described. Secondly, current status and research works on chlorine-compounds, which attract special attention in recent years as environmentally hazardous materials, are reported. Thirdly, research works on stable chlorine isotopes, {sup 35}Cl and {sup 37}Cl, are described with a focus laid on the newly-developed techniques; isotopic ratio mass spectrometry (IRMS) and thermal ionization mass spectrometry (TIMS). Fourthly, recent research works on chlorine radioisotopes, {sup 36}Cl etc., are described, focusing on the development of accelerator mass spectrometry (AMS) and its application to geochemistry and others. Finally, taking account of the above-mentioned recent works on Cl isotopes, possible future research subjects are discussed. (author)

A novel approach to the production of medical radioisotopes: the homogeneous SLOWPOKE reactor

International Nuclear Information System (INIS)

Bonin, H.W.; Hilborn, J.W.; Carlin, G.E.; Gagnon, R.; Busatta, P.

2015-01-01

In 2009, the unexpected 15-month outage of the Canadian NRU nuclear reactor resulted in a sudden 30% world shortage, with higher shortages experienced in North America than in Europe. Commercial radioisotope production is from just eight nuclear reactors, most being aging systems near the end of their service life. This paper proposes a more efficient production and distribution model. Tc-99m unit doses would be distributed to regional hospitals from ten integrated 'industrial radiopharmacies', located at existing licensed nuclear reactor sites in North America. At each site, one or more 20 kW Homogeneous SLOWPOKE nuclear reactors would deliver 15 litres of irradiated aqueous uranyl sulfate fuel solution daily to industrial-scale hot cells, for extraction of Mo-99; and the low-enriched uranium would be recycled. Purified Mo-99 would be incorporated in large Mo-99/Tc-99m generators for extraction of Tc-99m five days a week; and each automated hot-cell facility would be designed to load up to 7,000 Tc-99m syringes daily for road delivery to all of the nuclear medicine hospitals within a 3-hour range. At the current price of $20 per unit dose, the annual gross income from 10 sites would be approximately $360 million. The Homogeneous SLOWPOKE reactor evolved from the inherently safe SLOWPOKE-2 research reactor, with a double goal: replacing the heterogeneous SLOWPOKE-2 reactors at the end-of-core life, enabling them to continue their primary missions of research and education, together with full time commercial radioisotope production. The Homogeneous SLOWPOKE reactor was modelled using both deterministic and probabilistic reactor simulation codes. The homogeneous fuel mixture is a dilute aqueous solution of low-enriched uranyl sulfate containing approximately 1 kg of U-235. The reactor is controlled by mechanical absorber rods in the beryllium reflector. Safety analysis was carried out for both normal operation and transient conditions. The most severe

A novel approach to the production of medical radioisotopes: the homogeneous SLOWPOKE reactor

Energy Technology Data Exchange (ETDEWEB)

Bonin, H.W., E-mail: bonin-h@rmc.ca [Royal Military College of Canada, Kingston, Ontario (Canada); Hilborn, J.W. [retired, Atomic Energy of Canada Limited, Chalk River, Ontario (Canada); Carlin, G.E. [Ontario Power Generation, Toronto, Ontario (Canada); Gagnon, R.; Busatta, P. [Royal Canadian Navy, Ottawa, Ontario (Canada)

2015-03-15

In 2009, the unexpected 15-month outage of the Canadian NRU nuclear reactor resulted in a sudden 30% world shortage, with higher shortages experienced in North America than in Europe. Commercial radioisotope production is from just eight nuclear reactors, most being aging systems near the end of their service life. This paper proposes a more efficient production and distribution model. Tc-99m unit doses would be distributed to regional hospitals from ten integrated 'industrial radiopharmacies', located at existing licensed nuclear reactor sites in North America. At each site, one or more 20 kW Homogeneous SLOWPOKE nuclear reactors would deliver 15 litres of irradiated aqueous uranyl sulfate fuel solution daily to industrial-scale hot cells, for extraction of Mo-99; and the low-enriched uranium would be recycled. Purified Mo-99 would be incorporated in large Mo-99/Tc-99m generators for extraction of Tc-99m five days a week; and each automated hot-cell facility would be designed to load up to 7,000 Tc-99m syringes daily for road delivery to all of the nuclear medicine hospitals within a 3-hour range. At the current price of $20 per unit dose, the annual gross income from 10 sites would be approximately $360 million. The Homogeneous SLOWPOKE reactor evolved from the inherently safe SLOWPOKE-2 research reactor, with a double goal: replacing the heterogeneous SLOWPOKE-2 reactors at the end-of-core life, enabling them to continue their primary missions of research and education, together with full time commercial radioisotope production. The Homogeneous SLOWPOKE reactor was modelled using both deterministic and probabilistic reactor simulation codes. The homogeneous fuel mixture is a dilute aqueous solution of low-enriched uranyl sulfate containing approximately 1 kg of U-235. The reactor is controlled by mechanical absorber rods in the beryllium reflector. Safety analysis was carried out for both normal operation and transient conditions. The most severe

Present status of application of radiation and radioisotopes in Bangladesh

International Nuclear Information System (INIS)

Hossain, Anwar

1984-01-01

Bangladesh has proceeded with the atomic energy programme in three phases: (1) research and development using radiation and radioisotopes and application of the results, (2) building the infrastructure in nuclear technology and (3) production of electricity from nuclear sources and development of associated facilities. It has entered the second phase of the programme. The following main areas of research and application were referred to: agriculture, food preservation, medical sterilization and radiation biology, medicine, non-destructive testing, isotope hydrology, elemental analysis, particle-induced x-ray emission (PIXE) methods, radioisotope-induced x-ray fluorescence (RIXFA) methods, flame atomic absorption spectrophotometric (AAS) methods, molecular absorption and fluorescence spectroscopy, health physics, and future programme with research reactor. (Namekawa, K.)

Radiation and radioisotopes in fruits and vegetable production and preservation

International Nuclear Information System (INIS)

Chapke, V.G.

1975-01-01

Use of radioisotopes is being made in the mutation breeding in obtaining the varieties resistant to certain diseases and pests. Nirale and Gour (1973) found that there is an average 50 percent increase in yield of chilli, onion and lettuse, with low doses of x-ray irradiation. radiotracers show that P and K are more rapidly absorbed through leaves than roots. This technique is useful in deciding economic use of fertilizers and micronutrients. The ultraviolet light inactivates some viruses in plants. The radiation processing of foods minimises the packing costs. (author)

Medical Isotope Production With The Accelerator Production of Tritium (APT) Facility

International Nuclear Information System (INIS)

Buckner, M.; Cappiello, M.; Pitcher, E.; O'Brien, H.

1998-01-01

In order to meet US tritium needs to maintain the nuclear weapons deterrent, the Department of Energy (DOE) is pursuing a dual track program to provide a new tritium source. A record of decision is planned for late in 1998 to select either the Accelerator Production of Tritium (APT) or the Commercial Light Water Reactor (CLWR) as the technology for new tritium production in the next century. To support this decision, an APT Project was undertaken to develop an accelerator design capable of producing 3 kg of tritium per year by 2007 (START I requirements). The Los Alamos National Laboratory (LANL) was selected to lead this effort with Burns and Roe Enterprises, Inc. (BREI) / General Atomics (GA) as the prime contractor for design, construction, and commissioning of the facility. If chosen in the downselect, the facility will be built at the Savannah River Site (SRS) and operated by the SRS Maintenance and Operations (M ampersand O) contractor, the Westinghouse Savannah River Company (WSRC), with long-term technology support from LANL. These three organizations (LANL, BREI/GA, and WSRC) are working together under the direction of the APT National Project Office which reports directly to the DOE Office of Accelerator Production which has program authority and responsibility for the APT Project

Radioisotope clocks in archaeology

Energy Technology Data Exchange (ETDEWEB)

Hedges, R E.M. [Oxford Univ. (UK). Research Lab. for Archaeology

1979-09-06

Methods of absolute dating which use the rate of disintegration of a radioactive nucleus as the clock, are reviewed. The use of the abundant radioisotopes (/sup 40/K, Th and U) and of the rare radioisotopes (/sup 14/C, /sup 10/Be, /sup 26/Al, /sup 32/Si, /sup 36/Cl, /sup 41/Ca, /sup 53/Mn) is discussed and radiation integration techniques (fission track dating, thermoluminescence and related techniques) are considered. Specific fields of use of the various methods and their accuracy are examined.

Uses of radioisotopes in Sudan

International Nuclear Information System (INIS)

Elradi, E. A. M.

2013-07-01

In this research project, an inventory for the different radioisotopes that were imported by public and private sectors of Sudan in the period between ( 2007-2011) has been set up. These organizations import the appropriates for different but in general we classify them into these applications: Medical, Industrial, Agricultural and Research. However, each broad discipline is subdivided into subgroups. This inventory will help those who are willing to establish research reactors in Sudan on the type and power of the reactors to be purchases according to the actual needs of Sudan with forecasting of the near and for future needs. Also the expenditure that has been spent by these organizations have been estimated for most of the radioisotopes. It was observed that almost 50% of the expenditure went for the fright charges as these radioisotopes need special handling and care by installing a research reactor in Sudan, the cost of purchasing will be cut down several folds. Also it will help in availability of the radioisotopes with very short half lives (hours to days). This will be reflected in the cut down the cost of tests and provision of new tests.(Author)

Production of neutrons in particle accelerators: a PNRI safety concern

International Nuclear Information System (INIS)

Garcia, Corazon M.; Cayabo, Lynette B.; Artificio, Thelma P.; Melendez, Johnylen V.; Piquero, Myrna E.; Parami, Vangeline K.

2002-09-01

In the safety assessment made for the first cyclotron facility in the Philippines, that is the cyclotron in the P.E.T. (Positron Emission Tomography) center of the St. Luke's Medical Center, the concern on the production of neutrons associated with the operation of particle accelerators has been identified. This takes into consideration the principles in the operation of particle accelerators and the associated production of neutrons resulting from their operation, the hazards and risks in their operation. The Bureau of Health Devices and Technology (BHDT) of the Department of Health in the Philippines regulates and controls the presently existing six (6) linear accelerators distributed in different hospitals in the country, being classified as x-ray producing devices. From the results of this study, it is evident that the production of neutrons from the operation of accelerators, produces neutrons and that activation due to neutrons can form radioactive materials. The PNRI (Philippine Nuclear Research Institute) being mandated by law to regulate and control any equipment or devices producing or utilizing radioactive materials should take the proper steps to subject all accelerator facilities and devices in the Philippines such as linear accelerators under its regulatory control in the same manner as it did with the first cyclotron in the country. (Author)

Utilization of radioisotopes in France, present and future

International Nuclear Information System (INIS)

Gauvenet, A.J.

1976-01-01

France is one of the countries having used radioisotopes very early. The first research reactor went critical in 1948, and has been used right from the start mainly to produce the radioisotopes for research and medicine. The growth in production was extremely fast, and the net receipts (excluding tax) amounted to F.52.3 million during 1974, of which F.20.9 million from export. The increase as compared with 1973 is 33%. The research and production facilities, which are concerned with medical applications, are in full expansion, Finally, the increasing use of trans-uranic elements, particularly of Pu-238 pacemakers, is noted. The uses of Cm-244 and Cf-252 are also growing. The problem at user level that undoubtedly requires the greatest attention is the regulations. The regulations on radioelements in France are reviewed in details on the following matters; poisonous substances, radioactive transport, waste, license for using artificial radioactive substances, etc. As the conclusion, the extremely ripid growth in the use of radioisotopes - mainly artificial ones - brought about the problems of adaptation with respect to the control and training regulations. One of the problems is obviously due to the fact that the personnel using such substances does not possess the specialization, training and managerial staff which marks the nuclear industry proper. It is therefore of prime significance to give unfailing attention to this use which is becoming the matter of major importance in France. The stress now placed on everything that concerns radiation has the great interest of forcing renewed awareness, thereby avoiding the degradation that the routine might bring. (Kobatake, H.)

General aspects of the cyclotrons and radiochemical separation of: 11 C, 15 O, 18 F and 14 N

International Nuclear Information System (INIS)

Alanis M, J.

1997-07-01

The particle accelerators, as the cyclotrons, are extraordinarily important as tools for the radioisotope production and its application in the area of the medicine. In this time, another method exists for the production of artificial radioisotopes, based on the irradiation of samples with alpha particles or with neutrons coming from a natural radioisotope being obtained a neutron source (Ra + Be, Rn + Be, Po + Be). However, its can be obtained a great quantity of radioisotopes by means of cyclotrons in very short time, compared with other methods. After the second world war, artificial radioisotopes took place by means of reactors and its had many applications, not only medical and in little time the accelerators were manufactured that were more indispensable that the reactors to produce radioisotopes with medical aims. For this reason, the accelerators, in few years became in machines very important for the production of artificial radioisotopes and consequently its were developed techniques of radioactive traces progressively more sophisticated, since it is evident that the production of radioactive nuclei through nuclear reactors its cannot satisfy all the demands. In general terms, only the neutrons can be used as nuclear projectiles in reactors and as a result, the production spectra of radioisotopes is limited and as alternative it is unavoidable that the cyclotrons are a good tool for this end. The use of a cyclotron to produce radioisotopes, it can be justified, only if the following conditions are completed. 1. If the radioisotopes of an element produced in a reactor don't favor with the nuclear properties for the purposes of the traced studies, for example: if the half life is very short or very big, if the decay system not to suit him. 2. If the wanted radioisotope cannot produce in the reactor with enough specific activity. (Author)

General aspects of the cyclotrons and radiochemical separation of: {sup 11} C, {sup 15} O, {sup 18} F and {sup 14} N; Aspectos generales de los ciclotrones y separacion radioquimica de {sup 11} C, {sup 15} O, {sup 18} F y {sup 14} N

Energy Technology Data Exchange (ETDEWEB)

Alanis M, J. [ININ, 52045 Ocoyoacac, Estado de Mexico (Mexico)

1997-07-15

The particle accelerators, as the cyclotrons, are extraordinarily important as tools for the radioisotope production and its application in the area of the medicine. In this time, another method exists for the production of artificial radioisotopes, based on the irradiation of samples with alpha particles or with neutrons coming from a natural radioisotope being obtained a neutron source (Ra + Be, Rn + Be, Po + Be). However, its can be obtained a great quantity of radioisotopes by means of cyclotrons in very short time, compared with other methods. After the second world war, artificial radioisotopes took place by means of reactors and its had many applications, not only medical and in little time the accelerators were manufactured that were more indispensable that the reactors to produce radioisotopes with medical aims. For this reason, the accelerators, in few years became in machines very important for the production of artificial radioisotopes and consequently its were developed techniques of radioactive traces progressively more sophisticated, since it is evident that the production of radioactive nuclei through nuclear reactors its cannot satisfy all the demands. In general terms, only the neutrons can be used as nuclear projectiles in reactors and as a result, the production spectra of radioisotopes is limited and as alternative it is unavoidable that the cyclotrons are a good tool for this end. The use of a cyclotron to produce radioisotopes, it can be justified, only if the following conditions are completed. 1. If the radioisotopes of an element produced in a reactor don't favor with the nuclear properties for the purposes of the traced studies, for example: if the half life is very short or very big, if the decay system not to suit him. 2. If the wanted radioisotope cannot produce in the reactor with enough specific activity. (Author)

Actual and future situations of the use of radioisotopes; Situacion actual y futura del empleo de radioisotopos

Energy Technology Data Exchange (ETDEWEB)

Paredes G, L C [ININ, 52045 Ocoyoacac, Estado de Mexico (Mexico)

2005-07-01

It is anticipated to medium term, an increase in the demand of the radioisotopes for medicine, industry and research, as well as the application of new radioisotopes derived from the development of new radiopharmaceuticals products for diagnosis and therapy applications. The personal and clinical dosimetry will have to be prepared for the new challenges. (Author)

Preliminary estimation of the dose rates of the operation room of the RPR radioisotope cell

International Nuclear Information System (INIS)

Rocha, A.C.S.; Silva, J.J.G.; Pina, J.L.S. de; Fajardo, P.W.

1986-07-01

During the preliminary studies, about the installations layout of a radioisotope production reactor, the possibility of construction of a radioisotope cell at the reactor building has been investigated. The decisions about that construction has considered mainly the level of the radiation dose over the cell operator. The dose rate has been calculated based on: neutron flux and gamma radiation from fission products and activation materials inside the reactor; volatile fission products such as noble gases and iodides; tritium form ternary fission. The objective was calculate the radiation dose over the cell operator during a journey of 8 hours of work per day. For those calculations some data have been obtained from the Angra-3 reactor. (author)

Accelerated approval of oncology products: the food and drug administration experience.

Science.gov (United States)

Johnson, John R; Ning, Yang-Min; Farrell, Ann; Justice, Robert; Keegan, Patricia; Pazdur, Richard

2011-04-20

We reviewed the regulatory history of the accelerated approval process and the US Food and Drug Administration (FDA) experience with accelerated approval of oncology products from its initiation in December 11, 1992, to July 1, 2010. The accelerated approval regulations allowed accelerated approval of products to treat serious or life-threatening diseases based on surrogate endpoints that are reasonably likely to predict clinical benefit. Failure to complete postapproval trials to confirm clinical benefit with due diligence could result in removal of the accelerated approval indication from the market. From December 11, 1992, to July 1, 2010, the FDA granted accelerated approval to 35 oncology products for 47 new indications. Clinical benefit was confirmed in postapproval trials for 26 of the 47 new indications, resulting in conversion to regular approval. The median time between accelerated approval and regular approval of oncology products was 3.9 years (range = 0.8-12.6 years) and the mean time was 4.7 years, representing a substantial time savings in terms of earlier availability of drugs to cancer patients. Three new indications did not show clinical benefit when confirmatory postapproval trials were completed and were subsequently removed from the market or had restricted distribution plans implemented. Confirmatory trials were not completed for 14 new indications. The five longest intervals from receipt of accelerated approval to July 1, 2010, without completion of trials to confirm clinical benefit were 10.5, 6.4, 5.5, 5.5, and 4.7 years. The five longest intervals between accelerated approval and successful conversion to regular approval were 12.6, 9.7, 8.1, 7.5, and 7.4 years. Trials to confirm clinical benefit should be part of the drug development plan and should be in progress at the time of an application seeking accelerated approval to prevent an ineffective drug from remaining on the market for an unacceptable time.

Radiopharmaceuticals in positron emission tomography: Radioisotope productions and radiolabelling procedures at the Austin and Repatriation Medical Centre

International Nuclear Information System (INIS)

Tochon-Danguy, H.J.; Sachinidis, J.I.; Chan, J.G.; Cook, M.

1997-01-01

Positron Emission Tomography (PET) is a technique that utilizes positron-emitting radiopharmaceuticals to map the physiology, biochemistry and pharmacology of the human body. Positron-emitting radioisotopes produced in a medical cyclotron are incorporated into compounds that are biologically active in the body. A scanner measures radioactivity emitted from a patient's body and provides cross-sectional images of the distribution of these radiolabelled compounds in the body. It is the purpose of this paper to review the variety of PET radiopharmaceuticals currently produced at the Austin and Repatriation Medical Centre in Melbourne. Radioisotope production, radiolabelling of molecules and quality control of radiopharmaceuticals will be discussed. A few examples of their clinical applications will be shown as well. During the last five years we achieved a reliable routine production of various radiopharmaceuticals labelled with the four most important positron-emitters: oxygen-15 (t, 1/2 =2min), nitrogen-13 (t 1/2 = 10 min), carbon-11 (t 1/2 =20 min) and fluorine-18 (t 1/2 = 110 min). These radiopharmaceuticals include [ 15 O]oxygen, [ 15 O]carbon monoxide, [ 15 O]carbon dioxide, [ 15 O]water, [ 13 N]ammonia, [ 11 C]flumazenil, [ 11 C]SCH23390, [ 18 F]fluoromisonidazole and [ 18 F]fluoro-deoxy-glucose ([ 18 F]FDG). In addition, since the half life of [ 18 F] is almost two hours, regional distribution can be done, and the Austin and Repatriation Medical Centre is currently supplying [ 18 F]FDG in routine to other hospitals. Future new radiopharmaceuticals development include a [ 18 F]thymidine analog to measure cell proliferation and a [ 11 C]pyrroloisoquinoline to visualize serotonergic neuron abnormalities. (authors)

Novel Radioisotope Applications in Industry Promoted by the IAEA

International Nuclear Information System (INIS)

Thereska, J.

2001-01-01

Presently, there is a lively activity in further development and use of radioisotope technology. Novel radioisotope applications in industry are promoted by the IAEA. Radioisotope technology is contributing significantly to improving and optimising process performance bringing an annual economic benefit to world-wide industry of several billion US$. Probably, an average benefit to cost ratio of 40:1 is reasonably representative of radioisotope applications in industry. There are few short-term investments, which will give a return of this magnitude. The cost effectiveness of radioisotope applications should be widely promulgated to encourage industrialists to take full advantage of the technology. (author)

Impurity production and acceleration in CTIX

Energy Technology Data Exchange (ETDEWEB)

Buchenauer, D. [Sandia National Laboratories, MS-9161, P.O. Box 969, Livermore, CA 94550 (United States)], E-mail: dabuche@sandia.gov; Clift, W.M. [Sandia National Laboratories, MS-9161, P.O. Box 969, Livermore, CA 94550 (United States); Klauser, R.; Horton, R.D. [CTIX Group, University of California at Davis, Davis, CA 95616 (United States); Howard, S.J. [General Fusion Inc., Burnaby, BC V5A 3H4 (Canada); Brockington, S.J. [HyperV Technologies Corp., Chantilly, VA 20151 (United States); Evans, R.W.; Hwang, D.Q. [CTIX Group, University of California at Davis, Davis, CA 95616 (United States)

2009-06-15

The Compact Toroid Injection Experiment (CTIX) produces a high density, high velocity hydrogen plasma that maintains its configuration in free space on a MHD resistive time scale. In order to study the production and acceleration of impurities in the injector, several sets of silicon collector probes were exposed to spheromak-like CT's exiting the accelerator. Elemental analysis by Auger Electron Spectroscopy indicated the presence of O, Al, Fe, and Cu in films up to 200 A thickness (1000 CT interactions). Using a smaller number of CT interactions (10-20), implantation of Fe and Cu was measured by Auger depth profiling. The amount of impurities was found to increase with accelerating voltage and number of CT interactions while use of a solenoidal field reduced the amount. Comparison of the implanted Fe and Cu with TRIM simulations indicated that the impurities were traveling more slowly than the hydrogen CT.

Facilities for Research and Development of Medical Radioisotopes

International Nuclear Information System (INIS)

Shin, Byung Chul; Choung, Won Myung; Park, Jin Ho

2003-03-01

This study is carried out by KAERI(Korea Atomic Energy Research Institute) to construct the basic facilities for development and production of medical radioisotope. For the characteristics of radiopharmaceuticals, the facilities should be complied with the radiation shield and GMP(Good Manufacturing Practice) guideline. The KAERI, which has carried out the research and development of the radiopharmaceuticals, made a design of these facilities and built them in the HANARO Center and opened the technique and facilities to the public to give a foundation for research and development of the radiopharmaceuticals. In the facilities, radiation shielding utilities and GMP instruments were set up and their operating manuals were documented. Every utilities and instruments were performed the test to confirm their efficiency and the approval for use of the facilities will be achieved from MOST(Ministry of Science and Technology). It is expected to be applied in development of therapeutic radioisotope such as Re-188 generator and Ho-166, as well as Tc-99m generator and Sr-89 chloride for medical use. And it also looks forward to the contribution to the related industry through the development of product in high demand and value

Application of accelerator mass spectrometry in nuclear science

International Nuclear Information System (INIS)

Wang Xiaobo; Hu Jinjun; Wang Huijuan; Guan Yongjing; Wang Wei

2013-01-01

Accelerator mass spectrometry (AMS) is a promising method to provide extreme sensitivity measurements of the production yields of long-lived radioisotopes, which cannot be detected by other methods. AMS technique plays an important role in the research of nuclear physics, as well as the application field of AMS covered nuclear science and technology, life science, earth science, environmental science, archaeology etc. The newest AMS field is that of actinide, particularly U and Pu, isotopic assay with expanding applications in nuclear safeguards and monitoring, and as a modern bomb-fallout tracer for atmospheric transport and surface sediment movement. This paper reviews the applications of AMS in the research of nuclear energy and nuclear security including the research of half life of radionuclides, cross section of nuclear reaction. (authors)

Radioisotopes in soil science

International Nuclear Information System (INIS)

Kotur, S.C.

2004-01-01

Soils form a thin veneer of the Earth that sustain the entire flora and fauna of the terra firma. To that extent the soil as a natural resource is very precious and needs to be managed in a sustainable manner. The fate of degradation of pesticides in soil and build-up of heavy metals in the overall biosafety scenario is also studied gainfully using radioisotopes. Radioisotopes are a very potent tool in the hands of the Soil Scientists, perhaps, the most important among the peaceful applications in service of the mankind

''Small'' accelerator, radionuclide and radiopharmaceutical production

International Nuclear Information System (INIS)

Ruth, T.J.; Wolf, A.P.

1978-01-01

The scope of this discussion is limited to the proton/deuteron accelerators capable of producing the positron emitting isotopes carbon-11, nitrogen-13, oxygen-15, and fluorine-18. Attention is focussed on the production process from the selection of the target gas to the synthesis of the desired radiopharamaceutical

Radioisotopic diagnosis in pediatrics. Radioizotopnaya diagnostika v pediatrii

Energy Technology Data Exchange (ETDEWEB)

Zubovskij, G A

1983-01-01

The material concerning the possibilities of modern radiodiagnostic methods in the practice of pediatric cardiology, pulmonology, uronephrology, gastroentorology, osteology, endocrinology and perinatology is presented. The data on techniques for production of radiopharmaceuticals, radiation loads on child and personnel and the rules of radiation safety are given. The value and the place of radioisotopic diagnosis in the complex of clinicoroentgenologic and instrumental investigations in pediatrics are based.

Does new product growth accelerate across technology generations?

NARCIS (Netherlands)

S. Stremersch (Stefan); E. Muller (Erwin); R. Peres (Renana)

2010-01-01

textabstractThe academic literature on the growth acceleration of new products presents a paradox. On the one hand, the diffusion literature concludes that more recently introduced products show faster diffusion than older ones. On the other hand, technology generation literature argues that growth

Economical Radioisotope Power

Data.gov (United States)

National Aeronautics and Space Administration — Almost all robotic space exploration missions and all Apollo missions to the moon used Radioisotopic Thermoelectric Generators (RTGs) to provide electrical power to...

Transmutation of fission products in reactors and accelerator-driven systems

International Nuclear Information System (INIS)

Janssen, A.J.

1994-01-01

Energy flows and mass flows in several scenarios are considered. Economical and safety aspects of the transmutation scenarios are compared. It is difficult to find a sound motivation for the transmutation of fission products with accelerator-driven systems. If there would be any hesitation in transmuting fission products in nuclear reactors, there would be an even stronger hesitation to use accelerator-driven systems, mainly because of their lower energy efficiency and their poor cost effectiveness. The use of accelerator-driven systems could become a 'meaningful' option only if nuclear energy would be banished completely. (orig./HP)

Regulations concerning the radionuclides uses in France; Reglementation de l'utilisation des radioisotopes en France

Energy Technology Data Exchange (ETDEWEB)

Vergne, J. [Commissariat a l' Energie Atomique, Saclay (France). Centre d' Etudes Nucleaires; Bugnard, L. [Institut national d' Hygiene (France)

1955-07-01

The progress in the uses of radioisotopes has been conditioned by increasing the number of trained workers and researchers and developing theoretical teaching in universities since 1950 in France as well as developing a national control of the distribution and uses of radioisotopes. With the large diffusion and development of radioisotopes uses and applications, new rules and regulations came to control the importation, exportation, transport and utilization of radioisotopes. In the first part, it described the different French laws since 1934 and their successive modifications which ruled on the production, manipulation and utilization of radioisotopes. An inter-ministerial committee was created in 1952 to advise and inform of all the questions related to the preparation, importation, exportation, possession and distribution of radioisotopes. The transport regulations are in constant evolution and has got to meet with international recommendations. It distinguished three different type of transport: road, river and railway transport, postal transport and finally air transport. All the different transports have their specific packaging, maximum transportable quantity, maximum material intensity and labelling requirements. The regulations about customs duties are specified as well as the administrative formalities for non natural radioisotopes importation. Since 1950, diseases caused by irradiation to natural or artificial radioactive materials are recognised as professional diseases and a table of the actual regulations is presented. (M.P.)

Accelerator mass spectrometry programme at BARC-TIFR pelletron accelerator. PD-1-2

International Nuclear Information System (INIS)

Bhagwat, P.V.

2007-01-01

Accelerator mass spectrometry (AMS) is an ultra sensitive means of counting individual atoms having sufficiently long half-life and available in small amount. The 14 UD Pelletron Accelerator is an ideal machine to carry out AMS studies with heavy isotopes like 36 Cl and 129 I. Cosmogenic radioisotope 36 Cl is widely being detected using AMS as it has got applications in ground water research, radioactive waste management, atmospheric 36 Cl transport mechanism studies of Arctic Alpine ice core etc . The AMS programme at the 14 UD Mumbai Pelletron Accelerator has taken off with the installation of the state of the art Terminal Potential Stabilizer setup and operation of the accelerator in Generating Volt Meter (GVM) mode. Feasibility studies have been carried out for detection/identification of 14 C from a charcoal sample and 3 He in natural Helium. As the primary interest of AMS programme at Mumbai Pelletron Accelerator is related to the cosmogenic nuclei, 36 Cl and 129 I, a segmented gas detector developed for identification of 36 Cl was tested for performance. Recently a beam chopper required for this measurement has also been developed

Materials considerations in accelerator targets

International Nuclear Information System (INIS)

Peacock, H.B. Jr.; Iyer, N.C.; Louthan, M.R. Jr.

1994-01-01

Future nuclear materials production and/or the burn-up of long lived radioisotopes may be accomplished through the capture of spallation produced neutrons in accelerators. Aluminum clad-lead and/or lead alloys has been proposed as a spallation target. Aluminum was the cladding choice because of the low neutron absorption cross section, fast radioactivity decay, high thermal conductivity, and excellent fabricability. Metallic lead and lead oxide powders were considered for the target core with the fabrication options being casting or powder metallurgy (PM). Scoping tests to evaluate gravity casting, squeeze casting, and casting and swaging processes showed that, based on fabricability and heat transfer considerations, squeeze casting was the preferred option for manufacture of targets with initial core cladding contact. Thousands of aluminum clad aluminum-lithium alloy core targets and control rods for tritium production have been fabricated by coextrusion processes and successfully irradiated in the SRS reactors. Tritium retention in, and release from the coextruded product was modeled from experimental and operational data. Newly produced tritium atoms were trapped by lithium atoms to form a lithium tritide. The effective tritium pressure required for trap or tritide stability was the equilibrium decomposition pressure of tritium over a lithium tritide-aluminum mixture. The temperature dependence of tritium release was determined by the permeability of the cladding to tritium and the local equilibrium at the trap sites. The model can be used to calculate tritium release from aluminum clad, aluminum-lithium alloy targets during postulated accelerator operational and accident conditions. This paper describes the manufacturing technologies evaluated and presents the model for tritium retention in aluminum clad, aluminum-lithium alloy tritium production targets

Productivity of a nuclear chemical reactor with gamma radioisotopic sources

International Nuclear Information System (INIS)

Anguis T, C.

1975-01-01

According to an established mathematical model of successive Compton interaction processes the made calculations for major distances are extended checking the acceptability of the spheric geometry model for the experimental data for radioisotopic sources of Co-60 and Cs-137. Parameters such as the increasing factor and the absorbed dose served as comparative base. calculations for the case of a punctual source succession inside a determined volume cylinder are made to obtain the total dose, the deposited energy by each photons energetic group and the total absorbed energy inside the reactor. Varying adequately the height/radius relation for different cylinders, the distinct energy depositions are compared in each one of them once a time standardized toward a standard value of energy emitted by the reactor volume. A relation between the quantity of deposited energy in each point of the reactor and the conversion values of chemical species is established. They are induced by electromagnetic radiation and that are reported as ''G'' in the scientific literature (number of molecules formed or disappeared by each 100 e.v. of energy). Once obtained the molecular performance inside the reactor for each type of geometry, it is optimized the height/radius relation according to the maximum production of molecules by unity of time. It is completed a bibliographical review of ''G'' values reported by different types of aqueous solutions with the purpose to determine the maximum performance of molecular hydrogen as a function of pH of the solution and of the used type of solute among other factors. Calculations for the ethyl bromide production as an example of one of the industrial processes which actually work using the gamma radiation as reactions inductor are realized. (Author)

Production of radioisotopes at the Boris Kidric Institute of Nuclear Sciences at Vinca, Yugoslavia; Proizvodnja radioaktivnih izotopa

Energy Technology Data Exchange (ETDEWEB)

Teofilovski, C [Institute of Nuclear Sciences Boris Kidric, Vinca, Beograd (Serbia and Montenegro)

1969-07-01

The investigations in order to master the production of radioisotopes were commenced simultaneously with the beginning of RA nuclear reactor construction at Vinca, in 1956. A new organization division - Laboratory for chemistry of high activity accepting beside other problems also the programme for mastering the regular production of radioactive material was formed in 1959. Various problems during the realization of this programme have been solved, starting with the staff training for work with radioactive material on the high level activity (to 7500 Ci/source), construction and equipment of the laboratory area for safe work, up to development of the whole series of chemical-technological procedures and techniques for regular production of various radioactive products, as well as the methods for their chemical, radiometric and pharmaceutical control. Owing to the successful realization of this programme, the Institute 'Boris Kidric' supplies to-day regularly 110 organizations in the country with various radioactive products, applied in medicine, industry and research. The annual product of the radioactive solutions of radioisotopes J-131, Au-198, P-32, S-35 etc., amounts to about 75 Ci, radiographic sources Ir-192 and Co-60 to 2000 Ci and Co-60 sources for teletherapy and the other applications to many thousand curies (author) [Serbo-Croat] Paralelno sa pocetkom izgradnje nuklearnog reaktora RA u Vinci 1956. godine zapoceta su istrazivanja u oblasti osvajanja proizvodnje radioizotopa. 1958. god. formirana je nova organizaciona jedinica - Laboratorija za hemiju visoke aktivnosti, koja je, pored ostalog, prihvatila i program osvajanja redovne proizvodnje radioaktivnog materijala. U toku realizacije programa reseni su raznovrsni problemi pocev od pripreme kadrova za rad sa radioaktivnim materijalom na visokom nivou aktivnosti (do 7500 Ci/izvor), izgradnje i opremanja laboratorijskog prostora za bezbedan rad, do razvoja citavog niza hemijsko-tehnoloskih postupaka i

Development of circular protons accelerator for ocular teletherapy

International Nuclear Information System (INIS)

Rabelo, L. A.; Campos, T.P.R.

2011-01-01

The proton therapy has been used for ocular tumors providing tumor control in most cases and vision preservations. The protons show high doses in depth depict lower scattering from beam than other particles, electrons and photons. The cyclotron is a type of accelerator that increases the kinetic energy of the charged particle, recirculating it on a magnetic field and crossing an accelerating electrical field. It can be used to produce radioisotopes to hospitals. The goal of this study is to investigate a unit of circular accelerator to be coupled in existing national cyclotrons to generate a proton beams suitable to ocular therapy. Herein, physical parameters are evaluable, including relativistic corrections. That result shows the viability of developing an accelerator unit to ocular proton therapy. (author)

Industrial applications of radioisotope tracers

International Nuclear Information System (INIS)

Easey, J.F.

1985-01-01

Radioisotope tracing techniques are powerful tools for analysing the behaviour of large systems and investigating industrially or economically important processes. The results of radioisotope experiments can yield important information, for example, on parameters such as flow rates, mixing phenomena, flow abnormalities and leaks. Some examples of current AAEC research are described, covering studies on hearth drainage in blast furnaces, flow behaviour in waste-water treatment ponds, and sediment transport in marine environments

Reflections on the juridical implications of the medical use of radiations and radioisotope

International Nuclear Information System (INIS)

Campos, Ana Celia P.P.; Cuperschmid, Ethel Mizrahy; Campos, Tarcisio P. Ribeiro de

2007-01-01

The pacific use of radiation and radioisotopes for the society presents radiological risks, due its capacity to produce damage to environmental and human being, contrasting with its high economic and social benefits. In the face of the risk, juridical system leans over to reach the required regulations that implies in the balance between human and environmental security and the expected improvements of the medical nuclear techniques. The Brazilian Constitution of 1988 tries to provide the normalization for the application of the nuclear energy and its radioisotopes. However, target as a strategically technology and due to its expansion, its regulations still deserves analyses and reflections. The present paper starts from the Constitution presenting the references about the theme and analyzing it. It is addressed the principle of the objective civil responsibility making analyses on the use of radiations and radioisotope on the medicine. It addresses the role of federal autonomy related to the 'MCT - Ministerio de Ciencia e Tecnologia' with its accumulative functions in society, such as scientific and technologic development, education, and its own focalization. The recent opening of the monopoly for the production of radioisotopes for very short half-lives is also discussed. It makes a comparison between juridical aspects of Brazil with international system. The present article contributes to open same topics of discussions on the Brazilian juridical aspects involving radiations and radioisotopes application on medicine. (author)

Reflections on the juridical implications of the medical use of radiations and radioisotope

Energy Technology Data Exchange (ETDEWEB)

Campos, Ana Celia P.P. [Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG (Brazil). Faculdade de Direito]. E-mails: anaceu2000@yahoo.com.br; Cuperschmid, Ethel Mizrahy [Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG (Brazil). Centro de Memoria da Medicina - CEMMOR]. E-mail: ethel.mizrahy@yahoo.com; Campos, Tarcisio P. Ribeiro de [Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG (Brazil). Programa de Pos-graduacao em Ciencias e Tecnicas Nucleares]. E-mail: campos@nuclear.ufmg.br

2007-07-01

The pacific use of radiation and radioisotopes for the society presents radiological risks, due its capacity to produce damage to environmental and human being, contrasting with its high economic and social benefits. In the face of the risk, juridical system leans over to reach the required regulations that implies in the balance between human and environmental security and the expected improvements of the medical nuclear techniques. The Brazilian Constitution of 1988 tries to provide the normalization for the application of the nuclear energy and its radioisotopes. However, target as a strategically technology and due to its expansion, its regulations still deserves analyses and reflections. The present paper starts from the Constitution presenting the references about the theme and analyzing it. It is addressed the principle of the objective civil responsibility making analyses on the use of radiations and radioisotope on the medicine. It addresses the role of federal autonomy related to the 'MCT - Ministerio de Ciencia e Tecnologia' with its accumulative functions in society, such as scientific and technologic development, education, and its own focalization. The recent opening of the monopoly for the production of radioisotopes for very short half-lives is also discussed. It makes a comparison between juridical aspects of Brazil with international system. The present article contributes to open same topics of discussions on the Brazilian juridical aspects involving radiations and radioisotopes application on medicine. (author)

Assessment of radioisotope heaters for remote terrestrial applications

International Nuclear Information System (INIS)

Uherka, K.L.

1987-05-01

This paper examines the feasibility of using radioisotope byproducts for special heating applications at remote sites in Alaska and other cold regions. The investigation included assessment of candidate radioisotope materials for heater applications, identification of the most promising cold region applications, evaluation of key technical issues and implementation constraints, and development of conceptual heater designs for candidate applications. Strontium-90 (Sr-90) was selected as the most viable fuel for radioisotopic heaters used in terrestrial applications. Opportunities for the application of radioisotopic heaters were determined through site visits to representative Alaska installations. Candidate heater applications included water storage tanks, sludge digesters, sewage lagoons, water piping systems, well-head pumping stations, emergency shelters, and fuel storage tank deicers. Radioisotopic heaters for water storage tank freeze-up protection and for enhancement of biological waste treatment processes at remote sites were selected as the most promising applications

Assessment of the radiological control at the IPEN radioisotope production facility

International Nuclear Information System (INIS)

Carneiro, Janete C.G.G.; Sanches, Matias P.; Rodrigues, Demerval L.; Campos, Daniela; Nogueira, Paulo R.; Damato, Sandra R.; Pecequilo, Brigitte R.

2014-01-01

The main objective of this work is to evaluate the 2013 annual radiological control results in the radiopharmaceuticals areas of the Instituto de Pesquisas Energeticas e Nucleares, IPEN/SP, and the environmental radiological impact, resulting from the practices there performed. The current evaluation was performed through the analysis of the results obtained from occupational and environmental monitoring with air samplers and TL dosimeters. All monitoring results were compared with the limits established by national standards. The radionuclides detected by air sampling (in charcoal and paper filters) at the workplace during radioisotope production were 131 I, 99m Tc and 99 Mo, with activities concentrations values below the annual limits values. For the radioactive gaseous releases (Bq/m 3 ), the activities concentrations also remained below the maximum permissible values, excepting to 125 I release due to an unusual event occurred in a researcher laboratory, but the radiological impact to environmental was no significant. The occupational monitoring assessment was confirmed by the Environmental Radiological Monitoring Program results with air samplers and TL dosimeters. The mean annual background radiation at IPEN in 2013, according to the Environmental Radiological Monitoring Program results was 1.06 mSv. y -1 , below the ICRP 103 recommended limit of 20 mSv.y -1 for workers. (author)

A set of portable radioisotopic control and measuring instruments

International Nuclear Information System (INIS)

Pospeev, V.V.; Sidorov, V.N.; Tesnavs, Eh.R.; Uleksin, V.I.

1979-01-01

The problems and perspectives are examined of the portable radioisotope instruments application in agriculture, building industry, engeeniring and geological survay and in melioration. Principles are given of creation a series of radioisotopic instruments based on the principle of ganging. The series described consists of radioisotopic densimeters and moisture gages of the portable type, based on the ganging principle. The instruments differ in the measuring converters and have unified information processing and power supply devices. Criteria are stated for the ganging principle estimation, in particular, estimation of the technical means' compatibility. Four different types of compatibility are distinguished: an information compatibility; a metrological compatibility; structural and operational compatibility. Description is given of the unified information processing device - the unified pulse counter of the SIP-1M type and description of a row of radioisotopic measuring converters, which provides a possibility for completing the portable radioisotope densimeter of the RPP-2 type, intended for measuring densities of concrets and soils in the surface layer up to 30 cm and the density range from 1000 to 2500 kg/m 3 ; portable radioisotope densimeter of the RPP-1 type having measuring range from 600 to 1500 kg/m 3 ; surface-depth radioisotopic densimeter of the PPGR-1 type and surface-depth radioisotopic moisture gage of the VPGR-1 type [ru

Radioisotopic indicators in microbiology

International Nuclear Information System (INIS)

Isamov, N.N.

1976-01-01

The book comprises data obtained by the laboratory of radiobiology (Uzbek Research Veterinary Institute) for 15 years and sums up data of domestic and foreign scientists; it discusses problems of the utilization of radioactive isotopes of sulphur, cadmium, phosphorus and other chemical elements by microorganisms; indicates the specificity of the utilization of radioisotopes in microbiology. The influence is considered of external factors on the inclusion of radioisotopes into microorganisms, methods are discussed of obtaining labelled microorganisms and their antigens, radioactivity of bacteria is considered as affected by the consistency and composition of the nutritive medium and other problems

Synthesis and granulation of a titanosilicate with adsorption capacity for Cs to be used for treating de ILLW of the Ezeiza Radioisotope Production Plant

International Nuclear Information System (INIS)

Curi, Rodrigo; Bianchi, Hugo L; Luca, Vittorio

2012-01-01

The sitinakite structured titanosilicate is widely used for treating ILLW thanks to its capacity for adsorbing both Cs-137 and Sr-90. Its effectiveness lies in its incredibly high selectivity for such radioisotopes, which makes it useful in complex isotope solutions and even in strong acid and alkaline conditions. In Argentina, an off-the-shelve titanosilicate was used in Ezeiza's radioisotope production plant. Because of commercial restrictions, it is no longer available so an inhouse production is being developed. The aim of this project consists of the following: 1. Synthesis of titanosilicate and structural characterization 2. Adsorption kinetics of Cs + 3. Upscale of the synthesis process 4. Assessment of the influence of synthesis temperature and time on product crystallinity 5. Measurement of adsorption capacity of commercial titanosilicates IE910, IE911 and novel RC15H 6. Separative performance column essay and breakthrough plot 7. Chemical and radiolysis resistance of the adsorbent powder binder Polyacrylonitrile (PAN) in contact with the actual waste Throughout this work we have studied the optimum synthesis conditions capable of rendering a sitinakite structured titanosilicate, assessed its Cs + adsorption kinetics, adsorption capacity, crystal phase and purity via DRX, particle size with Laser Light Scattering technique. We have also conducted column breakthrough experiments and tried the chemical and radiolysis resistance of the final product (author)

Production of radionuclides and preparation of labelled compounds. Nuclear chemical technology

International Nuclear Information System (INIS)

Anon.

1976-01-01

A general review is presented of methods of producing radionuclide preparations and labelled compounds, such as their production from natural raw materials, from a nuclear reactor, a particle accelerator, and using radioisotope generators. Also described are the fundamental kinetic relations of nuclear reactions. Basic methods are surveyed of obtaining labelled compounds by chemical synthesis, biosynthesis, exchange reactions, recoil reactions, by the Wilzbach method and the Szillard-Chalmers reaction. (L.K.)

Computerized control system for administration of the radioisotope use

International Nuclear Information System (INIS)

Sago, Tsutomu; Ito, Shin; Isozumi, Yasuhito; Kurihara, Norio

1986-01-01

An on-line computer system for administration of the radioisotope use has been developed. This system consists of a multi-job type host computer and two sets of personal computers with identification card-readers. The personal computers are employed as terminal devices for radioisotope users. By the use of an identification card, entrance and leaving times are recorded automatically. Furthermore, an easy operation of the personal computer permits users to access to the information of their resistered radioisotopes, such as nuclides, chemical forms, updated activities, storage locations, and history of usage. A recording sheet on which those data are printed is provided from the personal computer. After the use of radioisotopes, users can record their data on the recording sheets. These records are used as the input data to this system to update the data of the used radioisotopes. Owing to the concise format of the recording sheet and various sorting programs developed in present work, this system enables us to grasp the exact flow of the radioisotopes from purchase to disposal. Out-put data from high-speed kanji printer can provide many important books which are legally requested to be kept for administration of the radioisotope use. (author)

Radiopharmaceuticals in positron emission tomography: Radioisotope productions and radiolabelling procedures at the Austin and Repatriation Medical Centre

Energy Technology Data Exchange (ETDEWEB)

Tochon-Danguy, H.J.; Sachinidis, J.I.; Chan, J.G.; Cook, M. [Austin and Repatriation Medical Centre, Melbourne, VIC (Australia). Centre for Positron Emission Tomography

1997-10-01

Positron Emission Tomography (PET) is a technique that utilizes positron-emitting radiopharmaceuticals to map the physiology, biochemistry and pharmacology of the human body. Positron-emitting radioisotopes produced in a medical cyclotron are incorporated into compounds that are biologically active in the body. A scanner measures radioactivity emitted from a patient`s body and provides cross-sectional images of the distribution of these radiolabelled compounds in the body. It is the purpose of this paper to review the variety of PET radiopharmaceuticals currently produced at the Austin and Repatriation Medical Centre in Melbourne. Radioisotope production, radiolabelling of molecules and quality control of radiopharmaceuticals will be discussed. A few examples of their clinical applications will be shown as well. During the last five years we achieved a reliable routine production of various radiopharmaceuticals labelled with the four most important positron-emitters: oxygen-15 (t,{sub 1/2}=2min), nitrogen-13 (t{sub 1/2}= 10 min), carbon-11 (t{sub 1/2}=20 min) and fluorine-18 (t{sub 1/2}= 110 min). These radiopharmaceuticals include [{sup 15}O]oxygen, [{sup 15}O]carbon monoxide, [{sup 15}O]carbon dioxide, [{sup 15}O]water, [{sup 13}N]ammonia, [{sup 11}C]flumazenil, [{sup 11}C]SCH23390, [{sup 18}F]fluoromisonidazole and [{sup 18}F]fluoro-deoxy-glucose ([{sup 18}F]FDG). In addition, since the half life of [{sup 18}F] is almost two hours, regional distribution can be done, and the Austin and Repatriation Medical Centre is currently supplying [{sup 18}F]FDG in routine to other hospitals. Future new radiopharmaceuticals development include a [{sup 18}F]thymidine analog to measure cell proliferation and a [{sup 11}C]pyrroloisoquinoline to visualize serotonergic neuron abnormalities. (authors) 23 refs., 2 tabs.

Integro-differential equation analysis and radioisotope imaging systems. Research proposal. [Testing of radioisotope imaging system in phantoms

Energy Technology Data Exchange (ETDEWEB)

Hart, H.

1976-03-09

Design modifications of a five-probe focusing collimator coincidence radioisotope scanning system are described. Clinical applications of the system were tested in phantoms using radioisotopes with short biological half-lives, including /sup 75/Se, /sup 192/Ir, /sup 43/K, /sup 130/I, and /sup 82/Br. Data processing methods are also described. (CH)

Intergrated approach to quality control procedures of radioisotopes and radiopharmaceuticals

International Nuclear Information System (INIS)

Rohani Mohamad

1986-01-01

Various aspects of the quality control procedures for radioisotopes and radiopharmaceuticals have been discussed. The paper high lighted those procedures that are important in ensuring the efficacy of the product. It also gives a general idea of the various procedures that are actually carried out by the Quality Control Section. (A.J.)

Radioisotope methodology course radioprotection aspects

International Nuclear Information System (INIS)

Bergoc, R.M.; Caro, R.A.; Menossi, C.A.

1996-01-01

The advancement knowledge in molecular and cell biology, biochemistry, medicine and pharmacology, which has taken place during the last 50 years, after World War II finalization, is really outstanding. It can be safely said that this fact is principally due to the application of radioisotope techniques. The research on metabolisms, biodistribution of pharmaceuticals, pharmacodynamics, etc., is mostly carried out by means of techniques employing radioactive materials. Radioisotopes and radiation are frequently used in medicine both as diagnostic and therapeutic tools. The radioimmunoanalysis is today a routine method in endocrinology and in general clinical medicine. The receptor determination and characterization is a steadily growing methodology used in clinical biochemistry, pharmacology and medicine. The use of radiopharmaceuticals and radiation of different origins, for therapeutic purposes, should not be overlooked. For these reasons, the importance to teach radioisotope methodology is steadily growing. This is principally the case for specialization at the post-graduate level but at the pre graduate curriculum it is worthwhile to give some elementary theoretical and practical notions on this subject. These observations are justified by a more than 30 years teaching experience at both levels at the School of Pharmacy and Biochemistry of the University of Buenos Aires, Argentina. In 1960 we began to teach Physics III, an obligatory pregraduate course for biochemistry students, in which some elementary notions of radioactivity and measurement techniques were given. Successive modifications of the biochemistry pregraduate curriculum incorporated radiochemistry as an elective subject and since 1978, radioisotope methodology, as obligatory subject for biochemistry students. This subject is given at the radioisotope laboratory during the first semester of each year and its objective is to provide theoretical and practical knowledge to the biochemistry students, even

Tritium production distribution in the accelerator production of tritium device

International Nuclear Information System (INIS)

Kidman, R.B.

1997-11-01

Helium-3 ( 3 He) gas is circulated throughout the accelerator production of tritium target/blanket (T/B) assembly to capture neutrons and convert 3 He to tritium. Because 3 He is very expensive, it is important to know the tritium producing effectiveness of 3 He at all points throughout the T/B. The purpose of this paper is to present estimates of the spatial distributions of tritium production, 3 He inventory, and the 3 He FOM

Radioisotope thermoelectric generator licensed hardware package and certification tests

International Nuclear Information System (INIS)

Goldmann, L.H.; Averette, H.S.

1994-01-01

This paper presents the Licensed Hardware package and the Certification Test portions of the Radioisotope Thermoelectric Generator Transportation System. This package has been designed to meet those portions of the Code of Federal Regulations (10 CFR 71) relating to ''Type B'' shipments of radioactive materials. The detailed information for the anticipated license is presented in the safety analysis report for packaging, which is now in process and undergoing necessary reviews. As part of the licensing process, a full-size Certification Test Article unit, which has modifications slightly different than the Licensed Hardware or production shipping units, is used for testing. Dimensional checks of the Certification Test Article were made at the manufacturing facility. Leak testing and drop testing were done at the 300 Area of the US Department of Energy's Hanford Site near Richland, Washington. The hardware includes independent double containments to prevent the environmental spread of 238 Pu, impact limiting devices to protect portions of the package from impacts, and thermal insulation to protect the seal areas from excess heat during accident conditions. The package also features electronic feed-throughs to monitor the Radioisotope Thermoelectric Generator's temperature inside the containment during the shipment cycle. This package is designed to safely dissipate the typical 4500 thermal watts produced in the largest Radioisotope Thermoelectric Generators. The package also contains provisions to ensure leak tightness when radioactive materials, such as a Radioisotope Thermoelectric Generator for the Cassini Mission, planned for 1997 by the National Aeronautics and Space Administration, are being prepared for shipment. These provisions include test ports used in conjunction with helium mass spectrometers to determine seal leakage rates of each containment during the assembly process

Elementary concepts of the radioisotopes uses

International Nuclear Information System (INIS)

Pisarev, Mario A.

2004-01-01

Endocrinology has been one of the specialties earlier benefited for the radioisotopes uses in the diagnosis and treatment of different affections. These applications are based on the radioisotopes property of biochemical behaving as non- radioactive molecules, and at the same time, radiations emitting that can be detected by suitable means (diagnostic utility) or that have effects on biological systems (therapeutic action). (author) [es

The SARAF Project - Soreq Applied Research Accelerator Facility

International Nuclear Information System (INIS)

Nagler, A.; Mardor, I.; Berkovits, D.; Piel, C.

2004-01-01

The relevance of particle accelerators to society, in the use of their primary and secondary beams for the analysis of physical, chemical and biological samples and for modification of properties of materials, is well recognized and documented. Nevertheless, apart of the construction of small accelerators for nuclear research in the 1960's and 70's, Israel has so far neglected this important and growing field. Furthermore, there is an urgent need in Israel for a state of the art research facility to attract and introduce students to current advanced physics techniques and technologies and to train the next generation of experimental scientists in various branches and disciplines. Therefore, Soreq NRC recently initiated the establishment of a new accelerator facility, named SARAF Soreq Applied Research Accelerator Facility. SARAF will be a continuous wave (CW), proton and deuteron RF superconducting linear accelerator with variable energy (5 - 40 MeV) and current (0.04 -2 mA). SARAF is designed to enable hands-on maintenance, which means that its beam loss will be below 10 -5 for the entire accelerator. These specifications will place SARAF in line with the next generation of accelerators world wide. Soreq expects that this fact will attract the Israeli and international research communities to use this facility extensively. Soreq NRC intends to use SARAF for basic, medical and biological research, and non-destructive testing (NDT). Another major activity will be the research and development of radio-isotopes production techniques. Given the availability of high current (up to 2 mA) protons and deuterons, a major activity will be research and development of high power density (up to 80 kW on a few cm 2 ) irradiation targets

Radioisotope-powered photovoltaic generator

International Nuclear Information System (INIS)

McKlveen, J.W.; Uselman, J.

1979-01-01

Disposing of radioactive wastes from nuclear power plants has become one of the most important issues facing the nuclear industry. In a new concept, called a radioisotope photovoltaic generator, a portion of this waste would be used in conjunction with a scintillation material to produce light, with subsequent conversion into electricity via photovoltaic cells. Three types of scintillators and two types of silicon cells were tested in six combinations using 32 P as the radioisotope. The highest system efficiency, determined to be 0.5% when the light intensity was normalized to 100 mW/cm 2 , was obtained using a CsI crystal scintillator and a Helios photovoltaic cell

Regulations of 1 March 1983 relating to production, imports and sales of radioisotopes

International Nuclear Information System (INIS)

1983-01-01

These regulations were issued by the Ministry of Health and Social Affairs, pursuant to the Act of 19th June 1938 on the use of radium and X-rays etc. The Regulations came into force on the date they were issued. They apply to radioisotopes used for industrial, commercial, agricultural, medical and scientific purposes. (NEA) [fr

Technology benefits resulting from accelerator production of tritium

International Nuclear Information System (INIS)

1998-01-01

One of the early and most dramatic uses of nuclear transformations was in development of the nuclear weapons that brought World War II to an end. Despite that difficult introduction, nuclear weapons technology has been used largely as a deterrent to war throughout the latter half of the twentieth century. The Accelerator Production of Tritium (APT) offers a clean, safe, and reliable means of producing the tritium (a heavy form of hydrogen) needed to maintain the nuclear deterrent. Tritium decays away naturally at a rate of about 5.5% per year; therefore, the tritium reservoirs in nuclear weapons must be periodically replenished. In recent years this has been accomplished by recycling tritium from weapons being retired from the stockpile. Although this strategy has served well since the last US tritium production reactor was shut down in 1988, a new tritium production capability will be required within ten years. Some benefits will result from direct utilization of some of the APT proton beam; others could result from advances in the technologies of particle accelerators and high power spallation targets. The APT may save thousands of lives through the production of medical isotopes, and it may contribute to solving the nation's problem in disposing of long-lived nuclear wastes. But the most significant benefit may come from advancing the technology, so that the great potential of accelerator applications can be realized during our lifetimes

Production of isometric forces during sustained acceleration.

Science.gov (United States)

Sand, D P; Girgenrath, M; Bock, O; Pongratz, H

2003-06-01

The operation of high-performance aircraft requires pilots to apply finely graded forces on controls. Since they are often exposed to high levels of acceleration in flight, we investigated to what extent this ability is degraded in such an environment. Twelve healthy non-pilot volunteers were seated in the gondola of a centrifuge and their performance was tested at normal gravity (1 G) and while exposed to sustained forces of 1.5 G and 3 G oriented from head to foot (+Gz). Using an isometric joystick, they attempted to produce force vectors with specific lengths and directions commanded in random order by a visual display. Acceleration had substantial effects on the magnitude of produced force. Compared with 1 G, maximum produced force was about 2 N higher at 1.5 G and about 10 N higher at 3 G. The size of this effect was constant across the different magnitudes, but varied with the direction of the prescribed force. Acceleration degrades control of force production. This finding may indicate that the motor system misinterprets the unusual gravitoinertial environment and/or that proprioceptive feedback is degraded due to increased muscle tone. The production of excessive isometric force could affect the safe operation of high-performance aircraft.

RADIOISOTOPE INVENTORY FOR TSPA-SR

International Nuclear Information System (INIS)

Leigh, C.; Rechard, R.

2001-01-01

The total system performance assessment for site recommendation (TSPA-SR), on Yucca Mountain, as a site (if suitable) for disposal of radioactive waste, consists of several models. The Waste Form Degradation Model (i.e, source term) of the TSPA-SR, in turn, consists of several components. The Inventory Component, discussed here, defines the inventory of 26 radioisotopes for three representative waste categories: (1) commercial spent nuclear fuel (CSNF), (2) US Department of Energy (DOE) spent nuclear fuel (DSNF), and (3) high-level waste (HLW). These three categories are contained and disposed of in two types of waste packages (WPs)--CSNF WPs and co-disposal WPs, with the latter containing both DSNF and HLW. Three topics are summarized in this paper: first, the transport of radioisotopes evaluated in the past; second, the development of the inventory for the two WP types; and third, the selection of the most important radioisotopes to track in TSPA-SR

National Biomedical Tracer Facility planning and feasibility study

Energy Technology Data Exchange (ETDEWEB)

Ketchem, L. (ed.); Holmes, R.A.

1991-03-02

Since its establishment in mid-1989, the DOE Office of Isotope Production and Distribution has examined the recommendations of the Los Alamos Report and the Health and Environmental Research Advisory Committee (HERAC) Report. The main recommendation from these deliberations is for the DOE to establish an accelerator dedicated to biomedical radioisotope production. Representatives of the nuclear medicine community, meeting at a DOE workshop in August 1988, evaluated present and future needs for accelerator-produced radioisotopes. Workshop participants concluded in the Los Alamos Report that approximately 90% of their radioisotope needs could be met by a machine that delivers a 70 million electronic volts (MeV), 500-microamp proton beam. The HERAC Report provides more quantification of radioisotope needs, and included isotopes that can be produced effectively only at higher energies. An accelerator facility with an upper energy limit of 100 MeV and beam current of 750 to 1,000 microamps, could produce all important accelerator- produced radioisotopes in current use, as well as those isotopes judged to have future potential value in medical research and clinical practice. We therefore recommend that the NBTF have a 100-MeV proton beam accelerator with an extracted beam current of 750 to 1,000 microamps.

National Biomedical Tracer Facility planning and feasibility study. Revision 1

Energy Technology Data Exchange (ETDEWEB)

Ketchem, L. [ed.; Holmes, R.A.

1991-03-02

Since its establishment in mid-1989, the DOE Office of Isotope Production and Distribution has examined the recommendations of the Los Alamos Report and the Health and Environmental Research Advisory Committee (HERAC) Report. The main recommendation from these deliberations is for the DOE to establish an accelerator dedicated to biomedical radioisotope production. Representatives of the nuclear medicine community, meeting at a DOE workshop in August 1988, evaluated present and future needs for accelerator-produced radioisotopes. Workshop participants concluded in the Los Alamos Report that approximately 90% of their radioisotope needs could be met by a machine that delivers a 70 million electronic volts (MeV), 500-microamp proton beam. The HERAC Report provides more quantification of radioisotope needs, and included isotopes that can be produced effectively only at higher energies. An accelerator facility with an upper energy limit of 100 MeV and beam current of 750 to 1,000 microamps, could produce all important accelerator- produced radioisotopes in current use, as well as those isotopes judged to have future potential value in medical research and clinical practice. We therefore recommend that the NBTF have a 100-MeV proton beam accelerator with an extracted beam current of 750 to 1,000 microamps.

National Biomedical Tracer Facility planning and feasibility study

International Nuclear Information System (INIS)

Ketchem, L.; Holmes, R.A.

1991-01-01

Since its establishment in mid-1989, the DOE Office of Isotope Production and Distribution has examined the recommendations of the Los Alamos Report and the Health and Environmental Research Advisory Committee (HERAC) Report. The main recommendation from these deliberations is for the DOE to establish an accelerator dedicated to biomedical radioisotope production. Representatives of the nuclear medicine community, meeting at a DOE workshop in August 1988, evaluated present and future needs for accelerator-produced radioisotopes. Workshop participants concluded in the Los Alamos Report that approximately 90% of their radioisotope needs could be met by a machine that delivers a 70 million electronic volts (MeV), 500-microamp proton beam. The HERAC Report provides more quantification of radioisotope needs, and included isotopes that can be produced effectively only at higher energies. An accelerator facility with an upper energy limit of 100 MeV and beam current of 750 to 1,000 microamps, could produce all important accelerator- produced radioisotopes in current use, as well as those isotopes judged to have future potential value in medical research and clinical practice. We therefore recommend that the NBTF have a 100-MeV proton beam accelerator with an extracted beam current of 750 to 1,000 microamps